[
  {
    "web-scraper-order": "1727319149-1",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5744",
    "stauts": "Correct",
    "question_title": "1.\n        A 23 year old female caught in a car fire was brought to the emergency room. She was conscious, oriented, pulse rate - 82 bpm and blood pressure - 130/70 mmHg. On further examination, her hard palate revealed blisters and the anterior nasal hair was burned. What is the next best step in the management of this patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Secure airway by endotracheal intubation \n                \n                  \n                    \nCorrect",
    "optionB": "B. Administer carbogen",
    "optionC": "C. Perform a cricothyroidotomy",
    "optionD": "D. Administer oxygen through bag and mask",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The next best step in the management of this patient is <strong>securing the airway by endotracheal intubation</strong>.(Option A)</p>\n<p>As the given clinical scenario of a female patient with <strong>stable vitals</strong> and examination findings of <strong>hard palate</strong> with <strong>blisters</strong> and <strong>anterior nasal hairs</strong> <strong>burned</strong> suggests a potential <strong>burned airway injury</strong> due to <strong>smoke</strong> or <strong>direct fire inhalation</strong>.&nbsp;</p>\n<p>In such cases, if the airway is not secured by a endotracheal tube immediately then complete occlusion of the airway due to laryngeal edema can occur rapidly. This will lead to difficult intubation at this stage and an <strong>emergency cricothyroidotomy</strong> is indicated. (Option C)</p>\n<p>Because of this, <strong>early intubation</strong> of suspected airway burn is the <strong>treatment of choice</strong> in such patients and the tube is&nbsp;left in place usually for about <strong>48 hours</strong> for the swelling to subside.</p>\n<p>The time frame from burns to airway occlusion is usually between 4 and 24 hours. Although antidotes exist to some specific components of smoke(carbon monoxide and cyanide), the treatment of smoke inhalation usually involves endotracheal intubation and ventilatory support (sometimes for several weeks).</p>\n<p>According to the<strong> latest ATLS guidelines</strong>, the <strong>order of primary survey</strong> in a burns patient is <strong>ABCDEF</strong> following the principle of ‘<strong>what kills first should be managed first</strong>’ -&nbsp;</p>\n<ul>\n<li><span>Airway</span></li>\n<li>Breathing</li>\n<li>Circulation with control of haemorrhage</li>\n<li>Disability(neurological)</li>\n<li>Exposure with environmental control</li>\n<li>Fluid resuscitation&nbsp;</li>\n</ul>\n<p>After securing the airway, <strong>breathing </strong>can be <strong>assessed</strong> by auscultating for <strong>breath sounds</strong> and a<strong> chest X-ray</strong> to look for a pneumothorax or hemothorax. Administering oxygen through a bag and mask is useful during desaturation only if the<strong> airway is patent</strong>. Therefore, securing the airway is the most important next step for this patient. (Option D) The patient's vital signs are stable, and there is no mention of neurological symptoms or other signs that might immediately suggest CO poisoning, therefore carbogen administration will not be helpful. (Option C)</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-2",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8870",
    "stauts": "Incorrect",
    "question_title": "2.\n        An infant has received exclusive breastfeeding by his mother till 6 months.  Which of the following factors in the breast milk give protection against E.coli?",
    "question_ADD": "<p>1. Bifidus Factor</p>\n<p>2. Low Para Amino Benzoic Acid</p>\n<p>3. Lactoferrin</p>\n<p>4. Lysozyme</p>",
    "question_imag": "",
    "optionA": "A. 1, 2, 3",
    "optionB": "B. 1, 3, 4 \n                \n                  \n                    \nCorrect",
    "optionC": "C. 2, 3, 4 \n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 1, 2, 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Lysozyme, Lactoferrin, </strong>and<strong> Bifidus factor </strong>give protection against <strong>E. coli.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Components of breast milk</strong></td>\n<td><strong>Protection against</strong></td>\n</tr>\n<tr>\n<td>Lysozyme</td>\n<td>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><strong>Escherichia coli</strong>, Salmonella</em></p>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Entamoeba histolytica</em></p>\n</td>\n</tr>\n<tr>\n<td>Lactoferrin</td>\n<td>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em><strong>E. coli</strong>, Shigella, Salmonella</em></p>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>E.histolytica, Giardia lamblia</em></p>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Plasmodium falciparum</em></p>\n<p>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Rotavirus</em></p>\n</td>\n</tr>\n<tr>\n<td>Bifidus factor</td>\n<td><em><strong>E. coli</strong>, Shigella, Salmonella</em></td>\n</tr>\n<tr>\n<td>Low levels of para-aminobenzoic acid</td>\n<td><em>Plasmodium</em></td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-3",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6467",
    "stauts": "Skipped",
    "question_title": "3.\n        Which of the following signs of pneumoperitoneum is incorrectly paired?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Rigler's sign - Air on both sides of the bowel wall",
    "optionB": "B. Football sign - Air outlines the peritoneal cavity",
    "optionC": "C. Cupola sign - Air around the urinary bladder\n                \n                  \n                    \nCorrect",
    "optionD": "D. Inverted V sign - Air outlines the lateral umbilical ligament",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Cupola sign</strong> refers to the presence of <strong>air under the central tendon</strong> of the diaphragm.</p>\n<p><strong>Signs of pneumoperitoneum</strong>:</p>\n<ul>\n<li>Bowel-related signs:\n<ul>\n<li>Double wall sign/&nbsp;<strong>Rigler's sign/ bas-relief</strong>&nbsp;sign -&nbsp;Air is seen on both sides of the bowel wall.</li>\n<li>Telltale triangle sign/ triangle sign - Triangle of gas formed between three loops of bowel or between the abdominal wall and 2 loops of bowel.</li>\n</ul>\n</li>\n<li>Peritoneal ligament-related signs:\n<ul>\n<li><strong>Football sign</strong> -&nbsp;Air <strong>outlines</strong> the confines of the <strong>peritoneal cavity</strong></li>\n<li>Falciform ligament sign -&nbsp; Air outlines the falciform ligament</li>\n<li>Lateral umbilical ligament sign/&nbsp;<strong>inverted \"V\"</strong>&nbsp;sign -&nbsp;Air outlines the lateral umbilical ligament</li>\n<li>Urachus sign - Air outlines the urachus</li>\n</ul>\n</li>\n<li>Right upper quadrant signs\n<ul>\n<li><strong>Cupola sign</strong> -&nbsp;Accumulation of<strong> air under the central tendon</strong></li>\n<li>Fissure for ligamentum teres sign - Air outlines the ligamentum teres</li>\n<li>Hepatic edge sign -&nbsp; cigar-shaped free-air pocket in the subhepatic region. It tracks superomedial following the contours of the liver</li>\n<li>Lucent liver sign - Reduction of hepatic radiodensity due to accumulation of free gas anterior to the liver</li>\n<li>Morison pouch sign/ Doge cap sign - Triangular/ crescentic gas lucency bound by the 11th rib</li>\n<li>Periportal free gas sign</li>\n</ul>\n</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Radiology"
  },
  {
    "web-scraper-order": "1727319149-4",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD8254",
    "stauts": "Skipped",
    "question_title": "4.\n        During the abdominal examination on a 6-month-old infant, you notice the following finding. Which of the following are false regarding this condition?",
    "question_ADD": "<ol>\n<li>Incidence of this condition is higher in premature births</li>\n<li>Sac decreases in size when the baby cries</li>\n<li>Commonly seen in children with congenital hyperthyroidism</li>\n<li>Obstruction and strangulation are common below the age of 2 years.</li>\n<li>Spontaneous resolution is unlikely if it persists beyond 2 years</li>\n</ol>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/8c1a42bc59da426396ad772a59cb4d68.PNG\">",
    "optionA": "A. 1 and 5",
    "optionB": "B. 2, 3, and 5",
    "optionC": "C. 2, 3 and 4\n                \n                  \n                    \nCorrect",
    "optionD": "D. 1, 2, 4, and 5",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows a mass protruding out of the umbilicus indicative of an <strong>umbilical hernia</strong>. Sac <strong>increases</strong> in size when the <strong>baby cries</strong>. Commonly seen in children with <strong>congenital hypothyroidism</strong>. Obstruction and strangulation are <strong>uncommon</strong> below the age of 3 years.</p>\n<p>An umbilical hernia occurs when a loop of the intestine protrudes through the umbilicus. It is common in newborn children, especially in <strong>premature babies.</strong> Both sexes are equally affected and the incidence in black infants is up to eight times higher than in white. The hernia is often <strong>symptomless</strong>, but increases in size on crying and assumes a <strong>classic conical shape</strong>.&nbsp;Obstruction and strangulation are uncommon in umbilical hernias.</p>\n<p class=\"p1\">Conservative treatment is indicated under the age of 2 years when the hernia is symptomless. The majority of them will <strong>resolve spontaneously</strong>. If the hernia persists <strong>beyond</strong> the age of <strong>2 years</strong> of age, <strong>surgical repair</strong> is indicated, as a spontaneous resolution becomes unlikely beyond 2 years of age.</p>\n<p class=\"p1\">Procedure: A small curved incision is made below the umbilicus and the neck of the sac is opened. The contents are returned to the peritoneal cavity and the redundant sac is excised after closing it. The defect in the linea alba is closed with interrupted sutures.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-5",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME2475",
    "stauts": "Incorrect",
    "question_title": "5.\n        Screening for inborn errors of metabolism in a newborn revealed the presence of severe hyperammonemia with respiratory alkalosis. Plasma levels of orotic acid were normal. Where is the deficient enzyme located in the cell?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Cytoplasm and mitochondria",
    "optionB": "B. Cytoplasm and nucleus",
    "optionC": "C. Mitochondria\n                \n                  \n                    \nCorrect",
    "optionD": "D. Cytoplasm\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the above scenario, hyperammonemia and normal orotic acid suggest a carbamoyl-phosphate synthetase (<strong>CPS</strong>) 1 enzyme <strong>deficiency.</strong>&nbsp;It is an enzyme located in the&nbsp;<strong>mitochondria</strong> of the cell.&nbsp;</p>\n<p>The <strong>urea cycle</strong> begins in the <strong>mitochondria</strong> and ends in the<strong> cytoplasm.</strong> During the metabolism of amino acids through the process of <strong>transamination,</strong> the amino acids are then cleaved into a carbon skeleton and an amino group that gets removed as <strong>ammonia</strong>. Ammonia later enters the urea cycle and gets converted into <strong>urea</strong> which is excreted in the urine.</p>\n<p>The urea cycle begins with one molecule of ammonia combined with CO2 in the presence of <strong>two</strong> molecules of <strong>ATP</strong> to form <strong>carbamoyl phosphate.</strong> The reaction is catalyzed by the mitochondrial enzyme carbamoyl phosphate synthetase-I (CPS-I).</p>\n<p>CPS-I reaction is the <strong>rate-limiting step</strong> in urea formation which is <strong>irreversible</strong> and <strong>allosterically</strong> regulated.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>CPS-1</strong></td>\n<td><strong>CPS-2</strong></td>\n</tr>\n<tr>\n<td>Site</td>\n<td><strong>Mitochondria</strong></td>\n<td>Cytosol</td>\n</tr>\n<tr>\n<td><strong>Pathway</strong></td>\n<td>Urea</td>\n<td><strong>Pyrimidine synthesis</strong></td>\n</tr>\n<tr>\n<td>Positive effector</td>\n<td>NAG</td>\n<td>Nil</td>\n</tr>\n<tr>\n<td>Source of NAG</td>\n<td>Ammonia</td>\n<td>Glutamine</td>\n</tr>\n<tr>\n<td>Inhibitor</td>\n<td>Nil</td>\n<td>CTP</td>\n</tr>\n</tbody>\n</table>\n<p>The <strong>enzymes involved</strong> in the <strong>urea cycle</strong> with their <strong>related disorders</strong> are given below:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Enzyme Deficient</strong></td>\n<td>&nbsp;<strong>Disorder&nbsp;</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td><strong>CPS 1</strong></td>\n<td><strong>Hyperammonemia type 1</strong></td>\n<td>Rare, characterized by severe hyperammonemia</td>\n</tr>\n<tr>\n<td><strong>Ornithine transporter</strong></td>\n<td><strong>HHH</strong> syndrome</td>\n<td><strong>H</strong>yperornithinemia, <strong>H</strong>yperammonemia, and <strong>H</strong>omocitrullinuria.</td>\n</tr>\n<tr>\n<td><strong>Ornithine transcarbamylase (OTC)</strong></td>\n<td><strong>Hyperammonemia type 2</strong></td>\n<td><strong>X-linked trait</strong> characterized by hyperammonemia and elevated glutamine levels in blood and CSF.</td>\n</tr>\n<tr>\n<td>Argininosuccinate synthetase</td>\n<td>&nbsp;</td>\n<td>Increased citrulline, <strong>citrullinuria</strong>, and hyperammonemia.</td>\n</tr>\n<tr>\n<td>Argininosuccinate lyase</td>\n<td>&nbsp;</td>\n<td><strong>Argininosuccinic acedemia </strong>and metabolic acidosis. Hyperammonemia is less severe and argininosuccinate is found in urine and CSF.</td>\n</tr>\n<tr>\n<td>Arginase</td>\n<td>&nbsp;</td>\n<td>Hyperargininemia and argininuria</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0573: Urea Cycle and its disorders</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0030: Sites of various pathways in cell</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sites of metabolism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mitochondria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fatty acid oxidation (βoxidation)</p>\n<p>Acetyl CoA production</p>\n<p>TCA Cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>Ketogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cytoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycolysis</p>\n<p>HMP Shunt</p>\n<p>Synthesis of steroids(SER)</p>\n<p>Proteins (RER and Ribosomes)</p>\n<p>Fatty acids</p>\n<p>Cholesterol</p>\n<p>Nucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heme synthesis</p>\n<p>Urea cycle</p>\n<p>Gluconeogenesis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-6",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5502",
    "stauts": "Incorrect",
    "question_title": "6.\n        A patient with pheochromocytoma is posted for surgery. Which of the following anesthetic agents is safe to use in this patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Ketamine\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Vecuronium\n                \n                  \n                    \nCorrect",
    "optionC": "C. Pancuronium",
    "optionD": "D. Atracurium",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Patients with<strong> pheochromocytoma</strong> have risk of increased release of catecholamines and their consequences like tachyarrythmias. Muscle relaxants like <strong>vecuronium and rocuronium</strong> have little to no role in causing such effects hence <strong>safe to use</strong> in patients with pheochromocytoma.</p>\n<p>Drugs that are contraindicated to use in patients with pheochromocytoma :&nbsp;</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>DRUGS</strong></td>\n<td><strong>REASON</strong></td>\n</tr>\n<tr>\n<td>Ketamine</td>\n<td>Sympathomimetic - exacerbation of symptoms</td>\n</tr>\n<tr>\n<td>Halothane</td>\n<td>Sensitizes myocardium to adrenaline (risk of tachyarrythmia)</td>\n</tr>\n<tr>\n<td>Atracurium</td>\n<td>Histamine release -&gt; compensatory catecholamine surge</td>\n</tr>\n<tr>\n<td>Pancuronium</td>\n<td rowspan=\"2\">Vagolytics -&gt; tachycardia &amp; tachyarrythmia</td>\n</tr>\n<tr>\n<td>Anticholinergics</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anaesthesia"
  },
  {
    "web-scraper-order": "1727319149-7",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD7262",
    "stauts": "Incorrect",
    "question_title": "7.\n        In a patient with an acute exacerbation of asthma with severely compromised lung function who is not responsive to nebulized beta-2 agonists, which of the following is the steroid of choice for systemic use?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Hydrocortisone\n                \n                  \n                    \nCorrect",
    "optionB": "B. Fluticasone propionate",
    "optionC": "C. Betamethasone",
    "optionD": "D. Dexamethasone\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>steroid</strong> of <strong>choice</strong> for <strong>systemic use</strong> in this above clinical scenario where there is an <strong>acute exacerbation of asthma </strong>(especially when the lung function is <strong>&lt;30%</strong> predicted and there is no improvement with a nebulized β2 agonist) is <strong>hydrocortisone</strong>.&nbsp;</p>\n<p>Hydrocortisone has the <strong>most rapid onset</strong> (5–6 hours after administration), compared to <strong>8 hours </strong>with <strong>prednisolone</strong>. It is given at a dose of <strong>4 mg/kg</strong> initially, followed by a <strong>maintenance dose</strong> of <strong>3 mg/kg </strong>every 6 hours.&nbsp;Intravenous therapy is usually given until a satisfactory response is obtained, and then it is replaced with oral prednisolone.</p>\n<p><strong>Mechanism of action</strong> of corticosteroids in an acute asthma attack:</p>\n<ul>\n<li>Increases <strong>responsiveness</strong> to <strong>beta-2 agonists</strong></li>\n<li><strong>Decreases</strong> <strong>mucous secretion</strong></li>\n<li>Decreases inflammatory cell response.</li>\n</ul>\n<p>Steroids increase the transcription of beta-2 receptor genes and hence, increased responsiveness to beta-2 agonists. <strong>Beta-2 agonists</strong>, on the other hand,&nbsp;<strong>increase</strong> the effect of steroids by enhancing the <strong>action</strong> of <strong>glucocorticoid receptors</strong>. <strong>Theophylline</strong> increases the effects of steroids by activating the enzyme histone deacetylase, which is the target for steroids as well.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-8",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8999",
    "stauts": "Correct",
    "question_title": "8.\n        Match the following vitamins with the respective ophthalmic manifestations of deficiency:",
    "question_ADD": "<p>&nbsp;</p>\n<table style=\"width: 364px; height: 483.18px;\">\n<tbody>\n<tr style=\"height: 54.3984px;\">\n<td style=\"width: 168px; text-align: center; height: 54.3984px;\">\n<p>Column A</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 54.3984px;\">\n<p>Column B</p>\n</td>\n</tr>\n<tr style=\"height: 76.7969px;\">\n<td style=\"width: 168px; height: 76.7969px; text-align: center;\">\n<p>a. Vitamin A</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 76.7969px;\">\n<p>1. Ophthalmoplegia, Optic neuritis</p>\n</td>\n</tr>\n<tr style=\"height: 121.594px;\">\n<td style=\"width: 168px; height: 121.594px; text-align: center;\">\n<p>b. Vitamin B1</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 121.594px;\">\n<p>2. Photophobia, cataracts, and Vascularization of the cornea&nbsp;</p>\n</td>\n</tr>\n<tr style=\"height: 76.7969px;\">\n<td style=\"width: 168px; height: 76.7969px; text-align: center;\">\n<p>c. Vitamin B2</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 76.7969px;\">\n<p>3. Xerophthalmia&nbsp;</p>\n</td>\n</tr>\n<tr style=\"height: 99.1953px;\">\n<td style=\"width: 168px; height: 99.1953px; text-align: center;\">\n<p>d. Vitamin C</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 99.1953px;\">\n<p>4. Zonular cataract, Increased lacrimation and Papilledema</p>\n</td>\n</tr>\n<tr style=\"height: 54.3984px;\">\n<td style=\"width: 168px; text-align: center; height: 54.3984px;\">\n<p>e. Vitamin D</p>\n</td>\n<td style=\"width: 168px; text-align: center; height: 54.3984px;\">\n<p>5. Hemorrhage in eyes</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>",
    "question_imag": "",
    "optionA": "A. a-5, b-1, c-2, d-3, e-4",
    "optionB": "B. a-3, b-1, c-2, d-5, e-4\n                \n                  \n                    \nCorrect",
    "optionC": "C. a-1, b-3, c-2, d-4, e-5",
    "optionD": "D. a-2, b-3, c-1, d-4, e-5",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correct match is a-3, b-1, c-2, d-5, e-4 (option B).</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Vitamin deficiency</strong></td>\n<td><strong>Ophthalmic manifestation</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong></td>\n<td>\n<ul>\n<li>Xerophthalmia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B1</strong></td>\n<td>\n<ul>\n<li>Ophthalmoplegia</li>\n<li>Optic neuritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B2</strong></td>\n<td>\n<ul>\n<li>Photophobia</li>\n<li>Cataract</li>\n<li>Vascularization of the cornea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C</strong></td>\n<td>\n<ul>\n<li>Hemorrhage in eye</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>D</strong></td>\n<td>\n<ul>\n<li>Zonular cataract</li>\n<li>Increased lacrimation</li>\n<li>Papilledema</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1462: Ophthalmic manifestation in vitamin deficiency</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Vitamin deficiency</strong></td>\n<td><strong>Ophthalmic manifestation</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong></td>\n<td>\n<ul>\n<li>Xerophthalmia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B1</strong></td>\n<td>\n<ul>\n<li>Corneal anesthesia</li>\n<li>Conjunctival and corneal dystrophy</li>\n<li>Acute retrobulbar neuritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B2</strong></td>\n<td>\n<ul>\n<li>Photophobia</li>\n<li>Burning sensation</li>\n<li>Vascularization of the cornea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B12</strong></td>\n<td>\n<ul>\n<li>Bilateral centrocecal scotoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C</strong></td>\n<td>\n<ul>\n<li>Hemorrhage in eye</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>D</strong></td>\n<td>\n<ul>\n<li>Zonular cataract</li>\n<li>Papilledema</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-9",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF4517",
    "stauts": "Incorrect",
    "question_title": "9.\n        You are an Intern posted in a rural PHC OPD. The mother of a 2 week old infant brings him to the OPD complaining of a “cursed birthmark” on the baby’s back. Upon examination, you notice the following lesion covered in coarse hair. What is the treatment of choice for the given condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/32828ed9548d476da261a54aaa6660e6.JPEG\">",
    "optionA": "A. Topical 5-Fluorouracil",
    "optionB": "B. Interferon alfa-2a & Vincristine",
    "optionC": "C. Total surgical excision\n                \n                  \n                    \nCorrect",
    "optionD": "D. Reassurance & observation\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario&nbsp;<span>suggests&nbsp;<strong>Giant Congenital Pigmented Nevus (GCPN).</strong>&nbsp;<strong>Total surgical excision </strong>is the<strong> treatment </strong>of choice</span>.</p>\n<p>Giant Congenital Pigmented Nevus (GCPN) is a rare congenital benign skin tumour with a <strong>5% chance</strong> of developing <strong>malignant melanoma.</strong> The<strong> risk increases</strong> with the <strong>nevus’s size, location</strong>, and presence of <strong>satellite lesions,</strong><strong>&nbsp;</strong>typically diagnosed around<strong> age 7.<br></strong></p>\n<p><strong>Early surgical intervention </strong>is recommended, ideally within the<strong> first few years </strong>of life, especially for large nevi or<strong> those </strong>on the <strong>head </strong>or <strong>spine</strong>. The exact timing may depend on imaging results and the presence of<strong> neural melanosis. </strong><strong>Total excision </strong>aims to <strong>remove </strong>the <strong>entire nevus </strong>to <strong>reduce melanoma risk</strong>, though it may require <strong>multiple surgeries</strong> and techniques like<strong> tissue expansion </strong>or <strong>grafting</strong>. Regular monitoring is crucial. <strong>Follow-up </strong>should be <strong>every 6 months</strong> for the<strong> first 5 years</strong> and then<strong> annually. MRI scans</strong> may be needed to check for <strong>complications </strong>like <strong>leptomeningeal melanocytosis.</strong></p>\n<p>Clinical features of a dysplastic nevus include:</p>\n<ul>\n<li>6- to 15-mm size</li>\n<li>Macular (flat)</li>\n<li>Pigmentation with variable colour</li>\n<li>indistinct margins</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>5</strong>-<strong>Fluorouracil</strong> <strong>cream</strong> is used in the treatment of low-risk basal cell carcinoma.</p>\n<p>Option B: <strong>Interferon</strong> <strong>alfa</strong>-<strong>2a</strong> &amp; <strong>Vincristine</strong> are used in the treatment of steroid-resistant hemangiomas.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2299: Variant forms of melanocytic nevi</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 1146\">\n<table><colgroup><col><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Nevus Variant</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Diagnostic Features</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Cytologic Features</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinical Significance</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Congenital nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Deep dermal and sometimes subcutaneous growth around adnexa, neurovascular bundles, and blood vessel walls</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Identical to ordinary acquired nevi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Present at birth; large variants have increased melanoma risk</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Blue nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Non-nested dermal infiltration, often with associated fibrosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Highly dendritic, <strong>heavily pigmented</strong> nevus cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Black-blue nodule; often <strong>confused with melanoma</strong> clinically</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Spitz nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Fascicular growth</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Large, plump cells with pink-blue cytoplasm; spindle to epithelioid cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Common in children; red-pink nodule; often <strong>confused with hemangioma</strong> clinically</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Halo nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Lymphocytic infiltration</strong> surrounding nevus cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Identical to ordinary acquired nevi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Host immune response against nevus cells and surrounding normal melanocytes</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Dysplastic nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Coalescent intraepidermal nests</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cytologic atypia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Potential marker or <strong>precursor of melanoma</strong></p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-10",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5961",
    "stauts": "Skipped",
    "question_title": "10.\n        All of the following groups of drugs should be avoided in a diabetic patient on captopril to avoid hyperkalemia, except _______.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Beta blockers",
    "optionB": "B. Calcium channel blockers\n                \n                  \n                    \nCorrect",
    "optionC": "C. Renal ENaC inhibitors",
    "optionD": "D. Aldosterone antagonists",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>All of the following groups of drugs should be avoided in a diabetic patient on captopril to avoid hyperkalemia, except <strong>calcium channel blockers</strong>.</p>\n<p><strong>Angiotensin-converting enzyme (ACE)</strong>&nbsp;<strong>inhibitors</strong> like <strong>captopril</strong> may cause <strong>hyperkalemia</strong>&nbsp;when taken along with <strong>K<sup>+</sup>-sparing diuretics and beta-receptor blockers (option A)</strong>,<strong>&nbsp;</strong>especially in <strong>diabetics</strong>. Calcium channel blockers are not associated with the development of any clinically significant hypo- or hyperkalemia. Hence, they are used as fixed-dose combinations as well.</p>\n<p>Hyperkalemia occurs due to the <strong>inhibition</strong> of <strong>angiotensin II-mediated aldosterone secretion</strong>. Decreased aldosterone levels result in <strong>decreased tubular excretion</strong> of potassium in the kidneys, leading to hyperkalemia.</p>\n<p>Other common adverse effects of ACE inhibitors include:</p>\n<ul>\n<li><strong>Hypotension</strong></li>\n<li><strong>Cough</strong></li>\n<li><strong>Angioedema</strong></li>\n<li><strong>Teratogenicity</strong></li>\n<li><strong>Dysgeusia</strong> (alteration in or loss of taste)</li>\n</ul>\n<p>Other options</p>\n<p>Option C: The most critical adverse effect of renal sodium channel inhibitors, such as <strong>amiloride</strong> and <strong>triamterene</strong>, is <strong>hyperkalemia</strong>. Triamterene may exacerbate <strong>megaloblastosis</strong> in <strong>cirrhotic</strong> patients due to its weak folic acid antagonism. It can also reduce glucose tolerance, induce <strong>photosensitizatio</strong>n, and is linked to interstitial nephritis and renal stones.&nbsp;Common side effects of <strong>amiloride</strong> include <strong>nausea, vomiting</strong>, diarrhea, and headache, while triamterene is more frequently associated with nausea, vomiting, <strong>leg cramps</strong>, and dizziness.</p>\n<p>Option D: The principal risk of <strong>aldosterone antagonists</strong>, such as <strong>eplerenone </strong>and<strong> finerenone</strong>, is <strong>hyperkalemia</strong>. They can cause <strong>metabolic acidosis </strong>in <strong>cirrhotic</strong> patients. <strong>Spironolactone</strong>&nbsp;is associated with side effects such as <strong>gynecomastia, impotence</strong>, and gastrointestinal issues like gastric bleeding, and <strong>peptic ulcers</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-11",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG3001",
    "stauts": "Correct",
    "question_title": "11.\n        The normal cardiac output curve is depicted in red in the image below. In which of the following conditions will a patients cardiac output curve be at point marked as B?",
    "question_ADD": "<ol>\n<li>Administration of spinal anesthesia.</li>\n<li>Opening an arteriovenous fistula.</li>\n<li>Thyrotoxicosis.</li>\n<li>Infusion of intravenous fluids</li>\n</ol>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/07129140011641cab15613f85b35d492.JPEG\">",
    "optionA": "A. 1 only\n                \n                  \n                    \nCorrect",
    "optionB": "B. 1,2",
    "optionC": "C. 1,3,4",
    "optionD": "D. 4 only",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The point B depicted in the graph shows the eﬀect of <strong>sympathetic inhibition</strong> caused by the administration of <strong>spinal</strong> <strong>anesthesia</strong> (option A) which leads to <strong>decreased cardiac output</strong> and <strong>decreased venous return</strong>.&nbsp;</p>\n<p><strong>Before anesthesia (Point A)</strong>, systemic filling pressure (Psf) is at a <strong>normal</strong> level, supporting adequate venous return and cardiac output. <strong>After spinal anesthesia</strong> is administered, sympathetic activity is reduced, leading to vasodilation and <strong>a significant drop in Psf to about 4 mm Hg</strong> (Point B). This decrease in Psf results in <strong>reduced venous return to the heart</strong>, causing the cardiac output to fall to approximately<strong> 60% of its normal</strong> value.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/11c0ffceeca1475aa3c11d10f4156cefx1280x1354.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option B: Opening an <strong>arteriovenous fistula</strong> allows blood to flow from the large arteries into the venous system, bypassing resistance elements of the peripheral circulation. This results in <strong>increased venous return</strong> <strong>and cardiac output</strong>.</p>\n<p>Option C: <strong>Thyrotoxicosis</strong> is characterized by an overactive thyroid gland leading to excessive production of thyroid hormones (T3 and T4) which causes <strong>peripheral vasodilation</strong>. Vasodilation reduces systemic vascular resistance, which decreases the afterload on the heart. The heart can more efficiently eject blood into the systemic circulation, further <strong>increasing cardiac output</strong>.</p>\n<p>Option D: Infusion of <strong>intravenous fluids</strong> increases blood volume and leads to compensatory effects such as <strong>increased capillary pressure, increased venous distention</strong>, and <strong>increased peripheral vascular resistance</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-12",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5753",
    "stauts": "Correct",
    "question_title": "12.\n        A 40-year-old male who is a welder by profession came with complaints of dyspnoea, high-grade fever and rigors. He has bluish discolouration of peripheries and profuse sweating. He reports that his symptoms are often resurfacing at the beginning of every week and subsiding later. What could be the probable diagnosis of the patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Saturnism",
    "optionB": "B. Hatter's shakes",
    "optionC": "C. Magnan's syndrome",
    "optionD": "D. Metal Fume fever\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The patient who is a <strong>welder </strong>by profession with the above-mentioned <strong>flu-like symptoms</strong> is likely to be suffering from <strong>Metal fume fever.&nbsp;</strong></p>\n<p>Metal fume fever is a<strong> self-limited, influenza-like syndrome</strong>. It can also mimic malaria. It is most commonly associated with welders due to inhaling tiny metal oxide particles during welding. These particles, primarily <strong>zinc oxide</strong> but also cadmium and manganese oxides, can inflame the lungs. Symptoms mimic the flu, including <strong>fever</strong>, tiredness, <strong>breathing difficulties</strong>, cyanosis, myalgia, salivation and tachycardia.</p>\n<p>Symptoms usually<strong> begin 6-8 hours</strong> after exposure to fumes and <strong>resolve within 24 hours</strong> of stoppage of exposure. it is usually <strong>mildest on Sundays</strong> and <strong>worst</strong> at the<strong> start of the workweek</strong>. Lab tests and chest X-rays are usually normal, except in severe cases. Teams of experts must recognize this as an <strong>occupational hazard</strong> and enforce <strong>safety measures</strong> like proper masks, ventilation, and work duration limits for welders.</p>\n<p>Other Options:</p>\n<p>Option A: <strong>Saturnism</strong> is a term given for <strong>chronic lead poisoning</strong> , symptoms include Anemia with basophilic stippling, Burtonian line (blue stippled line on gums), Constipation and colic (abdominal pain), drop (wrist and foot drop) due to neuropathy, Encephalopathy (Mostly seen in infants presenting with severe ataxia, vomiting, lethargy, stupor, convulsion, and coma), Facial pallor (Earliest sign).</p>\n<p>&nbsp;Option B: <strong>Hatter's shake</strong> is caused due to <strong>Hydrargyrism</strong> or mercury poisoning.&nbsp; They are coarse jerky movements causing severe impairment of daily activities involving delicate movements like shaving, writing, and holding a tumbler or spoon.</p>\n<p>Option C: <strong>Magnan's syndrome</strong> or <strong>cocaine bugs </strong>characteristic of chronic cocaine abuse. It is a feeling as if grains of sand are lying under the skin or some small insects are creeping on the skin giving rise to an itching sensation(formication, tactile hallucinations) with resultant excoriation, leading to irregular scratches and ulcers.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2101: Lead Poisoning/Plumbism/Saturnism</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lead Toxicity</strong></td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Occupational exposure</p>\n<p>Lead paint</p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Children - GI tract</p>\n<p>Adults - Respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<ul>\n<li>Binds to sulfhydryl groups and inhibits\n<ul>\n<li>ALA dehydratase</li>\n<li>Ferrochelatase</li>\n</ul>\n</li>\n<li>Inhibits pyrimidine 5' nucleotidase</li>\n<li>Competes with <strong>calcium</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(acute</strong> toxicity)</td>\n<td>\n<p>GI tract, Bone marrow, Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(chronic</strong> toxicity)</td>\n<td>\n<p>CNS, Kidney</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p><strong>A - </strong>Anemia with basophilic stippling</p>\n<p><strong>B - </strong>Burtonian line (blue stippled line on gums)</p>\n<p><strong>C - </strong>Constipation and colic (abdominal pain)</p>\n<p><strong>D - </strong>Drop (wrist and foot drop) due to neuropathy</p>\n<p><strong>E - </strong>Encephalopathy-&nbsp;<strong>Mostly seen in infants</strong> presenting with severe ataxia, vomiting, lethargy, stupor, convulsions, and coma</p>\n<p><strong>F - Facial pallor (Earliest sign)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood lead levels</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Calcium EDTA; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2099: Arsenic poisoning</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL –treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen’s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees’s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes – oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-13",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0074",
    "stauts": "Incorrect",
    "question_title": "13.\n        A 14-year-old boy presented with jaundice, fever and mild splenomegaly. The patient is asked to get an Eosin-5’-maleimide (EMA) test which turns out to be positive. In this condition, what property of the red blood cells produces the graph (A) in the osmotic fragility curve?",
    "question_ADD": "<p>SA - Surface area&nbsp;</p>\n<p>V- Volume&nbsp;</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/9fbc32d84cc841259a2dce3884933090.JPEG\">",
    "optionA": "A. Initial increase then decrease in SA/V ratio",
    "optionB": "B. Decreased V/SA ratio\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Increased V/SA ratio\n                \n                  \n                    \nCorrect",
    "optionD": "D. Initial decrease then increase in SA/V ratio",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><span>In the given clinical scenario, the symptoms of <strong>jaundice, fever</strong> and <strong>mild splenomegaly</strong> with a positive Eosin-5′-maleimide (<strong>EMA</strong>)–binding test, point towards the diagnosis of <strong>Hereditary spherocytosis</strong>. This can be confirmed by the <strong>right shift</strong> seen in the osmotic fragility curve which occurs due to an <strong>increased V/SA ratio.</strong></span></p>\n<p><span>Osmotic fragility is the ability of red blood cells to resist hemolysis when placed in <strong>increasing dilutions</strong> of saline solution. In the graph, the x-axis represents the saline concentration while the y-axis represents the percentage of red cells that have undergone hemolysis. Normal hemolysis <strong>begins</strong> at a concentration of <strong>0.5% </strong>NaCl and is <strong>completed</strong> at a concentration of <strong>0.3%</strong> NaCl as shown in the graph.</span></p>\n<p><span>In Hereditary Spherocytosis, the osmotic fragility of the red blood cells is characteristically <strong>increased</strong> and they lyse more easily in a hypotonic solution than normal discoid RBCs due to the <strong>increased volume/surface area ratio.</strong>&nbsp;This is seen as a <strong>right</strong> shift in the osmotic fragility graph. Here hemolysis begins at a higher concentration of the saline solution.&nbsp;</span></p>\n<div class=\"page\" title=\"Page 254\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>Decreased osmotic fragility indicates the presence of unusually flattened red cells (leptocytes) in which the RBCs have<strong> decreased volume/surface area ratio. </strong>Such changes occur in <strong>iron deficiency anaemia</strong> and <strong>thalassaemia</strong> in which the red cells with <strong>low</strong> mean cell haemoglobin <strong>(MCH) </strong>and mean cell volume <strong>(MCV)</strong> are unusually resistant to osmotic lysis. This is seen as a <strong>left</strong> shift in the osmotic fragility graph.</span></p>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95a58cb42c2e4626a8a7dbb6c7271e89x1280x1123.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><span>Hereditary spherocytosis is a type of <strong>hemolytic</strong> anaemia that is most commonly inherited in an autosomal <strong>dominant</strong> pattern. Mutations in <strong>α-spectrin</strong>, <strong>β-spectrin, ankyrin, band 4.2 </strong>and <strong>band 3</strong> weaken the association of the membrane skeleton with the overlying plasma membrane, making them <strong>spheroid</strong> and less deformable. Patients usually present with anaemia, fatigue, <strong>splenomegaly,</strong> and <strong>jaundice</strong> and the age of presentation varies with the severity of the disease.</span></p>\n<p><span>The life span of affected red cells is decreased on average to <strong>10 to 20</strong> days from the normal 120 days.</span></p>\n<p><span>The peripheral smear shows numerous spherocytes which present as small, dark-staining (<strong>hyperchromic</strong>) red cells <strong>without</strong> the central zone of pallor that is present in normal red blood cells.</span></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/ca83ecf1d6404ea0880cc349cf9a0097.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 643\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\"><span>The diagnosis can be confirmed by the </span><strong>acid glycerol lysis </strong><span>test and the </span><strong>eosin-5′-maleimide (EMA)–binding test.</strong><span>&nbsp; It is a flow cytometric test based on the interaction between the dye eosin-5-maleimide and band 3 protein.</span></div>\n</div>\n</div>\n</div>\n<p><span>There is no specific treatment available besides <strong>splenectomy.&nbsp;</strong></span></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1247: Classification of Hemolytic Anemias</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Hemolytic anemias can be classified in 2 ways:</p>\n<p>1. Based on the <strong>type of defect</strong>:</p>\n<table width=\"595\">\n<tbody>\n<tr>\n<td><strong>Type&nbsp;</strong></td>\n<td><strong>Intracorpuscular Defects</strong></td>\n<td><strong>Extracorpuscular Factors</strong></td>\n</tr>\n<tr>\n<td>Hereditary</td>\n<td>\n<p>Hemoglobinopathies</p>\n<p>Enzymopathies</p>\n<p>Membrane-cytoskeletal defects</p>\n</td>\n<td>Familial (atypical) hemolytic uremic syndrome</td>\n</tr>\n<tr>\n<td>Acquired</td>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)</td>\n<td>\n<p>Mechanical destruction (microangiopathic)</p>\n<p>Toxic agents</p>\n<p>Drugs</p>\n<p>Infectious</p>\n<p>Autoimmune</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>2. Based on the <strong>sites</strong> of <strong>hemolysis:</strong></p>\n<p><strong>Intravascular&nbsp;</strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\"TextRun SCXW225898103\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW225898103\">Mechanical injury</span></span>\n<ul>\n<li aria-setsize=\"-1\">Trauma caused by cardiac valves&nbsp;</li>\n<li aria-setsize=\"-1\">Microangiopathic hemolytic anaemias (hemolytic uremic syndrome, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura)&nbsp;</li>\n<li aria-setsize=\"-1\">Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW46333709\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW46333709\">Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li aria-setsize=\"-1\">Hemolytic disease of the newborn- ABO incompatibility </li>\n<li aria-setsize=\"-1\">Transfusion reaction&nbsp;&nbsp;</li>\n<li aria-setsize=\"-1\">Drug-induced&nbsp;</li>\n</ul>\n</li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Infections&nbsp;of red blood cells&nbsp;</span></span>\n<ul>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">Malaria</span></span></li>\n<li><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW127641793\">B</span></span><span class=\"TextRun SCXW127641793\" lang=\"EN-GB\"><span class=\"SpellingError SCXW127641793\">abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\"EOP SCXW127641793\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">Exogenous toxic factors&nbsp;- c</span></span></span><span class=\"EOP SCXW127641793\"><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\"><span class=\"SpellingError SCXW261552469\">lostridial</span></span><span class=\"TextRun SCXW261552469\" lang=\"EN-GB\"><span class=\"NormalTextRun SCXW261552469\">&nbsp;sepsis</span></span></span></li>\n</ul>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\"><strong>Extravascular&nbsp;</strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anemia</li>\n<li>Hemolytic disease of the newborn- Rh incompatibility</li>\n</ul>\n<p><strong>Both</strong>&nbsp;intravascular and extravascular hemolysis:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anemia</li>\n</ul>\n</div>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1268: Features of Peripheral Blood Smear in Different Anemias</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl’s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),‘Bite’ cells</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-14",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6805",
    "stauts": "Skipped",
    "question_title": "14.\n        Considering the growing population of India, the government started categorizing various states based on their total fertility rate (TFR). Manipur with a TFR of 2.2 would be kept under ____?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Very high focus",
    "optionB": "B. Non-high focus",
    "optionC": "C. High focus\n                \n                  \n                    \nCorrect",
    "optionD": "D. Low focus",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The state of Manipur with a <strong>total fertility rate</strong> of <strong>2.2</strong> would be categorised under<strong>&nbsp;high focus</strong>.</p>\n<p>The Government of India has categorized states according to total fertility rate (TFR) level into 3 categories.</p>\n<ul>\n<li>Very high-focus (more than or equal to 3.0) states, it includes Bihar.</li>\n<li><strong>High-focus</strong> (more than 2.1 and less than 3.0) states, it includes states like Meghalaya, Manipur, and Uttar Pradesh.</li>\n<li>Non-high focus (less than or equal to 2.1) states</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-15",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6440",
    "stauts": "Incorrect",
    "question_title": "15.\n        Match the following:",
    "question_ADD": "<table style=\"border-collapse: collapse; width: 41.6667%; height: 226px;\" border=\"1\">\n<tbody>\n<tr>\n<td style=\"width: 36.3517%;\"><strong>&nbsp; &nbsp; &nbsp; &nbsp; Drug</strong></td>\n<td style=\"width: 63.6483%; text-align: center;\"><strong>Important Adverse Effect</strong></td>\n</tr>\n<tr>\n<td style=\"width: 36.3517%;\">a. Valproate</td>\n<td style=\"width: 63.6483%;\">1. Steven Johnson Syndrome</td>\n</tr>\n<tr>\n<td style=\"width: 36.3517%;\">b. Lamotrigine</td>\n<td style=\"width: 63.6483%;\">2. Visual field contraction</td>\n</tr>\n<tr>\n<td style=\"width: 36.3517%;\">c. Felbamate</td>\n<td style=\"width: 63.6483%;\">3. Fulminant hepatic failure</td>\n</tr>\n<tr>\n<td style=\"width: 36.3517%;\">d. Vigabatrin</td>\n<td style=\"width: 63.6483%;\">4. Pancreatitis</td>\n</tr>\n</tbody>\n</table>",
    "question_imag": "",
    "optionA": "A. a-1; b-4; c-3; d-2",
    "optionB": "B. a-4; b-1; c-3; d-2  \n                \n                  \n                    \nCorrect",
    "optionC": "C. a-4; b-2; c-1; d-3",
    "optionD": "D. a-3; b-4; c-2; d-1\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched option is <strong>a-4; b-1; c-3; d-2 </strong>(option 2).&nbsp;&nbsp;</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Important Adverse Effect</strong></td>\n</tr>\n<tr>\n<td>Valproate</td>\n<td>Pancreatitis</td>\n</tr>\n<tr>\n<td>Lamotrigine</td>\n<td>Steven Johnson Syndrome</td>\n</tr>\n<tr>\n<td>Felbamate</td>\n<td>Fulminant hepatic failure</td>\n</tr>\n<tr>\n<td>Vigabatrin</td>\n<td>Visual field contraction</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1697: Important Adverse Effects of Anti-epileptic Drugs</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antiepileptic drugs</strong></p>\n</td>\n<td>\n<p><strong>Adverse effects</strong></p>\n</td>\n</tr>\n<tr>\n<td>Carbamazepine</td>\n<td>Stevens-Johnson syndrome (SJS), diplopia, ataxia, hyponatremia</td>\n</tr>\n<tr>\n<td>Phenytoin</td>\n<td>Gum hyperplasia, hirsutism, osteomalacia, ataxia</td>\n</tr>\n<tr>\n<td>Valproic acid</td>\n<td>Hepatotoxicity, thrombocytopenia, transient alopecia, tremors, pancreatitis</td>\n</tr>\n<tr>\n<td>Phenobarbital</td>\n<td>Sedation, depression, ataxia, automatism</td>\n</tr>\n<tr>\n<td>Vigabatrin</td>\n<td>Loss of peripheral vision</td>\n</tr>\n<tr>\n<td>Felbamate</td>\n<td>Fulminant hepatic failure, aplastic anemia</td>\n</tr>\n<tr>\n<td>Lamotrigine</td>\n<td>Hypersensitivity reactions, SJS</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Paresthesias, renal calculi, weight loss, acute glaucoma</td>\n</tr>\n<tr>\n<td>Oxcarbazepine</td>\n<td>Hyponatremia, SJS</td>\n</tr>\n<tr>\n<td>Ezogabine</td>\n<td>Urinary retention</td>\n</tr>\n<tr>\n<td>Zonisamide</td>\n<td>Renal calculi</td>\n</tr>\n<tr>\n<td>Perampanel</td>\n<td>Homicidal ideation</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-16",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF7819",
    "stauts": "Incorrect",
    "question_title": "16.\n        A young female patient came with complaints of joint pain, a butterfly-shaped rash on her face, fever, and weight loss. On investigation, ANA, anti-dsDNA antibodies, and anti-Smith antibodies are positive. Which of the following is the immunofluorescence pattern most likely to be associated with her condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/5ae4fd322a7b432087c179305a17dff9.JPEG\">",
    "optionA": "A. Image A\n                \n                  \n                    \nCorrect",
    "optionB": "B. Image B\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Image C",
    "optionD": "D. Image D",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical vignette is suggestive of <strong>systemic lupus erythematosus</strong> (SLE), and <strong>Image A</strong>, which shows&nbsp;<strong>homogenous or diffuse nuclear</strong> staining, is the immunofluorescence pattern associated with it.</p>\n<p><strong>SLE</strong> is an autoimmune disease that most commonly presents with arthralgia accompanied by early morning stiffness. The other important features of SLE include malar rash, discoid rash, photosensitivity, oral ulcers, pleuritis, pericarditis, and lupus nephritis.</p>\n<p><strong>ANA</strong>, <strong>anti-dsDNA</strong> antibodies, and&nbsp;<strong>anti-Smith</strong> antibodies are positive in SLE.&nbsp;<strong>Homogenous or diffuse</strong> staining and <strong>peripheral</strong> staining pattern are most commonly seen in SLE.</p>\n<p>The image below shows the homogenous or diffuse immunofluorescence staining pattern seen in SLE:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5c92164de4d14a9aa04b17ddb09a662ax720x665.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p><strong>Sjogren's syndrome</strong> is an autoimmune disease characterized by lymphocytic infiltration of salivary and lacrimal glands.&nbsp;Patients present with <strong>dry eye</strong> (keratoconjunctivitis sicca) and <strong>dry mouth</strong> (xerostomia) due to fibrosis of the lacrimal and salivary gland, respectively.</p>\n<p><strong>Anti-Ro</strong>&nbsp;and <strong>anti-La</strong> antibodies are positive in Sjogren's syndrome. <strong>ANA</strong> and <strong>RF</strong> (rheumatoid factor) can also be seen. The&nbsp;<strong>centromeric pattern </strong>and<strong> speckled pattern</strong> of staining are seen in Sjogren's syndrome.</p>\n<p>Image 1 below shows a speckled pattern, and image 2 shows a centromeric pattern of staining.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95bc8244d8f546e7883d65f4934bc778x655x600.JPEG\"><img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4a04e2db5dd4eec9a2ebd9acc2f0308x719x599.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Systemic sclerosis (SSc) is an autoimmune connective tissue disorder that results in fibrosis of the skin, vasculature, and internal organs. It is of two types, namely&nbsp;<strong>diffuse</strong>&nbsp;cutaneous systemic sclerosis and&nbsp;<strong>limited</strong>&nbsp;cutaneous systemic sclerosis.&nbsp;</p>\n<p><strong>Nucleolar pattern</strong> of ANA staining in immunofluorescence&nbsp;is most commonly seen in systemic sclerosis. A <strong>centromeric&nbsp;pattern</strong> is also seen.</p>\n<p>The image below shows nucleolar pattern in immunofluorescence seen in systemic sclerosis.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59e586d9ed414230bd3c71767291c566x616x600.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3278e0bdb5e04a509a588d3eb835e760x1280x1541.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2173: Pattern of nuclear body suggests the type of antibody present in patient’s serum.</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Five basic patterns of nuclear fluorescence is recognized for anti-nuclear antibodies:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Staining pattern</strong></td>\n<td><strong>Antigen</strong></td>\n</tr>\n<tr>\n<td>Homogenous or diffuse nuclear staining</td>\n<td>Antibodies to <strong>chromatin, histones, </strong>and occasionally<strong> double-stranded DNA</strong></td>\n</tr>\n<tr>\n<td>Rim or peripheral staining</td>\n<td>Antibodies <strong>to double-stranded DNA, </strong>and sometimes to <strong>nuclear envelope proteins</strong></td>\n</tr>\n<tr>\n<td>Speckled pattern</td>\n<td>\n<p>One of the most commonly observed patterns of fluorescence, the least specific.&nbsp;</p>\n<p>Antibodies to non-DNA nuclear constituents such as <strong>Sm antigen, ribonucleoprotein, and SS-A and SS-B reactive antigens</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>Nucleolar pattern</td>\n<td>\n<p>Few discrete spots of fluorescence within the nucleus and represent&nbsp;<strong>antibodies to RNA</strong>.</p>\n<p><strong>Seen in systemic sclerosis.</strong></p>\n</td>\n</tr>\n<tr>\n<td>Centromeric pattern</td>\n<td>\n<p>Seen in systemic sclerosis</p>\n<p>Often contain antibodies specific for centromeres, which give rise to this pattern.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/79cff1e8d6244910afe4f779bd0d86aax1280x4885.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2428: Autoantibodies Seen in Autoimmune Diseases</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"469\">\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sjögren’s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-17",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6456",
    "stauts": "Incorrect",
    "question_title": "17.\n        A 42-year-old male patient came to the emergency department after a road traffic accident with a vertebral fracture in the dorso lumbar region which was diagnosed by X-ray. Which of the following braces can be used to support the spine after spinal surgery?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Milwaukee brace\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. SOMI brace",
    "optionC": "C. Taylor brace\n                \n                  \n                    \nCorrect",
    "optionD": "D. Boston brace",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The brace that can be used to support the spine after spinal surgery is <strong>Taylor brace.</strong></p>\n<p>After a spinal surgery, <strong>Taylor brace</strong> can be used to support sitting, standing, and walking after spinal surgery. Taylor brace is indicated for stabilization of the spine in <strong>dorsolumbar spinal injury</strong>. It is designed to control the upper and lower regions of the spinal column and support the spine while <strong>standing, sitting, </strong>and <strong>walking </strong>after<strong> spinal surgery.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bcf10af39164787b682158dd20f7d3cx810x744.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options :&nbsp;</p>\n<p>Option A: <strong>Milwaukee brace</strong> can be used for the management of<strong> Scoliosis</strong> and <strong>kyphosis</strong>. Also known as <strong>cervico-thoraco-lumbosacral</strong> <strong>orthosis</strong> or <strong>CTLSO</strong>, it is a back brace used in the treatment of spinal curvatures (such as scoliosis or kyphosis) in children. It is less commonly used nowadays due to the convenience of modern braces.&nbsp;</p>\n<p>A picture depicting the same is shown below.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/77424faf29744e519b0892f1ceccb8dax700x738.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option B: <strong>SOMI brace (sterno-occipital-mandibular immobilization device)</strong> is a rigid <strong>cervical brace</strong> that positions our neck with alignment to the spine. It can be used in conditions such as severe neck injury or for cervical pain caused by a chronic condition, such as rheumatoid arthritis. It may also be prescribed as a recovery aid <strong>after Cervical spine surgery</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/37d7030fefeb4301a295d981ca9659c4x908x614.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D: <strong>Boston brace</strong> (image below) is a <strong>mold brace</strong> and is the <strong>most commonly</strong> used brace nowadays for the treatment of<strong> scoliosis</strong>. It is a type of <strong>Thoracic - Lumbar - Sacral orthrosis(TLSO).</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a094601d48854d06a555cbd5746e77f1x682x690.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1489: Commonly used splints and their indications</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Name of the Splint</strong></span></p>\n</td>\n<td>\n<p><span><strong>Uses</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Used in Lower Limbs</strong></span></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Thomas Splint</p>\n<p>Bohler-Braun splint</p>\n</td>\n<td>\n<p>Fracture femur</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toe raising splint</p>\n</td>\n<td>\n<p>Foot drop</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dennis Brown splint</p>\n</td>\n<td>\n<p>CTEV</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Used in Upper Limbs</strong></span></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Cock up splint</p>\n</td>\n<td>\n<p>Radial nerve palsy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Volkmann's turn buckle splint</p>\n<p>&nbsp;</p>\n</td>\n<td>Volkmann's ischemic contracture&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Knuckle bender splint</p>\n</td>\n<td>\n<p>Claw hand (Ulnar Nerve)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aeroplane splint</p>\n</td>\n<td>\n<p>Brachial plexus injury</p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Used for Spine</strong></span></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Milwaukee brace</p>\n<p>Boston brace</p>\n</td>\n<td>Scoliosis&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>SOMI brace</p>\n</td>\n<td>\n<p>Cervical spine injury</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ASHE (anterior spinal hyperextension) brace&nbsp;</p>\n</td>\n<td>\n<p>Dorso lumbar spinal injury</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-18",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC2480",
    "stauts": "Correct",
    "question_title": "18.\n        In a town with a population of 5,00,000, the number of slides examined in one year was 2000. Out of these 250 slides were positive for malaria. The annual parasite incidence (API) is______",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 0.1",
    "optionB": "B. 0.5\n                \n                  \n                    \nCorrect",
    "optionC": "C. 1",
    "optionD": "D. 1.5",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The annual parasite incidence based on the given data is&nbsp;<strong>0.5.</strong></p>\n<p>Annual parasite incidence is a measure of malaria morbidity for a given year at any given geographical level. It helps in determining the&nbsp;<strong>burden of the disease.&nbsp;</strong>It is calculated as</p>\n<p>API = Confirmed cases in one year / Population under surveillance&nbsp;× 1000</p>\n<p>&nbsp; &nbsp; &nbsp; = 250 / 500000&nbsp;× 1000</p>\n<p>&nbsp; &nbsp; &nbsp; = 0.5</p>\n<p>Areas with&nbsp;<strong>API&gt;= 2 per 1000</strong>&nbsp;population are classified as&nbsp;<strong>high-risk areas</strong>&nbsp;and are eligible for vector control.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2084: Malarial parameters</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Malarial parameters:</p>\n<table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>Formula</td>\n</tr>\n<tr>\n<td>Annual Parasite Incidence</td>\n<td>\n<p>Confirmed cases in one year</p>\n<p>-----------------------------------×1000<br>Population under surveillance</p>\n</td>\n</tr>\n<tr>\n<td>Annual Blood Examination Rate</td>\n<td>\n<p>Number of slides examined</p>\n<p>-----------------------------------×100 <br>&nbsp; &nbsp; &nbsp; Population</p>\n</td>\n</tr>\n<tr>\n<td>Slide positivity Rate</td>\n<td>Percentage of slides found positive irrespective of species</td>\n</tr>\n<tr>\n<td>Slide Falciparum Rate</td>\n<td>Percentage of slides positive for <em>P. falciparum</em></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1682: Malaria in the National Vector Borne Disease Control Programme (NVBDCP)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>National Framework for Malaria Elimination in India (2016-2030)</strong></p>\n<ul>\n<li><strong>Goals:</strong> To eliminate malaria and maintain malaria-free status.</li>\n<li><strong>Objectives:</strong>\n<ul>\n<li>By 2022, transmission of malaria interrupted and zero indigenous cases.</li>\n<li>By 2024, incidence of malaria to be reduced to &lt;1 case per 1000 population.</li>\n<li>By 2030, malaria to be eliminated throughout the country.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Classification of states/UTs according to the Annual Parasite Index (API):</strong></p>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Category</strong>&nbsp;</td>\n<td><strong>Criteria&nbsp;</strong></td>\n<td><strong>Major measures:</strong></td>\n</tr>\n<tr>\n<td>Category 0&nbsp;</td>\n<td>States/UTs with zero indigenous cases&nbsp;</td>\n<td>Detect re-introduced cases and notify and maintain malaria-free status.&nbsp;</td>\n</tr>\n<tr>\n<td>Category 1&nbsp;</td>\n<td><strong>Elimination phase –</strong> States/UTs with API &lt;1 and all their districts reporting API &lt;1&nbsp;</td>\n<td>Interruption of local transmission.</td>\n</tr>\n<tr>\n<td>Category 2&nbsp;</td>\n<td><strong>Pre-elimination phase –</strong> States/UTs with API &lt;1 but some districts reporting API&nbsp;≥1.&nbsp;</td>\n<td>\n<p>Screening.&nbsp;</p>\n<p>Setting up one-stop mobile centres/clinics.&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Category 3&nbsp;</td>\n<td><strong>Intensified control phase –</strong> States/UTs with API&nbsp;≥1.&nbsp;</td>\n<td>&nbsp;Same as category 2</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li>The <strong>National Strategic Plan (NSP) for Malaria Elimination&nbsp;</strong>(2017-22) was launched by the Ministry of Health and Family Welfare under NVBDCP, which is based on the <strong>National Framework for Malaria Elimination </strong>(2016 – 2030).</li>\n<li>The <strong>NSP</strong> focuses mainly on the <strong>districts</strong> which function as the <strong>operational units.</strong></li>\n</ul>\n<p>Accordingly, all the districts are classified into the following <strong>four</strong> categories:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category of districts</strong></td>\n<td><strong>Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Category 0</strong>: Prevention of re-establishment phase</td>\n<td>&nbsp;Includes all districts in which no incidence of malaria was reported in the last 3 years.</td>\n</tr>\n<tr>\n<td><strong>Category 1:</strong> Elimination phase</td>\n<td>&nbsp;Districts with API &lt;1 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 2: </strong>Pre elimination phase</td>\n<td>&nbsp;Districts with API in between 1-2 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 3:</strong> Intensified control phase</td>\n<td>&nbsp;Districts with API &gt;2 per 1000 population.</td>\n</tr>\n</tbody>\n</table>\n<p>The above classification is more operational than the classification mentioned in the <strong>NFME</strong> which is <strong>state</strong> focussed.</p>\n<p>The goal of&nbsp;<strong>NSP strategy </strong>is the phased elimination of malaria in India. The National Framework for Malaria Elimination (<strong>NFME</strong>) in India has set <strong>2030</strong> as the goal for eliminating malaria, and the goals of NSP in consonance with overall goals.</p>\n<p><strong>The goals of NSP 2017 – 2022 are:</strong></p>\n<ul>\n<li>Eliminate malaria in <strong>category 1</strong> (API &lt; 1) districts by <strong>2020</strong>, and <strong>category 2</strong> (API 1-2) districts by <strong>2022</strong>.</li>\n<li>Reduce transmission in <strong>category 3</strong> districts to stabilize API at&nbsp;<strong>&lt;1 </strong>by <strong>2022</strong>.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-19",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0711",
    "stauts": "Correct",
    "question_title": "19.\n        Which of the following uroflow patterns can be observed in a patient with urethral stricture ?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/56723015512243ebb03bac316e3cb482.JPEG\">",
    "optionA": "A. 3",
    "optionB": "B. 2\n                \n                  \n                    \nCorrect",
    "optionC": "C. 1",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>second</strong> diagram depicts the uroflow pattern in a patient with <strong>urethral stricture</strong>.&nbsp;</p>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Uroflow pattern&nbsp;</strong></td>\n<td><strong>Pathology</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>Reduced detrusor contractility</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Normal flow pattern</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Neurogenic bladder</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;In RGU, the urethra is visualized with the instillation of contrast into the&nbsp;<strong>anterior urethra</strong>&nbsp;(penile urethra and bulbar urethra). It is helpful for diagnosing&nbsp;<strong>anterior urethral abnormalities</strong>.</p>\n<p>The following image shows an RGU with bulbar urethral stricture:</p>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"ng-star-inserted\">\n<div class=\"h-400-scroll mb-2 ng-star-inserted\"><img class=\"img-fluid hover-max\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3e25e9ceb90c490d861289d850eac22ex608x520.PNG\" width=\"402\" height=\"344\"></div>\n<div class=\"h-400-scroll mb-2 ng-star-inserted\">The common causes of urethral stricture are:</div>\n<div class=\"h-400-scroll mb-2 ng-star-inserted\">\n<div class=\"page\" title=\"Page 1503\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Inflammatory</strong></td>\n<td><strong>Traumatic</strong></td>\n<td><strong>Iatrogenic</strong></td>\n</tr>\n<tr>\n<td>Urethritis</td>\n<td>Bulbar urethral injury<br><br></td>\n<td>Urethral instrumentation including catheterization and transurethral prostatectomy<br><br><br></td>\n</tr>\n<tr>\n<td>Balanitis xerotica obliterans (BXO)</td>\n<td>Pelvic fracture urethral disruption injury</td>\n<td>Radical prostatectomy</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Radiotherapy for prostate cancer</td>\n</tr>\n</tbody>\n</table>\n<p>Clinical features include hesitancy of micturition, straining to void and a poor urinary stream. Diagnosis is made by uroflowmetry, urethroscopy, urethrography and ultrasound scanning. Retrograde cystourethrography is the investigation of choice.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>The management of a urethral stricture&nbsp;depends on the site, the length, and the cause of the stricture. They include:</p>\n<ul>\n<li><strong>Endoscopic urethrotomy</strong> - The stricture is released using a knife passed through a <strong>rigid urethroscope</strong>.</li>\n<li><strong>Urethroplasty</strong> - <strong>Excision of the stenosed length</strong> of the urethra and <strong>re-anastomosis</strong>&nbsp;is done. A&nbsp;<strong>buccal mucosa graft</strong>&nbsp;can be used to bridge the gap. It is considered when a stricture is due to <strong>trauma</strong> or recurred following e<strong>ndoscopic treatment</strong>.&nbsp;</li>\n<li><strong>Urethral dilation</strong> - The <strong>urethra is stretched</strong> using urethral dilators. This is a blind procedure and it can cause <strong>injury</strong>. Hence, it is not done frequently.</li>\n<li><strong>Intermittent self-dilatation</strong> -&nbsp;In patients with <strong>recurrent strictures</strong> who are <strong>unable to undergo urethroplasty</strong>, then intermittent self-dilatation with soft hydrophilic catheters is done on a daily basis.</li>\n</ul>\n<p>In voiding cystourethrogram,&nbsp;after injecting contrast into the bladder using a Foleys catheter,&nbsp;the&nbsp;<strong>posterior urethra&nbsp;</strong>(membranous urethra and prostatic urethra)&nbsp;is visualized during micturition. It is the investigation of choice for&nbsp;<strong>vesicoureteric reflux</strong>&nbsp;(VUR) and&nbsp;<strong>posterior urethral valve</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-20",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD7186",
    "stauts": "Skipped",
    "question_title": "20.\n        A 30-year-old male who is a known case of ulcerative colitis presents with exacerbation of symptoms. His stool frequency suddenly increased to 10-12 times in the past 24 hours, with blood in stools. Investigations revealed a CRP of 60 mg/L. Which of the following is used to define the severity of this disease?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Truelove–Witts criteria\n                \n                  \n                    \nCorrect",
    "optionB": "B. McDonald’s criteria",
    "optionC": "C. Montreal classification",
    "optionD": "D. King's College Hospital Criteria",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given clinical scenario, the patient presented with <strong>acute severe ulcerative colitis</strong>.&nbsp;<strong>Truelove-Witts criteria</strong>&nbsp;is used to define acute severe colitis.</p>\n<p>Truelove-Witts criteria define acute severe colitis as the presence of:</p>\n<ol>\n<li><strong>≥ 6 bloody stools/24 hrs</strong></li>\n<li>Plus, one or more of the following features suggestive of systemic toxicity:\n<ul>\n<li>Anemia (Hemoglobin &lt;10 g/dL).</li>\n<li>Mild fever (&gt;100.04°F)<strong>.</strong></li>\n<li>Tachycardia (Pulse ≥90 beats/min).</li>\n<li>High inflammatory markers (ESR &gt; 30 mm/hr <strong>or</strong>&nbsp;CRP &gt;30 mg/L).</li>\n</ul>\n</li>\n</ol>\n<p>Other options :</p>\n<p>Option B: The 2017 <strong>revised&nbsp;McDonald’s criteria</strong>&nbsp;is used in the diagnosis of&nbsp;<strong>multiple sclerosis.&nbsp;</strong>It&nbsp;takes into consideration the clinical attacks and objective lesions. In addition, it also involves the assessment of the lesions based on MRI and other imaging techniques.</p>\n<p>Option C: The <strong>Montreal classification&nbsp;</strong>is<strong>&nbsp;</strong>used for classifying <strong>Crohn's disease</strong>.</p>\n<p>Option D:<strong> The King's College Hospital Criteria</strong>&nbsp;is a&nbsp;prognostic tool&nbsp;for patients with&nbsp;acute liver failure&nbsp;(ALF).</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1847: Inflammatory Bowel Disease (IBD)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Crohn's disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset&nbsp;</strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis&nbsp;with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td>&nbsp;None&nbsp;</td>\n<td>\n<p>Smoking&nbsp;</p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life&nbsp;</p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1&nbsp;</td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement&nbsp;</p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps&nbsp;</p>\n<p>Backwash ileitis&nbsp;</p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings&nbsp;</strong></td>\n<td>\n<p class=\"p1\">Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia&nbsp;&nbsp;</p>\n</td>\n<td>\n<p class=\"p1\">Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications&nbsp;</strong></td>\n<td>\n<p>Fistulas&nbsp;</p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings&nbsp;</strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Episcleritis, uveitis&nbsp;</p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 807\">\n<div class=\"page\" title=\"Page 807\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><br><br></p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-21",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MB3786",
    "stauts": "Correct",
    "question_title": "21.\n        Which of the following are membrane bound, pattern recognition receptors (PRRs)?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. NOD like receptors",
    "optionB": "B. Toll like receptors\n                \n                  \n                    \nCorrect",
    "optionC": "C. RIG-1 proteins",
    "optionD": "D. Peptidoglycan recognition proteins",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>membrane-bound, pattern recognition receptors (PRRs) </strong>from the following option are <strong>Toll-like receptors(TLR).</strong></p>\n<p>TLRs are the <strong>membrane-bound</strong> Pattern recognition receptors (<strong>PRRs</strong>). When pathogens breach the skin barrier, they encounter macrophages and other phagocytic cells equipped with specialized \"<strong>microbial sensors</strong>.\" These sensors include TLRs, <strong>NOD-like receptors</strong> (NLRs), <strong>RIG-I</strong>-like helicases, and <strong>MDA-5</strong>. Among these, TLRs are a crucial part of the <strong>innate immune response</strong>. They are evolutionarily conserved PRRs that detect <strong>pathogen-associated molecular patterns (PAMPs)</strong>, which are unique to each pathogen and are essential molecular structures required for the pathogens' survival.</p>\n<p>The PRRs are either <strong>localized</strong> on the <strong>cell surface</strong> to detect <strong>extracellular pathogens</strong> or within the <strong>endosomes</strong> and <strong>cellular matrix</strong> where they detect intracellular invading viruses. They are involved in activating <strong>pro-inflammatory signaling pathways</strong>, stimulating phagocytic responses (macrophages, neutrophils, and dendritic cells), or binding to micro-organisms as <strong>secreted proteins</strong>.</p>\n<p>Based on the localization and functional characteristics, PRRs are classified as</p>\n<ul>\n<li>\n<ul>\n<li><strong>Membrane-bound PRRs</strong> <br>\n<ul>\n<li>TLR</li>\n<li>C-type lectin receptors (CLR)</li>\n</ul>\n</li>\n<li><strong>Cytoplasmic (intracellular) PRRs</strong> <br>\n<ul>\n<li>Nucleotide oligomerization (NOD) like receptors (NLR) – these include NODs (NOD1 and NOD2).</li>\n<li>Retinoic acid-inducible gene I (RIG-I) like receptors (RLR)</li>\n</ul>\n</li>\n<li><strong>Secreted PRRs</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Peptidoglycan recognition proteins (PGRPs) </strong>are a group of proteins that play a crucial role in the<strong> innate immune system </strong>by <strong>recognizing </strong>and <strong>binding</strong> to<strong> peptidoglycan</strong>, a major component of bacterial cell walls. Their levels often <strong>increase</strong> in response to<strong> bacterial presence, </strong>mediating<strong> immune responses.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-22",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3099",
    "stauts": "Correct",
    "question_title": "22.\n        A 23-year-old G2P1 lady with a previous history of cesarean section was found to have placenta accreta on ultrasonography. Imperfect development of which layer leads to this condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/8c44476505fd4b63a505a21b81b017c5.JPEG\">",
    "optionA": "A. 2",
    "optionB": "B. 1\n                \n                  \n                    \nCorrect",
    "optionC": "C. 3",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p class=\"p1\">Imperfect development of the <strong>Nitabuch</strong>&nbsp;layer,<strong>&nbsp;</strong>which is marked as&nbsp;<strong>1</strong> in the given image, leads to <strong>placenta accreta</strong>.</p>\n<p class=\"p1\">The other structures marked in the image are: <strong>2</strong> and <strong>4</strong> are <strong>cytotrophoblast</strong> and <strong>3</strong> is <strong>inner syncytiotrophoblast</strong>.&nbsp;</p>\n<p class=\"p1\"><strong>Placenta accreta</strong>&nbsp;is a condition in which the placenta is directly attached to the&nbsp;<span class=\"s1\">myometrium either&nbsp;</span>partially or completely without any intervening decidua. This abnormal attachment to myometrium&nbsp;is due to the partial&nbsp;or total absence of the&nbsp;<strong>decidua&nbsp;basalis</strong>&nbsp;and&nbsp;imperfect development of the <strong>Nitabuch&nbsp;layer</strong>.</p>\n<p class=\"p1\">The <strong>definitive placenta </strong>consists of the <strong>chorionic plate</strong> on the fetal aspect and a <strong>basal plate</strong> on the maternal aspect with the intervillous space between them. The structures in each of these parts are as follows:&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00df0e967b934f8e8dd41c2cf5fec8c2x1280x1831.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><span class=\"ILfuVd\" lang=\"en\"><span class=\"hgKElc\"><strong>Morbidly adherent placenta</strong> (MAP) occurs when the placenta fails to detach from the uterine wall and these include:&nbsp;</span></span></p>\n<ul>\n<li><strong>Placenta&nbsp;accreta&nbsp;</strong>- villi&nbsp;are attached to the&nbsp;myometrium</li>\n<li>Placenta&nbsp;increta - villi invade the&nbsp;myometrium</li>\n<li>Placenta&nbsp;percreta - villi&nbsp;penetrate through the&nbsp;myometrium&nbsp;and to or through the&nbsp;serosa</li>\n</ul>\n<p>The image given below shows different types of morbidly adherent placenta.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/48a592d10403431ebcb2b4e5809af151x600x1200.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Risk factors for MAP include <strong>prior cesarean delivery,</strong> placenta previa, prior uterine surgeries like hysterotomy, prior curettage, and endometrial ablation.</p>\n<p><strong>Ultrasound imaging</strong>, <strong>color doppler,&nbsp;</strong>and <strong>MRI</strong> have all been helpful in the diagnosis of MAP during pregnancy.</p>\n<p class=\"p1\"><span class=\"s1\">Management:</span></p>\n<ul>\n<li class=\"p1\"><span class=\"s1\"><strong>Partial placenta accreta</strong> - p</span>lacental tissue is removed and bleeding areas are oversewed.</li>\n<li class=\"p1\"><span class=\"s1\"><strong>Total placenta accreta -&nbsp;</strong></span>\n<ul>\n<li class=\"p1\">Parous women - hysterectomy is done&nbsp;</li>\n<li class=\"p1\">If the patient desires to have a child - the umbilical cord is cut close to its base so that the placenta left behind gets autolyzed</li>\n</ul>\n</li>\n<li class=\"p1\">If MAP&nbsp;<strong>invades </strong>the<strong> bladder</strong>, hysterectomy and partial cystectomy are required.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-23",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME2398",
    "stauts": "Skipped",
    "question_title": "23.\n        Pick out the incorrect statements regarding the 'RHIME' Model.",
    "question_ADD": "<ol>\n<li><span data-preserver-spaces=\"true\">RHIME model was introduced by the Central Administration and Sample Registration System (SRS) to record maternal deaths utilizing a verbal autopsy.</span></li>\n<li><span data-preserver-spaces=\"true\">RHIME stands for Representative, Re-sampled, Routine Household Interview of Mortality with Medical Evaluation.&nbsp;</span></li>\n<li><span data-preserver-spaces=\"true\">It is usually conducted by the ASHA worker in her area.</span></li>\n<li><span data-preserver-spaces=\"true\">Information is collected in a form on the symptoms, signs, and key circumstances leading to death.</span></li>\n<li><span data-preserver-spaces=\"true\">After the information is collected, the assignment on the cause of death as per ICD-10 guidelines is done by a team of two general physicians together.&nbsp;</span></li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 2, 3, 4, and 5",
    "optionB": "B. 2, 4, and 5 only",
    "optionC": "C. 3 and 5 only\n                \n                  \n                    \nCorrect",
    "optionD": "D. 1 and 3 only",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The incorrect statements are&nbsp;<strong>3 and 5.&nbsp;</strong></p>\n<p>The information is&nbsp;<span>usually collected by the <strong>trained SRS field worker.&nbsp;</strong>This is not included in the roles and responsibilities of an&nbsp;ASHA worker. Also, after the information is collected, the assignment on the cause of death as per ICD-10 guidelines is done by two general physicians&nbsp;<strong>independently.&nbsp;</strong></span>If disagreements are noted between the two doctors, then the opinion of a&nbsp;<strong>third doctor&nbsp;</strong>is obtained.&nbsp;</p>\n<p><strong>RHIME MODEL:</strong></p>\n<ul>\n<li><span>RHIME stands for <strong>R</strong>epresentative, <strong>R</strong>e-sampled, <strong>R</strong>outine <strong>H</strong>ousehold <strong>I</strong>nterview of <strong>M</strong>ortality with <strong>M</strong>edical <strong>E</strong>valuation.</span></li>\n<li><span>RHIME model was introduced by the Central Administration and <strong>Sample Registration System</strong> (SRS) to record maternal deaths utilizing a <strong>verbal autopsy.</strong></span></li>\n<li><span>Information is collected in a form on the symptoms, signs, and key circumstances leading to death.</span></li>\n<li><span>The information is&nbsp;usually collected by the <strong>trained SRS field worker.&nbsp;</strong></span></li>\n<li><span>After the information is collected, the assignment on the cause of death as per <strong>ICD-10 guidelines</strong> is done by two general physicians&nbsp;independently.&nbsp;If disagreements are noted between the two doctors, then the opinion of a&nbsp;third doctor&nbsp;is obtained.&nbsp;</span></li>\n<li><span>Web-based systems are developed for such studies.</span></li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1698: Maternal Mortality Ratio</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Maternal death</strong> is defined as the death of a woman <strong>while pregnant or within 42 days of termination of pregnancy</strong>, irrespective of the duration and site of pregnancy, from <strong>any cause related to or aggravated by the pregnancy</strong> or its management but not from accidental or incidental causes.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/19493f9439a24b529b7a098cbbce594cx1280x644.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The main global causes of maternal deaths are <strong>severe bleeding, indirect causes</strong> (anemia, malaria, heart diseases), <strong>infections, unsafe abortions, eclampsia, obstructed labor,</strong> and other direct causes like ectopic pregnancy, anesthesia-related complications, etc.</p>\n<p>In India, the most common causes of maternal deaths are hemorrhage (leading cause), sepsis, obstructed labor, hypertensive disorders, etc.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0156: ASHA</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>ASHA stands for&nbsp;<strong>Accredited Social Health Activist.</strong></p>\n<p>General norms with respect to ASHA workers:</p>\n<ul>\n<li>Must be a <strong>woman</strong>&nbsp;in the age group of 25-45 years -&nbsp;married/divorced/widow</li>\n<li>Must be a <strong>resident</strong> of that village</li>\n<li>Formal education of up to <strong>10<sup>th</sup> standard&nbsp;</strong>\n<ul>\n<li>If no candidates are available, the requirement can be relaxed to the 8<sup>th</sup> standard</li>\n</ul>\n</li>\n<li>At least <strong>1 ASHA</strong> for a <strong>population of 1000&nbsp;</strong>\n<ul>\n<li>In tribal, hilly, and desert areas, the norm can be relaxed to 1 ASHA per habitation</li>\n</ul>\n</li>\n</ul>\n<p>States can relax the norms on population and educational qualifications on a case-to-case basis, depending on the local conditions. However, these are exceptions and not the general norm.</p>\n<p><strong>Responsibilities </strong>of ASHA:</p>\n<ul>\n<ul>\n<li>Health <strong>education</strong> and awareness</li>\n<li><strong>Reproductive and child health</strong> and family planning</li>\n<li>Facilitate the access to health services</li>\n<li>Promotion of <strong>sanitation</strong> and household toilet construction</li>\n<li>Provision of primary medical care for <strong>minor ailments</strong></li>\n<li>Provider of <strong>DOTS</strong></li>\n<li><strong>Depot holder</strong> of essentials like ORS, iron and folic acid tablets, condoms, disposable delivery kits, etc.</li>\n<li>Dispersal of <strong>health information</strong> on her community to higher centres</li>\n<li>Some responsibilities are integrated with Anganwadi workers and Auxiliary Nurse Midwife</li>\n</ul>\n</ul>\n<p>Home visits by ASHA under Home-based Newborn care (HBNC)&nbsp;</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\">\n<li><strong>7 visits</strong> after <strong>home delivery</strong> (on days 1, 3, 7, 14, 21, 28 and 42)</li>\n<li><strong>6 visits</strong> after <strong>institutional delivery</strong> (on days 3, 7, 14, 21, 28 and 42) in case of a <strong>vaginal delivery</strong>; and <strong>5 visits</strong> in cases of <strong>Caesarean section</strong> delivery, where the mother returns home after 5-6 days, i.e, on days - 7, 14, 21, 28 and 42.</li>\n</ul>\n<p>Home visits by ASHA under Home-based care of young child (HBYC)</p>\n<ul>\n<li>A total of&nbsp;<strong>5 visits</strong>&nbsp;are scheduled&nbsp;<strong>after 42 days</strong>&nbsp;under the&nbsp;<strong>Home-Based Care of the Young Child(HBYC).</strong></li>\n<li>ASHA will provide <strong>quarterly home visits</strong> on the 3rd, 6th, 9th, 12th and 15th months</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-24",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF2363",
    "stauts": "Correct",
    "question_title": "24.\n        A 30-year-old G2P1L1 woman is 18 weeks pregnant. She mentions that her previous labor was prolonged and tedious and eventually the doctor used an instrument to deliver her first child. Which of the following measurements would point towards the diagnosis of cephalo-pelvic disproportion at the pelvic inlet?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Interspinous diameter  < 8 cm",
    "optionB": "B. Diagonal conjugate  < 11.5 cm\n                \n                  \n                    \nCorrect",
    "optionC": "C. Interischial diameter  < 8 cm",
    "optionD": "D. Transverse diameter < 13 cm",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario is suggestive of the diagnosis as <strong>cephalo-pelvic disproportion (CPD).</strong> Cephalo-pelvic disproportion at the pelvic <strong>inlet</strong> is diagnosed when the <strong>diagonal conjugate &lt; 11.5 cm.</strong></p>\n<div class=\"page\" title=\"Page 432\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Disproportion with respect to the maternal pelvis is a state where the normal proportion between the size of the fetus to the size of the pelvis is disturbed. The disparity in the relation between the head and the pelvis is called cephalopelvic disproportion.</p>\n<p>It can either occur due to an average size baby with a small pelvis or a relatively large baby with a normal pelvis. A&nbsp;history of <strong>prolonged or tedious</strong> <strong>labor</strong>, followed by either spontaneous or difficult <strong>instrumental delivery</strong> is suggestive of <strong>pelvic contraction</strong>. Difficult vaginal delivery ending in a stillborn or neonatal death without any etiological factor also suggests a contracted pelvis. Past history of fracture, <strong>rickets, osteomalacia, tuberculosis</strong> of the pelvic joints or spines, and <strong>poliomyelitis</strong> is elicited.</p>\n<p>CPD can occur at the inlet, mid pelvis, or at the pelvic outlet. It is diagnosed at these levels by the following measurements.</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong>Inlet CPD</strong>\n<ul>\n<li>Anteroposterior diameter &lt; 10 cm</li>\n<li><strong>Diagonal conjugate &lt; 11.5 cm</strong></li>\n<li><strong>Transverse diameter &lt; 12 cm.</strong></li>\n</ul>\n</li>\n<li><strong>Midpelvis CPD</strong>\n<ul>\n<li>Sum of the interspinous and posterior sagittal diameters of the mid pelvis &lt;/= 13.5 cm</li>\n<li><strong>Interspinous diameter &lt; 8 cm</strong></li>\n</ul>\n</li>\n<li><strong>Outlet CPD</strong>\n<ul>\n<li><strong>Interischial diameter &lt;/= 8 cm.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-25",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA1730",
    "stauts": "Correct",
    "question_title": "25.\n        The following type of wound can be seen in all, except ?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/5ed8a58d1c9a4f0ebe14d00dd742ebd4.PNG\">",
    "optionA": "A. Bursting of skull",
    "optionB": "B. Firearm Exit wound",
    "optionC": "C. Contact shot",
    "optionD": "D. Close shot\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above image shows a <strong>stellate/ cruciate type </strong>of wound, which is seen in a contact shot, <strong>not </strong>in a&nbsp;close shot.</p>\n<p><strong>Close-shot</strong> wound features include wounds with the victim within a range of <strong>5 </strong>to<strong> 8 cm</strong>, characterized by <strong>circular shapes</strong> with <strong>inverted edges</strong>. Notable signs include <strong>blackening</strong> and <strong>tattooing</strong> around the wound area. Additionally, there may be burning of hair, along with abrasion and the presence of a <strong>grease collar</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Bursting</strong> of the <strong>skull</strong> is associated with a <strong>contact shot wound</strong>. &nbsp;</p>\n<p>Option B: <strong>Firearm exit wounds</strong> can be of various shapes, such as round, <strong>cruciate</strong>, stellate, elliptical, or crescent-shaped. Exit wounds of the head are usually star-shaped.</p>\n<p>Option C: <strong>Contact shot </strong>features are :</p>\n<ul>\n<li>An imprint of muzzle around the wound – Recoil abrasion.</li>\n<li>Back spatter -&nbsp;Sucking of tissue, Cloth fibers, inside the barrel.</li>\n<li>Pinkish-red discoloration due to CO.</li>\n<li>Shape -&nbsp;<strong>Stellate, Cruciate, Elliptical</strong>.</li>\n<li>Margins - everted.</li>\n<li>Bursting fractures – In head wounds.</li>\n<li>Cavitation - abdominal wounds.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-26",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0846",
    "stauts": "Incorrect",
    "question_title": "26.\n        Which of the following is likely to be elicited from the history of a patient with the following ocular finding?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/55e8c6e8243045c9aa213b852f3bb769.JPEG\">",
    "optionA": "A. History of working with infrared radiation",
    "optionB": "B. History of use of steroids\n                \n                  \n                    \nCorrect",
    "optionC": "C. History of chronic dacryocystitis",
    "optionD": "D. History of contact lens usage\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above lesion is a <strong>geographic ulcer, </strong>which represents corneal ulceration due to a worsened dendritic ulcer or reactivation of<strong>&nbsp;herpes simplex</strong> virus, commonly following history of<strong> immunosuppression and steroid usage.</strong></p>\n<p>Herpetic simplex keratitis, also known as <strong>herpetic keratoconjunctivitis</strong> and<strong> herpes viral keratitis</strong>, is a form of keratitis caused by recurrent herpes simplex virus (HSV) infection in the cornea.</p>\n<p>The<strong> classic herpetic lesion</strong> consists of a <strong>linear branching corneal ulcer (dendritic ulcer)</strong>. The ulcer is initially superficial and spreads in all directions as grey striae, which extend and increase in length.&nbsp;Patients with epithelial keratitis complain of<strong> foreign-body sensation, light sensitivity, redness,</strong> and<strong> blurred vision</strong> associated with focal or diffuse <strong>reduction in corneal sensation. Stromal keratitis </strong>manifests as a <strong>disc-shaped </strong>area of <strong>corneal edema. </strong>In patients who are<strong> immunocompromised</strong> due to pre-existing disease or using <strong>corticosteroids</strong>, the<strong> ulcer may become large</strong>; in such cases, the lesion is called a <strong>geographic ulcer.</strong></p>\n<p>Corneal ulcers can be <strong>detected with</strong> the help of <strong>fluorescein sodium dye</strong> and a <strong>cobalt-blue filter</strong>. The<strong> epithelial defect</strong> of the cornea appears <strong>opaque green</strong> with a cobalt blue filter.&nbsp;</p>\n<p>Treatment: <strong>Topical antivirals </strong>such as<strong> 1% Trifluorothymidine drops, 3% acyclovir ointment, 3% vidarabine ointment </strong>are the first-line treatment. Systemic antivirals in cases of increased severity or recurrence. Topical antibiotics to prevent secondary bacterial infection</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0710: Ocular lesions of Herpes Simplex</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Primary herpes:</strong></p>\n<ul>\n<li>Cornea\n<ul>\n<li>Fine <strong>epithelial</strong> punctate keratitis</li>\n<li>Coarse <strong>epithelial</strong> punctate keratitis</li>\n<li><strong>Dendritic</strong> ulcer</li>\n</ul>\n</li>\n<li>Conjunctiva: acute follicular conjunctivitis</li>\n<li>Skin lesions</li>\n</ul>\n<p><strong> Recurrent herpes:</strong></p>\n<ul>\n<li>Active epithelial keratitis\n<ul>\n<li>Punctate <strong>epithelial</strong> keratitis</li>\n<li><strong>Dendritic</strong> ulcer</li>\n<li><strong>Geographica</strong>l ulcer</li>\n</ul>\n</li>\n<li>Stromal keratitis</li>\n<li><strong>Disciform</strong> keratitis</li>\n<li><strong>Diffuse</strong> stromal necrotic keratitis</li>\n<li>Trophic keratitis (meta-herpetic)</li>\n<li>Herpetic iridocyclitis</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a1db947bf72446dc836793b85945c4a9x1280x2341.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-27",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3324",
    "stauts": "Incorrect",
    "question_title": "27.\n        The instrument shown in the image is used for _______",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/6355239fc4e64a0fb5f35bb5d161065a.JPEG\">",
    "optionA": "A. Measuring the degree of heterophoria",
    "optionB": "B. Testing color vision\n                \n                  \n                    \nCorrect",
    "optionC": "C. Refining the power and axis of cylindrical lens\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Measuring intraocular pressure",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows an<strong> anomaloscope,</strong> which is used for <strong>testing colour vision.</strong></p>\n<p>An anomaloscope is based on a <strong>colour match</strong>. On one side, you have a <strong>yellow color</strong> which can be adjusted in <strong>brightness</strong>. The other side consists of a <strong>red and a green light</strong> whereas the proportion of mixture is variable.</p>\n<p><strong>Jackson’s cross cylinder (flip-cross technique);</strong>&nbsp;used to refine the&nbsp;<strong>power and axis of the cylindrical lens </strong>is shown below.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0372a10f374844d4aefab1e3ef7e451dx720x518.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Maddox rod consists of parallel red or colorless cylinders stacked together. Maddox rod test is a macular function test used to measure the degree of heterotropia or heterophoria in cases of torsional diplopia.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b49efb09e644acf8fbc80f860d08f16x600x695.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Intraocular pressure is measured by tonometry.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-28",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8796",
    "stauts": "Correct",
    "question_title": "28.\n        The complications associated with refeeding syndrome are:",
    "question_ADD": "<ol>\n<li>Hyperkalemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypercalcemia</li>\n<li>Hypophosphatemia</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1 and 3",
    "optionB": "B. 2 and 4\n                \n                  \n                    \nCorrect",
    "optionC": "C. 1, 2, and 4",
    "optionD": "D. 1, 2, 3, and 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Hypomagnesemia</strong> and <strong>hypophosphatemia,</strong> both occur in <strong>refeeding syndrome.</strong></p>\n<p>Options 1 and 3 are false as, <strong>hypokalemia </strong>and <strong>hypocalcemia</strong> (NOT hyper), are <strong>complications</strong> of refeeding syndrome.</p>\n<p><strong>Refeeding syndrome </strong>is a fatal condition that can occur with rapid and excessive feeding of patients with <strong>severe underlying malnutrition</strong> which may be due to:</p>\n<ul>\n<li>Starvation</li>\n<li>Alcoholism</li>\n<li>Delayed nutritional support</li>\n<li>Anorexia nervosa</li>\n<li>Massive weight loss in obese patients</li>\n</ul>\n<p>With excessive refeeding, there is a <strong>shift in metabolism</strong> from fat to carbohydrate substrate which stimulates <strong>excessive insulin release</strong>. As a result, there is an increase in the cellular uptake of electrolytes, particularly phosphate, magnesium, potassium, and calcium.</p>\n<p>Hence the metabolic abnormalities include:</p>\n<ul>\n<li>Hypophosphatemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypokalemia</li>\n<li>Hypocalcemia</li>\n</ul>\n<p>These electrolyte disorders can result in <strong>myocardial infarction, arrhythmias, respiratory dysfunction, liver dysfunction</strong>, seizures, confusion, <strong>coma,</strong> tetany, and death.</p>\n<p>The condition may be <strong>prevented</strong> by instituting the caloric repletion <strong>slowly and gradually </strong>increasing it over the first week.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2166: Complications of total parenteral nutrition</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>A. Related to nutrient deficiency</strong></p>\n<ul>\n<li>Hypoglycemia/hypocalcaemia/hypophosphatemia/hypomagnesaemia (<strong>refeeding syndrome</strong>)</li>\n<li>Chronic deficiency syndromes (essential fatty acids,&nbsp;<strong>zinc</strong>, mineral and trace elements)</li>\n</ul>\n<p><strong>B. Related to overfeeding</strong></p>\n<ul>\n<li><strong>Excess glucose:</strong>&nbsp;Hyperglycemia, hyperosmolar dehydration, hepatic steatosis, hypercapnia, increased sympathetic activity, fluid retention, electrolyte abnormalities</li>\n<li><strong>Excess fat:</strong>&nbsp;Hypercholesterolemia and formation of lipoprotein X, hypertriglyceridemia, hypersensitivity reactions</li>\n<li><strong>Excess amino acids:</strong>&nbsp;Hyperchloremic metabolic acidosis, hypercalcemia, aminoacidemia, uremia</li>\n</ul>\n<p><strong>C. Related to sepsis</strong></p>\n<ul>\n<li>Catheter-related sepsis</li>\n<li>Possible increased predisposition to systemic sepsis</li>\n</ul>\n<p><strong>D. Related to IV line</strong></p>\n<ul>\n<li><strong>On insertion:</strong>&nbsp;Pneumothorax, damage to adjacent artery, air embolism, thoracic duct damage, cardiac perforation or tamponade, pleural effusion, hydro mediastinum</li>\n<li><strong>Long-term use:</strong>&nbsp;Occlusion, venous thrombosis</li>\n</ul>\n<p><strong>E. Related to motility</strong></p>\n<ul>\n<li>Cholestasis</li>\n<li><strong>Gallstones</strong></li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-29",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC8724",
    "stauts": "Skipped",
    "question_title": "29.\n        Which of the following paraneoplastic conditions is matched incorrectly with the malignancy?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Necrolytic migratory erythema-Glucagonoma",
    "optionB": "B. Pityriasis rotunda-Hepatocellular carcinoma",
    "optionC": "C. Erythema gyratum repens-Lung cancer",
    "optionD": "D. Sign of Leser-Trelat-Carcinoid syndrome\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Sign of <strong>Leser-Trelat</strong> is associated with <strong>gastrointestinal adenocarcinoma.</strong></p>\n<p>It is characterized by the<strong> sudden appearance</strong> or <strong>rapid increase</strong> in number and size of<strong> seborrheic keratoses,</strong> which are benign skin lesions.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/aaa80db950b542268e6be28b1c2ba737x707x900.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Necrolytic migratory erythema</strong> is a<strong> red, blistering and eroding</strong> skin lesions that form painful and itchy plaques. These are often associated with<strong> glucagonoma,</strong> a rare pancreatic neuroendocrine tumor that secretes excessive amounts of glucagon.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3081977bfbda4675a5105c36be4858cex1200x894.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Pityriasis rotunda</strong> is commonly associated with <strong>hepatocellular carcinoma</strong>. It is characterized by discrete, round, scaly, pigmented patches.</p>\n<p><strong>Erythema gyratum repens</strong> is most frequently associated with <strong>lung cancer</strong>. It is characterized by figurate erythema commonly with <strong>concentric erythematous bands</strong> forming a <strong>wood-grain appearance</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcb397232b8d4498ae687f5e3d6efbb9x675x899.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0272: Paraneoplastic Syndromes and Underlying Cancers</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"0\" width=\"472\">\n<tbody>\n<tr>\n<td width=\"157\">\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td width=\"157\">\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td width=\"157\">\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Cushing Syndrome</p>\n</td>\n<td width=\"157\">\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td width=\"157\">\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td width=\"157\">\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td width=\"157\">\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Hypercalcemia</p>\n</td>\n<td width=\"157\">\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td width=\"157\">\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Hypoglycaemia</p>\n</td>\n<td width=\"157\">\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td width=\"157\">\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Polycythemia</p>\n</td>\n<td width=\"157\">\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td width=\"157\">\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td width=\"157\">\n<p>Osteomalacia</p>\n</td>\n<td width=\"157\">\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td width=\"157\">\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2060: Paraneoplastic dermatoses</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Cutaneous markers and their commonly associated internal malignancy:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Skin condition</strong></td>\n<td><strong>Most commonly associated malignancy</strong></td>\n</tr>\n<tr>\n<td>Acanthosis nigricans</td>\n<td>Gastric adenocarcinoma</td>\n</tr>\n<tr>\n<td>Acanthosis palmaris</td>\n<td>Bronchial carcinoma</td>\n</tr>\n<tr>\n<td>Sign of LeserTrélat</td>\n<td>Gastrointestinal adenocarcinoma</td>\n</tr>\n<tr>\n<td>Acquired-ichthyosis</td>\n<td>Hodgkin disease</td>\n</tr>\n<tr>\n<td>Pityriasis rotunda</td>\n<td>Hepatocellular carcinoma</td>\n</tr>\n<tr>\n<td>Paraneoplastic pigmentation</td>\n<td>Small cell bronchial carcinoma</td>\n</tr>\n<tr>\n<td>Acrokeratosis paraneoplastica</td>\n<td>Squamous cell carcinoma of the upper respiratory or gastrointestinal<br>tracts</td>\n</tr>\n<tr>\n<td>Erythema gyratum-repens</td>\n<td>Lung cancer</td>\n</tr>\n<tr>\n<td>Necrolytic migratory erythema</td>\n<td>Glucagon secreting<br>pancreatic islet cell adenoma</td>\n</tr>\n<tr>\n<td>Dermatomyositis</td>\n<td>Lung cancer in men, breast and gynaecological tumours in women and&nbsp;colorectal cancers in both sexes</td>\n</tr>\n<tr>\n<td>Scleroderma‐like skin changes</td>\n<td>Carcinoid syndrome</td>\n</tr>\n<tr>\n<td>Paraneoplastic pemphigus</td>\n<td>B‐cell proliferations and thymoma or thymoma‐like neoplasms; specifically Non Hodgkin's lymphoma (42%)</td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis</td>\n<td>Lymphoma</td>\n</tr>\n<tr>\n<td>Porphyria cutanea- tarda and variegate porphyrias</td>\n<td>Hepatocellular Carcinoma</td>\n</tr>\n<tr>\n<td>Erythroderma and exfoliative dermatitis</td>\n<td>Mycosis fungoides or&nbsp;Sézary syndrome</td>\n</tr>\n<tr>\n<td>Pyoderma gangrenosum</td>\n<td>Hematological malignancy</td>\n</tr>\n<tr>\n<td>Sweet syndrome</td>\n<td>Hematological malignancy</td>\n</tr>\n<tr>\n<td>Migratory thrombo-phlebitis (Trousseau's syndrome)</td>\n<td>Carcinoma Pancreas</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-30",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8980",
    "stauts": "Correct",
    "question_title": "30.\n        Assertion: Oral and Intravenous doses of Linezolid are the same.\nReason: Linezolid has 100% bioavailability.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Both Assertion and Reasons are true and the Reason is the correct explanation for the Assertion\n                \n                  \n                    \nCorrect",
    "optionB": "B. Both Assertion and Reasons are true, but the Reason is not the correct explanation for the Assertion",
    "optionC": "C. The assertion is true, but the Reasons is false",
    "optionD": "D. The assertion is false, but the Reasons is true",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Linezolid</strong> is well absorbed orally and the<strong> bioavailability </strong>is<strong> 100%</strong>. So, <strong>intravenous and oral doses</strong> for linezolid are the <strong>same</strong>. So, both assertion and reason are independently true/correct statements and the reason is the correct explanation for the assertion.</p>\n<p>Linezolid exhibits excellent <strong>oral bioavailability</strong> (<strong>100%</strong>) and can be taken with or without food, with no difference in dosing between oral and intravenous forms. Its <strong>half-life </strong>is approximately <strong>4-6 hours</strong> and 30% protein bound, distributing widely to well-perfused tissues. The drug undergoes <strong>nonenzymatic oxidation</strong> to aminoethoxyacetic acid and hydroxyethyl glycine derivatives. About <strong>80%</strong> of the administered dose <strong>appears in urine</strong>, while 10% is excreted via feces. <strong>No dose adjustment</strong> is necessary for <strong>renal insufficiency</strong>, although linezolid and its metabolites are dialyzable, requiring administration post-hemodialysis.</p>\n<p><strong>Linezolid</strong> binds to the <strong>P site of the 50s ribosomal subunit </strong>and<strong> inhibits bacterial protein synthesis</strong>. It is an&nbsp;<strong>oxazolidinone </strong>that is active against various resistant organisms including MRSA. Linezolid is associated with the side effects of <strong>myelosuppression</strong>( anemia, leukopenia, pancytopenia, and thrombocytopenia) and <strong>serotonin syndrome</strong> due to <strong>monoamine oxidase(MAO) inhibition</strong>. <strong>Thrombocytopenia</strong> is the<strong> most common side effect</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-31",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME9619",
    "stauts": "Incorrect",
    "question_title": "31.\n        An elderly patient was started with metformin therapy for the newly diagnosed type 2 diabetes mellitus. However, after 3 months, there was no significant decline in the HbA1c levels. The doctor decides to start injectable exenatide for this patient. This drug is an analogue of a hormone that is released in our gastrointestinal system. Which of the following will not be seen during this therapy?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Increased gastric emptying\n                \n                  \n                    \nCorrect",
    "optionB": "B. Weight loss\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Inhibition of glucagon release",
    "optionD": "D. Increased release of insulin from the pancreas",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Exenatide&nbsp;</strong>is a glucagon-like peptide-1 analogue known to cause <strong>delayed gastric emptying.</strong></p>\n<p>&nbsp;Glucagon-like peptides are derived from proglucagon and are secreted by <strong>intestinal L cells.&nbsp;</strong>They are released after the meals. Their main actions are</p>\n<ul>\n<li><strong>Stimulate insulin secretion</strong> leading to decreased blood sugar levels</li>\n<li>Inhibit glucagon release</li>\n<li>Delay gastric emptying</li>\n<li><strong>Decrease food intake</strong> leading to <strong>weight loss</strong></li>\n</ul>\n<p>These peptides are inactivated by dipeptidyl peptidase-4 (DPP-4).&nbsp;</p>\n<p><strong>Clinical correlate</strong><span><strong>—</strong>GLP-1 receptor agonists have been used in the treatment of&nbsp;<strong>diabetes mellitus.</strong>&nbsp;They are exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, etc. Because they cause&nbsp;<strong>weight loss</strong>, they can be used in the management of diabetes in<strong>&nbsp;obese patients.</strong> Since they are peptide hormones, they are metabolised if given orally and must</span>&nbsp;be given through a percutaneous route.</p>\n<p><strong>Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as alogliptin, linagliptin, saxagliptin, sitagliptin, and vildagliptin, have also been used in the management of diabetes mellitus. These inhibitors</strong>&nbsp;increase the plasma concentrations of GLP-1 and its analogues.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1290: Source and actions of gastrointestinal hormones</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Action</strong></p>\n</td>\n<td>\n<p><strong>Gastrin</strong></p>\n</td>\n<td>\n<p><strong>CCK</strong></p>\n</td>\n<td>\n<p><strong>Secretin</strong></p>\n</td>\n<td>\n<p><strong>GIP</strong></p>\n</td>\n<td>\n<p><strong>Motilin</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p>G cells in the stomach (antrum)</p>\n</td>\n<td>\n<p>I cells of duodenum and jejunum</p>\n</td>\n<td>\n<p>S cells deep in the mucosa of upper small intestine</p>\n</td>\n<td>\n<p>K cells in mucosa of duodenum and jejunum</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 749\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mo cells of the duodenum and jejunum</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Acid secretion</strong></p>\n</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>I</td>\n<td>I</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastric emptying</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>I</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pancreatic HCO<sup>3-</sup></strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pancreatic enzymes</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin release</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;S</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gall bladder contraction</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Biliary&nbsp;</strong></p>\n<p><strong>HCO<sup>3-</sup></strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastric motility</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>S</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intestinal motility</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>S</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucosal growth</strong></p>\n</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Exocrine pancreas growth</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><strong>KEY</strong></p>\n<p>S→Stimulates</p>\n<p>I→ Inhibits</p>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1289: Hormones/Paracrines regulating gastrointestinal function</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Hormones/Paracrines</strong></p>\n</td>\n<td>\n<p><strong>Cells</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastrin</strong></p>\n</td>\n<td>\n<p>G cells in the stomach (antrum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CCK</strong></p>\n</td>\n<td>\n<p>I cells of duodenum and jejunum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secretin</strong></p>\n</td>\n<td>\n<p>S cells deep in the mucosa of upper small intestine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>GIP</strong></p>\n</td>\n<td>\n<p>K cells in mucosa of duodenum and jejunum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Somatostatin</strong></p>\n</td>\n<td>\n<p>D cells of pancreatic islets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucagon</strong></p>\n</td>\n<td>\n<p>A cells of pancreatic islets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Motilin </strong></p>\n</td>\n<td>\n<p>Enterochromaffin cells and Mo cells in stomach, small intestine, and colon</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-32",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA1740",
    "stauts": "Skipped",
    "question_title": "32.\n        The following ossification centres are present before birth except",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Talus",
    "optionB": "B. Calcaneum",
    "optionC": "C. Mandible",
    "optionD": "D. Head of femur\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Head of femur appears at 6 months to 1 year of age.</p>\n<p><strong>Ossification centres present before birth:</strong></p>\n<ul>\n<li>2 months – upper segment of sacrum, mandible.</li>\n<li>3 months – middle segment of sacrum.</li>\n<li>6 months – Calcaneum.</li>\n<li>7 months – talus.</li>\n<li>8 months – lower segment of sacrum.</li>\n<li>9 months – lower end of femur.</li>\n<li>10 months – upper end of tibia.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-33",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6756",
    "stauts": "Incorrect",
    "question_title": "33.\n        A 45-year-old man has the following lesion over the face. The patient is apprehensive about history of brain tumors and similar skin pathologies in the family. On examination he had scoliosis and Chest X ray  revealed bifid ribs. Which of the following  gene mutation can be expected in this patient?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/99e537e159e74e1cae55473736ea6322.JPEG\">",
    "optionA": "A. PTEN gene\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. VHL gene",
    "optionC": "C. PTCH gene\n                \n                  \n                    \nCorrect",
    "optionD": "D. APC gene",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given family histories <strong>brain tumours</strong>, with the image showing an ulcer over the face with pearly, rolled-out borders suggestive<strong> basal cell carcinoma</strong> and association of <strong>bifid ribs </strong>and<strong> vertebral anomalies</strong>&nbsp;likely points to the diagnosis of <strong>Gorlin syndrome</strong>. Mutation of <strong>PTCH gene </strong>is seen in this condition.</p>\n<p><strong>Gorlin syndrome</strong> also known as <strong>nevoid basal cell carcinoma &nbsp;syndrome</strong> is an <strong>autosomal dominant </strong>condition caused by mutations in the <strong>PTCH gene</strong> which codes for <strong>PATCHED protiens</strong>. In the absence of PATCHED proteins, there is unopposed Hedgehog signaling that increases the expression of a number of pro-growth genes. It is associated with a high risk of <strong>basal cell carcinoma </strong>and<strong> medulloblastoma.</strong></p>\n<p>Other&nbsp;features that can be seen associated are:</p>\n<ul>\n<li>Highly characteristic facies (with large forehead)</li>\n<li><strong>Bifid or misshapen ribs</strong></li>\n<li>Vertebral and other skeletal anomalies (Scoliosis)</li>\n<li><strong>Pits of the skin of the palms and soles</strong></li>\n<li>Dysgenesis of the corpus callosum</li>\n<li>Calcification of the falx cerebri (at an earlier age than is seen in non‐affected individuals)</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-160X-7-2/MediaObjects/13005_2009_Article_194_Fig1_HTML.jpg?as=webp\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:&nbsp;</p>\n<p>Option A: <strong>Cowden syndrome/ Multiple hamartoma syndrome</strong> is an autosomal dominant condition caused by mutations in <strong>PTEN</strong> <strong>gene</strong>. It is associated with <strong>hamartomas</strong> of all three embryonal cell layers and dysplastic gangliogliocytoma of the cerebellum. Most common harmartomas include facial <strong>trichilemmomas</strong>.</p>\n<p>Option B: <strong>VHL gene&nbsp;</strong> mutation is seen in <strong>von Hippel–Lindau syndrome</strong> which is associated with <strong>cerebellar hemangioblastoma</strong>, <strong>retinal angioma</strong>, renal cell carcinoma, <strong>pheochromocytoma</strong> and <strong>cystic lesions </strong>of kidneys, pancreas, liver, and inner ear (endolymphatic sac tumors).</p>\n<p>Option C: <strong>Turcot syndrome</strong> is caused by mutations in <strong>APC gene </strong>or mismatch repair genes and is associated with<strong> intestinal polyposi</strong>s and multiple CNS tumors like <strong>Medulloblastoma or glioblastoma.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <!---->\n        <svg width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"ng-star-inserted\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0282: Inhibitors of Mitogenic Signaling Pathway</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"86\">\n<p><strong>Gene</strong></p>\n</td>\n<td width=\"89\">\n<p><strong>Protein</strong></p>\n</td>\n<td width=\"88\">\n<p><strong>Function</strong></p>\n</td>\n<td width=\"95\">\n<p><strong>Familial Syndromes</strong></p>\n</td>\n<td width=\"92\">\n<p><strong>Sporadic Cancers</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>APC</em></p>\n</td>\n<td width=\"89\">\n<p>Adenomatous polyposis coli protein</p>\n</td>\n<td width=\"88\">\n<p>Inhibitor of WNT signaling</p>\n</td>\n<td width=\"95\">\n<p>Familial colonic polyps and carcinomas</p>\n</td>\n<td width=\"92\">\n<p>Carcinomas of stomach, colon, pancreas, melanoma</p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>NF1</em></p>\n</td>\n<td width=\"89\">\n<p>Neurofibromin-1</p>\n</td>\n<td width=\"88\">\n<p>Inhibitor of RAS/MAPK signaling</p>\n</td>\n<td width=\"95\">\n<p>Neurofibromatosis type 1</p>\n<p>(neurofibromas and malignant peripheral nerve sheath tumors)</p>\n<p>&nbsp;</p>\n</td>\n<td width=\"92\">\n<p>Neuroblastoma, juvenile myeloid leukemia</p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>NF2</em></p>\n</td>\n<td width=\"89\">\n<p>Merlin</p>\n</td>\n<td width=\"88\">\n<p>Cytoskeletal stability, Hippo pathway signaling</p>\n</td>\n<td width=\"95\">\n<p>Neurofibromatosis type 2 (acoustic schwannoma and meningioma</p>\n</td>\n<td width=\"92\">\n<p>Schwannoma, meningioma</p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>PTCH</em></p>\n</td>\n<td width=\"89\">\n<p>Patched</p>\n</td>\n<td width=\"88\">\n<p>Inhibitor of Hedgehog signaling</p>\n</td>\n<td width=\"95\">\n<p>Gorlin syndrome (basal cell carcinoma, medulloblastoma, several benign tumors)</p>\n</td>\n<td width=\"92\">\n<p>Basal cell carcinoma, medulloblastoma</p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>PTEN</em></p>\n</td>\n<td width=\"89\">\n<p>Phosphatase and tensin homologue</p>\n</td>\n<td width=\"88\">\n<p>Inhibitor of PI3K/AKT signaling</p>\n</td>\n<td width=\"95\">\n<p>Cowden syndrome (variety of benign skin, GI and CNS growths; Breast, endometrial and thyroid carcinoma)</p>\n</td>\n<td width=\"92\">\n<p>Diverse cancers, particularly carcinomas and lymphoid tumors</p>\n</td>\n</tr>\n<tr>\n<td width=\"86\">\n<p><em>SMAD2, SMAD4</em></p>\n</td>\n<td width=\"89\">\n<p>SMAD2, SMAD4</p>\n</td>\n<td width=\"88\">\n<p>Component of TGFb signaling pathway, repressors of MYC and CDK4 expression, inducers of CDK inhibitor expression</p>\n</td>\n<td width=\"95\">\n<p>Juvenile polyposis</p>\n</td>\n<td width=\"92\">\n<p>Frequently mutated (along with other components of the TGFb signaling pathway) in colonic and pancreatic carcinoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-34",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA4965",
    "stauts": "Skipped",
    "question_title": "34.\n        The prevalence of the disease 'X' in a population is 30%. The diagnostic test for this disease has a specificity of 0.80 and a sensitivity of 0.90. What is the negative predictive value of the test?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 45%",
    "optionB": "B. 62%",
    "optionC": "C. 70%",
    "optionD": "D. 95%\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The negative predictive value of the above test is&nbsp;<strong>95%.</strong></p>\n<p>For convenience, let us assume that the total population in this scenario is <strong>100</strong>.</p>\n<p>The prevalence of the disease is 30%. So the total number of people with the <strong>disease </strong>is <strong>30</strong>(TP+FN) and <strong>disease-free</strong>(FP+TN)&nbsp;is&nbsp;<strong>70.</strong></p>\n<p>Since sensitivity is 0.90, i.e. TP/(TP + FN) = 90%.</p>\n<p>The total <strong>true positives (TP) =</strong>&nbsp;90/100 x (TP+FN) = 90/100 x 30 = <strong>27</strong></p>\n<p>False-negative(FN) = 30-27 =&nbsp;<strong>3</strong></p>\n<p>Since specificity is 0.80, i.e. TN/(FP+TN) = 80%.</p>\n<p>Total <strong>true negatives (TN)</strong>&nbsp;=(FP+TN) x 80/100 = 70 x 80/100 =<strong> 56</strong></p>\n<p>False-positive(FP) = 70-56 = <strong>14</strong></p>\n<p>The given data is represented below:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Disease +</strong></p>\n</td>\n<td>\n<p><strong>Disease -</strong></p>\n</td>\n<td>\n<p>Total</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Test +</strong></p>\n</td>\n<td>\n<p>27 (TP)</p>\n</td>\n<td>\n<p>14 (FP)</p>\n</td>\n<td>\n<p>41</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Test -</strong></p>\n</td>\n<td>\n<p>3 (FN)</p>\n</td>\n<td>\n<p>56 (TN)</p>\n</td>\n<td>\n<p>59</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Total</p>\n</td>\n<td>\n<p>30(TP+FN)</p>\n</td>\n<td>\n<p>70(FP+TN)&nbsp;</p>\n</td>\n<td>\n<p>100</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Negative predictive value<strong> (NPV) </strong>= TN/(FN + TN) x 100 = 56/59 = 0.949 = <strong>95%</strong>.</p>\n<p>An<strong> alternate formula</strong>(<strong>Bayes</strong> theorem)&nbsp;that can be used is <strong>NP</strong><strong>V</strong> = (1-P) x Sp /[P x (1-Sn)] +[(1-P) x Sp]</p>\n<p>Sn- Sensitivity,&nbsp;P- Prevalence,&nbsp;Sp- Specificity</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0358: Validity of a Screening Test</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Validity/ accuracy </strong>of a screening test depends upon the <strong>sensitivity, specificity,</strong> and<strong> predictive accuracy</strong> of the test.</li>\n<li>It represents the closeness to a true value/ actual value.</li>\n<li>These are the <strong>inherent properties</strong> of a screening test.</li>\n<li>P<strong>P</strong>V and N<strong>P</strong>V are <strong>dependent</strong> on the <strong>P</strong>revalence of disease.</li>\n<li>Sensitivity &amp; Specificity are independent of prevalence of disease.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62275b1d441443bc92db11bb3add523ex1280x959.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Formulae</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Sensitivity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TP</strong>&nbsp; &nbsp;&nbsp;</span></span><br><span><strong>TP</strong> + FN</span></td>\n</tr>\n<tr>\n<td><span>Specificity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TN&nbsp; &nbsp;&nbsp;</strong></span><sub><br></sub>FP + <strong>TN</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a positive test (<strong>P</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>P&nbsp; &nbsp;&nbsp;</strong></span><sub><br></sub>T<strong>P</strong> + F<strong>P</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a negative test (<strong>N</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>N&nbsp; &nbsp;&nbsp;</strong>&nbsp;</span><sub><br></sub>T<strong>N</strong> + F<strong>N</strong></span></td>\n</tr>\n<tr>\n<td><span>Percentage of false positives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FP&nbsp; &nbsp; &nbsp;</span><sub><br></sub>FP + TN</span></td>\n</tr>\n<tr>\n<td><span>Percentage of false negatives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FN&nbsp; &nbsp; &nbsp;</span><sub><br></sub>TP + FN</span></td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>PPV</strong> varies <strong>directly</strong> with prevalence</li>\n<li><strong>NPV</strong> varies <strong>inversely</strong> with prevalence</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-35",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6472",
    "stauts": "Incorrect",
    "question_title": "35.\n         A patient presents with painless hematuria because of a worm that matures in the vesical venous plexus. Which of the following eggs are most likely to be seen in the urine analysis?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/6272bacf0609450e8e9605b30aff4849.JPEG\">",
    "optionA": "A. 1\n                \n                  \n                    \nCorrect",
    "optionB": "B. 2\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. 3",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given clinical scenario, the presence of <strong>painless hematuria</strong> due to a worm <strong>maturing in the vesical venous plexus</strong> strongly suggests an infection with <strong>Schistosoma haematobium</strong>. This parasite is known for its distinct <strong>ovoid, non-operculated eggs, </strong>which have a <strong>brownish-yellow transparent shell</strong> and a characteristic <strong>terminal spine </strong>at one pole, as illustrated in Figure A.</p>\n<p>Schistosoma haematobium is a parasitic worm and one of the species of <strong>trematodes,</strong> commonly known as blood flukes, that cause <strong>schistosomiasis.</strong> It is predominantly found in <strong>Africa</strong> and the <strong>Middle East</strong>.&nbsp;</p>\n<p>The <strong>transmission</strong> of Schistosoma haematobium involves several stages:</p>\n<ul>\n<li>Cercariae Penetration: The infection begins when <strong>cercariae,</strong> the larval stage of the parasite, <strong>penetrates</strong> the skin of humans who are in contact with <strong>contaminated freshwater sources</strong>.</li>\n<li><strong>Migration:</strong> After skin penetration, the cercariae transform into <strong>schistosomula</strong> and <strong>travel through peripheral venules</strong> into the systemic circulation.</li>\n<li><strong>Maturation:</strong> The schistosomula eventually migrate to the<strong> vesical and pelvic venous plexuses</strong>, where they <strong>mature</strong> into adult worms and lay eggs.</li>\n<li>They pass embryonated eggs in <strong>urine</strong> that hatch in water to release the free-living <strong>ciliated miracidia</strong>. Miracidia infects the<strong> liver of snails </strong>and produces first and second-generation <strong>sporocysts.</strong> Large numbers of cercariae are produced by asexual reproduction within the second-generation sporocysts and are released into the water. Metacercaria and redia stages are not seen in schistosomes.&nbsp;</li>\n</ul>\n<p>Clinical Features:</p>\n<ul>\n<li><strong>Painless Hematuria</strong>: One of the <strong>hallmark</strong> symptoms due to the eggs causing inflammation in the bladder.</li>\n<li>Urinary Symptoms: <strong>Frequent urination, dysuria</strong> (painful urination), and sometimes urinary tract infections.</li>\n<li>Chronic Infection: Long-term infection can lead to<strong> bladder fibrosis</strong>, increased risk of <strong>urinary bladder cancer,</strong> and renal impairment.</li>\n<li>Other Symptoms: Abdominal pain, fever, and occasionally systemic symptoms if the infection is severe.</li>\n</ul>\n<p><strong>Praziquantel</strong> is the treatment of choice for schistosomiasis, effectively targeting adult worms.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Schistosoma mansoni </strong>eggs have a<strong> lateral spine</strong> near the posterior end. The adult stage of Schistosoma mansoni inhabits the<strong> inferior mesenteric veins</strong> of the large intestine.</p>\n<p>Option C:<strong> Schistosoma japonicum</strong> eggs are<strong> large and rounded</strong>. The spine is <strong>smaller</strong> and less conspicuous. The adult worms live in the<strong> inferior and superior mesenteric veins</strong> of the small intestine.</p>\n<p>Option D: The eggs of <strong>Fasciola hepatica</strong> are l<strong>arge, ovoid, operculated, and bile stained.</strong></p>\n<p>Given below are the images for the eggs mentioned above.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/79fb2b174aee4272bb5aa58632dc8fcdx1280x1361.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1765: Eggs in parasitology</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fa0f4c159e7489eb20351c22109ef72x600x3219.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-36",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6831",
    "stauts": "Correct",
    "question_title": "36.\n        A 70-year-old man who has prostate cancer is being treated with a long-acting GnRH agonist. After prolonged injection of GnRH, which of the following will most likely be seen in this patient?",
    "question_ADD": "<p>↓-Low levels, ↑-High levels</p>\n<table style=\"height: 110px;\" width=\"332\">\n<tbody>\n<tr>\n<td style=\"width: 71.4844px; text-align: center;\"><strong>Options</strong></td>\n<td style=\"width: 71.4609px; text-align: center;\"><strong>FSH</strong></td>\n<td style=\"width: 71.4531px; text-align: center;\"><strong>LH</strong></td>\n<td style=\"width: 89.6016px; text-align: center;\"><strong>Testosterone</strong></td>\n</tr>\n<tr>\n<td style=\"width: 71.4844px; text-align: center;\"><strong>A</strong></td>\n<td style=\"width: 71.4609px; text-align: center;\">↓</td>\n<td style=\"width: 71.4531px; text-align: center;\">↓</td>\n<td style=\"width: 89.6016px; text-align: center;\">↑</td>\n</tr>\n<tr>\n<td style=\"width: 71.4844px; text-align: center;\"><strong>B</strong></td>\n<td style=\"width: 71.4609px; text-align: center;\">↓</td>\n<td style=\"width: 71.4531px; text-align: center;\">↓</td>\n<td style=\"width: 89.6016px; text-align: center;\">↓</td>\n</tr>\n<tr>\n<td style=\"width: 71.4844px; text-align: center;\"><strong>C</strong></td>\n<td style=\"width: 71.4609px; text-align: center;\">↑</td>\n<td style=\"width: 71.4531px; text-align: center;\">↑</td>\n<td style=\"width: 89.6016px; text-align: center;\">↑</td>\n</tr>\n<tr>\n<td style=\"width: 71.4844px; text-align: center;\"><strong>D</strong></td>\n<td style=\"width: 71.4609px; text-align: center;\">↑</td>\n<td style=\"width: 71.4531px; text-align: center;\">↑</td>\n<td style=\"width: 89.6016px; text-align: center;\">↓</td>\n</tr>\n</tbody>\n</table>",
    "question_imag": "",
    "optionA": "A. A",
    "optionB": "B. B\n                \n                  \n                    \nCorrect",
    "optionC": "C. C",
    "optionD": "D. D",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Prolonged</strong> injection of<strong> GnRH(gonadotropin-releasing hormone)</strong> will lead to<strong> decreased LH, FSH,</strong>&nbsp;and <strong>testosterone</strong><strong>&nbsp;</strong>levels.</p>\n<p>A constant administration of GnRH produces an <strong>initial</strong> agonistic action known as \"<strong>flare</strong>\", followed by&nbsp;<strong>downregulation</strong> of GnRH receptors&nbsp;( decrease in GnRH receptor concentration). This <strong>desensitizes the pituitary</strong> to the action of GnRH and a <strong>hypogonadotropic-hypogonadal</strong> state is induced. This is characterized by <strong>low LH</strong><span> (luteinizing hormone) and <strong>FSH</strong> (follicle-stimulating hormone) levels,&nbsp;thereby&nbsp;<strong>reducing</strong></span><strong>&nbsp;testosterone</strong> production (i.e., <strong>chemical castration</strong>).</p>\n<p>The regulation of <strong>gonadotropin secretion</strong> by the <strong>hypothalamus</strong> involves the <strong>pulsatile release </strong>of <strong>GnRH</strong>. GnRH is secreted in pulses lasting between 5 to 25 minutes at 1 to 2 hours intervals. This <strong>intermittent release</strong> is crucial for stimulating the <strong>anterior pituitary gland</strong> to secrete <strong>LH</strong> and <strong>FSH</strong>. Continuous infusion of GnRH, in contrast, leads to the <strong>downregulation</strong> of <strong>GnRH receptors</strong> in the pituitary, resulting in <strong>reduced secretion</strong> of <strong>LH </strong>and<strong> FSH</strong>.</p>\n<p>In the treatment of <strong>prostate cancer</strong>, which is driven by the <strong>carcinogenic effects </strong>of <strong>testosterone</strong>, continuous infusion of GnRH agonists is used. This treatment <strong>effectively suppresses testosterone levels</strong> by <strong>downregulating GnRH receptors</strong>, thereby reducing the stimulation of LH and FSH. In the case of a 70-year-old man undergoing long-term GnRH agonist therapy for prostate cancer, the expected outcome would be decreased levels of FSH, LH, and testosterone due to the prolonged suppression of GnRH signaling.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-37",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6443",
    "stauts": "Skipped",
    "question_title": "37.\n        A patient with a history of schizophrenia presents to the clinic with complaints of new-onset tremors, muscle rigidity, and bradykinesia. He recently had a change in his antipsychotic medication. Which of the following medications can be prescribed to avoid the current complication?",
    "question_ADD": "<ol>\n<li>Clozapine</li>\n<li>Quetiapine</li>\n<li>Chlorpromazine</li>\n<li>Loxapine</li>\n<li>Aripiprazole</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 2, and 5\n                \n                  \n                    \nCorrect",
    "optionB": "B. 1 and 5",
    "optionC": "C. 2 and 3",
    "optionD": "D. 2, 3, and 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The complaints of <strong>new-onset tremors, muscle rigidity</strong>, and <strong>bradykinesia</strong> suggest <strong>extrapyramidal side effects (EPS) </strong>from the recent medication change; therefore&nbsp;<strong>Clozapine, quetiapine,</strong> and <strong>aripiprazole</strong> are the best alternatives that <strong>do not show EPS </strong>as a major side effect.</p>\n<ul>\n<li><strong>Clozapine</strong>: An<strong> atypical antipsychotic </strong>with a very low incidence of EPS.</li>\n<li><strong>Quetiapine</strong>: Another <strong>atypical antipsychotic</strong> with a favourable EPS profile.</li>\n<li><strong>Aripiprazole</strong>: A <strong>third-generation antipsychotic</strong> (also known as a <strong>dopamine partial agonist</strong>) that has a low risk of EPS and can be considered a good alternative.</li>\n</ul>\n<p><strong>Chlorpromazine</strong> and <strong>loxapine</strong>&nbsp;are <strong>typical antipsychotics</strong> that are more likely to cause EPS. Chlorpromazine, while sometimes used for its sedative properties, still carries a significant risk of EPS. Haloperidol is well-known for its high propensity to induce EPS and is not an appropriate alternative in this scenario.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Psychiatry"
  },
  {
    "web-scraper-order": "1727319149-38",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1569",
    "stauts": "Incorrect",
    "question_title": "38.\n        An immunocompromised patient receiving total parenteral nutrition through a central venous catheter has had high-grade fever for 1 week. 2D Echo shows vegetations on the mitral valve. Blood cultures are negative for bacterial growth after 72 hours. Empiric antibiotic therapy has not shown improvements in his condition. What is the likely causative organism?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Aspergillus fumigatus",
    "optionB": "B. Candida albicans\n                \n                  \n                    \nCorrect",
    "optionC": "C. HACEK organisms\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Staphylococcus epidermidis",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In this <strong>immunocompromised patient</strong> with a <strong>central venous catheter (CVC)</strong>, presenting with <strong>high-grade fever, mitral valve vegetations,</strong> and <strong>negative blood cultures</strong> after 72 hours, likely suggests a diagnosis of <strong>infective endocarditis</strong>, with the causative organism being <em><strong>Candida albicans</strong></em>. The <strong>absence</strong> of <strong>bacterial growth</strong> and <strong>lack</strong> of<strong> improvement</strong> with <strong>broad-spectrum antibiotics</strong> suggest fungal aetiology, and Candida species are known to cause infections in such scenarios.</p>\n<p>For patients with a<strong> CVC</strong>, common pathogens include skin flora like <em><strong>Staphylococcus aureus</strong></em> and <em><strong>Staphylococcus epidermidis</strong></em>, as well as Candida species. While <strong>Staphylococcus</strong> infections typically show up on <strong>blood cultures</strong>, Candida infections may not always be detected this way, especially in the context of systemic candidiasis. <strong>Candida</strong> should be suspected when<strong> cultures </strong>are <strong>negative</strong>, and <strong>symptoms persist</strong> despite <strong>antibiotic therapy</strong>.</p>\n<p>Candida albicans is a frequent cause of opportunistic infections in immunocompromised patients, including <strong>candidal endocarditis</strong>. It can lead to systemic infections where traditional cultures might be negative. Candida infections are diagnosed based on clinical presentation, lack of bacterial growth on cultures, and response to antifungal treatment.</p>\n<p>Morphologically, they are <strong>yeast-like fungi.</strong> They exist as <strong>yeast</strong> and <strong>pseudohyphae</strong> (Shown in the image below). It appears as <strong>budding gram-positive</strong> cells on wet films and smears. <strong>Mycelial</strong> forms suggest <strong>colonization. <em>Candida albicans</em></strong> form <strong>chlamydospores</strong> on <strong>corn meal agar.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fb75be8908954909a4de0edae07fc284x1280x801.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option A: <em><strong>Aspergillus fumigatus</strong></em> rarely causes infective endocarditis and is more commonly associated with <strong>invasive fungal infections</strong>, such as <strong>aspergillosis</strong>, which primarily affect the<strong> lungs</strong> but can disseminate to other organs, including the heart.</p>\n<p>Option C: <strong>H</strong>aemophilus,<strong> A</strong>ggregatibacter, <strong>C</strong>ardiobacterium, <strong>E</strong>ikenella, and<strong> K</strong>ingella species—are known causes of endocarditis, particularly in patients with predisposing conditions. They are often <strong>identified </strong>in <strong>cultures</strong> but usually present with a more <strong>subacute</strong> or <strong>chronic course</strong>.&nbsp;</p>\n<p>Option D: <em><strong>Staphylococcus epidermidis,</strong></em> a <strong>coagulase-negative</strong> staphylococcus, is a <strong>common skin flora</strong> and often a cause of infections related to indwelling devices. It can <strong>cause endocarditis</strong>, particularly in patients with prosthetic valves or CVCs. However, their infections usually produce <strong>positive blood cultures</strong>, and the negative cultures here suggest a fungal rather than bacterial cause.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-39",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD4320",
    "stauts": "Correct",
    "question_title": "39.\n        An epidemiologist is tasked with ensuring the disinfection of wells in a city to reduce the spread of water-borne illnesses. 30 grams of bleaching powder was required to disinfect 2275 liters of well water. When measuring the chlorine demand with the Horrocks apparatus for this well water, which cup would have shown the blue color after adding the indicator?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 2nd cup",
    "optionB": "B. 3rd cup\n                \n                  \n                    \nCorrect",
    "optionC": "C. 4th cup",
    "optionD": "D. 5th cup",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Horrocks apparatus</strong> used to measure <strong>chlorine demand </strong>of water. The <strong>3rd cup</strong> would have shown a blue color for it to require 30 grams of bleaching powder to disinfect 2275 liters of well water.</p>\n<p>Since 2275/455=5, the amount of bleaching powder required to disinfect<strong> 455 liters</strong> of water is 30/5=<strong>6 grams</strong></p>\n<p>To calculate the <strong>dose of bleaching</strong> required to disinfect<strong> 455</strong> liters of water, the formula is<strong> (n×2)</strong>, We know the dose required,<strong> and we have to calculate 'n'&nbsp;</strong>(n represents the position of the cup which was first to show the color).</p>\n<p>6=n×2, therefore <strong>n=3.</strong></p>\n<p>The<strong> third cup</strong> would have turned<strong> blue</strong> upon adding the indicator.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1610: Horrock’s Apparatus</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Horrock’s Apparatus</strong> is used to estimate the <strong>chlorine demand</strong> of water.</li>\n<li>This is widely used in the&nbsp;<strong>disinfection of wells</strong> to find out <strong>how much</strong> <strong>bleaching powder is required</strong>.</li>\n<li><strong>Contents</strong> of this water-testing apparatus:\n<ul>\n<li><strong>6 white cups</strong> of 200 ml each and <strong>one black cup</strong> with a circular mark</li>\n<li>2 metal spoons (each holds 2g of bleaching powder)</li>\n<li>7 glass stirring rods and 1 special pipette</li>\n<li>Two droppers</li>\n<li><strong>Starch-iodide indicator solution</strong></li>\n</ul>\n</li>\n<li><strong>Procedure:</strong>\n<ul>\n<li>Use 2g of bleaching powder to create a thin paste in the black cup. It is now called the&nbsp;<strong>Chlorine stock solution</strong>.</li>\n<li>The six white cups are filled with the water to be tested</li>\n<li>Add one drop of the stock solution to the 1<sup>st</sup> cup, two drops to the 2<sup>nd</sup> cup, three drops to the 3<sup>rd</sup> cup, and so on till adding six drops to the 6<sup>th</sup> cup.</li>\n<li>Stir the cups and wait for half an hour.</li>\n<li>Add 3 drops of starch-iodide indicator to each cup</li>\n<li>Development of <strong>blue color</strong> in the apparatus indicates <strong>free residual chlorine</strong>.&nbsp;</li>\n<li>The first cup which develops this color gives an estimate of the amount of bleaching powder needed to disinfect<strong> 455 Litres</strong> of the sample water.</li>\n</ul>\n</li>\n<li><strong>Chlorine demand</strong> or the&nbsp;<strong>dose of bleaching powder</strong> required is given by <strong>(n x 2) g</strong>&nbsp;for<strong> 455 liters of water, </strong>i.e., (n x 2) g of bleaching powder is required to disinfect 455 liters of water. Here, <strong>n</strong> represents the<strong> position of the cup</strong> (1, 2, 3, etc.) that was <strong>first to show a distinct blue color</strong>.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/bed65d5582c142b8ab4533128373dcabx383x287.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-40",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1953",
    "stauts": "Skipped",
    "question_title": "40.\n        Which of the following statements are true regarding errors of amino acid metabolism?",
    "question_ADD": "<ol>\n<li>Hartnup disease - defect in the intestinal and renal transport of tryptophan</li>\n<li>Maple syrup urine disease - defective branched chain α-keto acid dehydrogenase complex</li>\n<li>Alkaptonuria - defective homogentisate oxidase&nbsp;</li>\n<li>Albinism - defective tyrosinase</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 2, 4",
    "optionB": "B. 1, 3",
    "optionC": "C. 2, 3, 4",
    "optionD": "D. 1, 2, 3, 4\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>All of the given statements are true.&nbsp;</p>\n<p>A defect in the <strong>intestinal </strong>and <strong>renal transport</strong> of amino acid <strong>tryptophan </strong>leads to <strong>Hartnup disease</strong>. The defect would lead to <strong>tryptophan deficiency</strong> and therefore <strong>affect niacin biosynthesis</strong>. Therefore <strong>symptoms similar to pellagra - dermatitis, diarrhea </strong>and <strong>dementia (3D's) </strong>are seen in Hartnup disease.</p>\n<p><strong>Maple syrup urine disease</strong> (MSUD) is an <strong>autosomal recessive disorder</strong> that occurs due to a <strong>deficiency</strong> of <strong>branched-chain α-ketoacid dehydrogenase</strong>&nbsp;complex (BCKDH). This impairs the metabolism of branched-chain amino acids <strong>valine, leucine, isoleucine,</strong> and <strong>alloisoleucine.</strong> The peculiar <strong>burnt sugar odor</strong> of <strong>urine</strong> is characteristic of this disease.</p>\n<p><strong>Alkaptonuria</strong> is an inborn error of metabolism due to the deficiency of an enzyme <strong>homogentisate oxidase</strong><strong>,</strong> leading to the <strong>accumulation</strong> of <strong>homogentisic</strong> acid in connective tissue resulting in <strong>ochronosis.</strong> Due to the <strong>oxidation</strong> and <strong>polymerization</strong> of <strong>homogenetic</strong> acid, it shows a <strong>characteristic blackening</strong> of <strong>urine</strong> on standing for a long time or <strong>black stain</strong> in <strong>diapers.</strong> They often present in the <strong>third</strong> to the <strong>fourth</strong> decade of life.&nbsp;</p>\n<p><strong>Albinism</strong>&nbsp;is due to a deficiency of <strong>copper-containing</strong> enzyme <strong>tyrosinase</strong> causing a <strong>defect</strong> in <strong>melanin</strong> production. The affected child has milky <strong>white hair</strong> and <strong>milky white</strong> skin.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0625: Amino acid Enzymatic Disorders and the Associated Enzymes</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1155: Conditions Associated with Pellagra-like Symptoms</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"196\">\n<p>Condition/Disease</p>\n</td>\n<td width=\"420\">\n<p>Reason for niacin deficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\"196\">\n<p>Hartnup disease</p>\n</td>\n<td width=\"420\">\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td width=\"196\">\n<p>Carcinoid syndrome</p>\n</td>\n<td width=\"420\">\n<p>Overproduction of serotonin that causes diversion of&nbsp; tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td width=\"196\">\n<p>Vitamin B6 deficiency</p>\n</td>\n<td width=\"420\">\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td width=\"196\">\n<p>Maize rich diet</p>\n</td>\n<td width=\"420\">\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td width=\"196\">\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td width=\"420\">\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1154: Vitamin Deficiency States (Water-soluble Vitamins)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke–Korsakoff’s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-41",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6857",
    "stauts": "Skipped",
    "question_title": "41.\n        Which of the following is not true about the Typbar vaccine?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. It is a conjugate vaccine, conjugated to tetanus toxoid",
    "optionB": "B.  It is a single IM dose recommended for infants > 6m till < 45 years of age",
    "optionC": "C. Effect lasts up to 2 years across all age groups",
    "optionD": "D. Co-administration with MR causes serological interference \n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Typbar</strong> <strong>TCV</strong> is safe and compatible due to which its co-administration with MCV/MMR <strong>does</strong> <strong>not</strong> cause serological interference.</p>\n<p><strong>Typbar</strong> is a <strong>conjugate</strong> <strong>vaccine</strong> for <strong>typhoid</strong> by <strong>Bharat</strong> <strong>Biotech</strong>.&nbsp;</p>\n<p>It contains <strong>Vi</strong> capsular polysaccharide of salmonella typhi Ty2 which is <strong>conjugated</strong> <strong>with</strong> a <strong>protein</strong> <strong>carrier</strong> viz <strong>tetanus</strong> <strong>toxoid</strong>, providing a foreign peptide protein that <strong>increases</strong> <strong>immunogenicity</strong>.&nbsp; It is not the part of national immunization schedule and is recommended as a single intramuscular dose of 0.5 ml in infants &gt;6 months and adults &lt; equal to 45 years in typhoid endemic areas. It causes 4-fold seroconversion across all age groups. It is the only vaccine available for children &lt; 2 years of age. It has a <strong>high</strong> <strong>avidity</strong>, especially IgG mediated which increases the strength of binding between antibody and antigen. This activity persists till 2 years of age.&nbsp;<br>A <strong>booster</strong> dose may be given <strong>after 3 years.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-42",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD1551",
    "stauts": "Correct",
    "question_title": "42.\n        A 36 year old female with bronchial asthma finds no improvement on a short acting beta agonist alone and thus a long acting beta agonist has to be added. Which of the following is not a long acting beta agonist?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Albuterol\n                \n                  \n                    \nCorrect",
    "optionB": "B. Formoterol",
    "optionC": "C. Salmeterol",
    "optionD": "D. Vilanterol",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Albuterol(salbutamol)</strong> is a <strong>short-acting beta-agonist</strong>, not a long-acting beta-agonist.</p>\n<p><strong>Short-acting beta-agonists (SABA):</strong></p>\n<ul>\n<li>Albuterol</li>\n<li>Levalbuterol</li>\n<li>Pirbuterol</li>\n<li>Terbutaline.&nbsp;</li>\n</ul>\n<p><strong>Long-acting beta agonists (LABA):</strong></p>\n<ul>\n<li>Salmeterol</li>\n<li>Formoterol</li>\n<li>Arformoterol</li>\n</ul>\n<p><strong>Ultra-Long-acting beta agonists (uLABA):</strong></p>\n<ul>\n<li>Indacaterol</li>\n<li>Olodaterol</li>\n<li>Vilanterol</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-43",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MB0984",
    "stauts": "Incorrect",
    "question_title": "43.\n        Identify the stage of senile cataract depicted in the given image.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/480b1f0f98b94bc182183a4faac59d8d.PNG\">",
    "optionA": "A. Intumescent cataract",
    "optionB": "B. Mature senile cataract\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Morgagnian cataract\n                \n                  \n                    \nCorrect",
    "optionD": "D. Sclerotic type of hypermature cataract",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image shows the characteristic appearance of&nbsp;<strong>Morgagnian hypermature cataract</strong>.</p>\n<p><strong>Morgagnian hypermature cataract&nbsp;</strong>is characterized by the&nbsp;<strong>liquefaction</strong>&nbsp;of the entire&nbsp;<strong>cortex.</strong>&nbsp;The&nbsp;lens is converted into a&nbsp;<strong>bag of milky fluid</strong>. The&nbsp;<strong>small, brownish nucleus</strong>&nbsp;settles at the&nbsp;<strong>bottom</strong>, its&nbsp;<strong>position altering&nbsp;</strong>with a&nbsp;change in the position of the head.</p>\n<p><strong>Senile Cataract </strong></p>\n<p><strong>Types: </strong></p>\n<ul>\n<li><strong>Cortical</strong> (<strong>soft</strong> cataract): 75%&nbsp;&nbsp;&nbsp;</li>\n<li><strong>Nuclear</strong> (<strong>hard</strong> cataract): 25%</li>\n</ul>\n<p><strong>Cortical cataract </strong>is<strong>&nbsp;</strong>further divided into the cuneiform and cupuliform types.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Cuneiform </strong>(70%)</td>\n<td><strong>Posterior subcapsular/Cupuliform</strong> (5%)</td>\n</tr>\n<tr>\n<td>\n<p><strong>Radial spoke-like</strong>&nbsp;opacity starting in the periphery and extending centrally</p>\n</td>\n<td>\n<p><strong>Central saucer-shaped</strong> opacity in the posterior cortex just below the capsule</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Late visual loss</p>\n</td>\n<td>\n<p>Early loss of visual acuity</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>Most visually handicapping senile cataract&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a0c1593bf00e49c4ab371eb7c9b3c866x619x419.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ed460ba1cda4c90ae7626e16d8f8667x620x451.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Nuclear cataract</strong></p>\n<ul>\n<li>Pigmented nuclear cataracts: Due to the deposition of <strong>urochrome</strong>&nbsp;pigment\n<ul>\n<li>Catarata <strong>brunescens</strong></li>\n<li>Catarata <strong>nigra</strong></li>\n<li>Catarata <strong>rubra</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0875: Maturation of Cortical Cataract</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>1. Stage of <strong>lamellar separation&nbsp;</strong></p>\n<p>2. Stage of <strong>incipient cataract- cuneiform</strong> and <strong>cupuliform</strong> patterns can be made out at this stage.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/98f893f1601a46219c2f54cddd4cb5fcx1280x2197.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>3.<strong>&nbsp;Immature senile cataract:&nbsp;</strong></p>\n<ul>\n<li>The lens is <strong>greyish white.</strong></li>\n<li><strong>Clear cortex</strong> is still present, so <strong>iris shadow</strong> is <strong>visible<br></strong></li>\n<li>Untreated immature cataracts can <strong>progress</strong> and develop into <strong>intumescent cataracts</strong> as a result of&nbsp;<strong>swelling</strong> and <strong>congestion of the lens</strong> due to <strong>degeneration of lens proteins.</strong></li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f0ee83fdc4a47f6bff960693b22465ex265x379.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>4.&nbsp;Mature cortical cataract/ Ripe cataract&nbsp;</strong></p>\n<ul>\n<li>The <strong>opacification</strong> is <strong>complete</strong></li>\n<li>The lens is <strong>pearly white</strong></li>\n</ul>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea3c22476864db293b757b52071f5b4x200x150.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>5.<strong> Morgagnian hypermature cataract</strong></p>\n<ul>\n<li>The whole <strong>cortex liquefies</strong> and the lens is converted into a <strong>bag of milky fluid</strong>.</li>\n<li>The <strong>small, brownish nucleus</strong> settles at the <strong>bottom</strong>, <strong>altering its position</strong> with a change in the position of the head.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/33749bf0e7344420af2d2dc2e29c22f4x239x175.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-44",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8493",
    "stauts": "Incorrect",
    "question_title": "44.\n        A primigravida patient has come for a routine antenatal checkup. Which among the following findings in her would you not consider a physiological change?",
    "question_ADD": "<ol>\n<li>Exaggerated splitting of S2</li>\n<li>Left axis deviation on ECG</li>\n<li>Fourth heart sound</li>\n<li>Loud&nbsp;third heart sound (S3)</li>\n<li>Grade 2 diastolic murmur</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 2, and 5\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. 2 and 5",
    "optionC": "C. 1, 2, and 3",
    "optionD": "D. 1, 3, and 5\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The findings among the given options that are not considered a part of the physiological changes in pregnancy are the <strong>exaggerated splitting</strong> of <strong>S2, fourth heart sound</strong>&nbsp;and <strong>grade 2 diastolic</strong> <strong>murmur</strong>.</p>\n<p>During pregnancy, the presence of a <strong>fourth heart sound(S4)</strong> (Statement 3) and a <strong>diastolic murmur </strong>(Statement 5) is considered a clinical indicator of <strong>heart disease </strong>during<strong> pregnancy</strong>.</p>\n<p><strong>Physiological changes</strong> in the <strong>cardiovascular</strong> system in pregnancy:</p>\n<div class=\"page\" title=\"Page 77\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ol>\n<li><strong>Exaggerated splitting </strong>of<strong> S1</strong> and<strong> increased loudness</strong> of both components.</li>\n<li><strong>Loud,</strong> easily heard <strong>third heart sound (S3)</strong>.</li>\n<li>A <strong>sys­tolic murmur</strong> that intensifies on inspiration or expiration.</li>\n<li>Soft diastolic murmur.</li>\n<li><strong>Mammary souffle</strong>- continuous murmur at 2<sup>nd</sup> to 4<sup>th</sup> intercostal space.</li>\n<li>A shift of&nbsp;the <strong>cardiac apex laterally</strong>.</li>\n<li>ECG changes:&nbsp;\n<ul>\n<li><strong>Left axis deviation</strong>.</li>\n<li>Q waves in leads 2, 3, and avF.</li>\n<li>Flat or inverted T waves in lead 3, V1-V3.</li>\n</ul>\n</li>\n<li><strong>Increased</strong> cardiac output, <strong>heart rate</strong>, and <strong>ejection fraction</strong>.</li>\n<li><strong>Decreased systemic vascular resistance</strong> and blood pressure.</li>\n</ol>\n<p>Clinical indicators of <strong>h</strong><strong>eart disease </strong><span>during pregnancy:</span></p>\n<p>Symptoms:</p>\n<ul>\n<li><strong>Progressive dyspnea</strong> or orthopnea</li>\n<li><strong>Nocturnal cough</strong></li>\n<li>Hemoptysis</li>\n<li>Syncope</li>\n<li>Chest pain&nbsp;</li>\n</ul>\n<p>Clinical signs:</p>\n<ol>\n<li>Cyanosis</li>\n<li><strong>Clubbing of fingers</strong></li>\n<li>Persistent neck vein distention</li>\n<li><strong>Systolic murmur grade 3/6 or greater</strong></li>\n<li><strong>Diastolic murmur </strong>of<strong> any grade</strong></li>\n<li>Cardiomegaly</li>\n<li>Persistent tachycardia and/or arrhythmia</li>\n<li><strong>Persistently split S2</strong></li>\n<li><strong>Fourth heart sound (S4)</strong></li>\n<li>Features of <strong>pulmonary hypertension</strong></li>\n</ol>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1815: Cardiovascular changes in pregnancy</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li class=\"p1\">The resting pulse rate increases by <strong>10 beats</strong>/<strong>min</strong></li>\n<li class=\"p1\">The apex is moved laterally&nbsp;</li>\n<li class=\"p1\">Cardiac output remains elevated throughout (maximum in the immediate postpartum period)</li>\n<li class=\"p1\">X-Ray shows a larger cardiac silhouette (due to benign pericardial effusion and shifted apex)</li>\n<li class=\"p1\">ECG: Slight&nbsp;<strong>left axis </strong>deviation</li>\n</ul>\n<p><strong>Heart sounds:</strong></p>\n<ul>\n<li class=\"p1\">First heart sound: Loud with an exaggerated split</li>\n<li class=\"p1\">Second heart sound: Normal but loud</li>\n<li class=\"p1\">Third heart sound: Loud and easily heard</li>\n</ul>\n<p><strong>Murmurs:</strong></p>\n<ul>\n<li>A systolic murmur<strong>&nbsp;</strong>that was intensified during inspiration or expiration</li>\n<li class=\"p1\">A soft diastolic murmur (in 20%)</li>\n<li class=\"p1\">Continuous murmur&nbsp;arising from the breast vasculature (in 10%)</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-45",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF1957",
    "stauts": "Incorrect",
    "question_title": "45.\n        A 56-year-old male patient with a history of diabetes mellitus was diagnosed with major depression. He attempted suicide by consuming a bottle of glipizide tablets. What is the antidote of choice for this case?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Glucagon",
    "optionB": "B. Octreotide\n                \n                  \n                    \nCorrect",
    "optionC": "C. Intravenous dextrose\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Leucovorin",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The antidote of choice for the above case scenario suggestive of <strong>sulfonylurea overdose&nbsp;</strong>(glipizide belongs to the sulfonylurea group) which resulted in <strong>severe hypoglycemia</strong> is <strong>o</strong><strong>ctreotide</strong>.</p>\n<p>Octreotide is a <strong>somatostatin analogue</strong>. It&nbsp;inhibits the secretion of growth hormone. It binds to <strong>somatostatin-2</strong> receptors on <strong>pancreatic beta cells</strong> and <strong>blocks</strong> the <strong>Ca<sup>2+</sup>&nbsp;influx</strong> resulting in a <strong>decrease </strong>in<strong> insulin secretion</strong>. Hence, it can be used to correct the hypoglycemia caused by sulfonylurea. overdose.</p>\n<p>Other uses of octreotide:</p>\n<ul>\n<li><strong>Acromegaly</strong></li>\n<li><strong>Esophageal varices</strong></li>\n<li>Thyrotrope adenomas</li>\n<li><strong>Carcinoid tumors</strong></li>\n<li>Adenomas secreting VIP(watery diarrhea)</li>\n<li>Diagnostic imaging of neuroendocrine tumors</li>\n<li><strong>Sulfonylurea toxicity</strong></li>\n</ul>\n<p>Adverse effects:&nbsp;</p>\n<ul>\n<li>Injection site pain</li>\n<li>Hyperglycemia</li>\n<li><strong>Gallstones</strong></li>\n</ul>\n<p>Other options:&nbsp;</p>\n<p>Option A: <strong>Glucagon</strong>&nbsp;can rectify hypoglycemia by promoting glycogenolysis and gluconeogenesis. However, it is not routinely administered as it can stimulate insulin release and is not useful in glycogen-depleted patients.</p>\n<p>Option C: <strong>Intravenous dextrose</strong> is not given because when administered it creates a hyperglycemic state thus stimulating insulin release, causing hypoglycemia again.</p>\n<p>Option D: <strong>Leucovorin&nbsp;</strong>(folinic acid) is the antidote of choice for <strong>methotrexate overdose</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-46",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6479",
    "stauts": "Correct",
    "question_title": "46.\n        Which of the following statements is incorrect about the tissue shown in the image below?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/833d79ed6e2e445297d58a0915b4a27a.PNG\">",
    "optionA": "A. Extracellular calcium is needed for contraction",
    "optionB": "B. Branching of fibers is typically seen",
    "optionC": "C. Gap junctions are not found in intercalated discs\n                \n                  \n                    \nCorrect",
    "optionD": "D. Sarcoplasmic reticulum is abundant",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above image shows a longitudinal section of the <strong>cardiac muscle</strong> stained by <strong>hematoxylin </strong>and<strong> eosin</strong><span><strong>.</strong> The incorrect statement is that \"gap junctions are absent,\" as they are essential for allowing <strong>rapid electrical communication</strong> between cardiac cells, which ensures <strong>coordinated heart contraction</strong></span><strong>.</strong></p>\n<p>On microscopy, cardiac muscle can be identified by:</p>\n<ol>\n<li>The junctions between adjoining cardiac myocytes are seen as <strong>dark staining transverse lines</strong> running across the muscle fiber. These lines are called <strong>intercalated discs</strong>.</li>\n<li>Presence of <strong>striations</strong> similar to the skeletal muscle.</li>\n<li>Presence of <strong>single</strong> and <strong>centrally placed nucleus</strong>. A <strong>perinuclear halo</strong> may be seen surrounding the nucleus.</li>\n<li>Cells within one fiber branch and join the cells in adjacent fibers.&nbsp;</li>\n</ol>\n<p><strong>Intercalated discs </strong>are unique to cardiac muscle, featuring transverse lines that cross fibers at irregular intervals where myocardial cells connect. These discs contain <strong>desmosomes</strong> and <strong>fascia adherens</strong> junctions in their transverse regions, providing strong cell adhesion during contractions. The less common longitudinal regions of intercalated discs contain <strong>gap junctions</strong>, which allow for rapid electrical communication between cells, ensuring synchronized contractions. Cardiac muscle cells also have a high <strong>mitochondrial density</strong>, store<strong> fatty acids </strong>as triglycerides, and may contain <strong>glycogen granules</strong> and<strong> lipofuscin pigment</strong>.</p>\n<p>Other options&nbsp;</p>\n<p>Option A: Cardiac muscle contraction depends on <strong>extracellular calcium</strong> and calcium from the <strong>sarcoplasmic reticulum</strong> for contraction.</p>\n<p>Option B: Cardiac muscle shows <strong>branching</strong> of muscle fibers.</p>\n<p>Option C: Cardiac muscles contain abundant <strong>sarcoplasmic reticulum</strong>&nbsp;as a <strong>source</strong> of <strong>intracellular calcium</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0705: Differentiating Features between Skeletal, Smooth and Cardiac Muscles</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"663\">\n<tbody>\n<tr>\n<td width=\"54\">\n<p>&nbsp;</p>\n</td>\n<td width=\"190\">\n<p><strong>Skeletal Muscle</strong></p>\n</td>\n<td width=\"210\">\n<p><strong>Smooth Muscle</strong></p>\n</td>\n<td width=\"210\">\n<p><strong>Cardiac Muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Location</p>\n</td>\n<td width=\"190\">\n<p>&nbsp;</p>\n<p>Limbs, body wall, tongue, pharynx, and beginning of the esophagus</p>\n</td>\n<td width=\"210\">\n<p>&nbsp;</p>\n<p>Esophagus (distal part), urogenital tract, urinary bladder, blood vessels, iris of the eye, arrector pili muscle</p>\n</td>\n<td width=\"210\">\n<p>&nbsp;</p>\n<p>Wall of the heart</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Cell shape</p>\n</td>\n<td width=\"190\">\n<p>Long and cylindrical</p>\n</td>\n<td width=\"210\">\n<p>Short, elongated, fusiform,or spindle-shaped</p>\n</td>\n<td width=\"210\">\n<p>Short, narrow, and cylindrical</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Branching</p>\n</td>\n<td width=\"190\">\n<p>Fibers unbranched</p>\n</td>\n<td width=\"210\">\n<p>Fibers unbranched</p>\n</td>\n<td width=\"210\">\n<p>Fibers branched</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Nucleus</p>\n</td>\n<td width=\"190\">\n<p>Multinucleated, peripheral</p>\n</td>\n<td width=\"210\">\n<p>Uninucleated, central</p>\n</td>\n<td width=\"210\">\n<p>Uninucleated, central</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Membrane</p>\n</td>\n<td width=\"190\">\n<p>Bounded by sarcolemma</p>\n</td>\n<td width=\"210\">\n<p>Bounded by plasmalemma</p>\n</td>\n<td width=\"210\">\n<p>Bounded by plasmalemma</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Striations</p>\n</td>\n<td width=\"190\">\n<p>Light and dark bands</p>\n</td>\n<td width=\"210\">\n<p>Absent</p>\n</td>\n<td width=\"210\">\n<p>Faint light and dark bands&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Cell-cell Junction</p>\n</td>\n<td width=\"190\">\n<p>No&nbsp;</p>\n</td>\n<td width=\"210\">\n<p>Gap junction (Nexus)</p>\n</td>\n<td width=\"210\">Intercalated Disc</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>T Tubules</p>\n</td>\n<td width=\"190\">\n<p>A-I junction, triad</p>\n</td>\n<td width=\"210\">\n<p>None</p>\n</td>\n<td width=\"210\">Z-line, diad</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Nerve supply</p>\n</td>\n<td width=\"190\">\n<p>Somatic nervous system</p>\n</td>\n<td width=\"210\">\n<p>Autonomic nervous system</p>\n</td>\n<td width=\"210\">\n<p>Autonomic nervous system</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Blood supply</p>\n</td>\n<td width=\"190\">\n<p>Abundant</p>\n</td>\n<td width=\"210\">\n<p>Scanty</p>\n</td>\n<td width=\"210\">\n<p>Abundant</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Source of ↑ cytosolic Ca<sup>2+</sup></p>\n</td>\n<td width=\"190\">Sarcoplasmic reticulum (SR)&nbsp;</td>\n<td width=\"210\">\n<p>SR and ECF&nbsp;</p>\n</td>\n<td width=\"210\">SR and ECF</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Special Features</p>\n</td>\n<td width=\"190\">Well developed Sarcoplasmic reticulum and T-Tubules</td>\n<td width=\"210\">\n<p>Dense bodies, caveolae, and cytoplasmic vesicles</p>\n</td>\n<td width=\"210\">Intercalated Disc</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Regeneration</p>\n</td>\n<td width=\"190\">Limited (Satellite cells)</td>\n<td width=\"210\">\n<p>Present</p>\n</td>\n<td width=\"210\">None</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Ca<sup>2+</sup> regulation</p>\n</td>\n<td width=\"190\">Troponin&nbsp;</td>\n<td width=\"210\">\n<p>Calmodulin (myosin)</p>\n</td>\n<td width=\"210\">Troponin</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Contraction</p>\n</td>\n<td width=\"190\">\n<p>Very rapid</p>\n</td>\n<td width=\"210\">\n<p>Slow</p>\n</td>\n<td width=\"210\">\n<p>Rapid</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Fatigue</p>\n</td>\n<td width=\"190\">\n<p>Get fatigued soon</p>\n</td>\n<td width=\"210\">\n<p>Do not get fatigued</p>\n</td>\n<td width=\"210\">\n<p>Never get fatigued</p>\n</td>\n</tr>\n<tr>\n<td width=\"54\">\n<p>Control</p>\n</td>\n<td width=\"190\">\n<p>Voluntary</p>\n</td>\n<td width=\"210\">\n<p>Involuntary</p>\n</td>\n<td width=\"210\">\n<p>Involuntary</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cd4784af8b7d40b1948877804cc07e58x1280x2577.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-47",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC7111",
    "stauts": "Correct",
    "question_title": "47.\n        Name the type of skull fracture.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/66bfe0c8beda429b90cac7d63c91e98c.PNG\">",
    "optionA": "A. Depressed fracture",
    "optionB": "B. Hinge fracture\n                \n                  \n                    \nCorrect",
    "optionC": "C. Pond fracture",
    "optionD": "D. Comminuted fracture",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows <strong>hinge fracture</strong>.</p>\n<p>Here base of skull is divided into 2 halves, each moving independently of each other like a hinge.</p>\n<p>Types of hinge fracture:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>Type I: Sideway impact on middle cranial fossa</td>\n<td>known as <strong>motorcyclist fracture</strong>. The fracture line reaches the opposite side through Sella tursica.</td>\n</tr>\n<tr>\n<td>Type II: Posterior impact</td>\n<td>Fracture line from posterior to anterior cranial fossa.</td>\n</tr>\n<tr>\n<td>Type III: Sideway impact on anterior cranial fossa</td>\n<td>Fracture in anterior cranial fossa.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://trello.com/1/cards/66d5a98b46a379901f843436/attachments/66d698025022ded5a2381804/previews/66d698025022ded5a2381a6a/download/1378_Types_of_Hinge_fracture_skull-FMT-INICET_GT_1-30944.jpg\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0822: Types of skull vault fracture</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Diastatic</strong> fracture/ <strong>sutural</strong> fracture - It involves the separation of sutures due to blow with a blunt weapon or from cerebral edema.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ba0902e972ff42d08d29c34cc50c1f54x327x150.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Fissured</strong> fracture/ <strong>linear</strong> fracture:</p>\n<ul>\n<li>They are breaks in the bone that traverse the full thickness of the skull from the outer to inner table.</li>\n<li>They are usually fairly straight with no bone displacement.</li>\n<li>The common cause of injury is blunt force trauma where the impact energy transferred over a wide area of the skull.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Pond</strong> fracture/ <strong>indented</strong> fracture - It occurs in children due to elasticity of bones.&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed4f9a37343641e59bcc73eda4ecffd1x167x176.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Depressed</strong> fracture/ <strong>signature</strong> fracture - It is caused by a heavy weapon with a small striking surface. Its shape indicates the type of weapon which is produced (signature fracture).</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b493f5278c3d460d906209a6d1462fbex1200x797.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Comminuted</strong> fracture/ <strong>spider-web</strong> fracture - It has a stellate appearance where there is no displacement of the fracture.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2090d8cd7b744d2d9e9136e65cdd7069x526x382.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Ring</strong> fracture - It is usually caused due to a fall from height landing on feet.&nbsp;These occur in the&nbsp;posterior fossa&nbsp;around the&nbsp;foramen magnum.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cfbc6a495f5f47f6b1be0a6dc8651bd3x1279x1477.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-48",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6488",
    "stauts": "Incorrect",
    "question_title": "48.\n         In a patient with lung disease in late stage of  sarcoidosis, which of the following would be most likely?",
    "question_ADD": "<p>DLCO: Diffusing capacity of lung for carbon monoxide</p>\n<p>A-a gradient: Alveolar-arterial gradient</p>",
    "question_imag": "",
    "optionA": "A. Increased DLCO, Increased A-a gradient",
    "optionB": "B. Increased DLCO, Decreased A-a gradient\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Decreased DLCO, Decreased A-a gradient",
    "optionD": "D. Decreased DLCO, Increased A-a gradient\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In patients with late stage of <strong>sarcoidosis,</strong> lung involvement is due to <strong>interstitial lung disease </strong>which is characterized by the <strong>decreased diffusing capacity of lung for carbon monoxide (DLCO)</strong> and <strong>increased alveolar-arterial (A-a) gradient</strong>.</p>\n<p>The most common cause of<strong> granulomatous interstitial lung disease</strong> is <strong>sarcoidosis.</strong> Sarcoidosis is a multisystem granulomatous disease that most commonly involves the lungs. Interstitial lung disease is characterized by <strong>decreased DLCO and increased A-a gradient.</strong></p>\n<p>Interstitial lung diseases are characterized by <strong>inflammation</strong> and <strong>fibrosis</strong> involving the <strong>lung parenchyma</strong>. Although there are multiple diseases under this subset, the clinical presentation for all of them is the same. The patients present with<strong> progressive exertional dyspnea</strong> and <strong>dry cough</strong>. On examination, <strong>fine inspiratory, velcro crackles</strong> may be heard.<strong> Digital clubbing</strong> and cyanosis are signs of advanced disease.</p>\n<p>Pulmonary function tests (PFT) will show:</p>\n<ul>\n<li><strong>Reduction</strong> of <strong>TLC, FEV1, and FVC (Restrictive)</strong></li>\n<li><strong>FEV1/FVC </strong>ratio is <strong>normal or increased</strong></li>\n<li>R<strong>eduction in DLCO</strong> due to<strong> a decrease</strong> in <strong>diffusion capacity</strong></li>\n<li>Normal PAO2 (Alveolar O2) and decreased PaO2 (arterial), causing an <strong>increased alveolar-arterial (A-a) gradient.&nbsp;</strong></li>\n</ul>\n<p>Idiopathic pulmonary fibrosis (IPF) is the <strong>most common interstitial lung disease</strong> occurring due to an unknown cause.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eef830d2d0f94fab86d0f1c385c6ab06x1200x2175.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1172: PFT for obstructive vs restrictive diseases</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"150\">\n<p><strong>PFT</strong></p>\n</td>\n<td width=\"150\">\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td width=\"150\">\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>FVC</p>\n</td>\n<td width=\"150\">\n<p>Decreased</p>\n</td>\n<td width=\"150\">\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>FEV1</p>\n</td>\n<td width=\"150\">\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td width=\"150\">Decreased</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td width=\"150\">\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td width=\"150\">\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>FEF 25-75</p>\n</td>\n<td width=\"150\">\n<p>&lt;50% predicted</p>\n</td>\n<td width=\"150\">\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>TLC</p>\n</td>\n<td width=\"150\">\n<p>Normal/ increased</p>\n</td>\n<td width=\"150\">\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>RV</p>\n</td>\n<td width=\"150\">\n<p>Increased</p>\n</td>\n<td width=\"150\">\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\"150\">\n<p>DLCO</p>\n</td>\n<td width=\"150\">\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td width=\"150\">\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-49",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC6607",
    "stauts": "Incorrect",
    "question_title": "49.\n        Which of the following Darrow Yannet diagram is suggestive of adrenal insufficiency?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/d0a42d44229e41febc721f9c5234af16.JPEG\">",
    "optionA": "A. 1",
    "optionB": "B. 4\n                \n                  \n                    \nCorrect",
    "optionC": "C. 2\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 3",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>The Darrow Yannet diagram</strong> shown in<strong> image 4</strong> depicts<strong> adrenal insufficiency</strong>. In adrenal insufficiency, there is hypo-osmotic volume contraction.</p>\n<p><strong>Darrow Yannet diagrams&nbsp;</strong>depict the change in plasma osmolarity and plasma volume in various conditions.&nbsp;The dotted line in the diagram is the change after either addition or removal of fluid.</p>\n<p>Adrenal insufficiency is characterized by <strong>aldosterone deficiency</strong> which leads to increased <strong>sodium loss</strong> (loss of hyperosmotic fluid). This results in:</p>\n<ul>\n<li>The osmolarity of extra-cellular fluid (ECF) decreases.</li>\n<li><strong>ECF volume decreases</strong>&nbsp;because of the loss of volume.</li>\n<li>Water shifts into the intracellular fluid (ICF). As a result,&nbsp;<strong>ICF osmolarity decreases&nbsp;</strong>until it is equal to ECF osmolarity, and&nbsp;<strong>ICF volume increases.</strong></li>\n<li>So, loss of hypertonic fluid causes hypotonic volume contraction.</li>\n</ul>\n<p>The image given below shows Darrow Yannet diagrams of various conditions:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcb0ef6062c5434b88378797f115c7ddx1280x1909.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Diagram 1 </strong>-&nbsp;The addition of isotonic saline (0.9% normal saline) to ECF does not cause any fluid shift from the ICF. Hence, it only leads to an increase in ECF volume without causing any change in osmolarity.</p>\n<p><strong>Diagram 2 </strong>- The addition of excess NaCl to ECF pulls the fluid from ICF into the ECF. This results in a decreased volume of ICF, increased volume of ECF, and increased osmolarity in both ECF and ICF.</p>\n<p><strong>Diagram 3 </strong>- SIADH (syndrome of inappropriate secretion of anti-diuretic hormone) is associated with euvolemic hyponatremia. This leads to a decrease in the osmolarity of the ECF. This causes a fluid shift from the ECF to the ICF until the osmolarity of both compartments becomes equal. The fluid influx also leads to a decrease in the ICF's osmolarity.&nbsp;Therefore, the net effect is an increase in extracellular volume, an increase in intracellular volume, and a fall in osmolarity in both compartments.</p>\n<p><strong>Diagram 4 </strong>- Adrenal insufficiency is associated with hypo-osmotic volume contraction. Due to a deficiency of aldosterone, there is a decrease in both plasma volume and osmolality.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0463: Disturbances in body fluids</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"100%\">\n<tbody>\n<tr>\n<td width=\"18%\">\n<p><strong>Type</strong></p>\n</td>\n<td width=\"16%\">\n<p><strong>Example</strong></p>\n</td>\n<td width=\"11%\">\n<p><strong>ECF volume</strong></p>\n</td>\n<td width=\"11%\">\n<p><strong>ICF volume</strong></p>\n</td>\n<td width=\"15%\">\n<p><strong>Osmolarity</strong></p>\n</td>\n<td width=\"15%\">\n<p><strong>Hematocrit</strong></p>\n</td>\n<td width=\"12%\">\n<p><strong>Plasma proteins</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Isosmotic volume contraction</p>\n</td>\n<td width=\"16%\">\n<p>Diarrhea,</p>\n<p>Burns</p>\n</td>\n<td width=\"11%\">\n<p>↓</p>\n</td>\n<td width=\"11%\">\n<p>No change</p>\n</td>\n<td width=\"15%\">\n<p>No change</p>\n</td>\n<td width=\"15%\">\n<p>↑</p>\n</td>\n<td width=\"12%\">\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Hyperosmotic volume contraction</p>\n</td>\n<td width=\"16%\">\n<p>Sweating,</p>\n<p>Fever,</p>\n<p>Diabetes insipidus</p>\n</td>\n<td width=\"11%\">\n<p>↓</p>\n</td>\n<td width=\"11%\">\n<p>↓</p>\n</td>\n<td width=\"15%\">\n<p>↑</p>\n</td>\n<td width=\"15%\">\n<p>No change</p>\n</td>\n<td width=\"12%\">\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Hyposmotic volume contraction</p>\n</td>\n<td width=\"16%\">\n<p>Adrenal insufficiency</p>\n</td>\n<td width=\"11%\">\n<p>↓</p>\n</td>\n<td width=\"11%\">\n<p>↑</p>\n</td>\n<td width=\"15%\">\n<p>↓</p>\n</td>\n<td width=\"15%\">\n<p>↑</p>\n</td>\n<td width=\"12%\">\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Isosmotic volume expansion</p>\n</td>\n<td width=\"16%\">\n<p>Infusion of isotonic NaCl</p>\n</td>\n<td width=\"11%\">\n<p>↑</p>\n</td>\n<td width=\"11%\">\n<p>No change</p>\n</td>\n<td width=\"15%\">\n<p>No change</p>\n</td>\n<td width=\"15%\">\n<p>↓</p>\n</td>\n<td width=\"12%\">\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Hyperosmotic volume expansion</p>\n</td>\n<td width=\"16%\">\n<p>High NaCl intake</p>\n</td>\n<td width=\"11%\">\n<p>↑</p>\n</td>\n<td width=\"11%\">\n<p>↓</p>\n</td>\n<td width=\"15%\">\n<p>↑</p>\n</td>\n<td width=\"15%\">\n<p>↓</p>\n</td>\n<td width=\"12%\">\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\"18%\">\n<p>Hyposmotic volume expansion</p>\n</td>\n<td width=\"16%\">\n<p>SIADH</p>\n</td>\n<td width=\"11%\">\n<p>↑</p>\n</td>\n<td width=\"11%\">\n<p>↑</p>\n</td>\n<td width=\"15%\">\n<p>↓</p>\n</td>\n<td width=\"15%\">\n<p>No change</p>\n</td>\n<td width=\"12%\">\n<p>↓</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0461: Indicators for measurement of body fluids</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"99\">\n<p><strong>Compartments</strong></p>\n</td>\n<td width=\"301\">\n<p><strong>Indicators</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>Plasma volume</p>\n</td>\n<td width=\"301\">\n<ul>\n<li>Evans’ blue(T1824)</li>\n<li>Human serum albumin tagged with radioactive iodine<sup>125</sup></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>RBC volume</p>\n</td>\n<td width=\"301\">\n<p>Tagging RBC with cr-51, Fe-59, 32P, also antigenic tagging</p>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>ECF volume</p>\n</td>\n<td width=\"301\">\n<ul>\n<li>Inulin</li>\n<li>Sucrose</li>\n<li>Mannitol</li>\n<li>Sodium thiosulphate</li>\n<li>Sodium thiocyanate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>Interstitial fluid</p>\n</td>\n<td width=\"301\">\n<p>Cannot be measured directly.</p>\n<p>ECF minus plasma volume gives the value</p>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>ICF</p>\n</td>\n<td width=\"301\">\n<p>Cannot be measured directly.</p>\n<p>TBW minus ECF gives the value (D2O minus Mannitol)</p>\n</td>\n</tr>\n<tr>\n<td width=\"99\">\n<p>TBW</p>\n</td>\n<td width=\"301\">\n<p>D2O (<sup>2</sup>H<sub>2</sub>O)</p>\n<p>Tritium oxide (<sup>3</sup>H<sub>2</sub>O)</p>\n<p>Antipyrine</p>\n<p>Aminopyrine</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0460: Body Fluids Compartments</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cc7d2c1c562482e8d734067f1adbe98x1200x1204.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>In ECF, a third specialised compartment, called the <strong>transcellular compartment</strong> (not shown in flow chart), is quantitatively small and includes the cerebrospinal, pleural, peritoneal, pericardial, synovial, intraocular and digestive fluids. It constitutes &lt;1% of TBW (1-2L).</li>\n<li>The ECF volume/intracellular fluid volume ratio is larger in infants and children than it is in adults, but the <strong>absolute volume of ECF in children is, of course, smaller than in adults</strong>. Therefore, <strong>dehydration develops more rapidly and is frequently more severe in children.</strong></li>\n<li>All solutes and water that enter or leave the body do so via the ECF.</li>\n<li>The ICF and ECF are in osmotic equilibrium. Water moves between these compartments only when an osmotic pressure gradient exists.</li>\n<li>Equilibration of ICF and ECF osmolality occurs primarily by shifts in water and not shifts in solutes.</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-50",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD2698",
    "stauts": "Incorrect",
    "question_title": "50.\n        A child of age 5 years presents with developmental delay and multiple episodes of seizure which could not be controlled with multiple drugs. A diagnosis of  Lennox–Gastaut syndrome is made. What is the characteristic electroencephalogram finding will you expect?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 4-5 Hz spike and a slow background in wakefulness",
    "optionB": "B. 1-2 Hz spike and slow wave and polyspike bursts in sleep\n                \n                  \n                    \nCorrect",
    "optionC": "C. 3 Hz spike and slow-wave with a fast background in wakefulness",
    "optionD": "D. Hypsarrhythmia and a slow background in wakefulness\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>1-2 Hz spike </strong>and<strong> slow waves </strong>and<strong> polyspike bursts </strong>in sleep,&nbsp;and a slow background in wakefulness is the characteristic electroencephalogram findings in&nbsp;<strong>Lennox–Gastaut syndrome.</strong></p>\n<p>A child with developmental delay, intractable seizures with an electroencephalogram (EEG) showing 1-2 Hz spike, and polyspike bursts in sleep are suggestive of the diagnosis of Lennox–Gastaut syndrome. It typically starts between the age of<strong> 2 and 10 years. </strong>Consists of a triad of</p>\n<ul>\n<li>Developmental delay</li>\n<li>Multiple seizure types (includes atypical absences, myoclonic, astatic, and tonic seizures)</li>\n<li>EEG findings <strong>1-2 Hz spike </strong>and slow waves,<strong> polyspike bursts in sleep</strong>, and a slow background in wakefulness</li>\n</ul>\n<p>Patients will have long-term cognitive impairment and intractable seizures despite multiple therapies.</p>\n<p>&nbsp;</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<table border=\"1\" width=\"348\">\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Disease</strong></td>\n<td><strong>&nbsp; &nbsp;Typical EEG feature</strong></td>\n</tr>\n<tr>\n<td><strong>Lennox-Gastaut syndrome</strong></td>\n<td><strong>1-2 Hz spike and polyspike bursts in sleep</strong></td>\n</tr>\n<tr>\n<td>Absence seizures</td>\n<td>3 Hz spike and slow-wave (spike and dome pattern)</td>\n</tr>\n<tr>\n<td>Juvenile myoclonic epilepsy</td>\n<td>4-5 Hz spike</td>\n</tr>\n<tr>\n<td>West syndrome&nbsp;(Infantile spasms)</td>\n<td>Hypsarrhythmia (high-voltage waves with chaotic background)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1695: First-line Agents in Different Types of Seizures</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-51",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2811",
    "stauts": "Correct",
    "question_title": "51.\n        After the birth of a full-term baby, the following was seen in the upper middle region of the infant's abdomen. What is the likely time of splitting of the embryo?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/d8a6cfd879684c69bb2d76cc2e0c5303.PNG\">",
    "optionA": "A. 3-8th day",
    "optionB": "B. <3 days",
    "optionC": "C. >13 days\n                \n                  \n                    \nCorrect",
    "optionD": "D. 2-6th day",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image shows a ‘<strong>parasitic twin</strong>’ which is a <strong>subtype</strong> of <strong>conjoined twins</strong> and the most likely time of the splitting of the embryo is <strong>&gt;13 days</strong>.</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; Time of division</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; Type of twin</strong></td>\n</tr>\n<tr>\n<td>&lt;4 days</td>\n<td>Dichorionic diamniotic (DCDA)&nbsp;</td>\n</tr>\n<tr>\n<td>4-8 days</td>\n<td>Monochorionic diamniotic (MCDA)</td>\n</tr>\n<tr>\n<td>&gt;8 days</td>\n<td>Monochorionic monoamniotic (MCMA)</td>\n</tr>\n<tr>\n<td>&gt;13 days&nbsp;</td>\n<td>Conjoined twins</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2236: Twinning</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4c8753494db4694a4b67e77bcea1502x1280x5795.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-52",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF2835",
    "stauts": "Correct",
    "question_title": "52.\n        A 6-year-old boy was brought to the orthopedic department with pain and swelling in the right thigh for a few weeks. X-ray of the right femur showed a lesion as shown below.  Biopsy from the lesion showed small blue tumor cells which are PAS-positive. What is the probable diagnosis?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/0b19a9608f86499c8b39877692c4875d.JPEG\">",
    "optionA": "A. Ewing sarcoma\n                \n                  \n                    \nCorrect",
    "optionB": "B. Osteosarcoma",
    "optionC": "C. Chondroblastoma",
    "optionD": "D. Chondrosarcoma",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A clinical scenario of a 6-year-old boy with painful swelling in his thigh and an X-ray showing<strong> onion skin periosteal reaction</strong> with biopsy demonstrating PAS-positive cells is suggestive of<strong> Ewing sarcoma.</strong></p>\n<p>Ewing sarcoma is the second most common non-hematologic primary bone malignancy in patients younger than 30 years. They are commonly seen in young patients aged<strong> 5 to 25</strong> years and predominantly in males.</p>\n<p>They commonly occur in the <strong>metaphysis</strong> of long bones which extend into <strong>diaphysis</strong> too. Most of the patients present with <strong>pain</strong> that is insidious in onset. Fever, swelling, and erythema may also be present. Laboratory findings may show an elevated WBC count, ESR, and CRP.</p>\n<p>Radiological examination shows a destructive lesion in the diaphysis of long bones with <strong>onion skin</strong> periosteal reaction.</p>\n<p>Cytogenetic examination of showing <strong>t(11:22</strong>)(q24:q12)is the most common translocation diagnostic of Ewing's sarcoma.</p>\n<p>Histology shows small blue round tumor cells that are <strong>PAS-positive</strong>, as tumor cells are rich in <strong>glycogen</strong>. However, they <strong>stain negatively</strong> for <strong>reticulin</strong>.</p>\n<p>The image given below shows PAS staining done in Ewing's sarcoma.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a538d9b6ff5a481994ee399fa9059c6cx1280x1048.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Note: Lymphomas&nbsp;are PAS negative and reticulin positive.</p>\n<p>Ewing sarcoma is <strong>radiosensitive</strong>. Large unresectable tumors are treated with radiation while small resectable tumors are more likely to be treated with <strong>surgery</strong>. Treatment always includes adjuvant or neoadjuvant <strong>chemotherapy</strong>.&nbsp;</p>\n<p>Histologic grade doesn't have any prognostic significance since<strong> all Ewing</strong> sarcoma are considered as <strong>high grade</strong>.</p>\n<p><strong>Poor prognostic</strong> factors of Ewing sarcoma :</p>\n<ul>\n<li>Distant metastases</li>\n<li>Size of the primary lesion</li>\n<li>Fever, anemia</li>\n<li>Elevated WBC count, ESR, and LDH</li>\n<li>Age between 12- 15 years</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Osteosarcoma</strong>&nbsp;is the&nbsp;most common primary malignancy&nbsp;of bone. It has a bimodal age distribution- at adolescence and in the seventh decade. It is typically seen in&nbsp;<strong>metaphyseal&nbsp;</strong>regions of the distal femur, proximal tibia, and proximal humerus.&nbsp;</p>\n<p>X-ray shows<strong>&nbsp;periosteal reaction&nbsp;</strong>and it may take the form of a&nbsp;<strong>Codman's triangle</strong>&nbsp;or it may have a&nbsp;<strong>sunburst (sunray) appearance </strong>as shown below.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ff78bc1e05bc4f678475eddaca4aaf75x720x765.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option C: <strong>Chondroblastoma</strong> is a benign cartilaginous tumor occurring mainly in long bones. On X-rays, they appear as a well-circumscribed, round, or oval lytic lesion in the center of the epiphysis of long bones with areas of calcification within the tumor. On histology presence of <strong>\"chicken wire calcification\"</strong> is pathognomic.</p>\n<p>The image below shows an X-ray with&nbsp;a well-circumscribed, round lytic lesion in the center of the epiphysis of the tibia suggestive of chondroblastoma.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/50515b1c35884329bd5c9cf42ab50502x621x747.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D: <strong>Chondrosarcoma</strong>&nbsp;is the second most common primary malignant bone tumor after osteosarcoma. It can present between the 3rd-8th decade of life. They are&nbsp;<strong>slow-growing tumors</strong>&nbsp;that produce deep pain with an enlarging mass and arise in any bone-derived from enchondral ossification. Radiographically, they appear as large, intraosseous, osteolytic tumors with irregular granular calcifications giving a '<strong>honeycomb'&nbsp;</strong>or '<strong>popcorn'&nbsp;</strong>appearance. CT and MRI are useful in the diagnosis. Chondrosarcoma is&nbsp;<strong>resistant</strong>&nbsp;to both&nbsp;<strong>chemotherapy and radiation</strong>. Surgical excision is the only treatment.</p>\n<p>The below radiograph shows<strong>&nbsp;popcorn</strong> <strong>calcification</strong>&nbsp;in&nbsp;chondrosarcoma.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/069468f522b64c8bb3b1b445299c64fex720x1359.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2329: Summary of Bone Tumors</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1339: Important radiosenstive and radioresistant bone tumours</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Radiosensitive</strong> tumors:</p>\n<ol>\n<li>Metastasis (except metastasis from renal cell carcinoma which is radioresistant)</li>\n<li>Ewing's sarcoma</li>\n<li>Multiple myeloma</li>\n<li>Lymphoma</li>\n</ol>\n<p><strong>Radioresistant</strong> tumors:</p>\n<ol>\n<li>Osteosarcoma</li>\n<li>Chondrosarcoma</li>\n<li>Fibrosarcoma</li>\n<li>Malignant fibrous histiocytoma</li>\n</ol></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-53",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0293",
    "stauts": "Correct",
    "question_title": "53.\n        A patient presents with fever associated with rigor and chills for 1 week, with abdominal distension and loss of appetite. On examination, there is marked hepato-splenomegaly. There is a poor response to antibiotics and antimalarials. The Widal test is negative but rk39 is positive. A sample from which of the following sites is the most sensitive to demonstrate the presence of the causative organism?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Splenic aspirate\n                \n                  \n                    \nCorrect",
    "optionB": "B. Bone marrow aspirate",
    "optionC": "C. Liver biopsy",
    "optionD": "D. Lymph node aspirate",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given clinical vignette of a patient with<strong> fever, rigor, chills, abdominal distension,</strong> and<strong> marked hepatosplenomegaly,</strong> alongside a<strong> positive rk39 test</strong>, the presentation is highly suggestive of <strong>visceral leishmaniasis (kala-azar)</strong>. The <strong>most sensitive diagnostic method </strong>for detecting the causative organism is<strong> splenic aspirate</strong>, which has a positive detection rate of up to 98%.<strong> </strong></p>\n<p><strong>Splenic aspiration</strong> is highly effective because it <strong>directly </strong>samples the <strong>site of infection</strong>. However, it is <strong>not routinely performed </strong>due to significant risks, such as <strong>haemorrhage</strong>, particularly in patients with<strong> </strong>advanced disease where the spleen is markedly enlarged and soft.</p>\n<p><strong>Kala-azar</strong> is a slowly progressing indigenous disease caused by a protozoan parasite of the genus <strong>Leishmania</strong>. Leishmaniasis is a <strong>parasitic</strong> disorder transmitted by the bite of an infected female <strong>Phlebotomus sandfly</strong> in developing countries. The disease is transmitted by <strong>sand flies</strong>, which inoculate the <strong>flagellated promastigotes</strong> into the skin of the host. It <strong>lowers immunity</strong> and causes persistent fever, anaemia, and <strong>hepatosplenomegaly</strong>, and if left untreated,<strong> death </strong>may occur due to <strong>opportunistic infection</strong>.</p>\n<p>In human beings, the disease presents in <strong>four different forms</strong> with a broad range of clinical manifestations:</p>\n<ul>\n<li><strong>Visceral</strong> leishmaniasis, or kala-azar,</li>\n<li><strong>Cutaneous</strong> leishmaniasis,</li>\n<li><strong>Mucocutaneous</strong> leishmaniasis, and</li>\n<li><strong>Diffuse cutaneous</strong> leishmaniasis.</li>\n</ul>\n<p>The <strong>life cycle</strong> of Leishmania involves two forms, the <strong>promastigote</strong> which develops and lives <strong>extracellularly</strong> in the <strong>sandfly vector</strong> and the <strong>amastigote&nbsp;</strong>form (as shown below)&nbsp;multiplies <strong>intracellularly</strong> in the <strong>reticuloendothelial cells</strong> of the <strong>host</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/827133dea5744a81910a22f7852f2d54x720x540.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Diagnosis</strong> of visceral leishmaniasis includes the <strong>rK39 rapid diagnostic test</strong> and <strong>Kala-azar dipstick test</strong>, as recommended by the <strong>National Vector Borne Disease Control Programme</strong> (NVBDCP) in India. Parasitological confirmation is achieved by demonstrating <strong>LD bodies</strong> in a <strong>buffy coat smear</strong>. The <strong>aldehyde test</strong> of <strong>Napier</strong> is used for <strong>surveillance</strong>, while serological tests like rapid dipstick, direct agglutination test, ELISA, and indirect fluorescent antibody test aid in diagnosis. The <strong>Leishmanin (Montenegro) test</strong> is useful for identifying <strong>endemicity</strong> and <strong>immune response</strong>, though it is typically <strong>positive 4-6 weeks</strong> after cutaneous leishmaniasis onset. The <strong>gold standard</strong> for diagnosing kala-azar is the <strong>microscopic demonstration</strong> of<strong> amastigotes</strong> in <strong>bone marrow</strong>, generally obtained by <strong>aspirating</strong> the <strong>sternal marrow </strong>(as shown below). Other samples may include peripheral blood, splenic aspirate, and enlarged lymph nodes.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fa9ff22b90b843d8939376ff59708580x600x949.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Treatment </strong>for visceral leishmaniasis typically includes medications such as <strong>sodium stibogluconate, miltefosine</strong>, and <strong>amphotericin B</strong>. In India,<strong> liposomal amphotericin</strong> is the<strong> first-line</strong> treatment, administered as a <strong>single intravenous</strong> dose of <strong>10 mg/kg</strong>. This regimen is preferred due to its efficacy and safety profile, providing a robust option for managing this serious and life-threatening parasitic disease.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1757: Various morphological stages of hemoflagellates</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>It is based on the&nbsp;arrangement of the flagella in relation to the position of the nucleus and its point of emergence from the cells.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2a3d60c324049fbb159d7eb6e51e0b1x1280x657.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Morphological characteristics</strong></td>\n<td><strong>Seen in</strong></td>\n</tr>\n<tr>\n<td><strong>Amastigote</strong></td>\n<td>\n<p>Rounded or ovoid, without any external flagellum.</p>\n<p>The nucleus, kinetoplast, and axial filaments can be seen.</p>\n<p>The axoneme extends up to the anterior end of the cell</p>\n</td>\n<td>Trypanosoma cruzi and Leishmania as the intracellular form in the vertebrate host.</td>\n</tr>\n<tr>\n<td><strong>Promastigote</strong></td>\n<td>\n<p>Lanceolate in shape.</p>\n<p><strong>Antenuclear kinetoplast-&nbsp;</strong>kinetoplast is anterior to the nucleus near the anterior end of the cell, from which flagellum emerges.</p>\n<p>There is <strong>no undulating membrane</strong></p>\n</td>\n<td>It is the infective stage of Leishmania, found in the insect vector as well as in cultures in­vitro.</td>\n</tr>\n<tr>\n<td><strong>Epimastigote</strong></td>\n<td>\n<p>Elongated.&nbsp;</p>\n<p><strong>Juxtanuclear kinetoplast </strong>-<strong>&nbsp;</strong>kinetoplast placed more posteriorly, close to and in front of the nucleus.</p>\n<p>The flagellum runs alongside the body as a short undulating membrane, before emerging from the anterior end.</p>\n</td>\n<td>\n<p>It is the form in which Trypanosoma brucei occurs in the salivary gland of the vector tsetse fly and Trypanosoma cruzi in the midgut of the vector reduviid bug.</p>\n<p><strong>Note:</strong> This stage is lacking in Leishmania.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Trypo-mastigote</strong></td>\n<td>\n<p>This stage is elongated, spindle-shaped with a <strong>central nucleus</strong>.</p>\n<p><strong>Postnuclear kinetoplast</strong>&nbsp;- kinetoplast is posterior to the nucleus and situated at the posterior end of the body.</p>\n<p>The flagellum runs alongside the entire length of the cell to form a long undulating membrane before emerging as a free flagellum from the anterior end.</p>\n</td>\n<td>\n<p>This is the infective stage of trypanosomes found in arthropod vector and in the blood of an infected vertebrate.</p>\n<p><strong>Note:</strong> This stage is lacking in Leishmania.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0657: Important serological tests for the diagnosis of parasitic infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Serological tests</strong> are helpful for the detection and surveillance of many protozoal and helminthic infections.</p>\n<p>These tests are basically of 2 types:</p>\n<ul>\n<li>Tests for antigen detection</li>\n<li>Tests for antibody detection</li>\n</ul>\n<p><strong>Antigen Detection:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antigen</strong></p>\n</td>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Galactose lectin antigen</p>\n</td>\n<td>\n<p><em>Entamoeba histolytica</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Giardia-specific antigen 65</p>\n</td>\n<td>\n<p><em>Giardia lamblia</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>WKK and rk39 antigen</p>\n</td>\n<td>\n<p><em>Leishmania donovani</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HRP-2 antigen</p>\n</td>\n<td>\n<p><em>Plasmodium falciparum</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vivax-specific pLDH</p>\n</td>\n<td>\n<p><em>Plasmodium vivax</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>200 KD Ag and OG4C3 antigen</p>\n</td>\n<td>\n<p><em>Wuchereria bancrofti</em></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Antibody detection:</strong></p>\n<ul>\n<li>Complement fixation test (CFT)</li>\n<li>Indirect hemagglutination test (IHA)</li>\n<li>Indirect immunofluorescent antibody test (IFA)</li>\n<li>Rapid immunochromatography test</li>\n<li>ELISA test</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2373: Infective form and diagnostic forms of various protozoa</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table dir=\"ltr\" border=\"1\" width=\"284\" cellspacing=\"0\" cellpadding=\"0\"><colgroup><col width=\"292\"><col width=\"271\"><col width=\"293\"></colgroup>\n<tbody>\n<tr>\n<td><strong>Parasite</strong></td>\n<td><strong>Infective form</strong></td>\n<td><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td><em>Entamoeba histolytica</em></td>\n<td>Mature quadrinucleate cyst</td>\n<td>Trophozoites, quadrinucleate cyst</td>\n</tr>\n<tr>\n<td><em>Giardia lamblia</em></td>\n<td>Quadrinucleate cyst</td>\n<td>Trophozoites, cyst</td>\n</tr>\n<tr>\n<td><em>Trichomonas vaginalis</em></td>\n<td>Trophozoites</td>\n<td>Trophozoites</td>\n</tr>\n<tr>\n<td><em>Naegleria fowleri</em></td>\n<td>Trophozoite</td>\n<td>Trophozoite in CSF</td>\n</tr>\n<tr>\n<td><em>Acanthamoeba</em></td>\n<td>Trophozoites and cysts</td>\n<td>Trophozoite in CSF</td>\n</tr>\n<tr>\n<td><em>Leishmania donovani</em></td>\n<td>Promastigote</td>\n<td>amastigotes in macrophage</td>\n</tr>\n<tr>\n<td><em>Trypanosoma cruzi</em></td>\n<td>Metacyclic Trypomastigote</td>\n<td>Trypomastigote</td>\n</tr>\n<tr>\n<td><em>Trypanosoma brucei</em></td>\n<td>Metacyclic Trypomastigote</td>\n<td>Trypomastigote</td>\n</tr>\n<tr>\n<td><em>Balantidium coli</em></td>\n<td>Cysts</td>\n<td>Cysts</td>\n</tr>\n<tr>\n<td><em>Plasmodium </em>spp.</td>\n<td>Sporozoites</td>\n<td>Schizont, immature trophozoite, mature trophozoite, gametocyte</td>\n</tr>\n<tr>\n<td><em>Babesia </em>spp.</td>\n<td>Sporozoites</td>\n<td>Maltese cross form</td>\n</tr>\n<tr>\n<td><em>Toxoplasma gondii</em></td>\n<td>All 3 morphological forms - oocyst, tachyzoite, bradyzoite</td>\n<td>Tachyzoites, tissue cysts</td>\n</tr>\n<tr>\n<td><em>Cryptosporidium parvum</em></td>\n<td>Sporulated oocyst</td>\n<td>Sporulated oocyst</td>\n</tr>\n<tr>\n<td><em>Cyclospora cayetanensis</em></td>\n<td>Sporulated oocyst</td>\n<td>unsporulated oocyst</td>\n</tr>\n<tr>\n<td><em>Isospora belli</em></td>\n<td>Sporulated oocyst</td>\n<td>unsporulated oocyst</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-54",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6490",
    "stauts": "Incorrect",
    "question_title": "54.\n        Which one of the following is a provision under the PPTCT (Prevention of Parent-to-Child Transmission) program for HIV?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Home births with HIV-infected mothers being counseled on safe birthing practices",
    "optionB": "B. Lifelong ART administration to all pregnant and breastfeeding HIV-infected women with CD4 count of less than 500/mm3",
    "optionC": "C. Plasma viral load testing at 32–36 weeks of gestation to determine the risk of HIV transmission to the baby\n                \n                  \n                    \nCorrect",
    "optionD": "D. Syrup Nevirapine and syrup Zidovudine from birth till 6 weeks for all infants of HIV positive mothers\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The PPTCT (Prevention of Parent-to-Child Transmission) program includes the crucial provision of <strong>plasma viral load testing at 32–36 weeks </strong>of gestation (Option C) to determine the<strong> risk of HIV transmission from mother to baby</strong>. This testing is essential for assessing the level of HIV in the mother's blood, allowing healthcare providers to <strong>tailor interventions to reduce transmission risk</strong>, such as adjusting antiretroviral therapy (<strong>ART</strong>) or scheduling a <strong>cesarean</strong> delivery.</p>\n<p>Other options:</p>\n<p>Option A: The PPTCT program emphasizes <strong>institutional deliveries</strong> for HIV-infected mothers to provide better management and immediate medical care, which is not feasible with home births.</p>\n<p>Option B: Lifelong ART is administered to all pregnant and breastfeeding HIV-infected women<strong> regardless of their CD4 count </strong>and clinical stage, ensuring comprehensive care and reducing the risk of transmission.</p>\n<p>Option D: The initiation of ARV in babies is differentiated based on the risk level.<strong> Low-risk infants </strong>receive only<strong> Syrup Nevirapine,</strong> while <strong>high-risk infants </strong>receive <strong>both</strong> Syrup Nevirapine and Syrup Zidovudine, with the duration varying based on feeding practices.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2199: Prevention of parent to child transmission (PPTCT)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Important provisions of PPTCT services for HIV:</p>\n<ul>\n<li>HIV counseling and testing for all pregnant women enrolled in antenatal care with ‘opt out’ option.</li>\n<li>Lifelong ART i.e. <strong>Tenofovir (TDF) + Lamivudine (3TC)+ Dolutegravir (DTG)</strong> administration to all pregnant and breastfeeding HIV-infected women <strong>regardless of CD4 count and clinical stage</strong>.</li>\n<li>Institutional deliveries of HIV-infected mothers</li>\n<li>Care of associated conditions (STI/RTI, TB, opportunistic infections, hypertension, diabetes)</li>\n<li>Exclusive breastfeeding counseling</li>\n<li><strong>Plasma viral load testing</strong> at <strong>32–36 weeks of gestation</strong> to determine the risk of HIV transmission to the baby</li>\n<li aria-level=\"1\">Initiation of ARV in babies:<br>\n<ul>\n<li aria-level=\"2\">Low-risk infants: <strong>Syrup Nevirapine</strong> from <strong>birth till 6 weeks</strong> of age</li>\n<li aria-level=\"2\">High-risk infants: <strong>Syrup Nevirapine+ syrup Zidovudine</strong> either from <strong>birth till 6 weeks</strong> of age (exclusive replacement feeding) or from <strong>birth till 12 weeks</strong> of age (exclusive breastfeeding)</li>\n</ul>\n</li>\n<li>Nutrition counseling and psychosocial support to HIV-infected pregnant women</li>\n<li>Ensure <strong>co-trimoxazole prophylactic therapy (CPT)</strong> and early infant diagnosis using HIV-DNA PCR at 6 weeks of age onwards as per guidelines</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-55",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6474",
    "stauts": "Correct",
    "question_title": "55.\n        A tonsillectomy is being performed by a first-year resident. The senior resident warned him to limit his dissection to a certain anatomical limit. What limit is he referring to?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Buccopharyngeal fascia",
    "optionB": "B. Pharyngobasilar fascia\n                \n                  \n                    \nCorrect",
    "optionC": "C. Styloid process",
    "optionD": "D. Superior constrictor muscle",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In this given scenario, the senior resident's warning to limit dissection during a tonsillectomy typically refers to <strong>pharyngobasilar fascia</strong> to <strong>avoid damage to the superior constrictor muscle</strong>, which has a rich blood supply.&nbsp;</p>\n<p>The <strong>structures</strong> forming the<strong> tonsillar bed</strong> from within outward are&nbsp;</p>\n<ol>\n<li>Pharyngobasilar Fascia</li>\n<li>Superior Constrictor</li>\n<li>Buccopharyngeal Fascia</li>\n<li>Styloglossus</li>\n<li>Glossopharyngeal Nerve</li>\n<li>Facial Artery</li>\n</ol>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3717cdd8bb7a4916b3b3fdd5d3396653x1280x2558.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong><br>Enlarged</strong> and <strong>infected</strong> tonsils often require surgical removal. The operation is called <strong>tonsillectomy.</strong>&nbsp;</p>\n<p><strong>Absolute indications</strong> for tonsillectomy are</p>\n<ol>\n<li><strong>Recurrent infections</strong> of the throat:&nbsp;\n<ul>\n<li>≥7 episodes in 1 year,</li>\n<li>≥5 episodes/year in 2 years,</li>\n<li>≥ 3 episodes/year in 3 years, or</li>\n<li>≥ 2 weeks of absence from school or work in 1 year</li>\n</ul>\n</li>\n<li><strong>Peritonsillar abscess</strong> (1 episode in a child or 2 episodes in adults)</li>\n<li>Tonsillitis causing<strong> febrile seizures</strong></li>\n<li><strong>Hypertrophy</strong> of the tonsils causing airway obstruction, difficulty in deglutition, or interference with speech</li>\n<li>Suspicion of <strong>malignancy</strong></li>\n</ol>\n<p>The <strong>relative indications</strong> are:</p>\n<ul>\n<li><strong>Diphtheria carriers</strong> who have not responded to antibiotics</li>\n<li><strong>Streptococcal carriers</strong> who may be a source of infection for others</li>\n<li><strong>Chronic</strong> tonsillitis with <strong>halitosis</strong> unresponsive to medical treatment</li>\n<li>Patient with <strong>valvular heart disease </strong>having recurrent streptococcal tonsillitis</li>\n</ul>\n<p>It is also indicated as a<strong> part of other procedures</strong> like palato- pharyngoplasty, glossopharyngeal neurectomy, removal of the styloid process.</p>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>Hemoglobin level<strong> less than 10g%</strong></li>\n<li>Presence of <strong>acute infection</strong> like acute tonsillitis due to increased incidence of bleeding during infection</li>\n<li>Children<strong> under 3 years</strong> of age due to poor surgical risk</li>\n<li><strong>Cleft palate</strong></li>\n<li><strong>Bleeding disorders</strong></li>\n<li>Uncontrolled systemic disease (diabetes, cardiac disease, hypertension, asthma</li>\n<li>During <strong>menses</strong></li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "ENT"
  },
  {
    "web-scraper-order": "1727319149-56",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6807",
    "stauts": "Incorrect",
    "question_title": "56.\n        A 46-year-old man came to your PHC with a history of transient painless genital ulcer. On examination, the inguinal region had painful and fluctuant swellings, as seen in the image below.  What is the best management option?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/4672348ccecb4a009d5645e1c343665a.JPEG\">",
    "optionA": "A. Start on black STD kit only and advise follow-up for 21 days\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Incision and drainage at your PHC",
    "optionC": "C. Refer to a higher centre for aspiration\n                \n                  \n                    \nCorrect",
    "optionD": "D. Start on white STD kit only and advise follow-up for 14 days",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario is suggestive of <strong>lymphogranuloma</strong> <strong>venereum</strong> (LGV) with fluctuation. If an inguinal bubo turns <strong>fluctuant</strong>, the most appropriate step should be a <strong>referral to a higher centre for aspiration.</strong></p>\n<p><strong>Lymphogranuloma</strong> <strong>venerum</strong> affects sexually active adults. The organism spreads from the site of the initial lesion to the regional lymph nodes, causing <strong>lymphangitis</strong>. There is <strong>infiltration of polymorphonuclear lymphocytes</strong> and plasma cells. The necrotic areas coalesce and enlarge to form a <strong>stellate</strong> <strong>abscess</strong>. Patients present with genital ulceration, rectal bleeding, and lymphadenopathy. It is caused by <strong>Chlamydia trachomatis serovars L1-L3.</strong></p>\n<p>There are three stages of the disease:&nbsp;</p>\n<ul>\n<li><strong>Primary</strong>: the incubation period is 3–30 days. The genital lesions may be painful or painless. The patient usually presents with symptoms of hemorrhagic proctitis. The condition is common among homosexuals.</li>\n<li><strong>Secondary:</strong> It may take days to weeks for the disease to manifest. It is characterised by tender unilateral or bilateral inguinal and/or femoral lymphadenopathy (groove sign). The lymph nodes coalesce to form painful buboes which rupture and form fistulae and sinus tracts.</li>\n<li><strong>Tertiary:</strong>&nbsp;genito-anorectal syndrome is seen. This occurs years after untreated primary infection. &nbsp;There is lymphatic obstruction due to chronic inflammation and fibrosis. This results in genital lymphoedema and inflammation which causes ulceration and chronic granulomatous fibrosis, resulting in esthiomene in women and elephantiasis in men. <strong>NACO kit 7 (black)</strong> is used for management. It includes a <strong>tab. Azithromycin 1 gm</strong> (OD - Stat) and <strong>tab. Doxycycline 100 mg</strong> (BD for 21 days).</li>\n</ul>\n<p>For patients who are diagnosed with inguinal bubo syndrome, <strong>all partners for the past 3 weeks are treated</strong>. Follow up on the <strong>7th</strong>, <strong>14th</strong>, and <strong>21st</strong> days for Inguinal Bubos (IB).</p>\n<p>An <strong>incision and drainage should never be done</strong> for an inguinal bubo, if turns <strong>fluctuant</strong>, the <strong>most appropriate step</strong> should be a referral to a<strong> higher centre for aspiration.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2024: Syndromic Management of Sexually Transmitted Infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e7908befff94f9a85b4a7b751999821x1280x1742.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0008: Comparison of Genital Ulcers</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Genital herpes</strong></span></td>\n<td><span><strong>&nbsp;Syphilitic chancre (Hard chancre)</strong></span></td>\n<td><span><strong>Donovanosis/ granuloma inguinale</strong></span></td>\n<td><span><strong>Chancroid (soft chancre)</strong></span></td>\n<td><span><strong>LGV</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Incubation period</strong></span></td>\n<td><span>2-7 days</span></td>\n<td>\n<p><span>10-90 days&nbsp;</span></p>\n<p><span>Average: 21days</span></p>\n</td>\n<td><span>1-12 weeks</span></td>\n<td><span>1-14 days</span></td>\n<td><span>3 days - 6 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Causative agent</strong></span></td>\n<td><span>HSV-2&gt;HSV-1</span></td>\n<td><em><span>Treponema pallidum</span></em></td>\n<td><em><span>Klebsiella granulomatis</span></em></td>\n<td><em><span>Hemophilus ducreyi</span></em></td>\n<td>\n<p><span><em>Chlamydia trachomatis</em></span><span>&nbsp;serovars L1,L2,L3</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Clinical presentation</strong></span></td>\n<td>\n<p><span>Cluster of vesicles on erythematous base.</span></p>\n<p><span> Painful and pruritic lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Single painless ulcer with a clean base and a firm raised border. </span></p>\n<p><span>Painless lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless papule or nodule erodes into beefy red granulomatous ulcer with rolled edges.</span></p>\n<p><span> No lymphadenopathy, pseudobubos are seen</span></p>\n</td>\n<td>\n<p><span>Painful ulcer (ducreyi makes you cry).</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless genital ulcer.</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Diagnosis&nbsp;</strong></span></td>\n<td><span>Tzanck preparation shows multinucleated giant cells, PCR</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Donovan bodies on biopsy</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Nucleic acid amplification tests</span></td>\n</tr>\n<tr>\n<td><span><strong>Treatment</strong></span></td>\n<td><span>Acyclovir/famcyclovir or valacyclovir</span></td>\n<td><span>Penicillin/Ceftriaxone</span></td>\n<td>\n<p><span>Azithromycin/</span><span>Doxycycline</span></p>\n</td>\n<td><span>Azithromycin/ceftriaxone</span></td>\n<td><span>&nbsp;Doxycycline</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-57",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6473",
    "stauts": "Incorrect",
    "question_title": "57.\n        An 8 month old male child presents with failure to thrive, developmental delay, and seizures. He has hepatosplenomegaly on examination. His urine has a chlorinated smell, labs reveal 4-hydroxyphenylpyruvic acid and severe metabolic acidosis. Which of the following is the most appropriate management for this child?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Low protein diet and vitamin C supplementation\n                \n                  \n                    \nCorrect",
    "optionB": "B. High protein diet and vitamin C supplementation",
    "optionC": "C. Low protein diet and vitamin B6 supplementation\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. High protein diet and vitamin B6 supplementation",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This patient has <strong>Hawkinsinuria</strong> based on clinical features, characteristic “<strong>chlorinated/swimming pool odour</strong>” and lab results with metabolites present in urine. Treatment consists of a <strong>low-protein diet/low-tyrosine diet during infancy.</strong>&nbsp;A trial with<strong> large doses of vitamin C (up to 1,000 mg/24 hr)</strong> is also recommended. and <strong>breastfeeding</strong> is encouraged.&nbsp;</p>\n<p>It is an <strong>autosomal dominant </strong>trait, caused due to certain<strong> missense mutations </strong>in the gene for<strong> 4-HPPD</strong>. (4-hydroxyphenylpyruvate dioxygenase) <strong>Hawkinsin,</strong> a cyclic amino acid that is also excreted in the urine. Clinical features include <strong>severe metabolic acidosis, ketosis, failure to thrive</strong>, and <strong>hepatomegaly.</strong> Mental development is usually normal. Symptomatic infants, asymptomatic affected children and adults excrete <strong>hawkinsin, 4-hydroxyphenylpyruvic acid</strong>, and its metabolites (4-hydroxyphenyllactic and 4-hydroxyphenyl acetic acids), <strong>4-hydroxycyclohexylacetic acid and 5-oxoproline</strong> in their <strong>urine.</strong> The<strong> plasma tyrosine </strong>level may also be <strong>elevated in symptomatic infants</strong>. The management of hawkinsinuria consists of a <strong>low-tyrosine diet </strong>and<strong> vitamin C supplementation</strong>. A low-tyrosine diet is necessary<strong> to reduce the amount of 4-HPP </strong>that is produced. Vitamin C supplementation helps to <strong>prevent the oxidation of 4-HPP and HGA</strong>.</p>\n<p>Other options:</p>\n<p>Option A: A <strong>high&nbsp;protein diet</strong> would <strong>worsen</strong> the symptoms of hawkinsinuria.</p>\n<p>Options C and D:<strong> B6 supplementation </strong>is neither necessary nor beneficial for hawkinsinuria.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0627: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-58",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0936",
    "stauts": "Incorrect",
    "question_title": "58.\n        A 27-year-old pregnant woman presents with a five-day history of fever, malaise, and symptoms of urinary frequency, urgency, and dysuria. She also reports pain in the costovertebral angle but has no history of similar episodes. Urinalysis reveals the presence of pus casts. All of the following statements about her condition are true except:",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Intratubular aggregates of neutrophils\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Thyroidization of the tubules\n                \n                  \n                    \nCorrect",
    "optionC": "C. Patchy interstitial suppurative inflammation",
    "optionD": "D. Neutrophilic tubulitis",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The clinical stem suggests acute pyelonephritis. <strong>Thyroidization</strong> <strong>of tubules</strong> is a feature of <strong>chronic pyelonephritis</strong> not acute.</p>\n<p>Points that favor the diagnosis of acute pyelonephritis are:</p>\n<ul>\n<li>systemic symptoms like <strong>fever</strong> and malaise for the past <strong>5 days</strong></li>\n<li>increased urinary <strong>frequency</strong>, <strong>urgency</strong>, and <strong>dysuria</strong></li>\n<li><strong>pain</strong> in the <strong>costovertebral angle</strong></li>\n<li>urine routine showing <strong>pus casts&nbsp;</strong></li>\n</ul>\n<p>Suppurative inflammation of the kidney caused by a bacterial and viral&nbsp;infection, which can reach the kidney by hematogenous spread or, more commonly, through the ureters in association with vesicoureteral reflux is known as <strong>acute pyelonephritis.</strong></p>\n<p>Acute pyelonephritis is associated with <strong>u</strong><strong>rinary tract obstruction</strong>&nbsp;(congenital or acquired), instrumentation of the urinary tract (catheterization), <strong>v</strong><strong>esicoureteral reflux,</strong> pregnancy, diabetes, preexisting renal lesions, and immunosuppression. Infections are much more frequent in females. However, with increasing age, the incidence in males rises as a result of prostatic hypertrophy.</p>\n<p><strong>Histopathological</strong> <strong>features</strong> of&nbsp;acute pyelonephritis are patchy interstitial suppurative inflammation, <strong>intratubular aggregates of&nbsp;</strong><strong>neutrophils</strong>, <strong>neutrophilic tubulitis</strong>, and <strong>tubular injury</strong>.</p>\n<p>Complications of acute pyelonephritis:</p>\n<ul>\n<li><strong>Papillary necrosis- i</strong>s mainly seen in <strong>diabetics</strong>, <strong>sickle cell disease</strong>, and urinary tract obstruction. It is usually bilateral. Areas of grey-white to yellow necrosis are seen at the tips or distal two-thirds of the pyramids. The necrotic tissue shows characteristic ischemic&nbsp;<strong>coagulative necrosis</strong>, with preservation of outlines of tubules</li>\n<li><strong>Pyonephrosis </strong>occurs when&nbsp;the suppurative exudate is unable to drain and fills the renal pelvis, calyces, and ureter with pus. This is seen when there is total or almost complete obstruction of the renal pelvis.&nbsp;</li>\n<li><strong>Perinephric abscess</strong> is an extension of suppurative inflammation into the perinephric tissue.</li>\n</ul>\n<p>Treatment: Uncomplicated acute pyelonephritis is mild, and symptoms disappear within a few days after appropriate antibiotic therapy is initiated.</p>\n<p><strong>Chronic pyelonephritis</strong> is a disorder in which there is chronic tubulointerstitial inflammation and scarring of the calyces and pelvis. Patients have a silent onset or present with manifestations of acute recurrent pyelonephritis, such as back pain, fever, pyuria, and bacteriuria. The hallmarks features include coarse, discrete, corticomedullary scars overlying dilated, blunted, or deformed calyces, and flattening of the papillae.</p>\n<p>The microscopic changes involve predominantly tubules and interstitium. The tubules show atrophy and hypertrophy or dilation. Dilated tubules with flattened epithelium may be filled with casts resembling thyroid colloid (<strong>thyroidization</strong>).&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2212: Risk Factors of UTI</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Risk Factors for Urinary Tract Infection</strong></p>\n<p><strong>Demographic factors</strong></p>\n<ul>\n<li>Female Gender</li>\n<li>Male infants (UTI is Males&gt;females during infancy alone)</li>\n</ul>\n<p><strong>Structural</strong> factors - Any anatomical hindrance to drainage</p>\n<ul>\n<li>Vesicoureteral reflux (for pyelonephritis)</li>\n<li>Neuropathic Bladder</li>\n<li>Pregnancy</li>\n<li>Constipation</li>\n<li>Obstructive uropathy</li>\n<li>Uncircumcised male</li>\n</ul>\n<p><strong>Practices &amp; Procedures</strong>:</p>\n<ul>\n<li>Toilet training</li>\n<li>Voiding dysfunction</li>\n<li>Wiping from back to front in Females (not males)</li>\n<li>Tight clothing (underwear)</li>\n<li>Urethral instrumentation</li>\n</ul>\n<p><strong>Infective Factors</strong></p>\n<ul>\n<li>Pinworm infestation</li>\n<li>Infection of Bacteria with P fimbriae</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-59",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0735",
    "stauts": "Incorrect",
    "question_title": "59.\n        A patient was diagnosed with pseudohemoptysis. He was informed that the color of the sputum is due to a pigment produced by a microorganism. Which of the following pigments is responsible for this?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Pyocyanin",
    "optionB": "B. Pyorubin\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Pyomelanin",
    "optionD": "D. Prodigiosin\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Pseudohemoptysis</strong> is most commonly caused by <em><strong>Serratia marcescens</strong></em> due to the red pigment called <strong>prodigiosin.</strong></p>\n<p><strong>Serratia marcescens</strong> is a<strong> pleomorphic coccobacilli</strong>. It may grow in sputum after collection. They may mimic hemoptysis (pseudo hemoptysis) because they produce a <strong>non-diffusible</strong> red pigment called <strong>prodigiosin.</strong></p>\n<p><em>S. marcescens</em> <strong>contaminate</strong> <strong>intravenous fluids</strong>, surgical instruments, and antiseptic solutions. Therefore, they are one of the important causes of <strong>healthcare-associated</strong> infections.</p>\n<p>Other options:</p>\n<p><strong>Pyocyanin</strong>(option A) (<strong>bluish-green</strong> pigment), <strong>pyorubin</strong>(option B) (<strong>red </strong>pigment) and <strong>pyomelanin</strong>(option C) (<strong>brown </strong>pigment) are pigments produced by <strong><em>Pseudomonas</em> </strong>species.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-60",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1949",
    "stauts": "Correct",
    "question_title": "60.\n        Which of the following is true regarding the enzyme kinetics of the patient in the graph shown below?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/a7765c2ecdc146a6a6dbfbf7a78b9fe4.JPEG\">",
    "optionA": "A. There is a decrease in the rate of enzyme synthesis",
    "optionB": "B. There is a mutation that decreases the Vmax of the enzyme",
    "optionC": "C. There is a mutation that increases the Km of the enzyme\n                \n                  \n                    \nCorrect",
    "optionD": "D. There is a non-competitive antagonist administered",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The curve representing the patient’s enzyme kinetics in the given graph shows that the <strong>Km</strong> is <strong>increased</strong> and <strong>Vmax remains</strong> the <strong>same</strong> This graph is possible either because of a <strong>mutation</strong> that <strong>increases</strong> the <strong>Km</strong> of the enzyme or if a <strong>competitive inhibitor</strong> is administered (Option D). <strong>Km</strong> is the <strong>substrate concentration</strong> at which <strong>velocity</strong> is <strong>half</strong> of its <strong>maximum velocity. Vmax</strong> is the <strong>maximum velocity</strong> of a <strong>reaction.</strong>&nbsp;</p>\n<p><strong>Competitive inhibition</strong> occurs when an <strong>inhibitor binds to the active site</strong> of the enzyme and <strong>physically impedes substrate binding</strong>. This inhibition can be <strong>overcome by increasing the substrate concentration.</strong>&nbsp;More substrate is required to reach half the maximum velocity. Therefore, in competitive inhibition, there is an <strong>increase in the Km </strong>of the enzyme while the <strong>Vmax&nbsp;remains the same</strong> (similar to the graph shown).&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ffd327a25fb045959c699d4ffb05e602x1280x2235.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In <strong>non-competitive </strong>inhibition, <strong>Vmax decreases</strong> since non-competitive inhibition <strong>cannot be overcome by increasing the substrate concentration.</strong>&nbsp;However, since it <strong>does not interfere with the binding</strong> of the substrate to the enzyme, the <strong>Km remains constant.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2d1c8cc6956485ab5d1c4109e670023x1280x2317.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0911: Difference between Reversible and Irreversible Inhibitors</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"308\">\n<p><strong>Reversible Inhibitors</strong></p>\n</td>\n<td width=\"308\">\n<p><strong>Irreversible Inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Binds via non-covalent interaction</p>\n</td>\n<td width=\"308\">\n<p>Binds via covalent interactions</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>No chemical change</p>\n</td>\n<td width=\"308\">\n<p>Inhibitor binds to the substrate &amp; prevent catalytic activity of enzymes</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Can be reversed, as there is no bonding between the inhibitor &amp; substrate</p>\n</td>\n<td width=\"308\">\n<p>Irreversibility due to strong covalent bonding</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0912: Difference between Competitive &amp; Non-Competitive inhibitors</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td width=\"308\">\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td width=\"308\">\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td width=\"308\">\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td width=\"308\">\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Inhibitor binds to active site</p>\n</td>\n<td width=\"308\">\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td width=\"308\">\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td width=\"308\">\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vmax remains constant</p>\n</td>\n<td width=\"308\">\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Km Increases</p>\n</td>\n<td width=\"308\">\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-61",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD1728",
    "stauts": "Incorrect",
    "question_title": "61.\n        Which of the following arteries are branches of the posterior division of the internal iliac artery?",
    "question_ADD": "<ol>\n<li>Superior gluteal artery</li>\n<li>Superior vesical artery</li>\n<li>Inferior vesical artery</li>\n<li>Inferior gluteal artery</li>\n<li>Iliolumbar artery</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 5\n                \n                  \n                    \nCorrect",
    "optionB": "B. 2, 3, 4",
    "optionC": "C. 1, 4, 5\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 1, 2, 3",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>superior gluteal artery</strong>&nbsp;and<strong> iliolumbar artery</strong> are branches of the&nbsp;<strong>posterior division</strong> of the <strong>internal iliac artery.</strong></p>\n<p>The<strong> internal iliac artery</strong>&nbsp;is the major artery of the pelvis. At the superior border of the greater sciatic foramen in the pelvis, it divides into anterior and posterior trunks.</p>\n<p>Branches of the <strong>posterior trunk</strong> of the internal iliac artery:</p>\n<ul>\n<li>Superior gluteal artery</li>\n<li>Iliolumbar artery</li>\n<li>Lateral sacral arteries</li>\n</ul>\n<p>Branches of the<strong> anterior trunk </strong>of the internal iliac artery:</p>\n<ul>\n<li>Obturator artery</li>\n<li>Superior vesical artery</li>\n<li>Inferior vesical artery&nbsp;</li>\n<li>Inferior gluteal artery</li>\n<li>Middle rectal artery</li>\n<li>Vaginal artery (in females)</li>\n<li>Uterine artery (in females)</li>\n<li>Internal pudendal artery</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1cdad39cdc4f44c397c36d57846351edx795x599.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-62",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME9283",
    "stauts": "Incorrect",
    "question_title": "62.\n        A 60-year-old male patient underwent gastric resection surgery for a gastrointestinal malignancy. Following the gastric resection, two Portex tube drains were placed- one in the Morrison's pouch and the other in the region of the gastrojejunostomy. Identify the true statements about the suture material used for securing the drains externally.",
    "question_ADD": "<ol>\n<li>It can be used for vascular prosthesis</li>\n<li>Increased risk of infection and tissue reaction</li>\n<li>Can be used for routine skin closure</li>\n<li>Gets absorbed over 1-2 years</li>\n<li>Encapsulation in fibrous tissue over 2-3 weeks</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1, 2, 5",
    "optionB": "B. 2, 3, 4",
    "optionC": "C. 2, 4, 5\n                \n                  \n                    \nCorrect",
    "optionD": "D. 1, 3, 5\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The suture material used to secure abdominal drains is <strong>s</strong><strong>ilk</strong>. It is black-colored, multifilament, braided, and is derived from the cocoon of the silkworm larva.</p>\n<p>Silk is&nbsp;<strong><span>unsuitable</span></strong>&nbsp;for use with a vascular prosthesis or in tissues requiring prolonged approximation under stress.&nbsp;<span>There is an&nbsp;<strong>increased risk of infection</strong>&nbsp;and&nbsp;<strong>tissue reaction,&nbsp;</strong>so </span>they are not used for routine skin closure.&nbsp;It can be used&nbsp;<span>to&nbsp;<strong>secure</strong></span><strong>&nbsp;drains</strong> externally. Fibrous <strong>encapsulation</strong> of the suture occurs in 2 to 3 weeks and it is <strong>absorbed</strong> slowly over <strong>1 to 2 years</strong>.</p>\n<p>It is shown in the image below:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/070c4a36525c468f927f1c1a977b7dd8x720x500.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"473\">\n<tbody>\n<tr>\n<td><strong>Suture</strong></td>\n<td><strong>Absorption rate</strong></td>\n<td><strong>Frequent uses</strong></td>\n</tr>\n<tr>\n<td>Silk</td>\n<td>Fibrous encapsulation in the body at 2–3 weeks Absorbed slowly over 1–2 years</td>\n<td>Ligation and suturing when long-term tissue support is necessary. For securing drains externally</td>\n</tr>\n<tr>\n<td>Nylon</td>\n<td>Degrades at approximately 15–20% per year</td>\n<td>General surgical use, e.g. skin closure, abdominal wall mass closure, hernia repair, plastic surgery, neurosurgery, microsurgery, ophthalmic surgery</td>\n</tr>\n<tr>\n<td>Polyester</td>\n<td>Non-absorbable: remains encapsulated in body tissues</td>\n<td>Cardiovascular, ophthalmic, plastic, and general surgery</td>\n</tr>\n<tr>\n<td>Polypropylene</td>\n<td>Non-absorbable: remains encapsulated in body tissues</td>\n<td>Cardiovascular surgery, plastic surgery, ophthalmic surgery, general surgical subcuticular skin closure</td>\n</tr>\n<tr>\n<td>Plain catgut</td>\n<td>Phagocytosis and enzymatic degradation happens in a span of 7–10 days</td>\n<td>Ligate superficial vessels, suture subcutaneous tissues Stomas and other tissues that heal rapidly</td>\n</tr>\n<tr>\n<td>Chromic catgut</td>\n<td>Phagocytosis<br>and enzymatic<br>degradation happens in a span of<br>90 days</td>\n<td>Same as for plain catgut</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-63",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8534",
    "stauts": "Incorrect",
    "question_title": "63.\n        Which nerve gives motor supply to the marked muscle of the gluteal region?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/e4d55c360fd04a3dafe143eb6c5ae26a.PNG\">",
    "optionA": "A. Branches from S1 and S2",
    "optionB": "B. Nerve to quadratus femoris\n                \n                  \n                    \nCorrect",
    "optionC": "C. Nerve to obturator internus\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Inferior gluteal nerve",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The marked muscle in the given image is <strong>gemellus inferior</strong>. It is innervated by<strong> nerve to quadratus femoris</strong>.&nbsp;</p>\n<p>Both the gemelli don't have their own specific nerve supply. While <strong>gemellus inferior</strong> is given motor supply by <strong>nerve to quadratus femoris</strong>, <strong>gemellus superior</strong> is innervated by <strong>nerve to obturator internus</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53a6b150670646bba2811699088375c0x960x720.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ea7a79e67c784f41af3f6c7a55c030e1x1280x1598.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Branches from S1 and S2</strong> innervate the <strong>piriformis</strong> muscle.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2280: Various muscles of the gluteal region and their innervation</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Muscles</strong></p>\n</td>\n<td>\n<p><strong>Innervation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluteus maximus</p>\n</td>\n<td>\n<p>&nbsp;Inferior gluteal nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluteus medius and minimus</p>\n</td>\n<td>\n<p>&nbsp;Superior gluteal nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyriformis</p>\n</td>\n<td>\n<p>&nbsp;Nerve to pyriformis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obturator internus, Gemellus superior</p>\n</td>\n<td>\n<p>&nbsp;Nerve to obturator internus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Quadratus femoris, Gemellus inferior</p>\n</td>\n<td>\n<p>&nbsp;Nerve to quadratus femoris</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2282: Gluteal Muscles</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div>&nbsp;</div>\n<table><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div><strong>Gluteus Medius</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Origin</strong>- Outer surface of <strong>ilium</strong> between anterior and posterior gluteal lines.</div>\n<div><strong>Insertion</strong> -Oblique ridge on the <strong>lateral</strong> surface of the <strong>greater trochanter.</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Gluteus Minimus</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Origin</strong>- Outer surface of ilium between anterior and inferior gluteal lines</div>\n<div><strong>Insertion</strong> -Ridge on the <strong>anterior</strong> surface of <strong>greater trochanter</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Gluteus Maximus</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Origin</strong> - Posterior aspect of dorsal ilium posterior to posterior gluteal line, posterior superior iliac crest, posterior inferior aspect of sacrum and coccyx, and sacrotuberous ligament</p>\n<p><strong>Insertion</strong> -&nbsp;Primarily in <strong>fascia lata</strong> at the iliotibial band; also into the gluteal tuberosity on posterior femoral surface</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1242: Structures Passing Through the Sciatic Foramens</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Structures passing through the greater sciatic foramen</strong></p>\n<p>The piriformis is the&nbsp;key muscle of this region. It emerges from the pelvis, and fills the foramen almost completely.</p>\n<p>Structures passing <strong>above</strong> the <strong>piriformis</strong></p>\n<ul>\n<li>Superior gluteal nerve</li>\n<li>Superior gluteal vessels</li>\n</ul>\n<p>Structures passing <strong>below</strong> the <strong>piriformis</strong></p>\n<ul>\n<li>Inferior gluteal nerve&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Inferior gluteal vessels</li>\n<li>Sciatic nerve&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n<li>Posterior cutaneous nerve of thigh</li>\n<li>Nerve to quadratus femoris&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n<li>Pudendal nerve</li>\n<li>Internal pudendal vessels&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n<li>Nerve to obturator internus</li>\n</ul>\n<p>Note: The last three structures, after a short course in the gluteal region, enter the lesser sciatic foramen, where the pudendal nerve and internal pudendal vessels run in the pudendal canal.</p>\n<p><strong>Structures passing through the lesser sciatic foramen</strong></p>\n<ul>\n<li>Tendon of obturator internus</li>\n<li>Pudendal nerve</li>\n<li>Internal pudendal vessels</li>\n<li>Nerve to obturator internus</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://trello.com/1/cards/66a0afedf56adc83e10a557a/attachments/66a0affaf0385ad79b9d8ff3/previews/66a0affbf0385ad79b9d913d/download/110._MCQ_14235%2C_Anatomy.jpg\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-64",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD7131",
    "stauts": "Correct",
    "question_title": "64.\n        Which of the following is incorrect regarding the needle shown below and the procedure it is used for?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/1a0fdcb1284845a2bd47a9104c6d9dc0.JPEG\">",
    "optionA": "A. It is used in obstetric anesthesia",
    "optionB": "B. It causes rapid onset of anesthesia within 1-2 minutes\n                \n                  \n                    \nCorrect",
    "optionC": "C. It is used along with catheter for continuous infusions for pain management",
    "optionD": "D. The blunt tip needle prevents accidental dural puncture",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shown is the 18 G&nbsp;<strong>Tuohy needle,</strong>&nbsp;which is used in<strong> epidural anesthesia.</strong>&nbsp;It does <strong>not</strong> cause <strong>rapid onset</strong> of anesthesia<strong>, </strong>instead&nbsp;has a <strong>slower onset</strong> of action ranging from 10-20 minutes compared to spinal anesthesia which has a relatively faster onset of action.</p>\n<p><strong>Identification points:</strong></p>\n<ul>\n<li>It has a <strong>blunt, curved tip (Huber tip)</strong>&nbsp;that helps to <strong>prevent accidental dural puncture</strong>.</li>\n<li>The needle shaft is marked in <strong>1-cm intervals</strong> so that the depth of insertion can be identified.</li>\n</ul>\n<p>It is used in<strong> obstetric anesthesia</strong>, segmental blocks, and chronic pain management.</p>\n<p>Image below shows epidural anesthesia set with Touhy's needle and epidural catheter:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ff6672d030d44312ae594220cddd9915x800x600.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Other epidural needles:<strong> Crawford needle</strong><strong>&nbsp;</strong>(straight needles without a curved tip):&nbsp;has a greater incidence of dural puncture.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anaesthesia"
  },
  {
    "web-scraper-order": "1727319149-65",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5655",
    "stauts": "Skipped",
    "question_title": "65.\n        Which of the following media can be used for culturing the organism shown in the image below?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/93eeafa0806c409a955eeaaff9ae967e.JPEG\">",
    "optionA": "A. Wilson and Blair medium",
    "optionB": "B. BCYE agar",
    "optionC": "C. Macleod medium\n                \n                  \n                    \nCorrect",
    "optionD": "D. Skirrow’s medium",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p class=\"p1\">The given image shows <strong>gram-positive rods </strong>with club-shaped ends, a beaded appearance, and a<strong> chinese-letter pattern</strong> of arrangement indicative of&nbsp;<em><strong>Corynebacterium diphtheriae</strong></em>. They are cultured in <strong>MacLeod's medium.</strong></p>\n<p><strong>Macleod's medium</strong>&nbsp;is <strong>selective</strong> for&nbsp;<em><strong>C. diphtheriae</strong></em>.&nbsp;<strong>Potassium tellurite</strong>&nbsp;in McLeod's medium or potassium tellurite agar is reduced to metallic tellurium by <em>C. diphtheriae</em> to produce black colonies. Additionally, tellurite (0.04%) inhibits the growth of most other bacteria, acting as a selective agent.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Wilson and Blair's medium</strong> is <strong>selective</strong> for <strong>Salmonella</strong> species. It is a type of selective and indicator media. <strong><em>Salmonella typhi</em></strong> reduces sulphite to sulphide in the presence of glucose and produces <strong>jet-black colonies</strong> with a metallic sheen due to the production of <strong>H2S </strong>on Wilson and Blair bismuth sulphite medium. It is also a differential media. While <em>S. typhi </em>forms large black colonies, with a metallic sheen <strong><em>S. paratyphi. A</em></strong> produces <strong>green</strong> <strong>colonies </strong>due to the absence of H2S production.&nbsp;</p>\n<p>Option B: <strong>BCYE agar</strong>&nbsp;or buffered charcoal, yeast extract agar is selective for&nbsp;<strong><em>Legionella</em> species</strong>.&nbsp;Legionellae are nutritionally fastidious. Their growth is enhanced with&nbsp;<strong>iron salts</strong> and depends on the supplementation of media&nbsp;<strong>L-cysteine</strong>.&nbsp;</p>\n<p>Option D:<strong> Skirrow’s medium</strong>&nbsp;is selective for&nbsp;<strong><em>Campylobacter</em> species</strong>. It contains vancomycin, polymyxin B, and trimethoprim to inhibit the growth of other bacteria.&nbsp;Plates were incubated at 43°C with 5 % oxygen, 10% carbon dioxide, and 85% hydrogen. Colonies may be observed after overnight incubation.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0001: Organisms and selective Culture Media</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Appropriate culture media for various bacteria:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Medium for culture</strong></td>\n</tr>\n<tr>\n<td>Staph aureus</td>\n<td>Mannitol salt agar<br>ludlam’s medium<br>salt milk agar</td>\n</tr>\n<tr>\n<td>Strep. Pyogenes</td>\n<td>Crystal violet blood agar</td>\n</tr>\n<tr>\n<td>Neisseria meningitidis</td>\n<td>Thayer martin medium</td>\n</tr>\n<tr>\n<td>Corynebacterium</td>\n<td>Potassium tellurite agar<br>Tinsdale medium<br>Mcleod medium</td>\n</tr>\n<tr>\n<td>B.anthrax</td>\n<td>PLET medium</td>\n</tr>\n<tr>\n<td>B.cereus</td>\n<td>MYPA (Mannitol egg yolk phenol red polymyxin agar)<br>PEMBA(polymyxin in egg yolk mannitol bromothymol blue agar</td>\n</tr>\n<tr>\n<td>Clostridium&nbsp;</td>\n<td>CCFA ( cefoxitin cycloserine fructose agar)</td>\n</tr>\n<tr>\n<td>Shigella</td>\n<td>DCA, XLD, SSA</td>\n</tr>\n<tr>\n<td>Salmonella</td>\n<td>Wilson and Blair bismuth sulphite medium</td>\n</tr>\n<tr>\n<td>Vibrio</td>\n<td>TCBS<br>Monsur GTTA</td>\n</tr>\n<tr>\n<td>Pseudomonas</td>\n<td>Cetrimide agar</td>\n</tr>\n<tr>\n<td>B.pseudomallei</td>\n<td>Ashdown medium</td>\n</tr>\n<tr>\n<td>H. influenza</td>\n<td>Fildes agar <br>Levinthal medium</td>\n</tr>\n<tr>\n<td>Bordetella</td>\n<td>Bordet-Gengou glycerine potato blood agar</td>\n</tr>\n<tr>\n<td>Brucella</td>\n<td>Casteneda medium</td>\n</tr>\n<tr>\n<td>B.burgdorferi</td>\n<td>BSK medium</td>\n</tr>\n<tr>\n<td>Campylobacter</td>\n<td>\n<p>Skirrow's, Butzler's and Campy BAP media</p>\n</td>\n</tr>\n<tr>\n<td>Legionella pneumophilia</td>\n<td>\n<p>BCYE medium</p>\n</td>\n</tr>\n<tr>\n<td>Leptospira</td>\n<td>EMJH medium&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-66",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6836",
    "stauts": "Incorrect",
    "question_title": "66.\n        Which one of the following drugs is a phosphodiesterase 3 inhibitor and is also a calcium sensitizer binding to troponin C used for the treatment of heart failure?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Levosimendan\n                \n                  \n                    \nCorrect",
    "optionB": "B. Milrinone      \n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Enoximone",
    "optionD": "D. Inamrinone",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Levosimendan</strong> is an ionotropic drug that acts as a <strong>calcium</strong> <strong>sensitizer</strong>. It increases the affinity of troponin C in the myocardium to calcium by binding to the thin filament in troponin C. This binding causes a conformational change, leading to stronger contraction and a positive ionotropic effect for a particular cytosolic calcium without actually increasing calcium levels. Additionally, <strong>PDE3 inhibitor</strong> action <strong>increases</strong> <strong>c</strong> <strong>AMP</strong> (by preventing its degradation) which causes increased contractility mediated by <strong>β1</strong> (c AMP acts as a 2nd messenger for β receptors).&nbsp;</p>\n<p>Increased c AMP levels in vascular smooth muscles cause relaxation and vasodilation. Opening of ATP-sensitive K channels is also a known action of this drug and it is primarily used in the treatment of <strong>acute decompensated heart failure.&nbsp;</strong></p>\n<p><strong>Adverse</strong> <strong>reactions</strong> include hypotension and arrhythmia owing to its PDE3 action.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Milrinone</strong> is a PDE3/4 inhibitors <strong>without</strong> <strong>calcium</strong>-<strong>sensitizing</strong> <strong>action</strong>. Milrinone is <strong>more</strong> <strong>PDE3</strong> <strong>selective</strong>. This drug causes positive ionotropy and vasodilation by increasing c AMP and are hence may be also referred to as being ionodilators.&nbsp;</p>\n<p>Option C: <strong>Enoximone</strong> is a PDE3/4 inhibitors <strong>without</strong> <strong>calcium</strong>-<strong>sensitizing</strong> <strong>action</strong>. This drug causes positive ionotropy and vasodilation by increasing c AMP and are hence may be also referred to as being ionodilators. Inamrinone can also cause dilatation of arteries and veins and thus reduce both preload and afterload.&nbsp;</p>\n<p>Option D: <strong>Inamrinone</strong> is a PDE3/4 inhibitors <strong>without</strong> <strong>calcium</strong>-<strong>sensitizing</strong> <strong>action</strong>. This drug causes positive ionotropy and vasodilation by increasing c AMP and are hence may be also referred to as being ionodilators. Inamrinone can also cause dilatation of arteries and veins and thus reduce both preload and afterload.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-67",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6831",
    "stauts": "Correct",
    "question_title": "67.\n        A 30-year-old nulliparous woman comes to gynecology OPD with complaints of chronic pelvic pain which increases during menstruation and infertility. Per abdomen shows a tender cystic mass and per speculum examinations are normal. Bimanual examination reveals pelvic tenderness and tender right adnexal mass. The TVS shows the following and the laparoscopy confirms the diagnosis. What is the appropriate management?",
    "question_ADD": "<p>TVS - Transvaginal ultrasound</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/c03f6d7ec8d24342949c861e650ec6d1.png\">",
    "optionA": "A. Periodic surveillance and follow up",
    "optionB": "B. Laparoscopic cystectomy \n                \n                  \n                    \nCorrect",
    "optionC": "C.  Clomiphene citrate followed by intrauterine insemination",
    "optionD": "D. Combined oral contraceptives for 1 cycle",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A 30-year-old <strong>nulliparous</strong> woman with <strong>chronic pelvic pain</strong> <strong>worsening</strong> during <strong>menstruation</strong>,<strong> infertility</strong>, and a <strong>tender right adnexal mass</strong> with a TVS showing a <strong>homogenous, right ovarian mass</strong> with <strong>vascularity</strong> suggests an <strong>endometrioma</strong>, also known as a <strong>chocolate cyst</strong>. The preferred <strong>management</strong> for symptomatic endometrioma, especially when associated with infertility, is <strong>laparoscopic cystectomy</strong>.</p>\n<p><strong>Endometrioma</strong> is a type of <strong>endometrial tissue</strong> that <strong>grows outside</strong> the <strong>uterus</strong>, typically in the <strong>ovaries</strong>. This <strong>estrogen-dependent</strong> condition is commonly seen in <strong>nulliparous women</strong> and may have a familial predisposition. It is associated with abnormalities of the genital outflow tract that lead to<strong> retrograde menstruation</strong>.</p>\n<p>Patients with endometrioma often present with <strong>chronic pelvic pain</strong>, which <strong>worsens during menstruation </strong>due to hormonal effects on the lesion and <strong>release</strong> of <strong>prostaglandin F2α</strong>. <strong>Infertility </strong>is related to various ovarian defects, including <strong>abnormal folliculogenesis, anovulation, luteal phase defects, luteinized unruptured follicle syndrome</strong>, and <strong>pelvic adhesions</strong>. Clinical examination may reveal a <strong>tender cystic mass, red-blue lesions,</strong> and <strong>powder-burn spots</strong>. <strong>Bimanual examination</strong> often shows a <strong>tender, enlarged adnexal mass, potential nodularity</strong> in the <strong>posterior cul-de-sac</strong>, and a <strong>fixed, retroverted uterus</strong>. <strong>Elevated CA125 levels</strong> may indicate <strong>ovarian malignancy</strong>, though it is not routinely used due to poor sensitivity. <strong>TVS</strong> is the primary imaging tool, showing a <strong>homogenous, cystic mass</strong> with a <strong>ground-glass </strong>appearance and <strong>pericystic flow</strong> on Doppler.</p>\n<p>The <strong>gold standard</strong> for diagnosis and treatment is <strong>laparoscopy</strong>, which can reveal characteristic variable-coloured lesions, including <strong>classic powder burns</strong> and <strong>chocolate cysts</strong>. While <strong>NSAIDs</strong> can <strong>manage pain</strong>, surgical intervention through<strong> laparoscopic cystectomy</strong> is recommended for women seeking to <strong>improve fertility</strong>, as it reduces recurrence and alleviates pain. However, excision of endometrioma may reduce ovarian reserves over time, so early intervention is advisable for those planning to conceive.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Periodic surveillance </strong>and <strong>ultrasound follow-up</strong> are done for endometriomas of <strong>&lt;5cm </strong>where the female does<strong> not desire pregnancy.&nbsp;</strong></p>\n<p>Option C: Although <strong>clomiphene citrate</strong> followed by <strong>intrauterine insemination</strong> is the <strong>infertility treatment</strong>, the <strong>chocolate cyst</strong> has to be <strong>removed first </strong>followed by a trial of <strong>natural conception</strong>. If that fails, artificial methods can be tried.&nbsp;</p>\n<p>Option D: <strong>Combined oral contraceptives</strong>&nbsp;is <strong>not</strong> <strong>advisable</strong> in this patient as she desires pregnancy.&nbsp;&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-68",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6041",
    "stauts": "Skipped",
    "question_title": "68.\n        Which of the following is the correct ascending order of half-lives of the following radioisotopes?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Iodine 125, Iodine 131, Iridium 192, Cobalt 60",
    "optionB": "B. Iodine 131, Iridium 192, Iodine 125, Cobalt 60",
    "optionC": "C. Iodine 131, Iodine 125, Iridium 192, Cobalt 60\n                \n                  \n                    \nCorrect",
    "optionD": "D. Cobalt 60, Iodine 125, Iodine 131, Iridium 192",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correct ascending order of half lives of the given radioisotopes is<strong>&nbsp;Iodine 131, Iodine 125, Iridium 192, Cobalt 60</strong>.</p>\n<table width=\"445\">\n<tbody>\n<tr>\n<td><strong>Radioisotope&nbsp;</strong></td>\n<td><strong>Half life</strong></td>\n</tr>\n<tr>\n<td>Iodine 131</td>\n<td>8 days</td>\n</tr>\n<tr>\n<td>Iodine 125</td>\n<td>60 days</td>\n</tr>\n<tr>\n<td>Iridium 192</td>\n<td>74 days</td>\n</tr>\n<tr>\n<td>Cobalt 60</td>\n<td>5.2 <strong>years</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1736: Half life of radio isotopes</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Radioisotope</strong></td>\n<td><strong>Half-life</strong></td>\n</tr>\n<tr>\n<td>Cobalt 60</td>\n<td>5.2 years</td>\n</tr>\n<tr>\n<td>Iridium 192</td>\n<td>74 days</td>\n</tr>\n<tr>\n<td>Iodine 131</td>\n<td>8 days</td>\n</tr>\n<tr>\n<td>Iodine 125</td>\n<td>60 days</td>\n</tr>\n<tr>\n<td>Iodine 123</td>\n<td>13 hours</td>\n</tr>\n<tr>\n<td>Iodine 132</td>\n<td>3 hours&nbsp;</td>\n</tr>\n<tr>\n<td>Cesium 137</td>\n<td>30 years</td>\n</tr>\n<tr>\n<td>Technetium 99m</td>\n<td>6 Hours</td>\n</tr>\n<tr>\n<td>18 FDG</td>\n<td>110 minutes</td>\n</tr>\n<tr>\n<td>Radon 222</td>\n<td>3.8 days</td>\n</tr>\n<tr>\n<td>Radium 226</td>\n<td>1600 years</td>\n</tr>\n<tr>\n<td>Strontium-89</td>\n<td>50.5 days</td>\n</tr>\n<tr>\n<td>Strontium- 90</td>\n<td>28 years</td>\n</tr>\n<tr>\n<td>Phosphorus 32</td>\n<td>14 days</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Radiology"
  },
  {
    "web-scraper-order": "1727319149-69",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6835",
    "stauts": "Incorrect",
    "question_title": "69.\n        Identify the drugs A and B and their respective uses.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/8761cb31d7994198b34220467355e9fe.JPEG\">",
    "optionA": "A. A- norepinephrine- hemorrhagic shock,  B- epinephrine- anaphylactic shock \n                \n                  \n                    \nCorrect",
    "optionB": "B. A- epinephrine- cardiogenic shock,  B- dopamine- hemorrhagic shock",
    "optionC": "C. A- norepinephrine- hemorrhagic shock, B- dopamine- septic shock\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. A- dopamine- septic shock, B- epinephrine- anaphylactic shock",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Graph A </strong>is<strong> norepinephrine, </strong>which can be used in<strong> hemorrhagic shock, graph B </strong>is<strong> epinephrine, </strong>which can be used in<strong> anaphylactic shock.&nbsp;</strong></p>\n<p><strong>Graph A</strong> is <strong>norepinephrine </strong>and it&nbsp;predominantly stimulates <strong>α and β1 receptors. &nbsp;</strong><br><strong>α</strong> <strong>1</strong> mediated <strong>vasoconstriction</strong> increases <strong>peripheral</strong> <strong>vascular</strong> <strong>resistance</strong>&nbsp;<br><strong>β 1</strong> stimulation causing an increase in both <strong>systolic (green line)</strong>&nbsp;and <strong>diastolic</strong> <strong>BP (red line)</strong>. Although β1 action should also cause an increase in heart rate, a compensatory vagal reflex overpowers it leading to bradycardia.&nbsp;<br>&nbsp;<br><strong>Norepinephrine</strong> is the <strong>drug</strong> <strong>of</strong> <strong>choice</strong> in <strong>hypovolemic</strong> <strong>shock</strong> and volume depletion, cardiogenic shock, and neurogenic shock as it restores blood pressure to maintain cerebral circulation.&nbsp;<br>&nbsp;<br><strong>Graph B</strong> is <strong>epinephrine</strong>. It stimulates <strong>α, β1, β2, β3 receptors.&nbsp;</strong><br><strong>β1</strong> stimulation causes an <strong>increase</strong> <strong>in</strong> <strong>heart</strong> <strong>rate </strong>(positive chronotropic) as well as <strong>increased</strong> <strong>force</strong> <strong>of</strong> <strong>contraction</strong> (positive ionotropy).&nbsp;</p>\n<p>The increase in <strong>systolic blood pressure</strong> <strong>(green line)</strong> is greater than the increase in <strong>diastolic blood pressure (red line)</strong>; hence, the <strong>pulse pressure decreases (orange line)</strong>.&nbsp;<br>Peripheral vascular resistance<strong> decreases as β2 receptors on blood vessels</strong> are more sensitive than α receptors.&nbsp;</p>\n<p><strong>Epinephrine</strong> is the <strong>drug</strong> <strong>of</strong> <strong>choice</strong> in <strong>anaphylactic</strong> <strong>shock,</strong> where it increases blood pressure along with improving bronchospasm, and laryngeal edoema.&nbsp;<br>&nbsp;<br>The action of <strong>dopamine</strong> on receptors depends upon the dose administered. At <strong>lower</strong> <strong>infusion</strong> <strong>rates</strong> (0-2 mcg/kg/min) It stimulates <strong>D1</strong> <strong>receptors</strong>, leading to renal vasodilation, increasing GFR, and promoting diuresis at <strong>2-10 mcg/kg/min</strong> acts on <strong>β1</strong> <strong>receptors</strong> increasing heart rate, and systolic BP with minimal effect on diastolic BP. D1-mediated vasodilation also decreases peripheral vascular resistance.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-70",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6806",
    "stauts": "Incorrect",
    "question_title": "70.\n        Identify the incorrect statement concerning the neonatal resuscitation program.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. The 2-finger technique of chest compressions increases blood pressure\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Delayed cord clamping is recommended for preterm infants",
    "optionC": "C. After 10 minutes, resuscitation can be terminated if there is no heartbeat\n                \n                  \n                    \nCorrect",
    "optionD": "D. Bag and mask ventilation should be avoided if the abdomen is scaphoid",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>If adequate resuscitation <strong>continues for 20 min</strong> without a detectable heart rate, resuscitative efforts <strong>can</strong> <strong>be</strong> <strong>terminated</strong>. Hence, <strong>option C is the incorrect statement.</strong></p>\n<p>The image given below shows the steps of neonatal resuscitation.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2c9ff66dc949451e90d0dca88a8c68c8x1280x3139.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option A: The <strong>2-finger technique</strong> of chest compressions is preferred over the thumb technique because it helps achieve<strong> high blood pressure</strong>, increases coronary perfusion, and results in less fatigue.</p>\n<p>Option B: <strong>Delayed cord clamping</strong> for 1-3 min is <strong>especially recommended</strong> for <strong>preterm infants</strong>. Additional benefits for preterm infants include improved haemodynamic stability, decreased need for inotropic support, decreased need for transfusions, and decreased risk of necrotising enterocolitis and intraventricular haemorrhage.</p>\n<p>Option D: A <strong>scaphoid abdomen</strong> or asymmetry in contour or movement of the chest suggests a <strong>diaphragmatic hernia</strong>, hence bag and mask ventilation should be avoided in these cases.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-71",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6321",
    "stauts": "Skipped",
    "question_title": "71.\n        Arrange the following organs in the order of appearance of rigor mortis.",
    "question_ADD": "<p>1 - Upper extremities<br>2 - Fingers<br>3 - Chest<br>4 - Legs<br>5 - Abdomen<br><br></p>",
    "question_imag": "",
    "optionA": "A. 1-3-5-4-2",
    "optionB": "B. 3-1-5-4-2\n                \n                  \n                    \nCorrect",
    "optionC": "C. 1-3-2-5-4",
    "optionD": "D. 3-1-2-5-4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correct sequence is 3-1-5-4-2. <strong>Chest -&gt; Upper extremities-&gt; Abdomen -&gt; Legs -&gt; Fingers.</strong><br>The basic sequence of the rigor mortis begins from the head down the body, in order. It disappears in the same order of appearance.</p>\n<p><strong>Nysten's rule</strong> describes the sequential onset of rigor mortis in the various muscle groups.&nbsp;Rigor mortis (cadaveric rigidity or death stiffening) refers to the&nbsp;<strong>stiffening</strong>&nbsp;and&nbsp;<strong>shortening</strong>&nbsp;of&nbsp;<strong>muscles following death.&nbsp;</strong>It usually&nbsp;begins <strong>1-2 hours</strong> after death&nbsp;and gets&nbsp;well established&nbsp;by<strong>&nbsp;9-12 hours.&nbsp;</strong>The order of appearance of rigor mortis: <strong>Left chamber</strong> of the heart is affected first.</p>\n<p>Other muscles are affected in the given order:</p>\n<ol>\n<li>Involuntary muscles: Heart</li>\n<li>Eyelids</li>\n<li>Neck and lower jaw</li>\n<li>Face</li>\n<li><strong>Chest</strong></li>\n<li><strong>Upper extremities</strong></li>\n<li><strong>Abdomen</strong></li>\n<li><strong>Legs</strong></li>\n<li><strong>Fingers and toes</strong></li>\n</ol>\n<div class=\"page\" title=\"Page 170\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In individual limbs, it usually progresses from above downwards.&nbsp;</p>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-72",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD7769",
    "stauts": "Incorrect",
    "question_title": "72.\n        A 78-year-old female patient has ECG findings below and a history of diabetes mellitus and hypertension. Which medication would prevent future complications in this patient?",
    "question_ADD": "<p>ECG - Electrocardiogram</p>\n<p>BP -&nbsp; Blood Pressure</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/b9e133655ccd4552aeb395676d1615e6.JPEG\">",
    "optionA": "A. Aspirin",
    "optionB": "B. Amiodorone\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Rivaroxaban\n                \n                  \n                    \nCorrect",
    "optionD": "D. Rosiglitazone",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The medication that would prevent future thrombotic complications in this patient with the given ECG showing an <strong>irregularly irregular rhythm</strong> with <strong>absent 'p' waves</strong>, which is consistent with <strong>atrial fibrillation (AF)</strong>&nbsp;is <strong>rivaroxaban</strong>.</p>\n<p>The <strong>CHA2DS2-VASc score</strong> is used to assess the <strong>risk </strong>of <strong>stroke</strong> in patients who have AF. <strong>Anticoagulation therapy</strong> is given when the score is <strong>≥1</strong>. The CHA<sub>2</sub>DS<sub>2</sub>-VASc score in this patient is 5. This patient needs <strong>anticoagulation</strong> with <strong>rivaroxaban</strong> to prevent future thrombotic complications.&nbsp;</p>\n<ul>\n<li>Age&nbsp;≥ 75 years = 2</li>\n<li>Diabetes = 1</li>\n<li>Hypertension = 1</li>\n<li>Female gender = 1</li>\n</ul>\n<p>Total score = 5</p>\n<p>For patients with <strong>non-valvular AF</strong>, <strong>oral</strong> anticoagulation has been proven to reduce the risk of stroke and other thromboembolic events. The preferred agents are <strong>non-Vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban or edoxaban.</strong>&nbsp;</p>\n<p>The situations in which <strong>warfarin</strong> may be considered as an option include:</p>\n<ul>\n<li>Patients <strong>already on warfarin</strong> who are comfortable with <strong>periodic INR</strong> monitoring and SC injections</li>\n<li>Patients with <strong>mechanical heart valves</strong> or <strong>severe mitral stenosis</strong></li>\n<li>Patients who are unlikely to comply with the dosing of oral medications</li>\n<li>Patients with <strong>eGFR &lt; 30 mL/min</strong></li>\n<li>Patients who are on enzyme-inducing epileptic drugs like <strong>phenytoin</strong> or <strong>protease inhibitors</strong> for HIV</li>\n</ul>\n<p>Other options :</p>\n<p>Option A: <strong>Aspirin</strong> may be used in patients with a <strong>score &lt; 2</strong> in patients with AF.</p>\n<p>Option B: <strong>Amiodarone</strong> may be used for <strong>rhythm control</strong> in patients with AF but is not used to prevent thrombotic complications.</p>\n<p>Option D: Rosiglitazone is an anti diabetic drug but is associated with increased risk of cardiac complications like congestive hear failure, MI.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1200: CHA2DS2-VASC scoring for risk of stroke  &amp; need for oral anticoagulation in AF</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"441\">\n<tbody>\n<tr>\n<td>\n<p><strong>Components</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C – Congestive heart failure</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H - Hypertension</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A – Age &gt; 75 years</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>D – Diabetes Mellitus</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S – Stroke/TIA/TE</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">VASc-Vascular disease (prior MI, Peripheral Arterial Disease,</p>\n<p class=\"p1\">or aortic plaque)</p>\n</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;A- Age 65–74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;S- sex category (i.e., female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table>\n<p class=\"p1\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td width=\"163\">\n<p><strong>CHADS2 score</strong></p>\n</td>\n<td width=\"280\">\n<p><strong>Antithrombotics </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"163\">\n<p>0</p>\n</td>\n<td width=\"280\">\n<p>Aspirin or no antithrombotics</p>\n</td>\n</tr>\n<tr>\n<td width=\"163\">\n<p>1</p>\n</td>\n<td width=\"280\">\n<p>Aspirin or oral anticoagulant</p>\n</td>\n</tr>\n<tr>\n<td width=\"163\">\n<p>&gt;1</p>\n</td>\n<td width=\"280\">\n<p>Oral anticoagulant</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2441: Supraventricular tachycardias</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-73",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6445",
    "stauts": "Correct",
    "question_title": "73.\n        The true statement regarding the trajectory of the growth curve of a neonate is:",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 10% of birth weight is lost in the 1st week of life\n                \n                  \n                    \nCorrect",
    "optionB": "B. Regains birth weight in 3 weeks",
    "optionC": "C. 10% of birth weight increases in the 1st week",
    "optionD": "D. 10% of birth weight is lost in the 1st 2 weeks of life",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The true statement regarding the trajectory of the growth curve of a neonate is that \"<strong>10% </strong>of <strong>birth weight</strong> is <strong>lost</strong> in the <strong>1st week </strong>of life\".</p>\n<p>In the <strong>first week</strong> after birth, newborns typically experience a temporary <strong>weight loss</strong> of around <strong>10%</strong> after <strong>vaginal delivery</strong> and up to <strong>12% </strong>after <strong>cesarean section</strong>. This initial decrease is primarily due to the elimination of excess fluid and <strong>limited early nutritional intake</strong>. As feeding progresses, colostrum gives way to higher-fat breast milk, and infants improve their ability to latch and suck effectively. Consequently, mothers become more adept at feeding techniques.</p>\n<p>By the <strong>second week</strong> of life, most infants <strong>regain</strong> their birth weight or surpass it. Throughout the <strong>first month</strong>, infants typically gain about <strong>30 grams</strong> (approximately 1 ounce) <strong>per day</strong>. This period marks the fastest phase of postnatal growth. Approximate daily weight gain is that : 0-3 months: 30 g/day; 3-6 months: 20 g/day; 6-9 months: 15 g/day; 9-12 months: 12 g/day.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2037: Weight and height changes in children</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div>\n<p>Term newborns may <strong>lose up to 10% of their birth weight</strong> in the first few days of life (due to extracellular fluid losses). Most healthy newborns typically <strong>regain their birth weight by 10 to 14 days</strong>. Thereafter, approximate daily weight gain is as follows :</p>\n<ul>\n<li>0-3 months ~ 30 grams/day</li>\n<li>3-6 months ~ 20 grams/day</li>\n<li>6-12months ~ 12-15 grams/day</li>\n</ul>\n<p><strong>Note :&nbsp;</strong>Infant weight approximately <strong>Doubles</strong> at 4-5 months , <strong>Triples</strong> by 1year and is&nbsp;<strong>4 times</strong> by 2 years of age.</p>\n</div>\n<p><strong>Weight gained with respect to birth weight</strong></p>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Weight</strong></td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>2 × birth weight</td>\n</tr>\n<tr>\n<td>1 year</td>\n<td>3 × birth weight</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>4 × birth weight</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>5 × birth weight</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Formulae for calculating the weight in children</strong></p>\n</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Formula</strong></td>\n</tr>\n<tr>\n<td>3-12 months</td>\n<td>\n<div>Weight =<span>[age (months) + 9] </span></div>\n<div>2</div>\n</td>\n</tr>\n<tr>\n<td>1-6 years</td>\n<td>Weight = [2×age (years)] + 8</td>\n</tr>\n<tr>\n<td>7-12 years</td>\n<td>\n<div>Weight = <span>[7×age (years) - 5]</span></div>\n<div>2</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Height with respect to age</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Height</strong></td>\n</tr>\n<tr>\n<td>At birth</td>\n<td>50 cm</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>65 cm</td>\n</tr>\n<tr>\n<td>1 year</td>\n<td>75 cm</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>90 cm</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>100 cm</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-74",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6430",
    "stauts": "Correct",
    "question_title": "74.\n        The expression of which of the following biomarkers can differentiate embryonal cell carcinoma from seminoma?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Cytokeratin \n                \n                  \n                    \nCorrect",
    "optionB": "B. OCT 3 / 4",
    "optionC": "C. KIT",
    "optionD": "D. Podoplanin",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>expression of cytokeratin</strong> can differentiate <strong>embryonal cell carcinoma</strong> from seminoma.</p>\n<p><strong>Embryonal cell carcinomas</strong> are known for their <strong>local aggressiveness</strong>, often spreading into the <strong>epididymis</strong> or <strong>spermatic cord</strong> through the tunica albuginea. The neoplastic cells appear epithelial, are large and anaplastic, and feature <strong>hyperchromatic nuclei</strong> with prominent nucleoli. Mitotic figures and tumor giant cells are commonly observed, and <strong>blood</strong> and <strong>lymphatic vessels</strong> are often invaded.</p>\n<p>A typical <strong>seminoma</strong> cell exhibits a <strong>round</strong> to <strong>polyhedral</strong> shape with a well-defined cell membrane. Its cytoplasm appears clear or watery and contains a <strong>large central nucleus</strong> with one or two prominent nucleoli. Using immunohistochemistry, the tumor cells of seminoma generally show <strong>positivity</strong> for <strong>KIT</strong>, <strong>OCT3/4</strong>, and <strong>podoplanin</strong>, while they <strong>do not express cytokeratin</strong>.</p>\n<p>Similar to seminoma, embryonal carcinoma stains positively for OCT3/4. However, it differs in being <strong>typically positive</strong> for <strong>cytokeratin</strong> and <strong>negative</strong> for <strong>KIT</strong> and <strong>podoplanin</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2277: WHO 2016 classification of testicular tumors</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 182\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>I. Germ-cell tumors (GCTs) derived from germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Germ-cell neoplasia in situ</li>\n<li>Seminoma</li>\n<li>Non-seminomatous GCTs\n<ul>\n<li>Embryonal carcinoma</li>\n<li>Yolk sac tumor, postpubertal-type</li>\n<li>Choriocarcinoma</li>\n<li>Teratoma, post-pubertal type</li>\n</ul>\n</li>\n<li>Mixed germ-cell tumors</li>\n</ul>\n<p><strong>II. Germ-cell tumors unrelated to germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Spermatocytic tumour</li>\n<li>Teratoma, prepubertal type</li>\n<li>Yolk sac tumor, prepubertal type</li>\n<li>Mixed</li>\n</ul>\n<p><strong>III. Sex cord stromal tumors</strong></p>\n<ul>\n<li>Leydig cell tumor</li>\n<li>Sertoli cell tumor</li>\n<li>Granulosa cell tumor</li>\n<li>Fibroma–thecoma</li>\n</ul>\n<p><strong>IV. Tumor containing both germ-cell and sex cord-stromal elements</strong></p>\n<ul>\n<li>Gonadoblastoma</li>\n</ul>\n<p><strong>V. Hematolymphoid tumors</strong></p>\n</div>\n</div>\n</div>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2279: Seminomatous germ-cell tumors (GCTs) vs Non-seminomatous GCT</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Seminoma</strong></td>\n<td><strong>Non- seminomatous GCT</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>2<sup>nd</sup> or 3<sup>rd</sup> decade (Never seen in prepubertal children)</td>\n<td>Occur at any age</td>\n</tr>\n<tr>\n<td><strong>Presentation</strong></td>\n<td>Localized to the testis for a&nbsp;long time</td>\n<td>Aggressive tumors; present&nbsp;at an advanced clinical stage</td>\n</tr>\n<tr>\n<td><strong>Spread</strong></td>\n<td>Lymphatic</td>\n<td>Hematogenous</td>\n</tr>\n<tr>\n<td><strong>Macroscopy</strong></td>\n<td>Homogenous</td>\n<td>Variegated</td>\n</tr>\n<tr>\n<td><strong>Cell type</strong></td>\n<td>Composed of primordial germ cells</td>\n<td>Composed of undifferentiated cells</td>\n</tr>\n<tr>\n<td><strong>Tumor marker</strong></td>\n<td>Placental alkaline phosphatase</td>\n<td>AFP, HCG</td>\n</tr>\n<tr>\n<td><strong>Radio-therapy</strong></td>\n<td>Radiosensitive</td>\n<td>Radioresistant</td>\n</tr>\n<tr>\n<td><strong>Prognosis</strong></td>\n<td>Better</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table>\n<p>AFP:&nbsp;Alpha-fetoprotein&nbsp;</p>\n<p>HCG: Human Chorionic Gonadotropin</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-75",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF3009",
    "stauts": "Incorrect",
    "question_title": "75.\n        You would not consider oral bisphosphonates as a management option in treating osteoporosis in all of the following patients except?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Barrett’s esophagus\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. CKD with eGFR <30mL/min",
    "optionC": "C. Seizure disorder on phenytoin\n                \n                  \n                    \nCorrect",
    "optionD": "D. Roux-en-Y gastric bypass done 6 months back",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Bisphosphonates are <strong>not contraindicated</strong> in patients with a <strong>seizure disorder </strong>or patients taking<strong> phenytoin</strong>. Phenytoin can cause secondary osteoporosis in patients.</p>\n<p>Contraindications for bisphosphonates:</p>\n<ul>\n<li>Esophageal disorders</li>\n<li>Severe gastroesophageal reflux disease (GERD)</li>\n<li>Inability to remain upright for 30 minutes</li>\n<li>Hypocalcemia</li>\n<li>Chronic kidney disease with an eGFR less than 30-35 mL/min</li>\n<li>Pregnancy and lactation</li>\n<li>History of osteonecrosis of the jaw (ONJ)</li>\n<li>Active upper gastrointestinal disease, including peptic ulcers, active gastritis, or recent gastrointestinal bleeding</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Barrett's Esophagus</strong>: Oral bisphosphonates can cause esophageal irritation, making them contraindicated in patients with Barrett’s esophagus due to the increased risk of esophagitis or esophageal cancer. Therefore, bisphosphonates are typically avoided in this population.</p>\n<p>Option B: Chronic Kidney Disease (CKD) with eGFR &lt;30 mL/min: Bisphosphonates are generally <strong>contraindicated</strong> in patients with <strong>severe CKD (eGFR &lt;30 mL/min)</strong> because they are excreted via kidneys and may cause a worsening renal function.</p>\n<p>Option D:<strong> Roux-en-Y Gastric Bypass</strong>: Patients with a history of gastric bypass surgery may have<strong> altered absorption of oral medications</strong>, including bisphosphonates, due to changes in the gastrointestinal tract. This makes bisphosphonates <strong>less effective or potentially irritating </strong>to the stomach, so they are generally avoided in these patients.</p>\n<p>Patients who are unable to take oral bisphosphonates can be started on <strong>IV</strong> bisphosphonates.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-76",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6438",
    "stauts": "Incorrect",
    "question_title": "76.\n        A middle-aged patient with obesity and elevated liver enzymes is diagnosed with nonalcoholic steatohepatitis (NASH). Which of the following is a newly approved drug for the treatment of  NASH with moderate to advanced liver scarring?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Elafibranor",
    "optionB": "B. Vamorolone",
    "optionC": "C. Obeticholic acid\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Resmetirom\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Resmetirom</strong> (brand name <strong>REZDIFFRA)&nbsp;</strong>is indicated for the treatment of adults with <strong>nonalcoholic steatohepatitis (NASH) </strong>with <strong>moderate to advanced liver fibrosis</strong> in conjunction with diet and exercise.</p>\n<p>It is a<strong> selective thyroid hormone receptor (THR)-beta agonis</strong>t. It acts primarily in the <strong>liver,</strong> where THR-beta is the predominant form of thyroid hormone receptor. Activation of THR-beta by resmetirom <strong>reduces intrahepatic triglycerides and liver fat content</strong>. This selective activation minimizes the effects of THR-alpha, which mediates thyroid hormone actions in the heart and bone.</p>\n<p>Common adverse effects include <strong>gastrointestinal symptoms</strong> such as diarrhoea, nausea, vomiting, constipation, and abdominal pain. <strong>Hepatotoxicity </strong>and <strong>gallbladder-related adverse reactions</strong> are significant concerns.</p>\n<p>Other options:</p>\n<p>Option A. <strong>Elafibranor</strong> is a medication used for the treatment of <strong>primary biliary cholangitis.</strong> It is a dual PPARα/δ agonist.</p>\n<p>Option B. <strong>Vamorolone</strong> is a synthetic corticosteroid, which is used for the treatment of <strong>Duchenne muscular dystrophy.&nbsp;</strong></p>\n<p>Option C. <strong>Obeticholic acid</strong> is used to treat <strong>primary biliary cholangitis.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-77",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME9303",
    "stauts": "Incorrect",
    "question_title": "77.\n        A 35-year-old man with no comorbidities presents with altered sensorium, severe headache, and 2 episodes of vomiting. Lumbar puncture reveals an elevated opening pressure and turbid cerebrospinal fluid, which is sent for analysis. Initial results revealed raised neutrophils. What medications should be started until the final reports are available?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Ceftriaxone + vancomycin\n                \n                  \n                    \nCorrect",
    "optionB": "B. Ampicillin + ceftriaxone + vancomycin\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Ampicillin + cefotaxime",
    "optionD": "D. Ceftriaxone + meropenam",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The clinical features&nbsp;<span>suggest&nbsp;<strong>meningitis;</strong></span>&nbsp;given the patient's age and absence of comorbidities, <strong>empirical therapy</strong> with <strong>ceftriaxone</strong> and <strong>vancomycin</strong> should be initiated.</p>\n<p>The patient has elevated intracranial pressure with nuchal rigidity, and <strong>positive Kernig's </strong>(pain on passive extension of the knee when the thigh is flexed on the abdomen)<strong>&nbsp;</strong>and<strong> Brudzinski's </strong>(spontaneous flexion of hips and knees on passive flexion of neck) signs. The cerebrospinal fluid (CSF) appears <strong>turbid</strong>. All these findings are suggestive of bacterial meningitis. The <strong>most common organism</strong> causing bacterial meningitis in adults is <strong>Streptococcus pneumoniae.</strong> Other less common causes are&nbsp;Neisseria meningitidis, Staphylococcus aureus, Listeria monocytogenes, Haemophilus sp., and Enterobacteriaceae, etc.</p>\n<p>Patients may have a fever, headache, nuchal rigidity, and seizures. Signs of meningeal irritation can be elicited by Kernig's and Brudzinki's signs.&nbsp;</p>\n<table width=\"444\">\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Cerebrospinal Fluid (CSF) abnormalities in bacterial meningitis</strong></td>\n</tr>\n<tr>\n<td>Opening pressure</td>\n<td>&gt;180 mmH<sub><span class=\"s1\">2</span></sub>O</td>\n</tr>\n<tr>\n<td>White blood cells</td>\n<td>10/μL to 10,000/μL; <strong>neutrophils</strong> predominate</td>\n</tr>\n<tr>\n<td>Red blood cells</td>\n<td>Absent in nontraumatic tap</td>\n</tr>\n<tr>\n<td>CSF/serum glucose</td>\n<td>&lt;0.4</td>\n</tr>\n<tr>\n<td>Protein</td>\n<td>&nbsp;&gt;0.45 g/L (&gt;45 mg/dL)</td>\n</tr>\n<tr>\n<td>Gram’s stain</td>\n<td>Positive in &gt;60%</td>\n</tr>\n<tr>\n<td>Culture</td>\n<td>Positive in &gt;80%</td>\n</tr>\n<tr>\n<td>PCR</td>\n<td>Detects bacterial DNA</td>\n</tr>\n<tr>\n<td><strong>Latex agglutination</strong></td>\n<td>May be positive in patients with meningitis due to Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, Escherichia coli, group B streptococci</td>\n</tr>\n</tbody>\n</table>\n<p class=\"p2\">As soon as bacterial meningitis is suspected, <strong>blood cultures</strong> should be <strong>immediately</strong> obtained and the patient should be started on <strong>empirical antibiotics</strong> and <strong>dexamethasone</strong>.&nbsp;</p>\n<p>Choice of empirical antibiotics in various situations is as follows :</p>\n<ul>\n<li class=\"p1\">Preterm infants to infants &lt;1 month - Ampicillin + cefotaxime</li>\n<li class=\"p1\">Infants 1 – 3 months - Ampicillin + cefotaxime or ceftriaxone</li>\n<li class=\"p1\">Immunocompetent children &gt; 3 months and <strong>adults &lt;55 years </strong>-&nbsp;<strong>Cefotaxime, ceftriaxone, or cefepime + vancomycin</strong></li>\n<li class=\"p1\"><strong>Adults &gt; 55 years</strong> and <strong>adults of any age with alcoholism</strong> or other debilitating illnesses - <strong>Ampicillin + cefotaxime, ceftriaxone, or cefepime +vancomycin</strong></li>\n<li class=\"p1\">Hospital-acquired meningitis, posttraumatic or post neurosurgery meningitis, neutropenic patients, or patients with impaired cell-mediated immunity - Ampicillin + ceftazidime or meropenem + vancomycin</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2433: Acute bacterial meningitis - causes and empirical treatment</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br>Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br>Ampicillin+<br>Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br><em>N. meningitidis</em><br><br></td>\n<td>\n<p>3rd generation cephalosporin+<br>Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br><em>N. meningitidis</em><br><em>L. monocytogenes</em><br>Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br>Vancomycin+<br>Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br>Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br>Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br>Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state&nbsp;</td>\n<td>\n<p><em>&nbsp;S. pneumoniae&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </em></p>\n<p><em>N. meningitidis&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</em></p>\n<p><em>L. monocytogenes&nbsp; &nbsp; &nbsp; &nbsp;</em></p>\n<p>Gram negative bacilli&nbsp;</p>\n</td>\n<td>\n<p>Vancomycin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Ampicillin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Cefepime&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;OR&nbsp;</p>\n<p>Vancomycin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Meropenem&nbsp; &nbsp; &nbsp;&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*PRSP= penicillin-resistant S pneumoniae&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2434: CSF findings in meningitis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;μL)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, ≤30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>↑↑PMNs (≥80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br>in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>↓ to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>↑↑ Eosinophils (≥50%)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-78",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6959",
    "stauts": "Incorrect",
    "question_title": "78.\n        Identify the arrow-marked structure and the corresponding vertebral level.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/468aaf2ca9c04d4d8bf1cb748ea3f7c0.JPEG\">",
    "optionA": "A. Pulmonary Trunk - T3",
    "optionB": "B. Arch of Aorta - T3\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Pulmonary Trunk - T5\n                \n                  \n                    \nCorrect",
    "optionD": "D. Arch of Aorta - T5",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The arrow marks the <strong>bifurcation </strong>of the <strong>pulmonary trunk. </strong>It corresponds to the <strong>T5</strong> level.</p>\n<p>The image shows a cross section of a cadaver at the <strong>T5 vertebral level</strong>. This corresponds anteriorly to the level of the sternal angle, and is also the level of division between the superior and inferior mediastinum.</p>\n<p>At this level, the other structures visible are:</p>\n<ul>\n<li>The <strong>origin</strong> and <strong>termination </strong>of the<strong> arch of aorta</strong>. The descending aorta can be identified to the left of the oesophagus. The arch of the aorta (Option D) would be visible at the T3-T4 cross sectional level.</li>\n<li>The <strong>superior vena cava</strong> (Option B), just lateral to the origin of the aorta, which can visually differentiated from the aorta based on the wall thickness. At this level, it penetrates the right atrium.</li>\n<li>The <strong>bifurcation</strong> of the <strong>pulmonary trunk.</strong></li>\n<li>The <strong>left </strong>and <strong>right main bronchi</strong>. The carina (Option A) is not visible as the trachea bifurcates more proximally at the T4 level.&nbsp;</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/3d8e3f54552b403497312a700fe57005.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2386: Divisions and contents of the mediastinum</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a16336888534350bce06ecc2f4483afx425x480.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td colspan=\"3\"><strong>Major contents of thoracic cavity</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><span><strong>Superior</strong> mediastinum</span></td>\n<td>\n<ul>\n<li><span>Trachea</span></li>\n<li><span>Esophagus</span></li>\n<li><span>Thoracic duct</span></li>\n<li><span>Thymus</span></li>\n<li><span>Vessels-</span>\n<ul>\n<li><span>Aortic arch</span></li>\n<li><span>Left common carotid artery</span></li>\n<li><span>Left subclavian artery</span></li>\n<li><span>Brachiocephalic trunk</span></li>\n<li><span>Right and left brachiocephalic veins</span></li>\n<li><span>Superior vena cava (upper half)</span></li>\n<li><span>Azygos vein near its opening into superior vena cava</span></li>\n</ul>\n</li>\n<li><span>Left recurrent laryngeal nerve</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><span><strong>Inferior</strong> mediastinum</span></td>\n<td><span>Anterior</span></td>\n<td>\n<ul>\n<li><span>Thymus (inferior extension)</span></li>\n<li><span>Mediastinal branches of internal thoracic vessels</span></li>\n<li><span>Sternopericardial ligaments</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Middle</span></td>\n<td>\n<ul>\n<li><span>Heart</span></li>\n<li><span>Phrenic nerve</span></li>\n<li><span>Tracheal bifurcation and bronchi</span></li>\n<li><span>Roots of great vessels</span>\n<ul>\n<li><span>Ascending aorta</span></li>\n<li><span>Superior vena cava (lower half)</span></li>\n<li><span>Inferior vena cava</span></li>\n<li><span>Pulmonary trunk and branches</span></li>\n<li><span>Pericardiophrenic arteries and veins</span></li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Posterior</span></td>\n<td>\n<ul>\n<li><span>Thoracic aorta</span></li>\n<li><span>Thoracic duct</span></li>\n<li><span>Esophagus</span></li>\n<li><span>Vagus nerve</span></li>\n<li><span>Azygos vein</span></li>\n<li><span>Hemiazygos vein</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2117: Angle of Louis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p class=\"p1\">The <strong>angle of Loius (sternal angle)</strong> is formed by the manubriosternal joint at the level of<strong> 2<sup>nd</sup> costal cartilage</strong> anteriorly.</p>\n<p class=\"p1\">A plane joining the angle of Louis to the<strong> intervertebral disc between T4 and T5</strong>, called the <strong>sternal plane</strong> marks the following anatomical landmarks:&nbsp;</p>\n<ul class=\"ul1\">\n<li class=\"li1\">Separates superior mediastinum form inferior mediastinum.&nbsp;</li>\n<li class=\"li1\">Marks the position superior limit of pericardium.</li>\n<li class=\"li1\">Bifurcation of pulmonary trunk</li>\n<li class=\"li1\">Bifurcation of&nbsp;trachea (newer studies&nbsp;shows its lower)&nbsp;&nbsp;</li>\n<li class=\"li1\">Origin of arch of aorta.</li>\n<li class=\"li1\">Site where superior venacava pierces the pericardium.</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-79",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6448",
    "stauts": "Correct",
    "question_title": "79.\n        Which of the following is not a contraindication for pancreaticoduodenectomy in a case of pancreatic cancer?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Liver metastases",
    "optionB": "B. Peri-pancreatic lymph node involvement\n                \n                  \n                    \nCorrect",
    "optionC": "C. Peritoneal seedings",
    "optionD": "D. Celiac lymph node involvement",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Among the following options,<strong> peri-pancreatic lymph node involvement</strong>&nbsp;is not a contraindication for pancreaticoduodenectomy.</p>\n<p>In pancreaticoduodenectomy, the following are generally considered contraindications:</p>\n<ul>\n<li><strong>Liver Metastases</strong>: (option A) The presence of liver metastases is a contraindication because it indicates that cancer has spread beyond the pancreas, making a <strong>curative resection unlikely.</strong></li>\n<li><strong>Peritoneal Seedings</strong>: (option C) This indicates widespread cancer within the peritoneal cavity and is a contraindication for resection, as it suggests <strong>metastatic disease</strong>.</li>\n<li><strong>Celiac Lymph Node Involvement</strong>: (Option D) Involvement of the celiac lymph nodes often signifies <strong>metastatic disease, </strong>which is generally considered a contraindication for resection.</li>\n</ul>\n<p>Peri-pancreatic Lymph Node Involvement is<strong> not an absolute contraindication</strong> for resection. While it suggests locally advanced disease and might influence the decision-making process, the presence of peri-pancreatic lymph node involvement alone<strong> does not preclude resection</strong> if the disease is otherwise localized and potentially resectable.&nbsp;</p>\n<p>Findings contraindicating resection:</p>\n<p>• <strong>Liver metastases (any size)</strong><br>•<strong> Celiac lymph node involvement</strong><br>• <strong>Peritoneal implants</strong><br>• Hepatic hilar lymph node involvement</p>\n<p>Findings <strong>not contraindicating</strong> resection:</p>\n<p>• Invasion at duodenum or distal stomach.<br>• Involved <strong>peri-pancreatic lymph nodes.</strong><br>• Involved lymph nodes along porta hepatis that can be removed along with the tumor.<br>• Involvement of superior mesenteric vein</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-80",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF1024",
    "stauts": "Correct",
    "question_title": "80.\n        Match the correct neurocutaneous disorder with its respective clinical spectrum.",
    "question_ADD": "<table style=\"height: 262px; width: 441px;\" border=\"1\">\n<tbody>\n<tr style=\"height: 18px;\">\n<td style=\"width: 216.242px; height: 18px;\"><strong>Condition</strong></td>\n<td style=\"width: 204.758px; height: 18px;\"><strong>Clinical spectrum</strong></td>\n</tr>\n<tr style=\"height: 54px;\">\n<td style=\"width: 216.242px; height: 54px;\">1. Neurofibromatosis type 1&nbsp;</td>\n<td style=\"width: 204.758px; height: 54px;\">A. Subependymal giant cell astrocytoma, ash-leaf spots</td>\n</tr>\n<tr style=\"height: 73.1953px;\">\n<td style=\"width: 216.242px; height: 73.1953px;\">2. Sturge-Weber syndrome</td>\n<td style=\"width: 204.758px; height: 73.1953px;\">B.&nbsp;Cerebellar haemangioblastoma, retinal angiomas</td>\n</tr>\n<tr style=\"height: 36px;\">\n<td style=\"width: 216.242px; height: 36px;\">3. Von Hippel Lindau disease</td>\n<td style=\"width: 204.758px; height: 36px;\">C. Iris hamartoma, optic glioma</td>\n</tr>\n<tr style=\"height: 54px;\">\n<td style=\"width: 216.242px; height: 54px;\">4. Tuberous Sclerosis</td>\n<td style=\"width: 204.758px; height: 54px;\">D.&nbsp;Port-wine birthmark, glaucoma</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>",
    "question_imag": "",
    "optionA": "A. 1-A, 2-C, 3-D, 4-B",
    "optionB": "B. 1-C, 2-D, 3-B, 4-A\n                \n                  \n                    \nCorrect",
    "optionC": "C. 1-B, 2-A, 3-C, 4-D",
    "optionD": "D. 1-D, 2-B, 3-A, 4-C",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Option B</strong> is the correctly matched answer to this question. The following table represents each condition matched to its clinical spectrum.</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Clinical spectrum</strong></td>\n</tr>\n<tr>\n<td>1. Neurofibromatosis type 1&nbsp;</td>\n<td>\n<p>C. Iris hamartoma/&nbsp;<strong>Lisch nodules</strong>, optic glioma</p>\n</td>\n</tr>\n<tr>\n<td>2. Sturge-Weber syndrome</td>\n<td>D.&nbsp;<strong>Port-wine</strong> birthmark, <strong>glaucoma</strong></td>\n</tr>\n<tr>\n<td>3. Von Hippel Lindau disease</td>\n<td>B.&nbsp;Cerebellar <strong>haemangioblastoma</strong>, retinal angiomas</td>\n</tr>\n<tr>\n<td>4. Tuberous sclerosis</td>\n<td>\n<p>A. Subependymal giant cell astrocytoma, <strong>ash-leaf spots</strong></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Neurocutaneous disorders are conditions that affect <strong>ectodermal derivatives</strong>, most commonly the <strong>skin</strong> and the <strong>CNS</strong>.&nbsp;</p>\n<p><strong>Neurofibromatosis type 1 </strong>(NF1)&nbsp;is due to an&nbsp;<strong>autosomal dominant</strong> loss-of-function mutation in the&nbsp;<em>NF1&nbsp;</em>gene. Other characteristic features of NF1 include <strong>cafe-au-lait macules, inguinal</strong> and<strong> axillary freckling</strong>, and&nbsp;neurofibromas.</p>\n<p>The images below show Lisch nodules, cafe-au-lait macules, and axillary freckling respectively.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e0be8bac55f44567b42985c93225ea26x720x480.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3fcdcd401f9b4f3eb7df7939fa31ec1ax800x600.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ac5a19f044d4431194b0ec3c4c311b4dx472x659.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Sturge-Weber syndrome&nbsp;</strong>is a neurocutaneous disorder characterized by vascular malformations limited to segments. It usually results from a <strong>mosaic mutation</strong> in the&nbsp;<strong><em>GNAQ&nbsp;</em></strong><strong>gene</strong>. Leptomeningeal angiomas are a common finding. Presenting complaints in patients range from developmental delay and headaches to <strong>seizures</strong>, hemiparesis, and stroke-like episodes.&nbsp;<strong>Port-wine</strong>&nbsp;marks and&nbsp;<strong>glaucoma </strong>are characteristic.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f62232bf40814c2297cc068bfb49c883x272x325.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Von Hippel Lindau (VHL)&nbsp;</strong>is an autosomal dominant condition that arises from a mutation affecting the&nbsp;<strong><em>VHL&nbsp;</em>tumor suppressor gene</strong>. Characteristic features of VHL include spinal hemangioblastomas, endolymphatic sac tumor, pheochromocytoma, and cystic lesions of the kidneys, pancreas, and liver.</p>\n<p><strong>Tuberous sclerosis complex (TSC)</strong> also follows an <strong>autosomal dominant</strong> pattern of inheritance. Other&nbsp;features of TSC also include <strong>shagreen patches, </strong>cardiac rhabdomyomas<strong>, renal angiomyolipoma, facial angiofibroma,</strong> and periungual fibromas which are shown in the images below.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2489: Cutaneous lesions of Tuberous sclerosis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Tuberous sclerosis (TS)&nbsp;is also known as&nbsp;tuberous sclerosis complex&nbsp;or&nbsp;Bourneville disease. It is a neurocutaneous disorder (<strong>phakomatosis</strong>) characterized by the development of&nbsp;<strong>multiple benign tumors&nbsp;</strong>of the<strong>&nbsp;embryonic ectoderm</strong>&nbsp;(e.g. skin, eyes, and nervous system). It is an&nbsp;<strong>autosomal dominant&nbsp;</strong>condition.&nbsp;&nbsp;The mutations are involved in the&nbsp;<strong>TSC1</strong>&nbsp;gene that encodes&nbsp;<strong>hamartin</strong>&nbsp;on&nbsp;<strong>chromosome 9</strong>&nbsp;and the&nbsp;<strong>TSC2 gene&nbsp;</strong>that&nbsp;encodes a protein&nbsp;<strong>tuberin</strong>&nbsp;on&nbsp;<strong>chromosome 16.</strong></p>\n<p>Tuberous sclerosis presents in childhood with a triad (<strong>Vogt triad</strong>). The triad comprises of:</p>\n<ul>\n<li>Seizures</li>\n<li>Mental retardation</li>\n<li>Adenoma sebaceum</li>\n</ul>\n<p><strong>Skin lesions in tuberous sclerosis</strong>:</p>\n<p><strong>Shagreen patch</strong> consists of a roughened, raised lesion with an orange-peel consistency, located primarily in the lumbosacral region. Shagreen is shark skin used as a decorative material present in the right image given below.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0cee876a9f6240469fbeeec41caa125ex1280x523.0933333333334.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The typical <strong>hypomelanotic ash leaf–type macules</strong> on the trunk and extremities are&nbsp;seen in 90% of the patients. It is visualized by the use of a wood ultraviolet lamp.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/181f1c6703df48e0b459ef3224c79828x973x697.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Facial angiofibromas (<strong>adenoma sebaceum</strong>) develop between 4 and 6 years of age; they appear as tiny red nodules over the nose and cheeks and are sometimes confused with acne. Later, they enlarge, coalesce, and assume a fleshy appearance.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7dd9904adb764d4492cce469f6b0ce88x800x525.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Periungual fibroma</strong> are small fibromas or nodules of skin, which form around fingernails or toenails in some adolescent patients</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d7eeecb16bbf4cfaa451b24185d0ab43x569x629.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Confetti skin lesions</strong>&nbsp;are seen less commonly as a minor feature of tuberous sclerosis.</p>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d30bdf16a3a42079eaa18cadb32ad7fx1280x521.892071952032.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-81",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD2222",
    "stauts": "Correct",
    "question_title": "81.\n        A 75-year-old woman presents with multiple, tense, pruritic bullae and blisters. A linear pattern is seen on immunofluorescence and histopathology demonstrates subepidermal, non-acantholytic blisters. Which of the following is true about this disease?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Anti-desmoglein antibodies positive",
    "optionB": "B. Blisters formed in suprabasal layer of epidermis",
    "optionC": "C. Nikolsky sign is negative\n                \n                  \n                    \nCorrect",
    "optionD": "D. Target antigens are intraepidermal",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This patient's clinical features are suggestive of&nbsp;<strong>bullous pemphigoid. </strong>Nikolsky sign is<strong> negative&nbsp;</strong>in bullous pemphigoid.</p>\n<p>Immunofluorescent microscopy will show the presence of<strong> subepidermal split and linear pattern deposition of IgG antibodies</strong> against bullous pemphigoid antigens <strong>(BPAGs)-</strong> BP 180 and BP 230- components of hemidesmosomes. S<strong>ubepidermal, nonacantholytic bullae</strong> are seen which are <strong>tense</strong> and don't rupture easily. Hence Nikolsky sign i.e exfoliation of skin on slight rubbing is absent.</p>\n<p>Bullous pemphigoid is one of the most common <strong>subepidermal immunobullous disorders</strong>. It is mostly a disease of the <strong>elderly.</strong></p>\n<p>Histopathology will show the presence of<strong> subepidermal bullae </strong>with <strong>eosinophils</strong> and <strong>basal cell layer vacuolization</strong>.&nbsp;</p>\n<p>Clinical features include a prodromal phase and a bullous phase.</p>\n<p><strong>A prodromal phase</strong> with excoriated papules, eczematous or urticarial skin lesions and haemorrhagic crusts may be seen.</p>\n<p><strong>The bullous phase</strong> is characterised by the:</p>\n<ul>\n<li><strong>Intense pruritus</strong> is almost constantly present.</li>\n<li><strong>Symmetrically</strong> distributed tense bullae and vesicles over the flexural aspects and abdomen of the body.</li>\n<li>Partly haemorrhagic crusts and erythematous plaques with an annular pattern are seen.</li>\n<li>Lesions heal <strong>without scarring</strong>, provided there are no superinfections.</li>\n<li>The bullae contain <strong>clear, sometimes haemorrhagic exudates</strong>.</li>\n<li><strong>Nikolsky's sign is negative.</strong></li>\n<li><strong>Oral or mucosal lesions</strong> and milia formation are <strong>rare</strong>.</li>\n</ul>\n<p>The image given below shows the lesions seen in bullous pemphigoid.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/75e3113d9e6349af963733a2482e82b2x800x1066.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p><br>Options A, B, and D: Blisters in <strong>suprabasal</strong> <strong>layers</strong> of <strong>epidermis</strong>, anti-desmoglein antibodies, and intraepidermal target antigens are all features of pemphigus vulgaris.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2085: Differences between pemphigus vulgaris and bullous pemphigoid</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Pemphigus vulgaris</strong></td>\n<td><strong>Bullous pemphigoid</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>30-40 years</td>\n<td>70-80 years</td>\n</tr>\n<tr>\n<td>Antibody</td>\n<td>Anti-desmoglein</td>\n<td>Anti-hemidesmosome</td>\n</tr>\n<tr>\n<td>Location of target antigens</td>\n<td>Intraepidermal</td>\n<td>Subepidermal</td>\n</tr>\n<tr>\n<td>Immuno-fluorescence</td>\n<td>Fish-net pattern</td>\n<td>Linear, shoreline pattern</td>\n</tr>\n<tr>\n<td>Bullae</td>\n<td>Thin and fragile</td>\n<td>Deep and tense</td>\n</tr>\n<tr>\n<td>Mouth involved</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Nikolsky’s sign</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Symptom</td>\n<td>Painful</td>\n<td>Pruritic</td>\n</tr>\n<tr>\n<td>Severity</td>\n<td>Life threatening</td>\n<td>Resolves</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0224: Vesiculobullous Disorders</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Clinical Manifestations</strong></td>\n<td><strong>Histology</strong></td>\n<td><strong>Immuno-pathology</strong></td>\n<td><strong>Autoantigens</strong></td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Flaccid blisters, denuded skin,oro-mucosal lesions</td>\n<td>Acantholytic blister formed in&nbsp;<strong>suprabasal layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG on keratinocytes- fish net pattern</td>\n<td><strong>Dsg3, Dsg1</strong> in patients with skin involvement</td>\n</tr>\n<tr>\n<td>Pemphigus foliaceus <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Crusts and shallow erosions on the scalp, central face, upper chest, and back</td>\n<td>Acantholytic blister formed in&nbsp;<strong>superficial layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG onkeratinocytes</td>\n<td><strong>Dsg1</strong></td>\n</tr>\n<tr>\n<td>Bullous pemphigoid <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Large tense blisters on flexor surfaces and trunk&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>eosinophil-rich</strong> infiltrate</td>\n<td>Linear band of IgG and/or C3 in epidermal BMZ&nbsp;</td>\n<td><strong>BPAG1, BPAG2</strong></td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis<strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Extremely pruritic small papules and vesicles on elbows, knees, buttocks, and posterior neck</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophils </strong>in dermal papillae&nbsp;</td>\n<td>Granular deposits of IgA at the tips of dermal papillae</td>\n<td><strong>Epidermal trans-glutaminase</strong></td>\n</tr>\n<tr>\n<td>Linear IgA disease <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Pruritic small papules on extensor surfaces; occasionally larger, arciform blisters&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophil</strong>-rich infiltrate&nbsp;</td>\n<td>Linear band of IgA in epidermalBMZ</td>\n<td><strong>BPAG2</strong></td>\n</tr>\n<tr>\n<td><strong>Epidermo-lysis bullosa acquisita</strong></td>\n<td>Tense bullae and erosions&nbsp;</td>\n<td>Subepidermal blister&nbsp;</td>\n<td>IgG and C3 DEJ – Continous and linear&nbsp;</td>\n<td><strong>Type VII collagen</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;The images below shows clinical pictures of pemphigus patients.</p>\n<ul>\n<li>Image A - oral erosions in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image B - heavily clotted and crusted lesions around the mouth in a patient with <strong>paraneoplastic pemphigus</strong></li>\n<li>Image C - skin lesions found on the trunk in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image D - skin lesions on the trunk in a patient with <strong>pemphigus foliaceus</strong></li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f91eeb50e144e818c6d6e857996c593x443x358.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-82",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC2453",
    "stauts": "Incorrect",
    "question_title": "82.\n        Following a kidney transplant, a 24-year-old male patient is placed on cyclosporine but after 48 hours complains of serious nausea and diarrhea and has a sudden increase in transaminases. You switch him to tacrolimus but nausea persists and he complains of getting dizzy and has dyspnea. Which of the following immunosuppressive agents would be an alternate drug in this scenario?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Mycophenolate mofetil\n                \n                  \n                    \nCorrect",
    "optionB": "B. Etanercept",
    "optionC": "C. Tocilizumab\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Basiliximab",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><span><strong>Mycophenolate</strong> <strong>mofetil</strong> is the immunosuppressive agent that would be an alternate drug in this scenario indicated as a prophylaxis for transplant rejection</span><strong>.&nbsp;</strong></p>\n<p>Mycophenolate mofetil is a prodrug that is rapidly converted to mycophenolic acid. It is a selective, non-competitive, <strong>reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH),</strong> an important enzyme in the de novo pathway of guanine nucleotide synthesis and a suitable alternative for managing transplant rejection in cases where cyclosporine or tacrolimus is not tolerated.&nbsp;</p>\n<p><strong>Cyclosporine</strong> is commonly used for <strong>immunosuppression</strong> following <strong>transplantation</strong> to <strong>prevent organ rejection</strong>. However, it can cause side effects such as <strong>nausea, diarrhoea</strong>, and <strong>elevated liver enzymes</strong>. These symptoms are <strong>adverse effects</strong> of cyclosporine rather than indicative of treatment failure.</p>\n<p><strong>Azathioprine</strong> may be used as another alternative, although it is <strong>less commonly preferred</strong> due to its potential for <strong>myelosuppression.</strong></p>\n<p>When a patient experiences i<strong>ntolerable side effects</strong> with <strong>cyclosporine, tacrolimus</strong> is often used as an <strong>alternative</strong>. Tacrolimus, another effective immunosuppressant, can also cause nausea, <strong>dizziness</strong>, and <strong>dyspnea</strong> in some patients.</p>\n<p>Other options:</p>\n<p>Option B:<strong> Etanercept</strong> is a <strong>TNF-α antagonist</strong> used in rheumatoid arthiritis and Crohn’s disease.</p>\n<p>Option C: <strong>Tocilizumab</strong> is an <strong>anti-IL-6 antibody</strong> that would be of little benefit following an organ transplant.</p>\n<p>Option D: <strong>Basiliximab</strong> is an interleukin-2 receptor antagonist for activated T lymphocytes that may cause shortness of breath. As the patient has dyspnoea, the administration of basiliximab will further worsen his condition.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-83",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6421",
    "stauts": "Correct",
    "question_title": "83.\n        A 23-year-old female patient is transfused with 1 unit of Packed red blood cells for anaemia. After 2 hours of transfusion, the patient complains of fever and chills with mild breathlessness. On examination, there are no signs of jaundice, dark urine, or hypotension, and her cardiovascular examinations is unremarkable. What is the mechanism responsible for this blood transfusion reaction?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Recipient is deficient in IgA",
    "optionB": "B. Antibodies against donor WBC\n                \n                  \n                    \nCorrect",
    "optionC": "C. Recipient IgE against donor components",
    "optionD": "D. ABO incompatibility",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario with complaints of <strong>fever, chills,</strong> and <strong>mild dyspnoea</strong> within <strong>2 hours</strong> of transfusion of packed red blood cells is suggestive of a <strong>febrile non-hemolytic transfusion reaction</strong>. The mechanism responsible for this reaction is <strong>antibodies</strong> against <strong>donor WBC</strong> and <strong>HLA antigens.</strong></p>\n<p>Febrile non-hemolytic transfusion reactions <strong>occur</strong> <strong>within 6 hrs </strong>of transfusion and are more commonly seen in patients with <strong>multiple</strong> <strong>transfusions</strong> and <strong>pregnant</strong> <strong>women</strong>. This is the <strong>most common</strong> type of transfusion reaction.</p>\n<p><strong>Management</strong> involves the usage of <strong>antipyretics</strong> and <strong>antihistamines.</strong> Transfusion should be stopped if the reaction is severe. This reaction can be prevented by the use of <strong>leukoreduced products</strong>. Leukoreduction involves the <strong>removal of WBCs</strong> from the blood products before transfusion, significantly<strong> reducing the risk of immune reactions.</strong> The most common method for achieving effective leukoreduction is the use of high-quality <strong>leukocyte reduction filters</strong>. Other methods that can sufficiently reduce leukocytes include <strong>saline washing</strong>, freezing and deglycerolizing, buffy coat removal, and microaggregate (\"second-generation\") filters.</p>\n<p>Other options:</p>\n<p>Option A: <strong>IgA deficient recipient</strong> leads to <strong>anaphylactic transfusion reaction</strong>. This occurs <strong>within seconds to minutes </strong>after transfusion and is a severe reaction, so transfusion must be stopped immediately.</p>\n<p>Option C: <strong>Recipient IgE</strong> acting against donor components leading to <strong>mast cell activation </strong>is seen in <strong>allergic/urticarial transfusion reactions.</strong> This occurs <strong>within 2-3 hrs </strong>of transfusion and is managed by stopping the transfusion with aggressive I.V. fluids administration.</p>\n<p>Option D: &nbsp;<strong>ABO incompatibility</strong> leads to an <strong>acute hemolytic transfusion reaction</strong> and this can occur from the <strong>start of transfusion to 24 hrs after</strong> transfusion. This should be managed by stopping the transfusion and with aggressive I.V. fluids administration.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <!---->\n        <svg width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"ng-star-inserted\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1451: Blood Transfusion Reactions</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td colspan=\"4\"><span><strong>Immunological Transfusion Reactions</strong>&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Reaction<br></strong></span><span><strong>(Onset)</strong></span></p>\n</td>\n<td><span><strong>Mechanism</strong></span></td>\n<td><span><strong>Presentation</strong></span></td>\n<td><span><strong>Management</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Anaphylactic transfusion reaction</strong></span></p>\n<p><span>(Seconds-minutes)</span></p>\n</td>\n<td>\n<p><span>Common in<strong> IgA</strong> deficient recipients&nbsp;</span></p>\n</td>\n<td>\n<p><span>Shock, respiratory distress, angioedema</span></p>\n</td>\n<td>\n<p>Stop transfusion immediately, give epinephrine</p>\n<p><span>Prevention – using IgA deficient plasma and washed cellular blood components</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Allergic/ Urticarial transfusion reaction</strong></span></p>\n<p><span>(Within 2-3 hours)</span></p>\n</td>\n<td>\n<p><span>Recipient <strong>IgE</strong> against donor components causing mast cell activation</span></p>\n</td>\n<td>\n<p><span>Urticaria, flushing, pruritus</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Febrile non-hemolytic transfusion reaction</strong></span></p>\n<p><span>(within&nbsp;</span><span>6h)</span></p>\n<p>&nbsp;</p>\n<p><span><span>(Most common complication of blood transfusion)</span></span></p>\n</td>\n<td>\n<p><span>Antibodies against donor WBC and <strong>HLA</strong> antigens (sensitization)</span></p>\n<p><span>Cytokine accumulation during blood storage</span></p>\n<p><span>More common in multipally transfused patients and multiparous women</span></p>\n</td>\n<td>\n<p><span>Fever and chills sometimes with mild dyspnoea</span></p>\n</td>\n<td>\n<p><span>Antihistamines and antipyretics</span></p>\n<p><span>Transfusion can be stopped if symptoms are severe</span></p>\n<p>Prevention: Leukoreduced products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Transfusion-related acute lung injury (TRALI)</strong></span></p>\n<p><span>(1-6 hours)</span></p>\n</td>\n<td>\n<p><span>Anti-HLA type 2 antibodies in donor plasma bind recipient WBCs, increase capillary permeability</span></p>\n</td>\n<td>\n<p><span>Hypoxia, non-cardiogenic pulmonary edema</span></p>\n<p><span>CXR: Bilateral interstitial infiltrates</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately</span></p>\n<p><span>Supportive care</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Acute hemolytic transfusion reaction</strong></span></p>\n<p><span>(during transfusion to within 24h)</span></p>\n</td>\n<td>\n<p><span>ABO incompatibility</span></p>\n<p><span>(Type 2 hypersensitivity)</span></p>\n<p><span>Pre-existing high affinity IgM antibodies rapidly induce complement mediated lysis, intra-vascular hemolysis, and hemoglobinuria</span></p>\n</td>\n<td>\n<p><span>Fever, chills, flank/back pain</span></p>\n<p><span>Sense of impending doom</span></p>\n<p><span>Hemoglobinuria</span></p>\n<p><span>DIC, Renal failure</span></p>\n<p><span>Coomb’s test positive, pink plasma</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delayed hemolytic transfusion reaction</strong></span></p>\n<p><span>occurs after 24 hours ( usually 2 weeks )</span></p>\n</td>\n<td>\n<p><span>Recipients have prior exposure to RBC antigens. </span><span>After the transfusion, anamnestic response results in antibody production</span></p>\n<p><span>Typically caused by IgG antibodies to foreign protein antigens and are associated with laboratory features of hemolysis.</span></p>\n</td>\n<td>\n<p><span>Mild fever, hemolytic anemia</span></p>\n<p><span>Coomb’s test positive</span></p>\n<p><span>Screening for new antibodies positive</span></p>\n</td>\n<td>\n<p><span>Supportive care</span></p>\n<p><span>Additional transfusions if needed</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><span><strong>Non-immune</strong> mediated transfusion reactions are as follows:</span></p>\n<ul>\n<li><span>Transfusion-associated circulatory overload (TACO)</span></li>\n<li><span>Hypothermia</span></li>\n<li><span>Electrolyte abnormality- hyperkalemia, hypocalcemia</span></li>\n<li><span>Iron overload</span></li>\n<li><span>Transient hypotension</span></li>\n<li><span>Immunomodulation</span></li>\n<li><span>Blood-borne infections&nbsp;</span></li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-84",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF1882",
    "stauts": "Correct",
    "question_title": "84.\n        A 32-year-old man was recently fired from work and he felt a strong urge to physically harm his boss. To try and control his urge he took up badminton to vent his anger. Identify the type of defense mechanism used by him.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Sublimation\n                \n                  \n                    \nCorrect",
    "optionB": "B. Altruism",
    "optionC": "C. Displacement",
    "optionD": "D. Projection",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The defense mechanism used is&nbsp;<strong>sublimation.</strong></p>\n<p>Sublimation is a <strong>mature</strong> defense mechanism. It means to gratify an impulse by changing the end goal from a <strong>socially objectionable</strong> one to a <strong>socially valued one</strong>. Sublimation of <strong>aggressive impulses</strong> generally takes place through <strong>games </strong>or<strong> sports</strong>. Sublimation allows instincts to be channeled and not dammed up or diverted. Hence, in sublimation, feelings are acknowledged, modified, and directed toward a socially valued/acceptable goal so that modest instinctual satisfaction is achieved.&nbsp;In the given scenario, the man sublimates his urge to physically harm his boss (socially objectionable) by taking up badminton (socially valued).</p>\n<p>Other options:</p>\n<p>Option B: <strong>Altruism</strong> is a <strong>mature</strong> defense mechanism. In altruistic defense, the person gratifies an impulse by providing service or help to others even though it can be detrimental to the person itself.&nbsp;Example: An alcoholic funding a rehabilitation center even though he may be poor.</p>\n<p>Option C: <strong>Displacement</strong> is a <strong>neurotic</strong> defense mechanism. In displacement, the person carries out purposeful, unconscious shifting of impulses from one object or person to another. Although the object is changed, the <strong>instinctual</strong> <strong>nature</strong> of the impulse and its aim <strong>remain</strong> <strong>unchanged</strong> and this differentiates it from sublimation where the end goal is changed to a socially acceptable one. Example: A person may be angry towards their boss for reprimanding him and wants to abuse his boss by using foul language. Here, the person displaces his anger by being rude and using foul language to his parents at home.&nbsp;<br><br>Option D: <strong>Projection</strong> is an <strong>immature</strong> defense mechanism. On a nonpsychotic level, projection involves attributing one's own unacknowledged feelings to others. At higher levels, it may include misinterpreting motives, attitudes, feelings, or intentions of others.<br>Example: A man wishes to cheat on his wife, instead he says that he is sure his wife is cheating on him. Here, he is projecting his own unacknowledged feelings on his wife.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0351: Defense mechanisms</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Narcissistic-psychotic defenses</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Denial</strong>:&nbsp;Used to avoid becoming aware of some painful aspects of reality.</span></p>\n<ul>\n<li><span>Eg: I know I do not have cancer.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Distortion</strong>:&nbsp;Grossly reshaping the experience of external reality to suit inner needs.</span></p>\n<ul>\n<li><span>Eg: I possess special powers and abilities and am superior to others.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Projection</strong> (psychotic):&nbsp;Attributing your own wishes, thoughts, or feelings onto someone else.</span></p>\n<ul>\n<li><span>Eg: I’m sure my wife is cheating on me.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Splitting</strong>:&nbsp;External objects are divided into all good or all bad.</span></p>\n<ul>\n<li><span>Eg: The morning staff is perfect, the evening staff is terrible.</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Immature defenses</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Acting out</strong>: Behavioral or emotional outburst.</span></p>\n<ul>\n<li><span>Eg: My 10-year-old started getting into trouble right after his mother and I got divorced.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Blocking</strong>:&nbsp;Temporary block in thinking.</span></p>\n<ul>\n<li><span>Eg: I have known him for years but can never seem to remember his name.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hypochondriasis</strong>:&nbsp;A defense style in which people say that no one understands their pain.</span></p>\n<ul>\n<li><span>Eg:&nbsp;No one understands the depth of my pain.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Introjection</strong>:&nbsp;Features of the external world are taken and made part of the self.</span></p>\n<ul>\n<li><span>Eg: The resident physician dresses like the attending whom he admires.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Passive-aggressive behavior</strong>: Aggressive intent is cloaked by a passive method.</span></p>\n<ul>\n<li><span>Eg: Procrastinating at work for not getting the promotion.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Projection (non-psychotic)</strong>: Unwanted feelings are displaced onto another person.</span></p>\n<ul>\n<li><span>Eg: A man who has been unfaithful to his wife but accuses his wife of cheating on him.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Regression</strong>:&nbsp;Return to an earlier stage of development, most immature.</span></p>\n<ul>\n<li><span>Eg: Ever since my divorce, my 5-year-old has begun to wet the bed.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Schizoid fantasy</strong>:&nbsp;Tendency to retreat into fantasy in order to resolve inner and outer conflicts.</span></p>\n<ul>\n<li><span>Eg: Adolescents day dreaming on pornographic materials.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Somatization</strong>:&nbsp;Psychic derivatives are converted into bodily symptoms.</span></p>\n<ul>\n<li><span>Eg: Just thinking of the exam I get butterflies in my stomach.</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Neurotic defenses</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Externalization</strong>:&nbsp;Perceiving one’s personality, impulses, moods and attitudes in the external world.</span></p>\n<ul>\n<li><span>Eg: An argumentative&nbsp;person perceives the doctor as argumentative whilst believing himself to be blameless.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Displacement</strong>: Shifting emotions about one object/ individual onto another object/ individual.</span></p>\n<ul>\n<li><span>Eg: Getting angry at your parents because you had a bad day at work.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Inhibition</strong>:&nbsp;conscious or unconscious constraint of a process or behavior.</span></p>\n<ul>\n<li><span>Eg: A&nbsp;desire to eat dessert versus the desire to lose weight.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Intellectualization</strong>:&nbsp;Excessive use of intellectual processes to avoid affective expression or experience.</span></p>\n<ul>\n<li><span>Eg: It is interesting to note the specific skin lesions which seem to arise as a consequence of my end-stage disease.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Isolation</strong>:&nbsp;Separation of an idea from the affect that accompanies it.</span></p>\n<ul>\n<li><span>Eg: As she arrived at the station to identify the body, she appeared to show no emotion.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Rationalization</strong>:&nbsp;Rational explanations are used to justify unacceptable attitudes, beliefs, or behaviors.</span></p>\n<ul>\n<li><span>Eg: I did not pass the test because it was harder this year than ever before.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Reaction formation</strong>:&nbsp;An unacceptable impulse is transformed into its opposite; results in the formation of character traits.</span></p>\n<ul>\n<li><span>Eg: Listen to him tell his family he was not afraid&nbsp;when I saw him crying.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Repression</strong>:&nbsp;An idea or feeling is withheld from consciousness; unconscious forgetting.</span></p>\n<ul>\n<li><span>Eg: I do not remember having had a dog.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sexualization</strong>:&nbsp;Endowing an object or function with sexual significance.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Undoing</strong>: Acting out the reverse of unacceptable behavior; consists of an act.</span></p>\n<ul>\n<li><span>Eg: I need to wash my hands whenever I have these thoughts.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Retroflexion</strong>: Self-destruction due to rage.</span></p>\n<ul>\n<li><span>Eg: A person cutting his wrist because he is angry with himself.</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Mature defenses</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Altruism</strong>: Getting pleasure from giving to others what the individual would have liked to receive.</span></p>\n<ul>\n<li><span>Eg:&nbsp;&nbsp;A former alcoholic funding a rehabilitation center.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Anticipation</strong>:&nbsp;Realistically planning or anticipating future inner discomfort.</span></p>\n<ul>\n<li><span>Eg:&nbsp;Moderate amount of anxiety before surgery.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Asceticism</strong>: Gratification derived from renunciation.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Humor</strong>:&nbsp;Permits the expression of feelings and thoughts without personal discomfort.</span></p>\n<ul>\n<li><span>Eg: Before execution, firing squad leader offers the man a cigarette. He replies \"no thanks I'm trying to quit\".</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sublimation</strong>:&nbsp;Impulse gratification has been achieved, but the aim or object has been changed from unacceptable to acceptable; allows instincts to be channeled. Most mature of the defenses.</span></p>\n<ul>\n<li><span>Eg: Jack the Ripper becomes a surgeon.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Suppression</strong>:&nbsp;Conscious forgetting. The&nbsp;only conscious defense mechanism.</span></p>\n<ul>\n<li><span>Eg: I would rather talk about my operation after the party is over.</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Psychiatry"
  },
  {
    "web-scraper-order": "1727319149-85",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6808",
    "stauts": "Correct",
    "question_title": "85.\n        A woman who was in the ICU on an invasive manual ventilator showed the following finding. She was having intermittent seizures. Which among the following can cause this?",
    "question_ADD": "<ol>\n<li>Air leaks from the ET tube.&nbsp;</li>\n<li>Increased drip rate of fentanyl.</li>\n<li>Increased respiratory rate in the ventilator.</li>\n<li>Putting her on assist control ventilation.</li>\n<li>Inadequate suction of ET tube.</li>\n</ol>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/b93b4e71448942628de0c4412286fc4e.JPEG\">",
    "optionA": "A. only 3",
    "optionB": "B. 2,5",
    "optionC": "C. 1,2,4",
    "optionD": "D. 3,4\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correct answer is 3,4. The given image shows <strong>carpopedal spasm</strong>, which in this case is due to<strong> respiratory alkalosis</strong> leading to <strong>hypocalcemia</strong>. Respiratory alkalosis occurs due to hyperventilation, which in this case may be due to <strong>high respiratory rate aided by the ventilator</strong> or <strong>assist control ventilation</strong>.</p>\n<p>Due to the <strong>hyperventilation</strong>, there is respiratory alkalosis leading to <strong>hypocalcemia</strong> due to the <strong>increased calcium-albumin binding.&nbsp;</strong></p>\n<p>The ionised calcium concentration is affected by multiple factors. <strong>Alkalosis</strong> is due to a <strong>decreased</strong> <strong>hydrogen</strong> <strong>ion</strong> concentration in the blood. In <strong>alkalosis</strong>, due to <strong>less H+</strong> in blood, the H+ bound to albumin is released, and in its place, more calcium binds to albumin. Thus, <strong>ionised</strong> <strong>calcium</strong> <strong>levels</strong> drop and hypocalcemia develops. The opposite occurs in acidosis.&nbsp;</p>\n<p>Of the total calcium in the blood, about 40% is bound to albumin, and 10% is complex to anions. The remaining 50% remains unbound and is known as ionised calcium. It is the only form that is physiologically active. A decrease in the ionised calcium concentration results in hypocalcemia. It presents with hyperreflexia, muscle cramps and twitching, numbness and tingling, and Chvostek’s and Trousseau’s signs.</p>\n<p>Statement 1 (air leak from the ET tube), 2 (opioid (fentanyl) overdose) and 5 (inadequate suction of the ET tube) can lead to decreased ventilation.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-86",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1930",
    "stauts": "Correct",
    "question_title": "86.\n        An echocardiography in a young man shows septal anterior motion of the mitral valve leaflet. Which of the following maneuvers will affect the murmur of this condition in a way similar to phase II of the maneuver shown in the given tracing?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/928c623b71cb48f4bd39e8a8280f8c42.JPEG\">",
    "optionA": "A. Squatting position",
    "optionB": "B. Handgrip",
    "optionC": "C. Passive leg raising",
    "optionD": "D. Standing up from supine\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given investigation findings in a <strong>young adult male</strong> are suggestive of a diagnosis of <strong>hypertrophic cardiomyopathy (HCM)</strong>. <strong>Phase II</strong>&nbsp;of the tracing shown in the image above is of the <strong>strain phase of the Valsalva maneuver</strong>, which <strong>accentuates the systolic murmur of HCM</strong>, and this effect can <strong>also</strong> be produced by <strong>standing up from a supine position.</strong></p>\n<p>The <strong>murmur of HCM </strong>is an <strong>ejection systolic murmur</strong> best heard at the <strong>lower left sternal border.&nbsp;</strong></p>\n<p>The <strong>intensity </strong>of the mid-systolic murmur is&nbsp;</p>\n<ul>\n<li><strong>Increased by</strong> -<strong>Valsalva</strong> strain phase, <strong>Standing</strong> posture, and exercise</li>\n<li><strong>Decreased by</strong> - <strong>Squatting</strong>, passive <strong>leg raising</strong> and <strong>handgrip</strong></li>\n</ul>\n<p>Patients with HCM have a <strong>dynamic left ventricular outflow tract (LVOT) obstruction </strong>due to<strong> septal hypertrophy </strong>and <strong>systolic anterior motion of the mitral valve leaflet (SAM)</strong>. SAM leads to <strong>mitral regurgitation </strong>with the jet directed posteriorly. It is characterized by <strong>misalignment of the enlarged myofibrils and myocytes.</strong></p>\n<p>The image below shows a <strong>cross-section of a heart </strong>with hypertrophic cardiomyopathy. When the left ventricular size is small, the <strong>approximation </strong>of the<strong> interventricular septum with the mitral valve increases</strong>. This increases the <strong>obstruction to the outflow of blood</strong> and<strong> increases the intensity of the murmur. </strong>The <strong>ventricular cavity </strong>is <strong>banana-shaped</strong> in HCM as <strong>seen on echocardiography</strong>. The other characteristic clinical feature is <strong>pulsus bisferiens.</strong></p>\n<p>Management: <strong>Beta-blockers </strong>and <strong>calcium channel blockers</strong> are the first-line treatment to reduce the severity of the obstruction. The medical or procedural interventions do not reduce the risk of sudden death, an <strong>implantable cardioverter-defibrillator(ICD)</strong> is advised.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6b37139f98954997b41211f568bd1071x600x1208.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Valsalva maneuver</strong> involves the performance of <strong>forced expiration against a closed glottis</strong>. It occurs during <strong>coughing, defecation,</strong> and <strong>heavy lifting</strong>. At the <strong>onset of straining</strong>, the <strong>blood pressure is raised</strong> because the <strong>increase in intrathoracic pressure </strong>is added to the <strong>pressure of the blood in the aorta.</strong> The <strong>pressure then falls</strong> as the <strong>high intrathoracic pressure compresses the veins</strong> and <strong>decreases the cardiac output.&nbsp;</strong></p>\n<p>There are <strong>4 phases</strong> in the Valsalva maneuver.&nbsp;</p>\n<p>Phase <strong>I</strong>- There is a <strong>transient increase in the cardiac output </strong>due to an<strong> increase in the intrathoracic pressure.</strong><br>Phase <strong>II</strong>- The <strong>increased pressure compresses the veins</strong> resulting in <strong>decreased venous return and the stroke volume.</strong><br>Phase <strong>III</strong>- There is a <strong>further reduction in left ventricular volume</strong> due to the <strong>expansion of the pulmonary vascular bed.</strong><br>Phase <strong>IV</strong>- <strong>Resumption of normal venous return</strong> to the heart <strong>stimulated by the sympathetic nervous system.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/892037b610384f579724fb517d2d287b.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0653: Dynamic auscultation of murmurs</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(↑venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>↑ intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(↑afterload )</p>\n</td>\n<td>\n<ul>\n<li>↑ intensity of MR, AR, and VSD murmurs</li>\n<li>↓ hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(↓ preload)</p>\n</td>\n<td>\n<ul>\n<li>↓ intensity of most murmurs (including AS)</li>\n<li>↑&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(↑venous return,↑preload,<br>↑ afterload)</p>\n</td>\n<td>\n<ul>\n<li>↓intensity of hypertrophic cardiomyopathy murmur</li>\n<li>↑&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1981: One-liners on Hypertrophic Cardiomyopathy (HCM)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>Autosomal dominant</li>\n<li>Missense mutation</li>\n<li>Most common mutation: Beta-chain of myosin</li>\n<li>Myofibre disarray on histology</li>\n<li>Asymmetric septal hypertrophy</li>\n<li>Diastolic dysfunction</li>\n<li>Systolic function normal</li>\n<li>On Echocardiography:\n<ol>\n<li>Left ventricular wall thickness &gt;15 mm</li>\n<li>Systolic anterior motion of left leaflet</li>\n<li>Banana shaped left ventricle</li>\n</ol>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-87",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3454",
    "stauts": "Incorrect",
    "question_title": "87.\n        The most common cause of first-trimester aneuploid chromosomal abortion is ______",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Monosomy X (45, X)",
    "optionB": "B. Triploidy\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Autosomal trisomy\n                \n                  \n                    \nCorrect",
    "optionD": "D. Tetraploidy",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Autosomal trisomy is the most common cause of first-trimester aneuploid chromosomal abortion.</p>\n<p><strong>Autosomal</strong> <strong>trisomy</strong> is the most common (50%) cytogenetic abnormality overall. The most common trisomy involved is Trisomy 16.</p>\n<p><strong>Monosomy</strong> <strong>X</strong> is the single most common specific chromosomal abnormality in miscarriages.</p>\n<p>Concerning first-trimester abortions, half of the miscarriages are anembryonic (no embryonic elements) and the other <strong>half are embryonic miscarriages</strong> (developmental abnormality of the zygote, embryo, or fetus).<br>Out of embryonic miscarriage, <strong>half of these are aneuploid abortions</strong> (have chromosomal anomalies) and the remaining half are euploid abortions (carrying a normal chromosomal complement).</p>\n<p>The percentages of Aneuploid abortions concerning all embryonic abortions</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>Autosomal trisomy &nbsp;</td>\n<td>Three copies of a particular chromosome, instead of two</td>\n<td>22 - 32%</td>\n</tr>\n<tr>\n<td>Monosomy X (45, X)&nbsp;</td>\n<td>Only one copy of a particular chromosome is present</td>\n<td>5 - 20%</td>\n</tr>\n<tr>\n<td>Triploidy</td>\n<td>69 chromosomes are present instead of 46 (3 sets of all chromosomes)</td>\n<td>6 - 8%</td>\n</tr>\n<tr>\n<td>Tetraploidy</td>\n<td>92 chromosomes are present instead of 46 (4 sets of all chromosomes)</td>\n<td>2 - 4%</td>\n</tr>\n<tr>\n<td>Structural anomaly&nbsp;</td>\n<td>-</td>\n<td>2%</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-88",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3524",
    "stauts": "Skipped",
    "question_title": "88.\n        A 72-year-old woman presented with fatigue and unrelenting severe bone discomfort. She currently resides in an old age home and has minimal exposure to sunlight. Serum 25-hydroxyvitamin D was 11 ng/ml. What is the therapeutic dosage of vitamin D to be started in this woman?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 5,000 IU/week",
    "optionB": "B. 10,000 IU/week",
    "optionC": "C. 50,000 IU/week\n                \n                  \n                    \nCorrect",
    "optionD": "D. 100,000 IU/week",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>therapeutic dosage </strong>of vitamin D deficiency is <strong>50,000 IU/week for 6-8 weeks.</strong> This is followed by a <strong>maintenance dose</strong> of <strong>800 IU/day </strong>from food and supplements once normal plasma levels have been attained.</p>\n<p>Vitamin D <strong>deficiency</strong> is 25 hydroxy vit D <strong>&lt;12 ng/ml.</strong><br>Vitamin D <strong>insufficiency</strong> is 25 hydroxy vit D <strong>12-20 ng/ml.</strong></p>\n<p>In adults, the risk factors for vitamin D deficiency are old age, lack of sun exposure, dark skin, fat malabsorption and obesity. It presents as osteomalacia with muscle soreness, weakness, bone pain and increased risk of fractures due to decreased bone density.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-89",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2205",
    "stauts": "Correct",
    "question_title": "89.\n         A 34-year-old primigravida with myasthenia gravis is admitted for preeclampsia with severe features. Which of the following medications should be avoided in this patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Magnesium Sulfate \n                \n                  \n                    \nCorrect",
    "optionB": "B. Hydralazine",
    "optionC": "C. Oxytocin",
    "optionD": "D. Nitroprusside",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Among the following medications, <strong>magnesium sulfate</strong> should be <strong>avoided</strong> in this patient, who has a history of <strong>myasthenia gravis</strong>, now admitted for <strong>preeclampsia</strong> with severe features.</p>\n<p><strong>Management</strong> of <strong>preeclampsia</strong> in <strong>myasthenia gravis</strong> patients involves careful medication choices and monitoring. While myasthenia gravis itself <strong>does not</strong> severely affect <strong>pregnancy outcomes</strong>, <strong>magnesium sulfate</strong> used for preeclampsia can <strong>trigger</strong> a <strong>myasthenic crisis</strong> (eg, oropharyngeal muscle weakness,<strong> respiratory failure </strong>requiring intubation) due to <strong>inhibition </strong>of <strong>acetylcholine release </strong>at the neuromuscular junction. <strong>Phenytoin</strong> is preferred for <strong>seizure prophylaxis </strong>in these patients due to its lower risk of complications compared to other drugs. <strong>Labour</strong> is generally <strong>unaffected</strong>, with <strong>oxytocin</strong> used as needed and cesarean delivery reserved for obstetric reasons. <strong>Narcotics</strong> should be used <strong>cautiously</strong> to <strong>avoid respiratory depression</strong>, and curariform drugs, including magnesium sulfate and muscle relaxants, should be avoided. Some patients may require <strong>operative vaginal delivery</strong> if they have impaired expulsive efforts during the second stage of labour.</p>\n<p>Drugs that may aggravate myasthenia gravis are:</p>\n<ul>\n<li>Antibiotics like aminoglycosides, quinolones, and macrolides</li>\n<li>Beta-blockers</li>\n<li>Botulinum toxin</li>\n<li>Local anesthetics</li>\n<li><strong>Magnesium</strong></li>\n<li>Non–depolarising muscle relaxants</li>\n<li>Penicillamine</li>\n<li>Quinine derivatives</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: <strong>Hydralazine</strong> is a vasodilator<strong> used in the treatment of heart failure</strong>, and <strong>hypertensive</strong> <strong>emergencies</strong>, especially <strong>preeclampsia</strong>.&nbsp;<strong>Hydralazine</strong>, unlike beta-blockers, is <strong>not contraindicated</strong> in myasthenia gravis.</p>\n<p>Option C: Myasthenia gravis is <strong>not a contraindication to oxytocin use.</strong></p>\n<p>Option D: <strong>Nitroprusside</strong> is reserved for <strong>refractory hypertensive emergencies</strong> in <strong>pregnancy.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-90",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD1873",
    "stauts": "Skipped",
    "question_title": "90.\n        Which among the following sentences about collagen is false?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Collagen has a triple helical structure, forming a right-handed superhelix",
    "optionB": "B. Proline and hydroxyproline confer rigidity to collagen",
    "optionC": "C. Enzyme lysyl oxidase is defective in Menkes disease which contains copper as a cofactor",
    "optionD": "D. Marfan syndrome is due to mutation in gene encoding collagen\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Among the following sentences about collagen, the false statement is (option D). <strong>Marfan syndrome</strong> is due to a mutation in the gene encoding <strong>fibrillin-1</strong> (not collagen).</p>\n<p>Collagen is the most abundant protein in the animal world. It has a <strong>triple helica</strong>l structure, forming a <strong>right-handed superhelix</strong>. A striking characteristic of collagen is the occurrence of <strong>glycine residues</strong> at <strong>every third position.</strong></p>\n<p><strong>Proline </strong>and<strong> hydroxyproline</strong> confer<strong> rigidity</strong> on the collagen molecule. Hydroxyproline and hydroxylysine are formed by the <strong>post-translational hydroxylation</strong> of proline and lysine residues catalyzed by the enzyme prolyl and lysyl hydroxylase, whose cofactors are<strong> ascorbic acid (vitamin C) and α-ketoglutarate.</strong></p>\n<p>Collagen is arranged in a <strong>quarter-staggered arrangemen</strong>t and further stabilized by covalent cross-links.</p>\n<p><strong>Menke disease </strong>is a <strong>progressive neurodegenerative</strong> condition with an<strong> X-linked recessive </strong>pattern of inheritance. It's caused by a <strong>defect</strong> in the<strong> ATP7A gene</strong>, leading to <strong>impaired intestinal copper absorption </strong>and <strong>transport, </strong>resulting in<strong> low serum copper </strong>and <strong>ceruloplasmin levels</strong>. This affects the <strong>cross-linking </strong>o<strong>f collagen </strong>by<strong> lysyl oxidase</strong>, which requires<strong> copper </strong>as a <strong>cofactor</strong>, leading to <strong>defective connective tissue formation.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2306: Synthesis of collagen and its disorders</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table width=\"291\">\n<tbody>\n<tr>\n<td>1. Collagen backbone</td>\n<td>Preprocollagen - Glycin-proline-lysine</td>\n</tr>\n<tr>\n<td>2. Hydroxylation</td>\n<td>\n<p>Of proline and lysine in the presence of Vit C.</p>\n<p>Deficiency of Vit C causes <strong>Scurvy.</strong></p>\n</td>\n</tr>\n<tr>\n<td>3. Glycosylation</td>\n<td>Formation of procollagen and resulting triple helix</td>\n</tr>\n<tr>\n<td>4. Cleavage of terminals of procollagen</td>\n<td>Resulting in the formation of tropocollagen</td>\n</tr>\n<tr>\n<td>5. Cross-linking by lysyl oxidase (copper-containing enzyme)</td>\n<td>\n<p>Formation of mature collagen.</p>\n<p>Defect causes <strong>Menkes disease</strong> and <strong>Ehlers-Danlos syndrome</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-91",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0988",
    "stauts": "Incorrect",
    "question_title": "91.\n        A 24-year-old woman was diagnosed with focal seizures and was prescribed ezogabine. What is the mechanism of action of this drug?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Potassium channel opener\n                \n                  \n                    \nCorrect",
    "optionB": "B. GABA transaminase inhibitor",
    "optionC": "C. T- type calcium channel blocker\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. GABA transporter inhibitor",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Ezogabine </strong>is a <strong>potassium channel opener.</strong></p>\n<p><strong>Ezogabine</strong> (retigabine) acts by <strong>opening</strong> <strong>neuronal</strong> <strong>potassium channels</strong>. By opening the K<sup>+</sup> channels, it stabilizes the resting membrane potential and reduces the excitability of the nerve membrane.</p>\n<p>It is used as an adjunctive treatment for focal seizures.</p>\n<p>Serious side effects associated with long-term therapy include <strong>retinal abnormalities</strong> causing visual defects, skin discoloration, QT prolongation, and neuropsychiatric symptoms.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Vigabatrin</strong> irreversibly <strong>inhibits&nbsp;GABA transaminase</strong>, which degrades GABA. Thereby, resulting in increased levels of extracellular GABA at its receptor and enhanced inhibitory GABAergic transmission.</p>\n<p>It is indicated in <strong>refractory focal seizures</strong> with impaired awareness and<strong> infantile spasms&nbsp;</strong>in tuberous sclerosis. Vigabatrin is associated with progressive and permanent bilateral <strong>visual loss.</strong></p>\n<p>Option C: <strong>Ethosuximide inhibits </strong>the <strong>T-type calcium currents</strong> in thalamic neurons. It is the first-line agent for the treatment of generalized <strong>absence seizures.</strong></p>\n<p>Option D:&nbsp;<strong>Tiagabine inhibits</strong> the <strong>GABA transporter GAT-1</strong> and thereby reduces&nbsp;GABA uptake into neurons and glia and prolongs the action of&nbsp;GABA in the synapse. It is also used an adjunct therapy for <strong>focal seizures.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2484: Mechanism of action of common anti-epileptics</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1695: First-line Agents in Different Types of Seizures</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0092: Types of calcium channels and their blockers</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Type&nbsp;of Calcium Channel</strong></td>\n<td><strong>Blockers</strong></td>\n</tr>\n<tr>\n<td>L type</td>\n<td>Verapamil, diltiazem, dihydropyridines</td>\n</tr>\n<tr>\n<td>T type</td>\n<td>Flunarizine, ethosuximide, mibefradil</td>\n</tr>\n<tr>\n<td>N type</td>\n<td>Gabapentin, ziconotide</td>\n</tr>\n<tr>\n<td>P/Q type</td>\n<td>Omega agatoxin IVa</td>\n</tr>\n<tr>\n<td>R type</td>\n<td>SNX-482, Omega agatoxin IIIa</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-92",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8896",
    "stauts": "Skipped",
    "question_title": "92.\n        Match the following vitamins with their assay/test:",
    "question_ADD": "<table style=\"height: 201.586px; width: 405px;\">\n<tbody>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 161px; height: 22.3984px;\">Column A - Vitamins</td>\n<td style=\"width: 232px; height: 22.3984px;\">Column B</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 161px; height: 22.3984px;\">1. Vitamin B9</td>\n<td style=\"width: 232px; height: 22.3984px;\">A. RBC Trans-ketolase</td>\n</tr>\n<tr style=\"height: 44.7969px;\">\n<td style=\"width: 161px; height: 44.7969px;\">2. Vitamin B2</td>\n<td style=\"width: 232px; height: 44.7969px;\">B. Serum methyl malonate level</td>\n</tr>\n<tr style=\"height: 44.7969px;\">\n<td style=\"width: 161px; height: 44.7969px;\">3. Vitamin B6</td>\n<td style=\"width: 232px; height: 44.7969px;\">C. FIGLU excretion/Histidine load test</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 161px; height: 22.3984px;\">4. Vitamin B12</td>\n<td style=\"width: 232px; height: 22.3984px;\">D. RBC transaminase</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 161px; height: 22.3984px;\">&nbsp;</td>\n<td style=\"width: 232px; height: 22.3984px;\">E. RBC glutathione reductase</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 161px; height: 22.3984px;\">&nbsp;</td>\n<td style=\"width: 232px; height: 22.3984px;\">&nbsp;</td>\n</tr>\n</tbody>\n</table>",
    "question_imag": "",
    "optionA": "A. 1-A, 2-B, 3-C, 4-D",
    "optionB": "B. 1-B, 2-E, 3-C, 4-A",
    "optionC": "C. 1-C, 2-E, 3-D, 4-B\n                \n                  \n                    \nCorrect",
    "optionD": "D. 1-C, 2-D, 3-E, 4-B",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched option is <strong>option c (1-C, 2-E, 3-D, 4-B).</strong></p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>Vitamins</td>\n<td>Assay/tests</td>\n</tr>\n<tr>\n<td>Vitamin B9</td>\n<td>FIGLU excretion/Histidine load test</td>\n</tr>\n<tr>\n<td>Vitamin B2</td>\n<td>RBC glutathione reductase</td>\n</tr>\n<tr>\n<td>Vitamin B6</td>\n<td>RBC transaminase</td>\n</tr>\n<tr>\n<td>Vitamin B12</td>\n<td>Serum methyl malonate level</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1153: Biochemical Assay for Vitamin Deficiency State</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td width=\"308\">\n<p><strong>Vitamin</strong></p>\n</td>\n<td width=\"308\">\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td width=\"308\">\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td width=\"308\">\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td width=\"308\">\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td width=\"308\">\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td width=\"308\">\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td width=\"308\">\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-93",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD4912",
    "stauts": "Correct",
    "question_title": "93.\n        A 4-year-old stunted boy presented with fever cough, cold, and conjunctivitis and developed pneumonia after a few days. The characteristic cells of this type of pneumonia are shown in the given slide. This child has____",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/9f00e25431234c1e9c9a1e6b4dba8dba.JPEG\">",
    "optionA": "A. Streptococcal pneumonia",
    "optionB": "B. Hecht's pneumonia\n                \n                  \n                    \nCorrect",
    "optionC": "C. Staphylococcal pneumonia",
    "optionD": "D. Atypical pneumonia",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong><span>Giant cells&nbsp;</span></strong><span>shown in the image are seen in</span><strong><span>&nbsp;Hecht's pneumonia</span></strong><span>, also known as&nbsp;</span><strong><span>giant cell pneumonia.&nbsp;</span></strong><span>&nbsp;It is a fatal but rare complication of&nbsp;</span><strong><span>measles</span></strong><span>, which is seen in children with immunodeficiency or severe malnutrition.&nbsp;</span></p>\n<p><span>The postmortem examination (autopsy) shows&nbsp;</span><strong><span>multinucleated giant cells or Warthin–Finkeldey giant cells</span></strong><span>&nbsp;lining the alveoli (air sacs) of the lungs.</span></p>\n<p><strong><span>Measles (Rubeola) </span></strong><span>is caused by</span><span> an RNA paramyxovirus. It spreads via <strong>d</strong></span><span><strong>roplets</strong>.&nbsp;</span><span>The incubation period is <strong>8–12</strong></span><span>&nbsp;days and the </span><strong>secondary attack rate </strong>is<strong> ≥90%. </strong></p>\n<p><span>The p</span><span>eriod of communicability is -3 to +5 days after the appearance of the rash. </span><span>The <strong>prodrome phase</strong> begins with mild fever, conjunctivitis, and upper respiratory tract infection. </span><span>The <strong>rash appears on 4th day of fever</strong>, most common sites are the face and retro auricular area.</span></p>\n<p><strong><span>Koplik spots</span></strong><span>&nbsp;and&nbsp;</span><strong><span>Warthin-Finkeldey giant cells</span></strong><span> are pathognomonic for measles. </span><span>The most common cause of death is pneumonia.</span></p>\n<p><span>Other complications are subacute sclerosing panencephalitis, multiple sclerosis, and Crohn's disease.</span></p>\n<p><span>It is a vaccine preventable infection. The vaccine is live-attenuated (</span><strong><span>Edmonston–Zagreb)</span></strong><span> strain or combined MMR given at 9 months of age.</span></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-94",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0196",
    "stauts": "Incorrect",
    "question_title": "94.\n        A patient presents to the OPD with complaints of fatigue and shortness of breath. The laboratory investigations are given below. Which of the following is used in the management of this condition?",
    "question_ADD": "<ul>\n<li>Hemoglobin - Reduced</li>\n<li>Serum ferritin - Raised</li>\n<li>Serum iron - Raised</li>\n<li>Total iron-binding capacity (TIBC) - Normal&nbsp;</li>\n<li>Hemoglobin electrophoresis - Normal</li>\n</ul>",
    "question_imag": "",
    "optionA": "A. Iron supplementation",
    "optionB": "B. Bone marrow transplantation",
    "optionC": "C. Pyridoxine supplemenation\n                \n                  \n                    \nCorrect",
    "optionD": "D. Folate supplementation\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given clinical scenario, laboratory investigations reveal <strong>raised iron</strong> and <strong>ferritin</strong> with <strong>normal TIBC</strong> and <strong>hemoglobin electrophoresis</strong> point toward the diagnosis of <strong>sideroblastic anemia. Vitamin B6&nbsp;</strong>is used in the management.</p>\n<p>Raised iron levels rule out iron deficiency anemia and anemia of chronic disease. Normal hemoglobin electrophoresis rules out thalassemia. Hence the most probable diagnosis in this case is sideroblastic anemia.</p>\n<p><strong>Laboratory findings in sideroblastic anemia:</strong></p>\n<ul>\n<li>Peripheral smear:&nbsp;<strong>Hypochromic</strong>,&nbsp;<strong>microcytic</strong> (sometimes normocytic) anemia</li>\n<li>Absolute values:&nbsp;<strong>MCV, and MCH are</strong><strong>&nbsp;reduced</strong> and <strong>RDW</strong> is <strong>increased</strong></li>\n<li>Bone marrow: <strong>Ring sideroblasts</strong>&nbsp;are present.</li>\n<li>Serum ferritin:&nbsp;<strong>Raised</strong></li>\n<li>Serum iron:&nbsp;<strong>Raised</strong></li>\n<li>TIBC:&nbsp;<strong>Normal</strong></li>\n<li>Haemoglobin electrophoresis:&nbsp;<strong>Normal</strong></li>\n</ul>\n<p><strong>Iron studies&nbsp;</strong></p>\n<ul>\n<li><strong>Serum iron</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 791\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The serum iron level represents the amount of <strong>circulating iron</strong> bound to transferrin.<br><span>Normal range</span><strong>: </strong><span>50–150 μg/dL</span></p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong><span>Ferritin</span></strong></li>\n</ul>\n<p><span>As free <strong>iron</strong> is toxic to cells it is <strong>stored</strong> in the form of <strong>ferritin. Apoferritin binds</strong> to free ferrous <strong>iron</strong> and stores it in a ferric state.&nbsp;<br>Normal values- Adult Males: 100 </span><span>μg/L and adult females: </span><span>30 μg/L</span></p>\n<ul>\n<li><strong><span>Transferrin saturation</span></strong></li>\n</ul>\n<p><span>Transferrin saturation is calculated with the following formula= <strong>serum iron</strong> <strong>x 100/TIBC</strong><br>Normal range: </span><span>25–50%</span></p>\n<ul>\n<li><strong><span>Total iron binding capacity</span></strong></li>\n</ul>\n<p><span>Iron binding capacity is the <strong>capacity of transferrin</strong> to <strong>bind</strong> with <strong>iron.</strong> Iron binding capacity is of two types, TIBC and unsaturated iron-binding capacity <strong>(UIBC).</strong> When <strong>iron</strong> stores are <strong>depleted,</strong> the <strong>transferrin</strong> levels <strong>increase</strong> in the blood. As only <strong>one-third</strong> of <strong>transferrin</strong> is <strong>saturated</strong> with iron, the transferrin present in serum has an <strong>extra binding capacity</strong> (67%). <strong>This</strong> is <strong>unsaturated iron-binding</strong> capacity. <strong>TIBC</strong> is the <strong>total</strong> of <strong>serum iron</strong> and <strong>UIBC.</strong></span></p>\n<p><span>Normal range: 300–360 μg/dL.</span></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2146: Differential Diagnosis of Microcytic Anaemia</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 µg/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 µg/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table>\n<p>TIBC: Total iron-binding capacity&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1285: Morphological Classification of Anemias</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microcytic Hypochromic </strong></p>\n<p><strong>(MCV &lt;80 fl)</strong></p>\n</td>\n<td>\n<p><strong>Normocytic Normochromic &nbsp; &nbsp;</strong></p>\n<p><strong>(MCV 80 - 100 fl)</strong></p>\n</td>\n<td>\n<p><strong>Macrocytic Normochromic </strong></p>\n<p><strong>(MCV &gt;100 fl)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron deficiency anemia</p>\n<p>Sideroblastic anemia</p>\n<p>Thalassemia</p>\n<p>Lead toxicity</p>\n</td>\n<td>\n<p>Acute blood loss</p>\n<p>Anemia of chronic disease</p>\n<p>Anemia of renal disease</p>\n<p>Hemolysis*</p>\n<p>Bone marrow suppression</p>\n<ul>\n<li>Aplastic anemia</li>\n<li>Pure red cell aplasia</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;&nbsp;</p>\n</td>\n<td>\n<p><strong>Megaloblastic:</strong></p>\n<p>Vitamin B12 deficiency</p>\n<p>Folate deficiency</p>\n<p>Thiamine deficiency</p>\n<p>Drugs - Methotrexate, Zidovudine, hydroxyurea</p>\n<p>Orotic aciduria</p>\n<p>&nbsp;</p>\n<p><strong>Non-megaloblastic:</strong></p>\n<p>Alcohol use</p>\n<p>Liver disease</p>\n<p>Hypothyroidism</p>\n<p>Hemolysis*</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Hemolysis can be associated with macrocytosis because of compensatory reticulocytosis. However, MCV can be normal depending on the degree of hemolysis.</p>\n<p>Note: In Orotic Aciduria, peripheral blood smear shows Hypochromic megaloblastic anemia.&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-95",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6427",
    "stauts": "Correct",
    "question_title": "95.\n        Which of the following granuloma is seen in patients with cerebral malaria caused by plasmodium falciparum?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Dürck granuloma \n                \n                  \n                    \nCorrect",
    "optionB": "B. Doughnut granuloma",
    "optionC": "C. Stellate granuloma",
    "optionD": "D. Non caseating granuloma",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Dürck granuloma</strong> is seen in patients with <strong>cerebral malaria</strong> caused by <strong>plasmodium falciparum</strong>.&nbsp;</p>\n<p>In cerebral malaria caused by P. falciparum, brain vessels are <strong>plugged</strong> with <strong>parasitized</strong> <strong>red cells</strong>. Around the vessels, there are <strong>ring hemorrhages</strong> that are probably related to <strong>local hypoxia</strong> incident to the <strong>vascular stasis</strong> and small focal <strong>inflammatory reactions</strong> (called <strong>malarial</strong> or <strong>Dürck granulomata</strong>).</p>\n<p>The image below shows dürck granuloma seen in cerebral malaria.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/72733ada5d834170a46c8a95b6efae39x1260x924.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options :&nbsp;</p>\n<p>Option B: <strong>Fibrin ring granuloma</strong> also known as <strong>doughnut granuloma</strong>(image below)&nbsp;is seen in cases of <strong>Q fever</strong>, <strong>Hodgkin’s disease</strong>, and <strong>Infectious mononucleosis</strong>. It consists of a <strong>central lipid vacuole</strong> (which appears as a central hole since fat is washed out during fixing and staining) surrounded by a <strong>fibrin ring </strong>and <strong>epithelioid macrophages.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ec46d4453e5a4146b4001578bbe051e2x512x385.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option C: <strong>Stellate granuloma</strong> is seen as <strong>cat scratch disease</strong>, caused by <em><strong>Bartonella henselae</strong></em>. They&nbsp;are granulomas containing <strong>central granular debris</strong> and <strong>neutrophils</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c924500eb16d4674aac4a3fa6a8c9d85x1018x832.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D: <strong>Sarcoidosis</strong> shows <strong>giant cells</strong> with cytoplasmic inclusions and <strong>non-caseating granuloma</strong> with fibroblastic proliferation at the periphery. Non-caseating granuloma is also seen in <strong>leprosy</strong>, <strong>Crohn’s disease</strong>, and <strong>histoplasmosis</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ca3d8cdc4bf34070b1dafd8f29845e9fx549x636.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <!---->\n        <svg width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"ng-star-inserted\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2355: Types of granulomas</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>GRANULOMA</strong></td>\n<td><strong>SEEN IN</strong></td>\n</tr>\n<tr>\n<td>Noncaseating granuloma</td>\n<td>\n<p>Crohn’s disease</p>\n<p>Leprosy</p>\n<p>Sarcoidosis</p>\n<p>Hodgkin’s lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>Caseating granuloma</td>\n<td>\n<p>Tuberculosis</p>\n<p>Histoplasmosis</p>\n<p>Syphilis</p>\n<p>Coccidiomycosis</p>\n</td>\n</tr>\n<tr>\n<td>Foreign body granuloma</td>\n<td>\n<p>Silicosis</p>\n<p>Berylliosis</p>\n</td>\n</tr>\n<tr>\n<td>Immune granuloma</td>\n<td>\n<p>Wegener’s granulomatosis</p>\n<p>Giant cell arteritis</p>\n</td>\n</tr>\n<tr>\n<td>Durck’s granuloma</td>\n<td>Cerebral malaria</td>\n</tr>\n<tr>\n<td>Stellate granuloma</td>\n<td>Cat scratch disease</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-96",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3731",
    "stauts": "Incorrect",
    "question_title": "96.\n        A middle-aged woman, who is on the workup for infertility and menstrual irregularities underwent hysterosalpingography (HSG). What features on HSG  would have helped the doctor to make a diagnosis of genital tuberculosis?",
    "question_ADD": "<p>1- Rigid non-peristaltic pipe-like tube.<br>2- Wedge-shaped defect at the uterine isthmus.<br>3- Tobacco-pouch appearance of hydrosalpinx.<br>4- Golf club appearance in the ampullary portion of the fallopian tube.</p>",
    "question_imag": "",
    "optionA": "A. 1, 3, 4\n                \n                  \n                    \nCorrect",
    "optionB": "B. 1, 2, 3, 4\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. 2, 3, 4",
    "optionD": "D. 3 and 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Hysterosalpingography features of genital tuberculosis (<strong>tubercular salpingitis)</strong> are:</p>\n<ul>\n<li><strong>Rigid non-peristaltic pipe-like</strong> tube (<strong>Lead pipe appearance</strong>)</li>\n<li>Beading and variation in filling defect</li>\n<li><strong>Calcification</strong> of the tube</li>\n<li>Jagged fluffiness of the tubal outline</li>\n<li><strong>Tobacco-pouch appearance</strong> of hydrosalpinx and pyosalpinx</li>\n<li><strong>Golf club appearance</strong> with slight or moderate dilatation of the ampullary portion of the fallopian tube.</li>\n<li>Rosette type appearance secondary to multiple small diverticular like out pouching surrounding the ampulla produced by caseous ulceration.</li>\n</ul>\n<p>A <strong>wedge-shaped</strong> defect (Option 2) at the uterine isthmus is seen in patients with cesarean section history with a uterine scar and not in genital tuberculosis.</p>\n<p>The following image shows the tobacco pouch appearance of the fallopian tubes:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6ee0620dba954100ab574b022b9e3057x512x294.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><br>Note :&nbsp;<strong>HSG</strong>&nbsp;should <strong>not</strong> be<strong> performed&nbsp;</strong>in<strong>&nbsp;</strong>a&nbsp;<strong>suspected case of genital tuberculosis</strong>&nbsp;as it causes dissemination of the infection. This further increases the damage to the fallopian tubes.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-97",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF1580",
    "stauts": "Correct",
    "question_title": "97.\n        A 40-year-old HIV patient who presented with dry, non-productive cough and dyspnea is diagnosed to have Pneumocystis jirovecii infection. Which of the following statements is false about this organism?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Trophozoite form is thin walled",
    "optionB": "B. Cyst wall stains black with methenamine silver stain",
    "optionC": "C. It grows readily on Sabouraud agar\n                \n                  \n                    \nCorrect",
    "optionD": "D. Trimethoprim-sulfamethoxazole is used for prophylaxis in HIV patients",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Among the following statements, the false statement is that \"<em><strong>Pneumocystis jirovecii </strong></em>grows readily on Sabouraud agar\".</p>\n<p><em>P. jirovecii</em> is an <strong>extracellular pathogen</strong> that primarily resides in the <strong>lung's surfactant layer</strong>, impairing oxygen exchange and leading to symptoms like <strong>cyanosis</strong>. <strong>Diagnosis</strong> involves examining specimens from <strong>bronchoalveolar lavage</strong>, <strong>lung biopsies</strong>, or induced sputum for trophozoites and cysts using specialized stains and fluorescent microscopy. <strong>Culture methods are ineffective for diagnosis</strong>, and serological tests mainly determine infection prevalence rather than aiding clinical diagnosis. Detection of a specific <strong>surface glycoprotein</strong> in serum is indicative of <strong>acute infection</strong>.</p>\n<p><em>P. jirovecii </em>has three morphological forms:</p>\n<ul>\n<li><strong>Trophozoite - thin-walled,</strong> irregularly shaped</li>\n<li><strong>Precyst</strong> - an intermediate stage of the sexual phase</li>\n<li><strong>Cyst</strong> - thick-walled, spherical in shape. It contains intracystic bodies</li>\n</ul>\n<p>Trophozoites can be demonstrated&nbsp;by Giemsa, toluidine blue, methenamine silver, and&nbsp;calcofluor white stains. The <strong>cyst wall stains black&nbsp;</strong>with<strong> methenamine silver stain.</strong></p>\n<p><em>P. jirovecii</em> causes <strong>pneumonia</strong> primarily in <strong>immunocompromised patients.</strong> It is commonly found in animals like rats and mice without causing disease unless the host's immune system is weakened. In humans, it historically affected malnourished infants and those undergoing immunosuppressive therapies, becoming a major cause of mortality in AIDS patients before effective preventive treatments. <strong>Trimethoprim-sulfamethoxazole</strong> (TMP-SMZ) and <strong>pentamidine isothionate </strong>are the drugs of choice for the treatment of <strong>acute cases</strong>. TMP-SMZ is also used for prophylaxis in HIV patients.</p>\n<p>The silver stain of <em>P. jirovecii </em>cysts in tissue is given below.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f062a1568b64ef6b003635283f2e591x720x479.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1786: Various stains and their applications in microbiology</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>A. Simple stains: </strong>Provides color contrast but gives same color to all bacteria and cells.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Acidic stains</strong></td>\n<td>\n<p>These include<strong> eosin, acid fuchsin, rose bengal, congo red</strong>, etc.</p>\n<p>Used to stain pathological specimens</p>\n</td>\n</tr>\n<tr>\n<td><strong>Basic stains</strong>.</td>\n<td>\n<p><strong>Loeffler’s methylene blue</strong> stain is used in <strong>Quellung reaction</strong>.&nbsp;</p>\n<p><strong>Polychrome methylene blue</strong> is used in <strong>McFadyean’s</strong> <strong>reaction.</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Neutral stains</strong></td>\n<td>\n<p><strong>Wright</strong> and <strong>Giemsa stains</strong> are <strong>Romanowsky stains</strong> used to stain peripheral blood and bone marrow smears. &nbsp;</p>\n<p><strong>Giemsa stain</strong> is used for histopathological diagnosis of malaria and other protozoan blood parasites.&nbsp;&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>B. Differential stains: </strong>Imparts different colors to different bacteria. (These contain more than one stain).</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Gram stain:</strong></td>\n<td>To differentiate between <strong>gram</strong> <strong>positive</strong> (stain purple/violet) and <strong>gram</strong> <strong>negative</strong> bacteria (stain pink or red).</td>\n</tr>\n<tr>\n<td><strong>Acid-fast stain:&nbsp;</strong></td>\n<td>Used in <strong>Ziehl–Neelsen staining</strong> technique for identification of <strong>acid–fast microorganisms </strong>such as <em>M. tuberculosis</em>, <em>M. leprae</em>, and Nocardia.</td>\n</tr>\n<tr>\n<td><strong>Fluorochrome staining:</strong></td>\n<td><strong>Auramine-rhodamine</strong> is used in fluorochrome staining for screening for <strong>tuberculosis</strong>.</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>C. Special stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Staining volutin-containing organisms</strong></td>\n<td><em><strong>Corynebacterium</strong> <strong>diphtheriae</strong> </em>stained by <strong>Albert’s stain</strong>. Green colored bacilli showing \"<strong>chinese-letter\" </strong>pattern<strong>, </strong>containing bluish-black <strong>metachromatic</strong> granules of cells<strong>.</strong></td>\n</tr>\n<tr>\n<td><strong>Flagella stain</strong></td>\n<td><em><strong>Salmonella</strong> <strong>typhimurium</strong></em> stained by <strong>modified Ryu stain</strong> to show peritrichous flagella</td>\n</tr>\n<tr>\n<td><strong>Endospore stain</strong></td>\n<td>Used in <strong>Schaeffer and Fulton staining technique</strong> to stain the endospores, where the primary stain is <strong>malachite</strong> <strong>green</strong>, and the counterstain is safranin.</td>\n</tr>\n<tr>\n<td><strong>Capsule stain</strong></td>\n<td>Used in negative staining (<em><strong>Cryptococcus</strong> <strong>neoformans</strong></em>), McFadyean’s reaction,&nbsp;Polychrome methylene blue (<strong>anthrax</strong> <strong>bacilli</strong>).</td>\n</tr>\n<tr>\n<td><strong>Silver impregnation</strong></td>\n<td><strong>Fontana’s silver impregnation</strong> method used for staining <strong>treponeme</strong> and <strong>leptospire</strong>.</td>\n</tr>\n<tr>\n<td><strong>Silver staining</strong></td>\n<td>Used in <strong>Grocott’s – Gomori’s methenamine silver stain. </strong>GMS stain is used to identify <em><strong>Pneumocystis jirovecii</strong></em>, which classically appear as <strong>crushed ping-pong balls.</strong> <strong>&nbsp;</strong> Warthin–starry silver stain for spirochetes.</td>\n</tr>\n<tr>\n<td><strong>Calcofluor white staining</strong></td>\n<td>The cell walls of fungi will bind the stain <strong>calcofluor white.&nbsp;</strong>It is especially useful for the identification of<strong> mucor</strong> and the causative agents of <strong>zygomycosis</strong>.&nbsp; It is also used in staining <strong>acanthamoeba</strong></td>\n</tr>\n<tr>\n<td><strong>Chance's staining</strong></td>\n<td>For cell wall demonstration</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2302: Opportunistic Infections/HIV related conditions and ART initiation</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td>Clinical scenario</td>\n<td>Action&nbsp;</td>\n</tr>\n<tr>\n<td>Any undiagnosed active infection with fever</td>\n<td>Diagnose and treat first; start Anti-Retroviral Therapy (ART) when stable</td>\n</tr>\n<tr>\n<td>Tuberculosis (TB)</td>\n<td>Start TB treatment first; start ART as soon as possible after 2 weeks and before 2 months. For those with CD4 less than 50/cmm, start ART within 2 weeks Caution is needed for PLHIV with TB meningitis, since immediate ART is associated with more severe adverse events than initiating ART 2 months after the start of TB treatment</td>\n</tr>\n<tr>\n<td>\n<p>Pneumocystis pneumonia (PCP)</p>\n</td>\n<td>Treat PCP first; start ART when PCP treatment is completed</td>\n</tr>\n<tr>\n<td>Invasive fungal diseases: Oesophageal candidiasis, penicilliosis, histoplasmosis</td>\n<td>Start treatment for oesophageal candidiasis first; start ART as soon as the patient can swallow comfortably. Treat penicilliosis, and histoplasmosis first; start ART when the patient is stabilized or opportunistic infection treatment is completed.</td>\n</tr>\n<tr>\n<td>Cryptococcal meningitis</td>\n<td>Treat cryptococcal meningitis. ART initiation should be deferred until there is evidence of sustained clinical response to anti-fungal therapy and after 4 weeks of induction and consolidation treatment with amphotericin B containing regimen.</td>\n</tr>\n<tr>\n<td>Bacterial pneumonia</td>\n<td>Treat pneumonia first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Malaria</td>\n<td>Treat malaria first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Acute diarrhoea which may reduce absorption of ART</td>\n<td>Diagnose the cause and treat diarrhoea first; start ART when diarrhoea is stabilized or controlled</td>\n</tr>\n<tr>\n<td>Non-severe anaemia (Hb&lt; 9 g/dl)</td>\n<td>Start ART if no other causes for anaemia are found (HIV is often the cause of anaemia)&nbsp;</td>\n</tr>\n<tr>\n<td>Skin conditions such as PPE and seborrhoeic dermatitis, psoriasis, HIV-related exfoliative dermatitis</td>\n<td>Start ART (ART may resolve these problems)&nbsp;</td>\n</tr>\n<tr>\n<td>Suspected Mycobacterium Avium Complex (MAC), Cryptosporidiosis and Microsporidiosis</td>\n<td>Start ART (ART may resolve these problems)</td>\n</tr>\n<tr>\n<td>Cytomegalovirus retinitis</td>\n<td>Start treatment for CMV urgently and start ART after 2 weeks of CMV treatment&nbsp;</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>Treat toxoplasmosis; start ART after 6 weeks of treatment and when the patient is stabilized</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-98",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA7308",
    "stauts": "Incorrect",
    "question_title": "98.\n        A 25-year-old woman having lower abdominal pain and shock is diagnosed with a ruptured ectopic pregnancy. The gynecologist decides to perform an emergency laparotomy via the incision shown in the image below. Which of these structures is not incised in this approach?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/9fd19c456e1448e5989fbdbdc1515401.JPEG\">",
    "optionA": "A. Transversalis fascia",
    "optionB": "B. Extraperitoneal fat",
    "optionC": "C. Campers and Scarpa fascia\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Transversus abdominis muscle\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows a <strong>midline incision</strong> used for emergency laparotomy.&nbsp;Transversus abdominis<strong> muscle</strong> is <strong>not incised</strong> in this&nbsp;approach.</p>\n<p><strong>Layers</strong> of the abdomen <strong>pierced</strong> in the&nbsp;<strong>midline</strong>&nbsp;<strong>approach&nbsp;</strong>(from superficial to deep):</p>\n<ul>\n<li>Skin</li>\n<li>Superficial fascia (Campers and Scarpa)</li>\n<li>Linea alba</li>\n<li>Transversalis fascia</li>\n<li>Extraperitoneal fat</li>\n<li>Parietal peritoneum</li>\n</ul>\n<p>There are <strong>no muscles</strong>&nbsp;pierced in this approach.&nbsp;</p>\n<p><strong>Layers</strong> of the abdomen <strong>pierced</strong> in the&nbsp;<strong>flanks </strong>(from superficial to deep):</p>\n<ul>\n<li>Skin</li>\n<li>Superficial fascia (Campers and Scarpa)</li>\n<li>External oblique</li>\n<li>Internal oblique</li>\n<li>Transversus abdominis</li>\n<li>Transversalis fascia</li>\n<li>Extraperitoneal fat</li>\n<li>Parietal peritoneum</li>\n</ul>\n<p>These layers are shown in the image below:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2fc07da321b248f4b706e5c8f4e43affx1280x1389.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Clinical Note: <strong>Umbilical</strong> and <strong>epigastric hernias</strong> can happen<strong> due to</strong> a congenital or acquired defect in the linea alba such as a <strong>midline abdominal incision</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-99",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD7164",
    "stauts": "Incorrect",
    "question_title": "99.\n        An elderly man with schizophrenia, on typical antipsychotics for 2 years, presents with involuntary, painless orofacial movements. The psychiatrist diagnosed it as an extrapyramidal side effect. Which of the following drugs is used for the treatment of his presenting symptoms?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Propanolol",
    "optionB": "B. Dantrolene",
    "optionC": "C. Valbenazine\n                \n                  \n                    \nCorrect",
    "optionD": "D. Trihexyphenidyl\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario describes the long-term <strong>extrapyramidal side effect</strong> of a typical antipsychotic known as <strong>tardive dyskinesia</strong>. FDA approved the VMAT2 inhibitors <strong>valbenazine</strong> and deutetrabenazine for its treatment.</p>\n<p>It develops after months to years of initiation of the drug.&nbsp;<strong>Choreiform movements</strong> affect the mouth, lips, and tongue. In severe cases, trunks, limbs, and respiratory muscles may also be affected.</p>\n<p>In one-third of cases, tardive dyskinesia remits within 3 months of stopping the drug, and improvement occurs over several years.</p>\n<p>Valbenazine is metabolized by CYP3A4 and CYP2D6. Hence, it is to be used with caution with inducers or inhibitors of each. It is also avoided in <strong>hepatic impairment.</strong>&nbsp;</p>\n<p>Other options:&nbsp;</p>\n<p>Option A: <strong>Beta-blockers</strong> like propranolol are used for <strong>akathisia</strong>.</p>\n<p>Option B: <strong>Dantrolene</strong> is used for <strong>neuroleptic malignant syndrome</strong>.</p>\n<p>Option D: <strong>Trihexyphenidyl</strong> is an anticholinergic drug that is used in <strong>acute dystonia and parkinsonism</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0479: Extrapyramidal side effects of antipsychotic drugs</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Adverse reactions</strong></span></div>\n</td>\n<td>\n<div><span><strong>Time of onset</strong></span></div>\n</td>\n<td>\n<div><span><strong>Features</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Acute dystonia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>1 to 5 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Spasm of muscles of tongue, face, neck, back</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Diphenhydramine or benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Akathisia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 60 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Restlessness</span></div>\n</td>\n<td>\n<div><span><strong>Propranolol</strong>,<strong>&nbsp;</strong>lorazepam, diphenhydramine, benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Parkinsonism</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>5 to 30 days</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Bradykinesia, rigidity, tremors</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Dose reduction, change medication, antiparkinsonian agents</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Tardive dyskinesia</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Months to years</span></div>\n</td>\n<td>\n<div class=\"p1\">\n<div class=\"p1\"><span>Orofacial dyskinesia (may be reversible with early recognition and drug discontinuation)</span></div>\n</div>\n</td>\n<td>\n<div class=\"p1\"><span>VMAT-2 inhibitors <strong>valbenazine</strong> and <strong>deutetrabenazine</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Weeks to months</span></div>\n</td>\n<td>\n<div class=\"p1\"><span>Extreme rigidity, fever, unstable blood pressure</span></div>\n</td>\n<td>\n<div class=\"p1\"><span><strong>Dantrolene</strong></span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-100",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA0718",
    "stauts": "Correct",
    "question_title": "100.\n        Identify the following logo:",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/1eec73fbbc8c4e3da397b3db2d6bbdd9.PNG\">",
    "optionA": "A. Cytotoxic waste\n                \n                  \n                    \nCorrect",
    "optionB": "B. Biohazard",
    "optionC": "C. Radiation",
    "optionD": "D. Genotoxic waste",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given logo represents <strong>cytotoxic waste</strong>.&nbsp;</p>\n<p>Cytotoxic drugs and the items contaminated with cytotoxic drugs are disposed in <strong>yellow bags</strong>. They are treated by <strong>incineration</strong>, plasma pyrolysis, or encapsulation.</p>\n<p>The image given below shows the different logos used in biomedical waste management.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9d88c4e785164527b34b6ecb249fac97x1280x782.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0038: Biomedical waste disposal</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br>followed by incineration or Plazma<br>Pyrolysis or for energy recovery.<br>In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br>cultures, stocks or&nbsp;specimens of microorganisms,<br>live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br>disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br>pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br>Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br>biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br>developing liquid,<br>discarded formalin,<br>infected <strong>secretions,</strong><br><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br>disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br>liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br>Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br>(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br>encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br>Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-101",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC5907",
    "stauts": "Correct",
    "question_title": "101.\n        A five year old child present with gradually progressive hoarseness of voice for 3 months and stridor for 2 weeks. What is the most likely diagnosis?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Vocal cord nodule",
    "optionB": "B. Croup",
    "optionC": "C. Hypothyroidism",
    "optionD": "D. Respiratory papillomatosis\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;The most likely diagnosis in this case scenario is <strong>Recurrent Respiratory Papillomatosis (RRP)</strong>, also known as <strong>juvenile papillomatosis.</strong> This condition is caused by a viral infection, specifically linked to <strong>human papillomavirus (HPV) types 6 and 11</strong>.</p>\n<p>RRP primarily affects the <strong>anterior part of the glottis,</strong> with the <strong>anterior commissure </strong>and <strong>vocal fold</strong>s being the most common sites of involvement. It is more frequently observed in children under the age of 5.</p>\n<p>The exact mode of transmission for RRP is not fully understood, but there is a recognized association between<strong> maternal genital warts </strong>and the development of recurrent laryngeal papillomatosis in offspring. The primary treatment for RRP is <strong>surgical removal,</strong> typically performed using endoscopic techniques. The<strong> CO2 laser</strong> is the most commonly used tool for this procedure. However, <strong>recurrence</strong> is common in RRP, often requiring multiple surgical interventions over time. Effective management is crucial due to the potential impact on the airway and vocal function.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Vocal nodule</strong> develops <strong>after voice abuse</strong> which is unlikely here.</p>\n<p>Option B: Croup presents acutely with <strong>fever.</strong></p>\n<p>Option C: Hoarseness of voice can be seen in <strong>hypothyroidism</strong> but not stridor.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "ENT"
  },
  {
    "web-scraper-order": "1727319149-102",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MB8612",
    "stauts": "Correct",
    "question_title": "102.\n        The following appearance on ERCP is characteristic of:",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/084476ad004c49a09ff507a03e6e068c.JPEG\">",
    "optionA": "A. Mucinous cystic neoplasm",
    "optionB": "B. Serous cystic neoplasm",
    "optionC": "C. Intraductal papillary mucinous neoplasm\n                \n                  \n                    \nCorrect",
    "optionD": "D. Pancreatic pseudocyst",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given appearance of the <strong>fish-eye lesion of the ampulla of Vater</strong> on ERCP is characteristic of<strong> intraductal papillary mucinous neoplasm (IPMN).</strong>&nbsp;</p>\n<p>Mucin can be seen extruding from the ampulla of Vater, a so-called <strong>fish-eye lesion</strong> that is virtually diagnostic of IPMN.</p>\n<p>Cyst fluid analysis of various pancreatic cystic neoplasms:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>Characteristics</td>\n<td><strong>Serous cystic neoplasm (SCN)</strong></td>\n<td><strong>Mucinous cystic neoplasm (MCN)</strong></td>\n<td>\n<p><strong>Intraductal papillary mucinous neoplasm (IPMN)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Cytology<br><br><br></td>\n<td>Scant glycogen-rich cells, with positive periodic acid-Schiff stain</td>\n<td>Sheets and clusters of columnar, mucin-containing cells</td>\n<td>Tall, columnar, mucin-containing cells</td>\n</tr>\n<tr>\n<td>\n<p>Mucin stain</p>\n</td>\n<td>Negative</td>\n<td>Positive</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>Amylase</td>\n<td>Low</td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td>CEA</td>\n<td>Low</td>\n<td>High</td>\n<td>High</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1605: Cystic Neoplasm of the Pancreas</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Serous Cystadenoma</strong></td>\n<td><strong>Mucinous Cystadenoma</strong></td>\n</tr>\n<tr>\n<td>Nature</td>\n<td>Benign</td>\n<td>Benign, but high risk of malignancy</td>\n</tr>\n<tr>\n<td>Epidemiology</td>\n<td>Common in females (F:M = 2:1) and older age&nbsp;<br>Associated with von Hippel Lindau syndrome&nbsp;</td>\n<td>Most common cystic neoplasm of the pancreas&nbsp;<br>Common in perimenopausal females</td>\n</tr>\n<tr>\n<td>Usual site</td>\n<td>\n<p>Usually tail of the pancreas, can be uniformly distributed</p>\n</td>\n<td>Body and tail of the pancreas</td>\n</tr>\n<tr>\n<td>Microscopy</td>\n<td>Microcysts giving a honey-comb appearance Glycogen-rich cells</td>\n<td>Mucin-producing epithelium<br>Ovarian-like stroma<br>Stains positive for estrogen and progesterone</td>\n</tr>\n<tr>\n<td>CT</td>\n<td>Central calcification, with radiating septa giving sunburst appearance.</td>\n<td>\n<p>Solitary cyst with fine septations, surrounded by a rim of calcification.</p>\n<p>Eggshell calcification, large tumor size, or a mural nodule are suggestive of malignancy</p>\n</td>\n</tr>\n<tr>\n<td>Cyst fluid analysis</td>\n<td>\n<p>Mucin negative</p>\n<p>Low CEA and amylase</p>\n</td>\n<td>\n<p>Mucin-rich aspirate</p>\n<p>High CEA and low amylase</p>\n</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>\n<p>Mainly conservative</p>\n<p>Resection: If symptomatic or if malignancy is suspected</p>\n</td>\n<td>Resection (because of risk of malignancy)</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>\n<p>Good</p>\n</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-103",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD1413",
    "stauts": "Incorrect",
    "question_title": "103.\n        Which of the following diseases follows the pattern of inheritance shown in the pedigree chart?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/c55de41387184f67b9ca49aeb42279b9.PNG\">",
    "optionA": "A. Leigh disease",
    "optionB": "B. Hunter's syndrome",
    "optionC": "C. Spinal muscular atrophy\n                \n                  \n                    \nCorrect",
    "optionD": "D. Achondroplasia\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The pedigree chart shows a pattern of inheritance of an&nbsp;<strong>autosomal-recessive disorder.&nbsp;</strong></p>\n<p>Examples of autosomal recessive disorders include- Spinal muscular atrophy, beta-thalassemia, sickle cell disease, phenylketonuria, and galactosemia.</p>\n<p>Points favoring autosomal recessive pattern:&nbsp;</p>\n<ul>\n<li>Horizontal pattern in pedigrees: the observation of multiple affected members in the same generation, but no affected family members in other generations.</li>\n<li><strong>Parents are unaffected</strong> (both are carriers/heterozygotes);<strong>25%</strong> of the children have <strong>normal genotypes</strong>, <strong>50%</strong> are <strong>carriers,</strong> <strong>25%</strong> are <strong>homozygous,</strong> and <strong>manifestations </strong>are<strong> seen only </strong>in the<strong> homozygous state.</strong></li>\n</ul>\n<p>Other Options:</p>\n<p>Option A: <strong>Leigh's</strong> disease follows <strong>mitochondrial</strong> inheritance. All offspring of an affected female are affected. All affected daughters transmit the disease. Sons are affected but do not transmit the disease</p>\n<p>Option B: <strong>Hunter's</strong> syndrome is an<strong> X-linked recessive</strong> disorder.&nbsp;</p>\n<p>Option D:&nbsp;<strong>Achondroplasia&nbsp;</strong>is an&nbsp;<strong>autosomal dominant&nbsp;</strong>disease.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1892: Pedigree chart for different inheritance patterns</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2055: Inheritance pattern of important diseases</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table class=\"t1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington’s disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\"p1\"><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>G</strong>: <strong>G</strong>aucher’s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\"td1\" valign=\"top\">Other conditions: Wilson's disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>N</strong>: <strong>N</strong>oonan's syndrome</span></td>\n<td class=\"td1\" valign=\"top\">Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\"td1\" valign=\"top\">Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\"><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table class=\"t1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Lady Hardinge College Girls Don’t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>L</strong>ady) <strong>L</strong>esch–Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ed) <strong>R</strong>ett’s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>H</strong>ardinge) <strong>H</strong>unter's syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot–Marie–Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>D</strong>on’t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p2\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\"><span>(<strong>W</strong>ords) <strong>W</strong>iskott–Aldrich syndrome</span></div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<div class=\"p1\">\n<div class=\"p1\"><span>Other conditions: Menke's disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\"td1\" valign=\"top\">&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><span>&nbsp;</span></p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-104",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6826",
    "stauts": "Correct",
    "question_title": "104.\n        Which of the following options correctly matches the stages of wound healing?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/35174b33a79147b7a1f025d23cf62d52.JPEG\">",
    "optionA": "A. 1: Late Inflammatory 2: Remodelling, 3: Proliferative, 4: Homeostatic",
    "optionB": "B. 1: Remodelling, 2: Late Inflammatory, 3: Haemostatic, 4: Proliferative",
    "optionC": "C. 1: Late Inflammatory, 2: Proliferative   3: Remodelling 4: Homeostatic",
    "optionD": "D. 1: Remodelling, 2: Haemostatic, 3: Late Inflammatory, 4: Proliferative\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched option is <strong>option D</strong>, i.e 1: Homeostatic, 2: Remodelling, 3: Proliferative, 4: Inflammatory&nbsp;</p>\n<p><strong>Stage 1</strong>: &nbsp;<strong>Haemostatic</strong> <strong>phase</strong> with early inflammatory phase: In this stage, there is the presence of platelet-enriched blood clots, dilated vessels, and neutrophil infiltration. This is shown in Image 2</p>\n<p><strong>Stage 2</strong>: <strong>Late</strong> <strong>Inflammatory</strong> phase: It is characterized by the presence of increased vascularity and an increase in Polymorphonuclear leukocytes lymphocytes and macrophages. This phase lasts for 2-3 days. This is shown in Image 3.</p>\n<p><strong>Stage 3</strong>: <strong>Proliferative</strong> <strong>phase</strong>: It is characterized by the presence of granulation tissue with capillary buds and fibroblasts. This lasts from Day 3 to the third week. Collagen deposited in this phase is predominantly Type 3. This is shown in Image 4.</p>\n<p><strong>Stage 4</strong>: <strong>Remodelling</strong> <strong>phase</strong>: This is characterized by the replacement of Type 3 collagen by Type 1 this leads to increased tensile strength i.e. 80% of original strength at the end of three months. It shows a mature contracted scar as shown in Image 1.</p>\n<p>The given images show different stages of wound healing.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af2bef1b1c3d431093f554139ab15a3dx1280x1304.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-105",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF4371",
    "stauts": "Incorrect",
    "question_title": "105.\n        A 3-year-old boy presented with maculopapular lesions and vesicles around his mouth,  as seen in the image below. Which of the following drugs is preferred for initial management?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/790a31a6ba7140ef9b4ee7ab3af7e41e.JPEG\">",
    "optionA": "A. Mupirocin\n                \n                  \n                    \nCorrect",
    "optionB": "B. Amoxicillin",
    "optionC": "C. Clindamycin\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. neomycin",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above clinical scenario with the image showing erythematous lesions with <strong>honey-colored crusts</strong> is suggestive of&nbsp;<strong>non-bullous impetigo</strong>. <strong>Topical mupirocin&nbsp;</strong>is the <strong>preferred initial management</strong> in this condition.</p>\n<p><strong>Topical antibiotics&nbsp;</strong>are preferable to oral antibiotics for limited impetigo. Three topical antibiotics recommended for impetigo are <strong>mupirocin 2%, retapamulin 1% ointment,</strong> and <strong>fusidic acid</strong>.</p>\n<p>Management of impetigo includes:</p>\n<ul>\n<li>Hygienic practices include <strong>cleaning minor injuries</strong> with soap and water, handwashing, regular bathing, and <strong>avoiding contact</strong> with <strong>infected children</strong> can help prevent infection.</li>\n<li><strong>Removal </strong>of <strong>crusts</strong> and <strong>washing</strong> the skin using <strong>antibacterials</strong>.</li>\n<li><strong>Topical antibiotics</strong>, as mentioned above.</li>\n<li><strong>Systemic antibiotics</strong> like <strong>Amoxicillin/ clavulanate</strong>, <strong>oral clindamycin</strong>, or<strong> tetracyclines</strong> are often reserved for severe infections. Treatment for seven days or more depends on the clinical response and antibacterial susceptibility.</li>\n<li><strong>Novel drugs</strong>:\n<ul>\n<li><strong>Retapamulin</strong> is a <strong>pleuromutilin</strong> used for ages <strong>more than 9 months</strong>.</li>\n<li><strong>Ozenoxacin</strong> is a <strong>topical quinolone</strong> indicated for the treatment of impetigo due to <strong>MRSA</strong> in ages <strong>older than 2 months</strong> of age.\n<ul>\n<li>It can be applied as a <strong>thin layer topically</strong> to the affected area twice daily for five days.</li>\n<li>The mechanism of action involves the <strong>inhibition</strong> of <strong>bacterial DNA replication enzymes, DNA gyrase A, </strong>and<strong> topoisomerase IV</strong> resulting in bactericidal activity.</li>\n<li>Resistance can arise through mutations of the genes that encode the enzymes.</li>\n<li><strong>Oral fluoroquinolones</strong> are <strong>not preferred</strong> because of <strong>low staphylococcal activity</strong> and their potential association with <strong>tendinopathy </strong>and<strong> arthropathies</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Non-bullous impetigo</strong> is a common skin infection, particularly prevalent among children aged <strong>2 to 5 years</strong>, and accounts for about <strong>70%</strong> of <strong>impetigo</strong> cases. It is primarily caused by <em><strong>Staphylococcus aureus, Streptococcus pyogenes, </strong></em>and anaerobic bacteria. The infection initially presents with <strong>maculopapular lesions</strong> and <strong>thin-walled vesicles</strong> that quickly burst, forming <strong>thick golden crusts</strong>. As these crusts dry, they leave behind erythematous marks that gradually fade over time. Typically affecting areas around the <strong>nose, mouth, face,</strong> and limbs, non-bullous impetigo rarely involves mucosal surfaces. The condition is characterized by <strong>pruritus</strong>, but pain is usually minimal, and systemic infection is uncommon.</p>\n<p>In contrast, <strong>bullous impetigo</strong> is less common and primarily affects children <strong>under 2 years </strong>of age. This form is predominantly caused by <em><strong>Staphylococcus aureus</strong></em>. It is marked by the presence of <strong>fluid-filled bullae</strong> less than 2 cm in diameter that spread and burst after several days, forming <strong>yellow crusts</strong>. The infection typically affects the <strong>trunk</strong> and <strong>limbs</strong>. They are more likely to present with systemic signs and <strong>lymphadenopathy</strong>, and it is associated with a higher likelihood of <strong>mucosal involvement, pruritus, </strong>and <strong>pain.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Given below is an image of a bullous form of impetigo.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fecb16cbe6fe4fc6ac705ae267dd540cx720x1060.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2454: Skin and soft tissue lesions caused by Streptococcus</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Streptococcus causes a variety of skin and soft tissue infections. These include:</p>\n<p>a. <strong>Impetigo</strong>- Infection of superficial layers of the skin. It presents as superficial vesicles which break down and are then encrusted by honey-colored scab. It usually occurs in children.</p>\n<p>The given image shows impetigo:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/402a0b1bedb94b8bb54931282ab18a5ax508x200.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>b.&nbsp;<strong>Erysipelas</strong>-</p>\n<ul>\n<li>Infection of the superficial epidermis.\n<ul>\n<li>It presents as an erythematous raised lesion with sharply demarcated edges that differentiate it from the surrounding skin.\n<ul>\n<li>The given image shows erysipelas- note the clear demarcation at the nasolabial folds seen in facial erysipelas.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af1d1306363b448490fd435fc60ee51bx1280x1211.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>c.&nbsp;<strong>Cellulitis</strong>- Infection of the skin and subcutaneous tissue. It presents with erythema and edema. It can be differentiated from erysipelas by - i. Erysipelas is a raised lesion whereas cellulitis is not, ii. Cellulitis is poorly demarcated from the surrounding skin whereas erysipelas is clearly demarcated.</p>\n<p>The given image shows cellulitis:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c81644e4fd8c407ea15b8e0f59c2f0bfx1280x960.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>d.&nbsp;<strong>Necrotizing fasciitis</strong>- Infection involving the fascial planes. It presents with dark areas of necrosis, erythema, and edema.</p>\n<p>The given image shows necrotizing fasciitis with areas of erythema and necrosis:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/23196395a943480fae2f0cfdcac858dbx1280x734.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>d.&nbsp;<strong>Myositis and myonecrosis</strong>- Infection of the muscle.</p>\n<p>The given image shows necrotizing myositis:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0e639e386c9d433e985751e75051ca46x996x690.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2455: Skin and soft tissue lesions caused by Staphylococcus</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Staphylococcus causes a variety of skin and soft tissue infections. These include:</p>\n<p>a. <strong>Furuncle</strong>/boil- Infection of the hair follicle.</p>\n<p>The given image shows a furuncle:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e85d867deb494725875ce9b6fcc453d4x1024x683.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>b. <strong>Carbuncle</strong>: A cluster of several furuncles:</p>\n<p>The given image shows a carbuncle:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/87a5f9e1f77542b29243f0335be022b5x1280x960.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>c. <strong>Bullous impetigo</strong>: Results in large blisters called bullae, usually seen in areas with skin folds such as armpits, groin, buttocks, etc.</p>\n<p>The given image shows ruptured bullous impetigo:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/281f980ab1544bf8ba1a75e41288ebd0x1280x1706.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>d. <strong>Cellulitis</strong>: It is a rapidly spreading infection of the skin and subcutaneous tissue, usually associated with wounds, incisions, burns, etc.</p>\n<p>The given image shows cellulitis following an abrasion. The red streaks indicate the involvement of the lymphatics:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/03beb37fad62438c82351579ddb30787x1280x960.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>e. <strong>Staphylococcal scalded skin syndrome</strong>: Caused by exfoliating toxin that causes peeling of the skin.</p>\n<p>The given image shows SSSS:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d2c892194a074752b3318b1d2172c9ffx363x274.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Note: The conditions shown above are most commonly caused by Staphylococcus. It is important to remember that they may also be caused by other bacteria. Cellulitis is more commonly caused by Streptococcus.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-106",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC4964",
    "stauts": "Correct",
    "question_title": "106.\n        A couple has come for pre-conceptional counseling to make a decision on pregnancy planning. The method of communication used for counseling to help the couple to make a decision about health is known as_________.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Delphi method",
    "optionB": "B. GATHER approach\n                \n                  \n                    \nCorrect",
    "optionC": "C. SPIKES protocol",
    "optionD": "D. Demonstration",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The method of communication used for counselling, wherein a person is helped to make a health decision is known as the <strong>GATHER&nbsp;approach,</strong> e.g. contraceptive counselling. Expansion:</p>\n<ul>\n<li>G-&nbsp;<strong>Greet</strong></li>\n<li>A-&nbsp;<strong>Ask</strong></li>\n<li>T-&nbsp;<strong>Tell</strong>&nbsp;options or give answers</li>\n<li>H-<strong>&nbsp;Help</strong>&nbsp;in making choices</li>\n<li>E-<strong>&nbsp;Explain</strong>&nbsp;everything about the decision</li>\n<li>R-&nbsp;<strong>Return</strong> for follow-up</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Delphi method:</strong>&nbsp;It is a systematic interactive forecasting method which is used to obtain a&nbsp;<strong>consensus forecast</strong>, i.e. to determine the degree of agreement on a topic. This method uses&nbsp;<strong>questionnaires, </strong>which are answered by&nbsp;<strong>experts</strong>&nbsp;in two or more rounds.</p>\n<p>Option C: <strong>Spikes protocol </strong>is used to <strong>convey distressing information</strong> and <strong>break bad news</strong> in an organised manner to patients and families.</p>\n<p>Option D: <strong>Demonstration</strong> is a carefully prepared presentation on how to perform a certain task, skill, or procedure. It arouses interest and incites ‘<strong>learning by doing’ and 'seeing</strong>&nbsp;<strong>is believing</strong>’ philosophies.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0174: Methods of Health Communication</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/48ba5eb0215744d389fb6f353dbe3813x538x361.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-107",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2972",
    "stauts": "Incorrect",
    "question_title": "107.\n        A patient is suspected to have pseudomembranous enterocolitis. An ELISA test is done on the stool sample. Which of the following is detected that is specific to the diagnosis?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Vacuolating cytotoxin",
    "optionB": "B. Pyrazinamidase",
    "optionC": "C. Glutamate dehydrogenase\n                \n                  \n                    \nCorrect",
    "optionD": "D. Colonization factor antigen\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Glutamate dehydrogenase </strong>is the enzyme present specifically in all strains of <strong>C. difficile</strong> and it is detected in the stool sample by ELISA in case of <strong>pseudomembranous enterocolitis.</strong></p>\n<p>Pseudomembranous enterocolitis is an infection caused by <strong>clostridioides difficile</strong> and it can occur commonly in those who have been <strong>hospitalised</strong> with <strong>broad-spectrum antibiotic coverage</strong> like ceftriaxone, ampicillin, etc. <strong>Diarrhea</strong> is the most common presentation.</p>\n<p>Analysis of the stool sample for <strong>toxin A &amp; toxin B</strong> of the organism and detection of the presence of glutamate dehydrogenase using ELISA is <strong>diagnostic.</strong> Polymerase chain reaction of genes encoding toxins A &amp; B can also be useful.</p>\n<p><strong>Oral vancomycin and fidaxomicin</strong> are the first-line drugs followed by metronidazole.</p>\n<p>Other options :&nbsp;</p>\n<p>Option A:<strong> Vacuolating cytotoxin</strong> is detected in the case of <strong>Helicobacter</strong> <strong>pylori</strong> infection.</p>\n<p>Option B:<strong> Pyrazinamidase</strong> is responsible for resistance against pyrazinamide in <strong>Mycobacterium</strong> <strong>tuberculosis</strong>.</p>\n<p>Option D<strong>: Colonization factor antigen</strong> is found in case of enterotoxigenic <strong>E</strong>.<strong>coli</strong> infection</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-108",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6804",
    "stauts": "Correct",
    "question_title": "108.\n        A researcher did a study to establish a relationship between prolonged screen time and ADHD in children. He did this study on 3000 kids, with 1500 being exposed to >4 hours of screen time daily and the other 150 with <4 hours. He found that the correlation coefficient (“r” value) is 0.9 (“p” value: 0.03). What does it mean?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. The study is invalid as the “p” value is less than 0.05.",
    "optionB": "B. The study is valid but there is no correlation between screen time and ADHD.",
    "optionC": "C. The study is valid and we can establish a positive correlation between screen time and ADHD.\n                \n                  \n                    \nCorrect",
    "optionD": "D. The data given is statistically insufficient to prove any correlation.",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given scenario, the “p” value of <strong>less than 0.05</strong> suggests that the study is <strong>valid</strong> and the correlation coefficient (“r”) which is <strong>more than 0</strong> (i.e. 0.9) suggests that there is a <strong>positive</strong> <strong>correlation</strong> between the two variables. Thus, it is likely that <strong>prolonged screen time</strong> can lead to <strong>ADHD</strong> in children.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1139: Correlation</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Correlation</strong> expresses the <strong>strength</strong> and <strong>direction</strong> of the relationship between two variables in terms of a <strong>correlation coefficient</strong>. It is represented by&nbsp;<strong>r</strong>.</p>\n<ul>\n<li>Values of r vary from <strong>-1</strong> (perfect negative correlation) to <strong>+1</strong> (perfect positive correlation).</li>\n<li>Value (size) of the coefficient: Indicates the strength of relationship</li>\n<li>Sign of the coefficient: Indicates direction of relationship</li>\n</ul>\n<p>Coefficients between ±0.5 and 1 are regarded as strong whereas those between ±0.5 and 0 are regarded as weak.</p>\n<p>The data is plotted in a <strong>scattergram</strong> as shown in the examples given below</p>\n<p>Examples:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/333f39128051444e8f62260f161639ebx1280x2998.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Types of correlation coefficients</strong></p>\n<ol>\n<li>Pearson coefficient</li>\n<li>Spearman coefficient</li>\n</ol></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/69ce1962b6b64f638b91fe579a829ac4x1280x1675.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Coefficient of Determination (CD) =&nbsp;&nbsp;r<sup>2</sup></strong></p>\n<p>It is simply the percentage variability in one factor due to change in another variable.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1098: Concepts in Hypothesis Testing</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Probability value (</strong><em>p</em><strong> value)</strong></p>\n<ul>\n<li>A&nbsp;<strong>probability value</strong>&nbsp;is the&nbsp;<strong>probability of an outcome given the hypothesis</strong>.</li>\n<li>It is not the probability of the hypothesis given the outcome, although the probability of the given hypothesis is not ignored.</li>\n<li>If the&nbsp;<strong>probability of an outcome is sufficiently low</strong>, we have&nbsp;<strong>evidence that the hypothesis is false</strong>.</li>\n<li>It is also called the&nbsp;<em>p</em><strong> value</strong>.</li>\n</ul>\n<p><strong>The Null Hypothesis and Alternative Hypothesis</strong></p>\n<ul>\n<li>The <strong>hypothesis that an apparent effect or outcome is only due to chance is a null hypothesis</strong>.</li>\n<li>In other words, a null hypothesis is one where there is <strong>no difference between the specified sample and population</strong> and any observed difference is due to chance or some other error.</li>\n<li>A null hypothesis is represented by <strong>H<sub>0</sub></strong>.</li>\n<li>If the <strong>null hypothesis</strong> is <strong>rejected</strong> as false, then there is an <strong>alternative</strong> or <strong>experimental hypothesis (H<sub>A</sub>)</strong>, which is logically accepted.</li>\n</ul>\n<p><strong>Criterion or Significance Level</strong> <strong>(α) </strong></p>\n<ul>\n<li>If the probability value of an outcome is sufficiently low, then the null hypothesis is rejected.</li>\n<li>This <strong>point below which we would define the probability value as being low enough</strong> to reject the null hypothesis is called the <strong>criterion</strong> or <strong>significance level </strong>or<strong> α (alpha) level</strong>.</li>\n<li>When the null hypothesis is rejected, the effect or outcome is said to be <strong>statistically significant</strong>.</li>\n<li>By <strong>convention</strong> (but not always), the <strong>level of α is 0.05</strong>, i.e., if the probability value of an outcome is <strong>less than or equal to 0.05 (</strong><em>p</em><strong> value ≤ 0.05)</strong>, then the null hypothesis is <strong>rejected</strong>.</li>\n<li>If it is <strong>greater than 0.05</strong>, then the null hypothesis is <strong>accepted</strong>.</li>\n<li>Although by convention the level of <strong>α is 0.05</strong>, it can be lower but cannot be any higher.</li>\n</ul>\n<p><strong>Type I Error</strong></p>\n<ul>\n<li>The interpretation of <strong><em>p</em> value ≤ 0.05 </strong>is that an investigator can be 95% sure that the result was not obtained by chance.</li>\n<li>It also means that there is a 5% probability that the result was obtained by chance.</li>\n<li>From this, we can deduce that the <strong>null hypothesis might indeed be true even though we rejected it</strong>.</li>\n<li>This is <strong>a type I error</strong>. In other words, <strong>when an alternative hypothesis is accepted even when it is false and the null hypothesis is true</strong>, it is a <strong>type I error</strong> or <strong>false positive error</strong>.</li>\n<li>It is also called an <strong>alpha (α) error</strong> as it is <strong>related to the criterion α</strong>.</li>\n<li>The <strong>lower the α level</strong>, the <strong>lower the rate of a type I error</strong> being made.</li>\n<li>Thus, it can be said that <strong>α is the maximum tolerable probability that a type I error is being made</strong> and that the <strong>p value is the probability that a significant difference is declared when there is none</strong>.</li>\n</ul>\n<p><strong>Type II Error</strong></p>\n<ul>\n<li>The error that is made by <strong>rejecting an alternative hypothesis when it is true</strong> or <strong>failing to reject a null hypothesis when it is false</strong> is called a <strong>type II error</strong>.</li>\n<li>It is also called a <strong>false negative error </strong>and more commonly, as a <strong>beta (β) error</strong>.</li>\n<li>If the null hypothesis is false, then the <strong>probability of a type II error</strong> is <strong>β</strong>.</li>\n<li>The <strong>power of a statistical test</strong> is indicated by <strong>1–β.</strong></li>\n</ul>\n<p><strong>Power of a Test</strong></p>\n<ul>\n<li>The <strong>power of a test</strong> is the <strong>ability</strong> of a statistical test to <strong>avoid a type II error</strong>, which depends on its <strong>ability to detect a false null hypothesis</strong>.</li>\n<li>It is <strong>equal to 1–β</strong>, which is the <strong>probability that a false null hypothesis will be rejected</strong>.</li>\n<li>By <strong>convention</strong>, a test is required to have a <strong>power of 0.8</strong> (or a <strong>β of 0.2</strong>) to be <strong>acceptable</strong>. This is to say that a study that has less than 80% chance of detecting a false null hypothesis is unacceptable.</li>\n<li><strong>Type I errors are easily reduced by reducing the criterion α</strong>.</li>\n<li>A <strong>test's power will increase</strong> in the following conditions:\n<ul>\n<li>If <strong>α increases</strong>, but this will increase the chance of a type I error.</li>\n<li>If the <strong>difference between </strong>the <strong>sample mean </strong>and<strong> hypothesized mean increases</strong>. This is also called <strong>effect size</strong>.</li>\n<li>If <strong>sampling error decreases</strong>.</li>\n<li>If the <strong>sample size (n) increases</strong>.</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-109",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD1911",
    "stauts": "Incorrect",
    "question_title": "109.\n        Blood supply during exercise remains unaltered in __________.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Inactive muscles\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Hepato-splanchnic circulation",
    "optionC": "C. Cerebral circulation\n                \n                  \n                    \nCorrect",
    "optionD": "D. Coronary circulation",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Cerebral circulation</strong> remains relatively <strong>unaltered during exercise</strong> by <strong>autoregulatory mechanisms </strong>to ensure a constant supply of oxygen and nutrients to the brain, maintaining stable function despite increased physical activity.</p>\n<p>Stable cerebral circulation during exercise helps maintain cognitive functions, such as concentration, coordination, and decision-making, which are essential during physical activity.</p>\n<p>In contrast, blood flow is <strong>redirected</strong> to <strong>active muscles</strong> and the <strong>heart</strong> (Option D), where it increases significantly to meet the heightened demand for oxygen and energy. Redirection is necessary to support the increased workload of these tissues. Other regions, such as <strong>inactive muscles</strong> (Option A) and <strong>hepato-splanchnic circulation</strong> (Option B), experience <strong>reduced blood flow</strong> as the body prioritizes areas directly involved in the exercise.</p>\n<p>As muscle work output rises, oxygen consumption increases, leading to the dilation of blood vessels in the muscles. This dilation <strong>enhances venous return</strong>, which in turn <strong>boosts cardiac output</strong>. In a <strong>normal, untrained person,</strong> cardiac output can increase by just <strong>over four times</strong> the resting level. In contrast, a <strong>well-trained athlete</strong> can boost their cardiac output by about <strong>six times.</strong> Remarkably, in some marathoners, cardiac outputs as high as 35 to 40 L/min have been recorded, which is seven to eight times the normal resting output.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-110",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6746",
    "stauts": "Correct",
    "question_title": "110.\n        A 52-year-old woman presented with acute abdominal pain and vomiting. Her abdominal X-ray is given below. What is the most likely diagnosis?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/373bef1604ad4a66b50fe1ee6616442c.JPEG\">",
    "optionA": "A. Sigmoid volvulus",
    "optionB": "B. Toxic megacolon",
    "optionC": "C. Caecal volvulus",
    "optionD": "D. Small bowel obstruction\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given scenario and the X-ray showing the characteristic&nbsp;<strong>string</strong> <strong>of</strong> <strong>pearls&nbsp;</strong>or <strong>string</strong> <strong>of</strong> <strong>beads&nbsp;</strong>appearance are suggestive of&nbsp;<strong>small bowel obstruction.&nbsp;</strong></p>\n<p>In&nbsp;<strong>small bowel</strong>&nbsp;obstructions, the<strong>&nbsp;</strong>obstructed bowel loops are&nbsp;<strong>central in location and lie transversely</strong>. The&nbsp;<strong>jejunal</strong>&nbsp;obstruction shows&nbsp;<strong>valvulae conniventes&nbsp;</strong>(mucosal folds that cross the entire diameter of the bowel) giving it a&nbsp;<strong>ladder effect.</strong>&nbsp;The distended cecum may show the presence of gas shadow in the right iliac fossa.</p>\n<p>In&nbsp;<strong>large bowel obstruction</strong>,&nbsp;the presence of&nbsp;<strong>haustrations</strong>&nbsp;is a feature. Haustral folds are irregular and do not cross the entire diameter of the bowel. These are absent in the caecum. The given image shows haustrations in large bowel obstruction. Caecal volvulus, sigmoid volvulus and toxic megacolon are examples of<strong> large bowel</strong> obstruction.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9cc573641ef94774b249856b6a829424x1280x1662.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6977312d05e04163a0fb9d10853b4c62x1280x1642.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Radiological features of small bowel obstruction:</p>\n<p><strong>X-ray:</strong></p>\n<ul>\n<li><strong>Erect X-ray</strong>&nbsp;\n<ul>\n<li>presence of <strong>more than 2 fluid levels</strong> within the dilated small bowel loops.</li>\n</ul>\n</li>\n<li><strong>Supine X-ray</strong>&nbsp;\n<ul>\n<li>a row of <strong>gas bubbles</strong> trapped between the valvulae conniventes, within fluid-filled dilated small bowels, resembling a&nbsp;<strong>string</strong> <strong>of</strong> <strong>beads</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>CT Scan:</strong></p>\n<ul>\n<li><strong>Angulation</strong> and <strong>tethering</strong> of the bowel loops suggestive of <strong>adhesions.</strong></li>\n<li><strong>Small bowel ‘faeces sign’&nbsp;</strong>due to prolonged stasis and water reabsorption.</li>\n<li>A <strong>‘transition</strong> <strong>point’ </strong>is&nbsp;seen in <strong>simple obstruction,</strong> with proximally dilated small bowel loops and distally collapsed loops.</li>\n<li>A <strong>U- or V-shaped configuration</strong> of the dilated loops may be seen with a fixed radial distribution, in a <strong>closed loop obstruction.</strong></li>\n</ul>\n<p><strong>Ultrasound:</strong></p>\n<ul>\n<li><strong>Fluid-filled loops&nbsp;</strong>of the small intestine.&nbsp;</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Sigmoid volvulus</strong>&nbsp;shows a large, dilated loop of the colon, often with a <strong>few air-fluid levels</strong>. Specific signs include the&nbsp;<strong>coffee bean sign&nbsp;</strong>and<strong>&nbsp;</strong>the<strong>&nbsp;absence of rectal gas.</strong> On the <strong>X-ray abdomen </strong>(given below),<strong> </strong>the apex of the&nbsp;<strong>sigmoid volvulus</strong>&nbsp;extends towards the <strong>right upper quadrant&nbsp;</strong>and the haustrations are usually lost.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/21a2ff08eb4d448dab68232579544914x720x882.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Option B: <strong>Toxic megacolon</strong>(image below)&nbsp;is defined as&nbsp;the<strong> dilatation</strong> of the<strong> transverse colon </strong>to a diameter of <strong>more than 6 cm</strong>&nbsp;and&nbsp;loss of <strong>haustrations</strong>.&nbsp;It is usually associated with<strong>&nbsp;severe ulcerative colitis.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ea2d24707ed449d87ef85493ef2eaafx720x870.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Option C: <strong>Caecal volvulus</strong>(image below)&nbsp; shows characteristic radiological findings like <strong>caecal dilatation</strong>,<strong>&nbsp;single air-fluid</strong>&nbsp;level extending into the left upper quadrant&nbsp;and <strong>absence of gas</strong> in the distal colon.&nbsp;The<strong> colonic haustrations</strong> are well maintained.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ea16b2611dc748a89c3dd90975dbf8e5x720x608.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Radiology"
  },
  {
    "web-scraper-order": "1727319149-111",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA7996",
    "stauts": "Correct",
    "question_title": "111.\n        Putrefaction is delayed in all except_____",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Barbiturate poisoning",
    "optionB": "B. Nicotine poisoning",
    "optionC": "C. Strychnine poisoning",
    "optionD": "D. Kidney disease with anasarca\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Putrefaction</strong> is <strong>delayed</strong> in all of the given options except in <strong>kidney disease</strong> with <strong>anasarca</strong>, which <strong>hastens putrefaction</strong>.</p>\n<p>Death by <strong>septic diseases</strong>, <strong>puerperal sepsis</strong>, <strong>kidney diseases with generalized (anasarca) edema,</strong> etc. can <strong>hasten</strong> putrefaction. Death by<strong> chronic alcoholism </strong>can <strong>retard </strong>putrefaction.</p>\n<p>Poisoning from substances like <strong>potassium cyanide</strong>, barbiturates, fluoride, phosphorus, endrin, <strong>datura</strong>, <strong>strychnine</strong>, <strong>yellow oleander</strong>, nicotine,<strong> arsenic</strong>, mercury, copper, antimony, lead, and thallium can resist putrefaction.</p>\n<p>Retarding putrefaction involves slowing down the process of decomposition, whereas resisting putrefaction prevents or reduces the extent of decomposition.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-112",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6422",
    "stauts": "Incorrect",
    "question_title": "112.\n        A man who was an industrial worker for 30 years died of lung cancer. The tumor biopsy suggests calretinin positivity. The suspected malignant neoplasm is known to have all of the following associations except",
    "question_ADD": "<p>BRCA1-Associated Protein 1 (BAP1)</p>",
    "question_imag": "",
    "optionA": "A. BAP1 mutation",
    "optionB": "B. Asbestos",
    "optionC": "C. Neurofibromatosis 2 mutation\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Mustard gas\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above clinical vignette of an <strong>industrial worker </strong>with a lung biopsy showing <strong>calretinin positivity </strong>is suggestive of <strong>mesothelioma</strong> and is known to have associations with <strong>BAP 1 germline mutation, asbestos, and Neurofibromatosis 2 (NF2) mutation </strong>except for <strong>mustard gas</strong> which is a known carcinogen for other types of cancers such as<strong> lung cancer</strong>&nbsp;but is not a recognized risk factor for mesothelioma.</p>\n<p><strong>Mustard</strong> <strong>gas</strong>, also known as sulfur mustard, is a chemical warfare agent that causes severe blistering and other toxic effects. While it is a known carcinogen, it is primarily linked to <strong>respiratory</strong> and <strong>skin</strong> <strong>cancers</strong> rather than mesothelioma.</p>\n<p>Malignant mesothelioma is a <strong>diffuse</strong> lesion arising from either the <strong>visceral</strong> or the <strong>parietal pleura</strong> that spreads widely in the pleural space. There is an increased incidence among people with <strong>heavy exposure to asbestos</strong> (Option B)</p>\n<p>The affected lung becomes ensheathed by a thick layer of <strong>soft, gelatinous, greyish-pink</strong> tumour tissue. Microscopically, malignant mesothelioma may be <strong>epithelioid</strong> (60% to 80%), <strong>sarcomatoid</strong> (10% to 12%), or <strong>biphasic</strong> (10% to 15%). Most mesotheliomas show strong positive for <strong>calretinin, Wilms tumour 1 (WT-1), cytokeratin 5/6,</strong> and <strong>podoplanin.&nbsp;</strong>The most common cytogenetic abnormality is <strong>homozygous deletion of chromosome 9p</strong> leading to loss of the tumor suppressor gene <strong>CDKN2A</strong> ( cyclin-dependent kinase inhibitor 2A), which occurs in about 80% of mesothelioma.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: The germline mutations in <strong>BRCA1-Associated Protein 1 (BAP1)</strong> have a markedly elevated risk of mesothelioma.&nbsp;</p>\n<p>Option C:<strong> Neurofibromatosis 2 (NF2) mutation</strong>: NF2 gene mutations can be involved in the development of mesothelioma.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-113",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6457",
    "stauts": "Incorrect",
    "question_title": "113.\n        A 28-year-old primigravida at 32 weeks of gestation presents for a routine prenatal visit. Her blood investigations were done and are given below. Which of the following is the most likely diagnosis?",
    "question_ADD": "<p>Hb: 12.5 g/dL</p>\n<p>TLC: 8500 /cubic mm</p>\n<p>Platelet count: 90000 /cubic mm</p>\n<p>AST: 22 U/L</p>\n<p>ALT: 28 U/L</p>\n<p>Total bilirubin: 0.8 mg/dL</p>\n<p>Normal coagulation profile</p>",
    "question_imag": "",
    "optionA": "A. Immune Thrombocytopenic Purpura (ITP)\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. HELLP Syndrome",
    "optionC": "C. Gestational Thrombocytopenia\n                \n                  \n                    \nCorrect",
    "optionD": "D. Thrombotic Thrombocytopenic Purpura (TTP)",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Gestational thrombocytopenia</strong> is the most likely diagnosis in this patient with no symptoms and a platelet count of <strong>90,000/mm³.</strong></p>\n<p>It is the <strong>most common cause</strong> of thrombocytopenia in pregnancy, typically occurring in the third trimester. It is usually mild, with platelet counts rarely falling below 70,000/mm³, and it is<strong> not</strong> associated with significant <strong>clinical symptoms</strong> or <strong>adverse pregnancy outcomes</strong>. Normal LFTs, bilirubin levels, and a normal coagulation profile support the diagnosis of gestational thrombocytopenia in this asymptomatic patient.&nbsp;</p>\n<p>This condition is believed to result from <strong>hemodilution</strong>&nbsp;due to increased blood volume during pregnancy. Additionally, the naturally increased size of the spleen during pregnancy may also play a role.</p>\n<p>ITP, HELLP syndrome, and TTP are less likely given the patient's lack of symptoms, normal LFTs, and coagulation profile. <strong>HELLP syndrome</strong> typically presents with <strong>hemolysis, elevated liver enzymes,</strong> and <strong>low platelets,</strong> while <strong>TTP</strong> is a rare condition associated with <strong>microangiopathic hemolytic anemia and thrombocytopenia</strong>, usually accompanied by other systemic findings.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-114",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6853",
    "stauts": "Incorrect",
    "question_title": "114.\n        A medical student comes to the ER with a history of needle prick while drawing blood. The hepatitis B status of the patient is unknown. The student has already completed a full course of Hep B but did not check for the response. Post-exposure anti-Hbs levels in his blood are 6 mIU/ml. What PEP will you advise in this case?",
    "question_ADD": "<p>HBIG: Hepatitis B hyperimmune globulin</p>\n<p>PEP - Post-exposure prophylaxis</p>",
    "question_imag": "",
    "optionA": "A.   Initiate revaccination  \n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B.  Two doses of HBIG 1 month apart and revaccination",
    "optionC": "C. Single dose of HBIG and initiate revaccination \n                \n                  \n                    \nCorrect",
    "optionD": "D. No action is needed.",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>For a patient who has <strong>completed 3 doses</strong> of <strong>hep</strong> <strong>B</strong> <strong>immunization</strong> with <strong>unknown</strong> <strong>response</strong>, anti-HBsAg levels should be checked post-exposure to check for immunity levels. The cut-off value is <strong>10mIU/ml, </strong>levels less than this <strong>warrant a dose of HBIG </strong>(hepatitis B immunoglobulin) <strong>as</strong> <strong>well</strong> <strong>as</strong> <strong>revaccination</strong>.&nbsp;<br>&nbsp;<br>Following a complete course of 3 doses at <strong>0, 1, and 6 months</strong>, the response is assessed and the individual is labelled as a <strong>responder</strong> or <strong>non-responder. </strong>Documented <strong>responders</strong> need <strong>no further management when exposed.&nbsp;</strong></p>\n<p>Non- responders after 3 doses should be given another 3 doses of the vaccine. Those not responding <strong>after 6 doses</strong> are called documented <strong>non</strong>-<strong>responders</strong>. Their management is based on whether the source is positive/unknown or negative. The former requires 2 doses of HBIG 1 month apart and revaccination. Revaccination could be the reinitiation of 3 doses or a single booster dose.<strong> No treatment</strong> is required if the <strong>source</strong> is <strong>negative</strong>.&nbsp;<br>If the response is unknown, post-exposure anti-hbs levels are to be checked. &nbsp;</p>\n<ul>\n<li><strong>&lt;10 mIU/ml</strong> with a <strong>positive</strong>/ <strong>unknown</strong> <strong>source</strong> should be given a <strong>single</strong> <strong>dose</strong> of <strong>HBIG</strong> and <strong>revaccination</strong> initiated.</li>\n<li><strong>&lt;10 mIU/ml </strong>with a <strong>negative</strong> source can be managed by <strong>revaccination</strong> <strong>alone</strong>.</li>\n<li><strong>&gt;10mIU/ml </strong>means the immunity is good hence <strong>no treatment</strong> is required.&nbsp;</li>\n</ul>\n<p>Unvaccinated individuals should be started on the complete vaccination schedule. A single dose of HBIG is to be given if the source is positive.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2488: Post-exposure management of healthcare personnel in Hepatitis B exposure</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Healthcare personnel status</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Post-exposure testing</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\"2\">\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Post-exposure prophylaxis</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Post-vaccination serological testing</strong></td>\n</tr>\n<tr>\n<td><strong>Source</strong><br><strong>patient (HbsAg)</strong></td>\n<td><strong>HCP testing (anti-HBs)</strong></td>\n<td>\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>HBIG</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Vaccination</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Documented<br>responder (after 3 doses)</td>\n<td colspan=\"5\">No action needed</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Documented non-responder (after 6 doses)</td>\n<td>Positive/&nbsp;<br>Unknown</td>\n<td>&nbsp;</td>\n<td>\n<p>HBIG x 2 <br>1 month apart</p>\n</td>\n<td>&nbsp;</td>\n<td>No&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 214\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Negative</p>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\"4\">No action needed</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<div class=\"page\" title=\"Page 214\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Response unknown (after 3 doses)</p>\n</div>\n</div>\n</div>\n</td>\n<td>Positive/<br>Unknown</td>\n<td>\n<div class=\"page\" title=\"Page 214\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&lt;10 mIU/ml</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>HBIG x 1</td>\n<td rowspan=\"2\">Initiate re-<br>vaccination</td>\n<td rowspan=\"2\">Yes</td>\n</tr>\n<tr>\n<td>Negative</td>\n<td>&lt;10 mIU/ml</td>\n<td>None</td>\n</tr>\n<tr>\n<td>Any result</td>\n<td>≥10 mIU/ml</td>\n<td colspan=\"3\">No action needed</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Unvaccinated/ incompletely vaccinated or vaccine refusers</td>\n<td>Positive/<br>Unknown</td>\n<td>&nbsp;</td>\n<td>HBIG x 1</td>\n<td>Complete&nbsp;<br>vaccination</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Negative</td>\n<td>&nbsp;</td>\n<td>None</td>\n<td>Complete&nbsp;<br>vaccination</td>\n<td>Yes&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Community Medicine"
  },
  {
    "web-scraper-order": "1727319149-115",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6834",
    "stauts": "Incorrect",
    "question_title": "115.\n        An HIV-positive woman complained of decreased visual acuity. She gave a history of apparent flies floating in her field of vision. Fundoscopy finding is given below.  At what CD4+T cell count does the majority of such cases occur?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/94cc04c840f4435a9b91deaf6025d57b.JPEG\">",
    "optionA": "A. < 500/μL",
    "optionB": "B. < 50/μL\n                \n                  \n                    \nCorrect",
    "optionC": "C. < 100/μL",
    "optionD": "D. < 350/μL\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p class=\"p1\">The given clinical scenario, along with the&nbsp;<strong>p</strong><strong>izza pie appearance </strong>on fundoscopy<strong>,&nbsp;</strong>is suggestive of <strong>cytomegalovirus (CMV) retinitis.</strong>&nbsp;The majority of such cases occur in HIV-infected patients with a CD4+T cell count <strong>&lt;50/μL</strong>.</p>\n<p>CMV retinitis is a necrotic retinal infection that results in a <strong>painless</strong>&nbsp;<strong>irreversible vision loss</strong>. Patients may complain of blurred vision, <strong>floaters&nbsp;</strong>(described by patient as flies or spiders in the field of vision), and scintillations. It is usually bilateral and is characterized by <strong>perivascular hemorrhage </strong>and <strong>exudates</strong> in the retina&nbsp;(<strong>pizza pie appearance</strong>&nbsp;or&nbsp;<strong>scrambled eggs and ketchup appearance</strong>).</p>\n<p>Treatment:</p>\n<ul>\n<li>Induction - IV <strong>ganciclovir </strong>(3 weeks)</li>\n<li>Maintenance - Oral <strong>valganciclovir </strong>(till CD4 count &gt; 100/μl for 6months)</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2302: Opportunistic Infections/HIV related conditions and ART initiation</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td>Clinical scenario</td>\n<td>Action&nbsp;</td>\n</tr>\n<tr>\n<td>Any undiagnosed active infection with fever</td>\n<td>Diagnose and treat first; start Anti-Retroviral Therapy (ART) when stable</td>\n</tr>\n<tr>\n<td>Tuberculosis (TB)</td>\n<td>Start TB treatment first; start ART as soon as possible after 2 weeks and before 2 months. For those with CD4 less than 50/cmm, start ART within 2 weeks Caution is needed for PLHIV with TB meningitis, since immediate ART is associated with more severe adverse events than initiating ART 2 months after the start of TB treatment</td>\n</tr>\n<tr>\n<td>\n<p>Pneumocystis pneumonia (PCP)</p>\n</td>\n<td>Treat PCP first; start ART when PCP treatment is completed</td>\n</tr>\n<tr>\n<td>Invasive fungal diseases: Oesophageal candidiasis, penicilliosis, histoplasmosis</td>\n<td>Start treatment for oesophageal candidiasis first; start ART as soon as the patient can swallow comfortably. Treat penicilliosis, and histoplasmosis first; start ART when the patient is stabilized or opportunistic infection treatment is completed.</td>\n</tr>\n<tr>\n<td>Cryptococcal meningitis</td>\n<td>Treat cryptococcal meningitis. ART initiation should be deferred until there is evidence of sustained clinical response to anti-fungal therapy and after 4 weeks of induction and consolidation treatment with amphotericin B containing regimen.</td>\n</tr>\n<tr>\n<td>Bacterial pneumonia</td>\n<td>Treat pneumonia first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Malaria</td>\n<td>Treat malaria first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Acute diarrhoea which may reduce absorption of ART</td>\n<td>Diagnose the cause and treat diarrhoea first; start ART when diarrhoea is stabilized or controlled</td>\n</tr>\n<tr>\n<td>Non-severe anaemia (Hb&lt; 9 g/dl)</td>\n<td>Start ART if no other causes for anaemia are found (HIV is often the cause of anaemia)&nbsp;</td>\n</tr>\n<tr>\n<td>Skin conditions such as PPE and seborrhoeic dermatitis, psoriasis, HIV-related exfoliative dermatitis</td>\n<td>Start ART (ART may resolve these problems)&nbsp;</td>\n</tr>\n<tr>\n<td>Suspected Mycobacterium Avium Complex (MAC), Cryptosporidiosis and Microsporidiosis</td>\n<td>Start ART (ART may resolve these problems)</td>\n</tr>\n<tr>\n<td>Cytomegalovirus retinitis</td>\n<td>Start treatment for CMV urgently and start ART after 2 weeks of CMV treatment&nbsp;</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>Treat toxoplasmosis; start ART after 6 weeks of treatment and when the patient is stabilized</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-116",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6833",
    "stauts": "Correct",
    "question_title": "116.\n        Given below is the graph of a displacement reaction where A-B + X leads to the formation of X-A + B. Which of the following is true about the given reaction?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/40b356101b004584b371cdb52deaefed.JPEG\">",
    "optionA": "A. Gibbs free energy of the reaction is negative and the reaction is spontaneous \n                \n                  \n                    \nCorrect",
    "optionB": "B. The free energy of the product is higher than that of the substrate",
    "optionC": "C. Gibbs free energy of the reaction is positive and the reaction is spontaneous",
    "optionD": "D. Enzyme catalyzing the reaction can change the Gibbs free energy",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The true statement concerning the above graph is Gibbs free energy of the reaction is <strong>negative</strong> and the reaction is <strong>spontaneous.</strong></p>\n<p>Gibbs free energy, ΔG is the energy difference between the <strong>free energy of the reaction product</strong> (2 to 3) <strong>and</strong> the <strong>reaction</strong> <strong>substrate</strong> (1 to 2).&nbsp;</p>\n<p>In the above graph, the free energy of the formation of products is lower than that of the substrate (3 is lower in the graph than 1)<span>. Therefore, the difference between the 2 is negative, which indicates that the&nbsp;<strong>reaction proceeds from left to right </strong></span><strong>and is spontaneous.&nbsp;</strong></p>\n<p>Since the energy level of the product is lower than the energy level of the substrate, ΔG cannot be positive in this case.&nbsp;</p>\n<p>Enzymes do not alter the Gibbs free energy, it remains the same irrespective of the enzyme action. Although the above reaction is spontaneous, it might<strong> not necessarily be fast </strong>i.e. it can have a higher transition state point, which is a point where neither free substrate exists nor free product( X-A-B). Enzymes lower the activation energy thus increasing the rate of the reaction.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2e73c5cacef542139f6d486a534255e4x1280x1186.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>C- energy level of substrate&nbsp;<br>D- energy level of product&nbsp;<br>C to A- activation energy in the absence of enzyme&nbsp;<br>C to B – activation energy in the presence of enzyme&nbsp;<br>B to A lowering of activation energy&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-117",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6856",
    "stauts": "Skipped",
    "question_title": "117.\n         A 65-year-old lady comes to the casualty with an accidental fall. X-ray of the right lower limb shows a shaft of femur fracture with diffusely decreased bone density. The orthopedic surgeon plans on performing upper tibial skeletal traction. Which one of the following pins will he use in the above case?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/8b5250dcf9f7488394ad4637fdaf00bc.JPEG\">",
    "optionA": "A. 1",
    "optionB": "B. 2\n                \n                  \n                    \nCorrect",
    "optionC": "C. 3",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A 65-year-old, female with a history of fall with femur fracture and diffusely reduced bone density on X-ray has osteoporosis. <strong>Denham</strong> <strong>pin (image 2)</strong>, being <strong>threaded</strong> in the center provides <strong>better</strong> <strong>grip</strong> and prevents <strong>lateral</strong> <strong>slippage</strong> in <strong>less dense bones.&nbsp;</strong></p>\n<p><strong>Conservative</strong> <strong>management</strong> of shaft of femur fracture is by skeletal traction by insertion of <strong>Steinman</strong> or <strong>Denham</strong> <strong>pin</strong> through the upper end of tibia. &nbsp;</p>\n<p><strong>Skeletal</strong> <strong>traction</strong> helps in the reduction of fractures by pulling the bones apart with the help of weights up to 20 kg, so they get aligned in a straight line which is confirmed by X-ray. (imagine stretching a rubber band which makes it straight). &nbsp;The pins are inserted using hand drills after giving adequate local anaesthesia.&nbsp; Below is an image showing Denham's pin.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8b45de4a893d4406b516636e29fa8369x1280x960.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://trello.com/1/cards/66d5b3ed07c560b0ad7a89a8/attachments/66d5b5318bd867e5f565a28f/previews/66d5b5328bd867e5f565a298/download/1385._Ortho_instruments-Orthopedics-INICET_GT_1-41155_1_copy_2.jpg\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option A: The <strong>Steinman</strong> <strong>pin</strong> is a straight steel rod that has a pointed tip and blunt end. It is the most common pin used for skeletal traction. Common sites include the upper end of the tibia, calcaneum, and supracondylar region of the femur. Given below is the image of a Steinmann pin.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://cdn1.dailyrounds.org/uploads/3c7a7b4964d74555ac3c44462ca9b56b.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D: The <strong>Schanz</strong> <strong>pin</strong>&nbsp;is partially threaded and has a trocar-shaped tip. It is used in external fixation in cases of open fractures, spanning fixators (fractures around joints), and limb lengthening procedures.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/70481d8a24884551adef70b6f43578c9x1280x341.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option C: <strong>K</strong> <strong>wires</strong> are metallic wires that can be sharp on one or both sides and are used to hold bone fragments together in fractures such as the olecranon, patella fracture, clavicle fracture, etc, and skeletal traction.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53c6fd19aa3740c582ed6762fe4586f9x1257x943.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-118",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG4467",
    "stauts": "Incorrect",
    "question_title": "118.\n        A 2 year old presented with the following finding. Which of the following is the cause for above abnormality?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/6f1f725eaa6443a99595c8a8a26d9162.JPEG\">",
    "optionA": "A. First pharyngeal pouch abnormality",
    "optionB": "B. Faulty invagination of first pharyngeal cleft",
    "optionC": "C. Improper fusion of auricular tubercles\n                \n                  \n                    \nCorrect",
    "optionD": "D. Third pharyngeal pouch abnormality\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image shows accessory appendages called <strong>pre-auricular tags</strong> caused by the <strong>fusion defect</strong> of <strong>auricular tubercles</strong> (also known as <strong>Hillocks of his</strong>).&nbsp;</p>\n<p>They are usually present along a line drawn from the tragus to the angle of the mandible. These may often contain <strong>cartilaginous components</strong>.&nbsp;</p>\n<p>Around the<strong> first ectodermal cleft</strong>, from the first and second arches, the <strong>6 mesodermal thickenings</strong> called <strong>Hillocks of His</strong> are formed. These 6 hillocks <strong>fuse</strong> to form a single framework of cartilage called the <strong>pinna</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2351: Embryology of the ear</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Structures of the ear</strong></td>\n<td><strong>Embryological origin</strong></td>\n</tr>\n<tr>\n<td>Auricle or pinna</td>\n<td>1st and 2nd pharyngeal arch</td>\n</tr>\n<tr>\n<td>External auditory meatus</td>\n<td>1st pharyngeal arch</td>\n</tr>\n<tr>\n<td>Tympanic membrane</td>\n<td>All 3 germ layers</td>\n</tr>\n<tr>\n<td>Malleus and incus</td>\n<td>1st pharyngeal arch</td>\n</tr>\n<tr>\n<td>Stapes suprastructure</td>\n<td>2nd pharyngeal arch</td>\n</tr>\n<tr>\n<td>Stapes footplate and annular ligament</td>\n<td>Otic capsule</td>\n</tr>\n<tr>\n<td>Tympanic cavity</td>\n<td>1st pharyngeal pouch</td>\n</tr>\n<tr>\n<td>Eustachian tube</td>\n<td>1st pharyngeal pouch</td>\n</tr>\n<tr>\n<td>Membranous labyrinth</td>\n<td>Otic vesicle</td>\n</tr>\n<tr>\n<td>Semicircular canals and utricle</td>\n<td>Pars superior</td>\n</tr>\n<tr>\n<td>Saccule and cochlea</td>\n<td>Pars inferior</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "ENT"
  },
  {
    "web-scraper-order": "1727319149-119",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8858",
    "stauts": "Correct",
    "question_title": "119.\n        Match the following:",
    "question_ADD": "<table style=\"height: 184px;\" width=\"356\">\n<tbody>\n<tr>\n<td style=\"width: 170px;\"><strong>Column A</strong></td>\n<td style=\"width: 170px;\"><strong>Column B</strong></td>\n</tr>\n<tr>\n<td style=\"width: 170px;\">1. Nystagmus</td>\n<td style=\"width: 170px;\">A. Organophosphate</td>\n</tr>\n<tr>\n<td style=\"width: 170px;\">2. Miosis</td>\n<td style=\"width: 170px;\">B. Aconite</td>\n</tr>\n<tr>\n<td style=\"width: 170px;\">3. Mydriasis</td>\n<td style=\"width: 170px;\">C. Phenytoin toxicity</td>\n</tr>\n<tr>\n<td style=\"width: 170px;\">4. Hippus</td>\n<td style=\"width: 170px;\">D. Amphetamine</td>\n</tr>\n</tbody>\n</table>",
    "question_imag": "",
    "optionA": "A. 1-C, 2-A, 3-D, 4-B\n                \n                  \n                    \nCorrect",
    "optionB": "B. 1-A, 2-B, 3-C, 4-D",
    "optionC": "C. 1-C, 2-D, 3-A, 4-B",
    "optionD": "D. 1-D, 2-A, 3-B, 4-C",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched set is<strong> 1-C, 2-A, 3-D, 4-B</strong>.</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>&nbsp;<strong>Column A</strong></td>\n<td><strong>Column B</strong></td>\n</tr>\n<tr>\n<td>1. Nystagmus</td>\n<td>C. Phenytoin Toxicity</td>\n</tr>\n<tr>\n<td>2. Miosis</td>\n<td>A. Organophosphate</td>\n</tr>\n<tr>\n<td>3. Mydriasis</td>\n<td>D. Amphetamine</td>\n</tr>\n<tr>\n<td>4. Hippus</td>\n<td>B. Aconite</td>\n</tr>\n</tbody>\n</table>\n<p><strong><br>Phenytoin</strong>, carbamazepine, barbiturates, benzodiazepines, and phencyclidine can cause <strong>nystagmus</strong>. Acute poisoning from phenytoin often presents with drowsiness, confusion, excitement, delirium, hallucinations, ataxia, vertigo, slurred speech, and <strong>visual disturbances</strong>, with severe cases potentially leading to<strong> irreversible brain damage</strong> if not managed promptly. <strong>Charcoal haemoperfusion</strong> is effective for removing highly protein-bound, lipid-soluble substances with a large volume of distribution, like phenytoin, barbiturates, and salicylates.</p>\n<p><strong>Organophosphate compounds</strong> are among the commonly used agricultural poisons, metabolized in the liver and detoxified via <strong>cytochrome P450</strong>. These compounds <strong>inhibit acetylcholinesterase</strong>, leading to an accumulation of acetylcholine at nerve endings and causing symptoms such as <strong>pinpoint pupils(miosis)</strong>, respiratory distress, and a characteristic <strong>kerosene-like odor</strong> from body fluids. Acute poisoning results in overactivity of the nervous system, with irreversible enzyme inactivation occurring within 24 to 36 hours, leading to persistent symptoms and potential paralysis.</p>\n<p><strong>Amphetamines</strong> increase the synaptic levels of <strong>dopamine</strong> and <strong>norepinephrine</strong> by blocking their reuptake and <strong>increasing catecholamine release</strong>, which can cause toxicity similar to cocaine. Symptoms of acute poisoning vary from mild restlessness, insomnia, and <strong>dilated pupils</strong> to severe delirium, hyperpyrexia, convulsions, and arrhythmias. In moderate cases, individuals may experience confusion, hypertension, tachycardia, and hallucinations.</p>\n<p><strong>Aconite</strong> is a <strong>cardiac poison</strong> derived mainly from the<strong> root </strong>and <strong>root tubers </strong>of the plant <em><strong>Aconitum napellus</strong></em> (shown below). <strong>Hippus</strong>, i.e. <strong>alternate dilatation </strong>and<strong> constriction </strong>of pupils, followed by complete dilation, is a characteristic feature. Symptoms of intoxication are due to action on the <strong>voltage-gated sodium channels</strong> on the cell membrane of nerves and skeletal and smooth muscles. Symptoms include intestinal (nausea, vomiting, perioral tingling and numbness, abdominal pain, and diarrhea), cardiovascular (chest pain, palpitations, hypotension, bradycardia), and neurological (vertigo and restlessness) manifestations.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/280330e98b0e439a9ebe7c2ecb75ff0cx1280x960.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-120",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD8198",
    "stauts": "Incorrect",
    "question_title": "120.\n        A 32-year-old G3P2 Rh-negative mother presented at 35 weeks of gestation for follow-up. Her husband is Rh-positive. She did not receive anti-D prophylaxis for her previous two pregnancies. Her current antibody titers are at 1:32. On Doppler velocimetry, the middle cerebral artery peak systolic velocity is at 1.7 multiples of median (MoM). What is the next step in management?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Intrauterine transfusion\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Deliver at 37 weeks",
    "optionC": "C. Deliver immediately\n                \n                  \n                    \nCorrect",
    "optionD": "D. Estimate fetal hemolysis",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Middle cerebral artery peak systolic velocity (MCA PSV) of <strong>&gt;1.5 MoM</strong> is suggestive of <strong>fetal anemia</strong> and the next step in management is to <strong>deliver immediately</strong> since the patient is at <strong>more</strong> <strong>than</strong>&nbsp;<strong>34 weeks of gestation.</strong></p>\n<p>The protocol for RH isoimmunisation is as follows:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/92aa0866225a4b8eb53805c73b029291x1280x3281.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options</p>\n<p>Option A: Intrauterine transfusion is usually done when <strong>fetal hematocrit</strong> is <strong>&lt;30%</strong>. It is done <strong>before 34 weeks</strong> of gestation.</p>\n<p>Option C: It would be advisable to wait till 37-38 weeks if <strong>MCA PSV &lt;1.5 MoM</strong>. In this case, fetal hemolysis has already occurred and immediate delivery is required.</p>\n<p>Option D: Estimation of fetal hemolysis is done through amniocentesis or MCA PSV. Follow-up of MCA PSV every 2 weeks till 37-38 weeks is done only <strong>when MCA PSV &lt;1.5 MoM</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-121",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5729",
    "stauts": "Incorrect",
    "question_title": "121.\n        A patient with myocardial infarction develops a sudden circulatory collapse. On examination, his BP is 80/70 mm Hg and his pulse rate is 40 beats/minute. Which of the following physiological reflexes is involved in this scenario?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Bain bridge reflex\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Cushing reflex",
    "optionC": "C. J receptor reflex",
    "optionD": "D. Bezold-jarisch reflex\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The circulatory collapse in a patient of MI (myocardial infarction) is due to&nbsp;<strong>Bezold-Jarisch Reflex.&nbsp;</strong></p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Carotid sinus baroreceptors</strong> sense the arterial hypotension and trigger afferent fibres that send autonomic signals resulting in an increase in heart rate and contractility, while pressure receptors in the left ventricular wall send signals that trigger paradoxical bradycardia and decreased contractility. This results in suddenly marked hypotension and the individual feels lightheaded and may lose consciousness for a brief period.</p>\n<p>The <strong>activation</strong> of <strong>chemosensitive vagal C fibres</strong> in the cardiopulmonary region (e.g. juxta capillary region of alveoli, ventricles, atria, great veins, and pulmonary artery) that causes profound <strong>brady­cardia, hypotension </strong>and a brief period of <strong>apnea </strong>followed by<strong> rapid shallow breathing </strong>is the<strong> Bezold Jarisch reflex</strong>.</p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>It can be elicited by :</p>\n<ul>\n<li>Substances like capsaicin, serotonin, phenylbiguanide, veratridine</li>\n<li>Myocardial ischemia and reperfusion as a result of increased production of oxygen radicals&nbsp;</li>\n<li>Radiocontrast agents for coronary angiography</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>Other options:</p>\n<p>Option A: <strong>Tachycardia</strong> following acute volume overload is due to the <strong>Bainbridge Reflex</strong>. The stretch receptors of the atria that elicit the Bainbridge reflex transmit their afferent signals through the vagus nerves to the medulla of the brain.&nbsp;Efferent signals are then transmitted back through vagal and sympathetic nerves to increase heart rate and strength of heart contraction.</p>\n<p>Option B: <strong>Hypertension</strong> following a head injury is due to the <strong>Cushing Reflex</strong>. When the intracranial pressure is increased, the blood supply to RVLM neurons is compromised. The local hypoxia and hypercapnia cause an increase in discharge from the neurons, producing hypertension, bradycardia, and irregular respiration.&nbsp;The resultant rise in systemic arterial pressure tends to restore the blood flow to the medulla.</p>\n<p>Option C: Apnea followed by rapid breathing after <strong>iv capsaicin</strong> is due to the <strong>J Reflex</strong>. C fibre-endings close to the pulmonary vessels are called&nbsp;J (juxtacapillary) receptors. These receptors are stimulated by <strong>hyperinflation</strong> of the<strong> lungs</strong> or intravenous administration of capsaicin. The reflex produced is apnea followed by rapid breathing, bradycardia, and hypotension. This is called the&nbsp;J reflex or <strong>pulmonary</strong> <strong>chemoreflex</strong>. A similar response is produced by receptors in the <strong>heart</strong> (Bezold-Jarisch reflex or the <strong>coronary</strong> <strong>chemoreflex</strong>).</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-122",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MA1777",
    "stauts": "Correct",
    "question_title": "122.\n        All of the following cause traumatic asphyxia, except",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Railway accident",
    "optionB": "B. Road traffic accident",
    "optionC": "C. Accidental strangulation\n                \n                  \n                    \nCorrect",
    "optionD": "D. Stampede in crowd",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Traumatic asphyxia, or&nbsp;Perthes's syndrome, </strong>is a medical emergency caused by an<strong> intense compression of the thoracic cage, </strong>causing back-flow of blood from the right side of the heart into the veins of the neck and the brain.</p>\n<p>This may occur during road traffic collisions or following collapse of structures such as mine tunnels, or buildings in earthquakes.</p>\n<p>Pressure on the chest that restricts movement may also occur if the individual simply gets into, or is placed into, a<strong> position in which the free movement of the chest is restricted.</strong> This positional asphyxia occurs most commonly in individuals that are<strong> rendered immobile through alcohol or drugs </strong>and may be seen following restraint in custodial settings.</p>\n<p>It may also be seen in the healthy, for example, attempting to<strong> climb through a small window</strong> to gain access to a property.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-123",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF9628",
    "stauts": "Skipped",
    "question_title": "123.\n         Which of the following statements are true regarding the grading of renal injury in patients with traumatic renal injury?",
    "question_ADD": "<ol>\n<li>Microscopic or gross haematuria with normal imaging is grade I.</li>\n<li>Laceration of &lt;1 cm parenchymal depth without extravasation of urine is grade II.</li>\n<li>Non-expanding peri-renal hematoma confined to the retroperitoneum is grade III.</li>\n<li>Avulsion of the renal hilum devascularizing the kidney is grade IV.</li>\n<li>A shattered kidney is grade V.</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1,2,5\n                \n                  \n                    \nCorrect",
    "optionB": "B. 1,4,5",
    "optionC": "C. 2,3,4",
    "optionD": "D. 2,3,5",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The statements that are true regarding the grades of renal injury are:</p>\n<ul>\n<li>Microscopic or gross haematuria with normal imaging is grade 1.</li>\n<li>Laceration of &lt;1 cm parenchymal depth without extravasation of urine is grade II.</li>\n<li>A shattered kidney is grade V</li>\n</ul>\n<p>A <strong>non-expanding</strong> peri-renal hematoma <strong>confined</strong> to the <strong>retroperitoneum</strong> belongs to<strong> grade II</strong>. <strong>Avulsion</strong> of the <strong>renal hilum</strong> devascularising the kidney belongs to <strong>grade V</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2238: American Association for the Surgery of Trauma (AAST) Kidney Injury Scale</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p class=\"p1\">GRADE&nbsp;&nbsp;</p>\n</td>\n<td>INJURY</td>\n<td>DESCRIPTION</td>\n</tr>\n<tr>\n<td>I</td>\n<td>\n<p class=\"p1\">Contusion</p>\n</td>\n<td>\n<p class=\"p1\">Microscopic or gross hematuria, urologic studies normal</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Hematoma</td>\n<td>\n<p class=\"p1\">Subcapsular, nonexpanding, without parenchymal laceration</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td>\n<p class=\"p1\">Hematoma</p>\n</td>\n<td>\n<p class=\"p1\">Nonexpanding perirenal hematoma confined to renal retroperitoneum</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Laceration</td>\n<td>\n<p class=\"p1\">&nbsp;&lt;1 cm parenchymal depth of renal cortex without urinary extravasation</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<p class=\"p1\">Laceration&nbsp;</p>\n</td>\n<td>\n<p class=\"p1\">&gt;1 cm depth of renal cortex, without collecting system rupture or urinary extravasation</p>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>Laceration</td>\n<td>\n<p class=\"p1\">Parenchymal laceration extending through the renal cortex, medulla, and collecting system</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Vascular</td>\n<td>\n<p class=\"p1\">Main renal artery or vein injury, with contained hemorrhage</p>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td>Laceration</td>\n<td>Completely shattered kidney</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Laceration&nbsp;&nbsp;</td>\n<td>Avulsion of renal hilum, which devascularizes kidney</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7b401ef41a614376a0bf729998a717a5x1280x2560.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-124",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF3607",
    "stauts": "Incorrect",
    "question_title": "124.\n        Match the antibodies seen in systemic lupus erythematosis with their specific clinical utility.",
    "question_ADD": "<table style=\"height: 317px; width: 435px;\">\n<tbody>\n<tr>\n<td style=\"width: 149.815px;\">1. Anti-Sm</td>\n<td style=\"width: 269.185px;\">a. Best screening test for SLE</td>\n</tr>\n<tr>\n<td style=\"width: 149.815px;\">2. Anti-histone</td>\n<td style=\"width: 269.185px;\">b. Predisposes to neonatal lupus with congenital heart block&nbsp;</td>\n</tr>\n<tr>\n<td style=\"width: 149.815px;\">3. Anti-nuclear</td>\n<td style=\"width: 269.185px;\">c. Predisposes&nbsp;clotting &amp; thrombocytopenia</td>\n</tr>\n<tr>\n<td style=\"width: 149.815px;\">4. Anti-phospholipid</td>\n<td style=\"width: 269.185px;\">d. Specific for SLE. Simultaneous RNP positivity is also seen.</td>\n</tr>\n<tr>\n<td style=\"width: 149.815px;\">5. Anti-Ro</td>\n<td style=\"width: 269.185px;\">e. More frequently associated with drug-induced lupus than SLE</td>\n</tr>\n</tbody>\n</table>",
    "question_imag": "",
    "optionA": "A. 1-d, 2-c, 3-a, 4-e, 5-b",
    "optionB": "B. 1-d, 2-e, 3-b, 4-c, 5-a",
    "optionC": "C. 1-b, 2-e, 3-a, 4-c, 5-d\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 1-d, 2-e, 3-a, 4-c, 5-b\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched antibodies seen in Systemic Lupus Erythematosis with their clinical relevance are given below.</p>\n<table>\n<tbody>\n<tr>\n<td>1. Anti-Sm</td>\n<td>d. Specific for SLE. Simultaneous RNP positivity is also seen</td>\n</tr>\n<tr>\n<td>2. Anti-histone</td>\n<td>e. More frequently associated with drug-induced lupus than SLE</td>\n</tr>\n<tr>\n<td>3. Anti-nuclear</td>\n<td>a. Best screening test for SLE</td>\n</tr>\n<tr>\n<td>4. Anti-phospholipid</td>\n<td>c. Predisposes&nbsp;clotting &amp; thrombocytopenia</td>\n</tr>\n<tr>\n<td>5. Anti-Ro</td>\n<td>b. Predisposes&nbsp;to neonatal lupus with congenital heart block</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Systemic lupus erythromatosis (SLE) </strong>is an <strong>autoimmune disease</strong> that causes cell damage due to autoantibodies and immune complexes. It is more commonly seen in <strong>females </strong>and<strong>&nbsp;</strong>is associated with autoimmune activation of innate immunity, autoantibodies, and T-cells. Several factors predispose to this disease including:</p>\n<ul>\n<li>Genetic factors: <strong>HLA-DR3</strong>, DNAse-1, STAT4, APOL-1</li>\n<li>Environmental factors: UV light, smoking, crystalline silica, Ebstein Barr Virus infection</li>\n</ul>\n<p><strong>Diagnosis</strong><span> of SLE is based on the characteristic clinical features and autoantibodies. </span></p>\n<p><strong>Systemic Lupus International Collaborating clinic criteria (SLICC)</strong><span> for diagnosis of SLE:</span></p>\n<p><strong><span>Clinical manifestations:</span></strong></p>\n<ol>\n<li><span>Skin:<br>- Acute/ Subacute: photosensitivity, <strong>malar rash,</strong> maculopapular lesions<br>- Chronic: <strong>discoid lupus,</strong> panniculitis</span></li>\n<li><span>&nbsp;Oral or nasal ulcers</span></li>\n<li><span>Non-scarring alopecia</span></li>\n<li><span>Renal:<br>- <strong>Protein/Creatinine &gt;=0.5</strong><br>- RBC casts<br>- Biopsy</span></li>\n<li><span><strong>Synovitis</strong> &gt;+2 joints</span></li>\n<li><span><strong>Serositis</strong> - pleurisy, pericarditis</span></li>\n<li><span>Neurologic:<br>- Seizures<br>- Psychosis<br>- Mononeuritis<br>- Myelitis<br>- Cranial neuropathies</span></li>\n<li><span>Hemolytic anemia</span></li>\n<li><span>Leukopenia or lymphopenia</span></li>\n<li><span>Thrombocytopenia</span></li>\n</ol>\n<p><strong><span>Immunologic manifestations:</span></strong></p>\n<ol>\n<li><span><strong>ANA</strong> &gt; reference negative value</span></li>\n<li><span><strong>Anti-dsDNA</strong> &gt; reference</span></li>\n<li><strong><span>Anti-Sm</span></strong></li>\n<li><span>Antiphospholipid:<br>- lupus anticoagulant<br>- anticardiolipin<br>- anti-beta glycoprotein I</span></li>\n<li><span>Low serum complements</span></li>\n<li><span><strong>Direct Coomb's test positive </strong>in the absence of hemolytic anemia</span></li>\n</ol>\n<p>The presence of <strong>any 4</strong> criteria with <strong>at least 1 in each</strong> category is diagnosed as SLE with 93% specificity and 92 % sensitivity. A positive <strong>renal&nbsp;biopsy</strong> is read as systemic lupus even if none of the other features is present.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1922: Antibodies in Systemic lupus erythematosus (SLE)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"0\">\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates&nbsp; with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP&nbsp;<br>More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not&nbsp;Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br>More common in blacks and whites&nbsp;</td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br>Primarily 60kDA and 52kDA</td>\n<td>Not&nbsp;Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased&nbsp; risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br>(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp;&nbsp;β2 G1,<br>Sensitive prothrombin time (DRVVT)<br>Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane&nbsp;</td>\n<td>&nbsp;Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br>This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br>(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-125",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC7927",
    "stauts": "Correct",
    "question_title": "125.\n        A 40-year-old woman presents with a sudden loss of vision in both eyes that occurred after a stressful argument with her boss. On examination, her visual acuity is recorded as 6/6 in each eye, and her pupils are equal, round, and reactive to light. There are no abnormalities found on ophthalmic examination or in other neurological evaluations. When asked to follow a moving object or identify visual stimuli, she demonstrates inconsistent performance. What is the most likely diagnosis?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Conversion disorder\n                \n                  \n                    \nCorrect",
    "optionB": "B. Catatonia",
    "optionC": "C. Central retinal vein occlusion",
    "optionD": "D. Eale's disease",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The most likely diagnosis based on the clinical vignette given is&nbsp;<strong>conversion disorder</strong>&nbsp;/functional neurologic symptom disorder.</p>\n<p>Conversion disorder is a condition with symptoms or deficits that involve <strong>voluntary motor</strong> or <strong>sensory functions</strong>. Though it points to an underlying medical condition, in reality, it arises due to <strong>psychological factors</strong>. The symptoms are <strong>not intentionally produced</strong> and the gain obtained is primarily psychological.&nbsp;</p>\n<p>It can be associated with <strong>depressive disorders</strong>, anxiety disorders, personality disorders, and somatization disorders. Paralysis, <strong>blindness</strong>, and mutism are the most frequently seen conversion disorder symptoms. <strong>Anaesthesia</strong> and<strong> paresthesia </strong>of the extremities, abnormal movements, and gait disturbance are the other features commonly seen.&nbsp;</p>\n<p>Conversion disorder usually <strong>resolves spontaneously</strong>. Insight-oriented or <strong>behavioural therapy</strong> is also helpful. Hypnosis and <strong>anxiolytics</strong> are used in some cases.&nbsp;</p>\n<p>Other options:&nbsp;</p>\n<p>Option B: <strong>Catatonia</strong>&nbsp;is a condition seen in advanced<strong>&nbsp;primary mood</strong>&nbsp;or&nbsp;<strong>psychotic illnesses</strong>.&nbsp;Some conditions that can cause catatonia include&nbsp;<strong>head trauma</strong>, encephalitis, and&nbsp;<strong>hepatic encephalopathy</strong>. Some medications such as<strong>&nbsp;corticosteroids</strong>, immunosuppressants, or antipsychotics can also result in the condition. Some clinical features include&nbsp;<strong>grimacing</strong>, mutism, <strong>echolalia,</strong> stupor, and posturing.</p>\n<p>Option C: <strong>Central retinal vein occlusion (CRVO)</strong>, especially in its<strong> ischemic </strong>form, usually presents with <strong>severe visual loss</strong>, marked<strong> retinal haemorrhages, cotton wool spots, optic disc oedema</strong>, and a <strong>relative afferent pupillary defect (RAPD)</strong>, often accompanied by detectable abnormalities on ophthalmic examination. However, this patient has normal visual acuity, normal pupillary reactions, and no detectable abnormalities on ophthalmic or neurological exams, making CRVO an unlikely diagnosis in this case.</p>\n<p>Option D: <strong>Eales' disease</strong>, common in <strong>young Asian males</strong>, features <strong>recurrent vitreous haemorrhage</strong> and <strong>retinal neovascularization</strong> due to peripheral <strong>retinal vein inflammation</strong>. It presents with a <strong>reddish vitreous mass</strong> and can lead to <strong>vision loss</strong> and complications like <strong>retinal detachment</strong>. However, it is less likely here due to the patient’s demographics and absence of characteristic findings.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0377: Conversion Disorder</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Conversion disorder</strong>: Also called functional neurological symptom disorder.</p>\n<p><strong>Common presenting symptoms</strong>:</p>\n<ul>\n<li>Weakness and/or paralysis</li>\n<li>Non-epileptic seizures</li>\n<li>Movement disorders</li>\n<li>Speech or visual impairment like mutism or blindness</li>\n<li>Swallowing difficulty</li>\n<li>Sensory disturbances</li>\n<li>Cognitive symptoms</li>\n</ul>\n<p><strong>Diagnostic criteria</strong>:</p>\n<ul>\n<li>Symptoms of altered neurological function-voluntary motor or sensory</li>\n<li>Often precipitated by a psychological stressor (the temporal relationship between stressor and symptoms is present)</li>\n<li>Not feigned or intentionally produced (as in factitious disorder or malingering)</li>\n<li>Findings incompatible with a recognized neurological condition</li>\n<li>Symptoms cause significant social or occupational impairment</li>\n</ul>\n<p><strong>Other important features</strong>:</p>\n<ul>\n<li><strong>Primary gain</strong> - Unconscious relief from stress&nbsp;as the focus of the patient shifts to&nbsp;the symptoms.</li>\n<li><strong>Secondary gain</strong> - Attention gained by the patient (from bystanders) as a result of the symptoms.</li>\n<li><strong>La-belle indifference </strong>-&nbsp;refers to an absence of concern towards one’s problem despite severe disability</li>\n<li><strong>Astasia abasia</strong> - Wildly ataxic, staggering gait accompanied by irregular, jerky truncal movements, thrashing and waving arm movements</li>\n</ul>\n<p><strong>Management options</strong>:</p>\n<ul>\n<li>First-line: Education and self-help technique</li>\n<li>Second-line: Cognitive-behavioral therapy</li>\n<li>Physical therapy for motor symptoms</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0376: Somatoform Disorder</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Somatoform Disorder</strong></td>\n<td>\n<p><strong>Key features of somatic symptom and related disorders</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Somatic symptom disorder</span></p>\n</td>\n<td>\n<p><span>Excessive anxiety and preoccupation with ≥1 unexplained symptom</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Illness anxiety disorder</span></p>\n<p><span>(hypochondriasis)</span></p>\n</td>\n<td>\n<p><span>Fear of having a serious illness despite few or no symptoms and consistently negative evaluations</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Conversion disorder</span></p>\n<p><span>(functional neurologic symptom disorder)</span></p>\n</td>\n<td>\n<p><span>Neurologic symptom&nbsp; incompatible with any known neurologic disease, often acute onset associated with stress</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Factitious disorder</span></p>\n</td>\n<td>\n<p><span>Intentional falsification or inducement of symptoms with a goal to assume the sick role</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Malingering</span></p>\n</td>\n<td>\n<p><span>Falsification or exaggeration of symptoms to obtain external incentives (secondary gain)</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1937: Classification of somatic symptom disorders: DSM-5 vs ICD-10</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DSM-5</strong></p>\n<p><span>(S</span><span>omatic symptom and related disorders)</span></p>\n</td>\n<td>\n<p><strong>&nbsp;ICD-10</strong></p>\n<p><span>(Somatoform disorders)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Somatic symptom disorder</span></td>\n<td>\n<p><span>Somatization disorder</span></p>\n<p><span>Undifferentiated somatoform disorder</span></p>\n<p><span>Persistent somatoform pain disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Conversion disorder</span><span>&nbsp;</span><span>(functional neurological</span><span>&nbsp;</span><span>symptom disorder)</span></td>\n<td><span>Dissociative (conversion) disorder</span></td>\n</tr>\n<tr>\n<td><span>Illness anxiety disorder</span></td>\n<td><span>Hypochondriacal disorder</span></td>\n</tr>\n<tr>\n<td><span>Factitious disorder</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td><span>Somatoform disorder NEC</span></td>\n<td>\n<p><span>Somatoform autonomic dysfunction</span></p>\n<p><span>Other somatoform disorders</span></p>\n<p><span>Somatoform disorder unspecified</span></p>\n<p><span>Neurasthenia (neurotic</span><br><span>disorders category)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Psychological factors affecting another medical condition</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Psychiatry"
  },
  {
    "web-scraper-order": "1727319149-126",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0359",
    "stauts": "Correct",
    "question_title": "126.\n        A patient on statins was advised to discontinue his medications as he developed statin induced myopathy. When he came for follow up 6 weeks later, his CK levels were normalized. What is the next step in the management of hypercholesterolemia for this patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Restart statin at a lower dose\n                \n                  \n                    \nCorrect",
    "optionB": "B. Advice dietary modifications only",
    "optionC": "C. Start him on ezetimibe",
    "optionD": "D. Start him on Omega 3 fatty acids",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This patient had <strong>statin-induced myopathy</strong> and now is presenting for further management of his <strong>hypercholesterolemia.</strong> The next step in his management would be to <strong>restart statins</strong> at a <strong>lower dose</strong> to see if he can <strong>tolerate</strong> them.&nbsp;</p>\n<p>Statin-induced myopathy presents with <strong>muscle pain, tenderness or weakness.</strong> The risk of statin-associated myalgia or myopathy is increased by factors such as <strong>older age, frailty, renal insufficiency</strong>, and the use of drugs that interfere with statin metabolism, including <strong>erythromycin</strong> and related antibiotics, <strong>antifungal</strong> agents, <strong>immunosuppressive drugs</strong>, and fibric acid derivatives, especially <strong>gemfibrozil.</strong> If muscle symptoms arise, a <strong>plasma CK level</strong> can be measured to distinguish myopathy from myalgia. CK levels would be higher in myopathy.</p>\n<p><strong>Statins</strong> are the most commonly used hypolipidemic drugs. Statins act by <strong>inhibiting</strong> the rate-limiting<strong> HMG-CoA reductase</strong> enzyme, which in turn <strong>inhibits cholesterol synthesis</strong>. They decrease low-density lipoproteins (LDL), and triglycerides and increase high-density lipoproteins in plasma.</p>\n<p>Examples of statins are lovastatin, Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin, and Pitavastatin.</p>\n<p>If a patient develops statin-induced myopathy, the next step is to stop medications and observe for normalisation of his CK levels over 4-6 weeks. Once his CK levels are normal, <strong>low-dose statins</strong> must be attempted first. If that is not tolerated, then a <strong>different class</strong> of drug can be attempted, for example, <strong>ezetimibe,</strong> a NPC1L1 inhibitor (Sterol absorption inhibitor). (Option C)</p>\n<p><strong>Pravastatin, pitavastatin,</strong> and <strong>fluvastatin</strong> have had lesser associations with muscle toxicity.&nbsp;</p>\n<p><strong>Alternate day dosing</strong> can also be tried if patients are not able to handle daily dosing.&nbsp;&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Dietary</strong> <strong>modification</strong> is unlikely to help a patient with hypercholesterolemia that is controlled with a drug as pharmacotherapy is usually attempted after conservative measures fail.&nbsp;</p>\n<p>Option D: Omega 3 fatty acids <strong>do</strong> <strong>not</strong> have enough supportive evidence to justify using them over proven efficacious drugs&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e09434b1ab15472f8cbdf4cdcc205a38x1280x2074.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-127",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF7540",
    "stauts": "Skipped",
    "question_title": "127.\n        Which of the following is a monoclonal antibody directed against integrin, used in the treatment of patients with multiple sclerosis?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Fingolimod",
    "optionB": "B. Teriflunomide",
    "optionC": "C. Ocrelizumab",
    "optionD": "D. Natalizumab\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Natalizumab</strong> is a humanized <strong>monoclonal antibody against the&nbsp;α<sub>4</sub> subunit of&nbsp;α<sub>4</sub>β<sub>1</sub> integrin</strong>.</p>\n<p>Natalizumab is <strong>highly effective</strong> and reduces the attack rate of <strong>multiple sclerosis</strong> thus improving the severity of the disease (both clinical and MRI). Natalizumab is given as an <strong>injectable</strong> preparation.&nbsp;</p>\n<p>The major concern of natalizumab is the <strong>risk</strong> of the development of <strong>progressive multifocal leukoencephalopathy</strong> (PML), which is also a life-threatening condition developed from the <strong>JC virus</strong> infection. The risk of developing PML is higher in patients taking natalizumab associated with <strong>JC antibody positive</strong>. Therefore, natalizumab is recommended only for JC antibody-negative patients.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Fingolimod&nbsp;</strong>is a <strong>sphingosine-1-phosphate modulator</strong>. It reduces the attack rate and improves the disease severity in multiple sclerosis. It is given as oral preparation. The patients on fingolimod are at risk of developing macular edema and <strong>disseminated varicella-zoster infection</strong>.</p>\n<p>Option B: <strong>Teriflunomide</strong> <strong>inhibits</strong> the mitochondrial enzyme, <strong>dihydro-orotate dehydrogenase</strong> present in de novo pyrimidine biosynthesis. It is given as oral preparation. The adverse effect includes Stevens-Johnson syndrome. It has teratogenicity and is considered a category X drug.&nbsp;</p>\n<p>Option C: <strong>Ocrelizumab</strong> is a humanized monoclonal antibody <strong>against</strong> the <strong>CD20 molecule</strong> located on the surface of mature B cells and is a highly effective medication for <strong>relapsing forms</strong> of multiple sclerosis. It is given as an intravenous preparation. It is associated with an increased risk of malignancy like breast cancer and infusion reactions.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-128",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF2918",
    "stauts": "Incorrect",
    "question_title": "128.\n        Identify the instrument given in the image below:",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/ac3d14affdb9440e8fda34d1aab3ca89.JPEG\">",
    "optionA": "A. DeBakey forceps",
    "optionB": "B. Payr's crushing clamp\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Bulldog clamp\n                \n                  \n                    \nCorrect",
    "optionD": "D. Lister's sinus forceps",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image is that of a <strong>Bulldog clamp</strong>.</p>\n<p>The utility of a bulldog clamp is as follows:</p>\n<ol>\n<li>To clamp the common hepatic duct to control the flow of bile during <strong>pancreaticoduodenectomy</strong>.&nbsp;</li>\n<li>Clamping the middle colic artery during <strong>left colonic interposition</strong>, for oesophageal replacement.&nbsp;</li>\n<li>Clamping of mesenteric vessels during <strong>Roux-en-y-replacement</strong>.</li>\n</ol></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:&nbsp;</p>\n<p>Option A: <strong>DeBakey's forceps</strong>&nbsp;are useful for holding vessel walls in vascular surgery. They allow the surgeon to grasp tissues firmly while minimising damage to the tissue held in the jaws of the forceps.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8502e1dd5e8a4c02a6ac1b50f498ed81x1280x589.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option B:<strong>&nbsp;Payr's crushing clamp&nbsp;</strong>is a stout, heavy instrument with a double level in the handle and it crushes the bowel once applied. It is used in gastrectomy.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/33dd4a997fb34bedbe807312f5580182x1280x1122.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D:&nbsp;<strong>Lister’s sinus forceps</strong>&nbsp;are used for&nbsp;<strong>blunt dissection.&nbsp;</strong>It is used during&nbsp;<strong>Hilton's method</strong>&nbsp;of&nbsp;<strong>abscess drainage</strong>&nbsp;to break the bacterial loculi and is&nbsp;also used for inserting or removing&nbsp;<strong>packing</strong>&nbsp;in the sinus cavity.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/90f26e7fd5484fea90311a5cce357811x1280x948.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-129",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG4453",
    "stauts": "Correct",
    "question_title": "129.\n        A 6-year-old boy presents with fatigue and yellowish discoloration of the eyes. The peripheral smear examination is given below. What is the underlying pathology involved in the disease associated with this condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/2c74a9dab60941989ee4a807a3175639.JPEG\">",
    "optionA": "A. Mutation of spectrin ankyrin proteins",
    "optionB": "B. Mutation of beta globin chain\n                \n                  \n                    \nCorrect",
    "optionC": "C. Increased osmotic fragility",
    "optionD": "D. Decreased mechanical fragility",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario of anaemia and jaundice with the peripheral smear showing <strong>sickle-shaped RBCs</strong> is suggestive of <strong>sickle cell disease</strong> and the pathology involved in the disease associated with this condition is the <strong>mutation </strong>of the<strong> beta-globin chain</strong>.&nbsp;</p>\n<p>Sickle cell anaemia is an <strong>autosomal recessive disorder</strong> that occurs due to the <strong>point mutation in the β-globin gene</strong>, which results in the replacement of <strong>glutamate</strong> residue with <strong>valine</strong>. This causes the production of sickle-shaped red blood cells due to the <strong>polymerization of deoxygenated haemoglobin (HbS)</strong>.</p>\n<p>Factors that predispose to sickling are -&nbsp;</p>\n<p><strong>Intracellular dehydration</strong> increases the mean corpuscular haemoglobin concentration(MCHC) which increases the aggregation and polymerization of RBCs during deoxygenation. Conversely, conditions that decrease the MCHC reduce disease severity. This occurs when an individual is homozygous for HbS but also has coexistent α-thalassemia, which reduces Hb synthesis and leads to milder disease.</p>\n<p><span>A <strong>decrease </strong>in<strong> intracellular pH </strong>reduces the <strong>oxygen affinity</strong> of haemoglobin, thereby increasing the levels of deoxygenated HbS at any given oxygen tension and augmenting the tendency for sickling.</span></p>\n<p>In most of the microvascular capillaries, the <strong>transit time of RBCs is too short</strong> for significant aggregation of deoxygenated HbS to occur. As a result, <strong>sickling </strong>is confined to microvascular capillaries with <strong>slow transit times</strong>. Blood flow is sluggish in the normal spleen and bone marrow, which are prominently affected in sickle cell disease.</p>\n<p>Note - The presence of <strong>HbF decreases sickling </strong>as it shows <strong>higher oxygen affinity</strong> than HbA and thereby reduces the levels of deoxygenated Hb which are prerequisites for sickling. <strong>Hydroxyurea</strong>, a drug used in sickle cell disease acts by <strong>promoting HbF production</strong>.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Hereditary spherocytosis</strong> is an <strong>autosomal dominant hereditary hemolytic anaemia</strong> caused by mutations in r<strong>ed blood cell surface proteins</strong> like <strong>spectrin</strong> and <strong>ankyrin</strong>.</p>\n<p>Option C: <strong>Hereditary spherocytosis</strong> is likely to have <strong>increased osmotic fragility, </strong>unlike<strong> sickle cell disease </strong>which has<strong> decreased osmotic fragility.</strong></p>\n<p>Option D: In <strong>Sickle cell disease</strong>, there is <strong>increased mechanical fragility</strong> like in cases of <strong>thalassemia, G6PD deficiency, </strong>and<strong> malaria</strong>. When subjected to <strong>mechanical stress</strong>, such as shearing forces, trauma, or <strong>turbulence, </strong>sickle cells have <strong>high mechanical fragility </strong>because they are <strong>more rigid </strong>and <strong>less deformable</strong> than normal red blood cells. This makes them more likely to break apart when subjected to mechanical stress.</p>\n<p>Note: Mechanical fragility measures the extent of hemolysis observed when red blood cells are exposed to mechanical stress, often through shear forces.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-130",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6822",
    "stauts": "Incorrect",
    "question_title": "130.\n        A 7-year-old boy with a recent history of travel to central Africa is brought to the ER with a painful blistering rash that started over the face and progressed to other regions. The rash started almost 5 days before the presentation. He also complained of associated low-grade fever, myalgia, and fatigue. On examination, there is palpable regional and inguinal lymphadenopathy and blisters, as shown in the image. He was accompanied by his mother, who was currently asymptomatic. Ideal management for her would be:",
    "question_ADD": "<p>ER - Emergency room</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://upload.wikimedia.org/wikipedia/commons/e/ef/Monkeypox.jpg\">",
    "optionA": "A. Only isolate for 21 days",
    "optionB": "B. Isolate for 21 days along with prophylactic antivirals\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Prophylactic antivirals only",
    "optionD": "D. Only Monitor for 21 days\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical vignette suggests a case of <strong>monkeypox (Mpox) virus&nbsp;</strong>and management of this patient's asymptomatic mother would be to <strong>monitor her for 21 days.</strong></p>\n<p>Management of <strong>asymptomatic</strong> contacts includes <strong>monitoring for 21 days</strong>. There is no role for prophylactic antivirals. If at any point in time in 21 days, the patient develops symptoms he should be placed for an <strong>empiric 5-day isolation</strong>. The natural reservoir is unknown. The <strong>incubation</strong> <strong>period</strong> might last from <strong>5 to 21 days.</strong> The communicability phase lasts 1-2 days before the rash appears and ends when all scabs fall off or diminish. There is evidence of both human-to-human and animal-to-human transmission.&nbsp;</p>\n<p>While monitoring a patient with monkeypox during this period of 21 days we may come across patients either in one of these two categories:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>If a <strong>rash</strong> occurs</td>\n<td>The patient needs to be isolated until the rash is examined and tested by a doctor and it is tested negative.</td>\n</tr>\n<tr>\n<td>Other signs or symptoms but <strong>no rash</strong></td>\n<td>\n<p>The patient needs to be observed<strong> for another 5 days</strong> for any more new signs or symptoms <strong>even if it extends beyond 21 days.&nbsp;</strong></p>\n<p>also, it is to be noted that if a new sign or symptom has been observed during this extended period of 5 days, the patient needs to be <strong>further</strong> <strong>observed</strong> for another 5 days. Whereas if there is no sign or symptom observed, monitoring may be stopped and the patient discharged.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><br>Mpox virus belongs to the <strong>orthopoxvirus</strong> genus of the <strong>Poxviridae</strong> family which is a <strong>double</strong>-<strong>stranded</strong> <strong>DNA</strong> <strong>Virus</strong> and <strong>enveloped</strong>. Mpox has been prevalent in parts of central and western Africa. The clinical features of the disease include fever, myalgia, fatigue, and back pain. It is associated with a painful rash starting on the Face and spreading to the trunk and chest. One of the characteristic differentiating features from chickenpox and smallpox is the <strong>presence of lymphadenopathy.</strong></p>\n<p>The<strong> monkeypox virus </strong>has been further classified into two types<strong> </strong>ie<strong>. Clade I and Clade II.</strong></p>\n<p><strong>Clade I: </strong>Predominantly found in<strong> Central and East Africa </strong>and<strong> </strong>is<strong> more severe.</strong></p>\n<p><strong>Clade II: </strong>Endemic to<strong> West Africa </strong>and is<strong> less severe.</strong></p>\n<p><strong>Diagnosis</strong> is done by RT-PCR of blister fluid or body fluids.</p>\n<p>Most cases of mpox present with mild symptoms and there is complete recovery within 2 to 4 weeks. There is <strong>no</strong> <strong>specific</strong> <strong>treatment</strong> for the disease yet, although antivirals such as <strong>Tecovirimat</strong> have been approved for the treatment of severe Mpox.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/71b0b57c0c8742fdb06d24d19c1796e6x851x560.JPEG\"><img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/71f419d6476a45a8a90bb0b44e7e7b27x506x539.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-131",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5396",
    "stauts": "Incorrect",
    "question_title": "131.\n        Structures are marked as 1, 2 ,3 and 4 in CT of the paranasal sinus below. In which of the following given structures does the nasolacrimal duct opens into?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/36cc638a4c984ed6842eefdff4dfacda.JPEG\">",
    "optionA": "A. 1\n                \n                  \n                    \nCorrect",
    "optionB": "B. 2",
    "optionC": "C. 3\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The structure marked as <strong>1 </strong>is<strong> the inferior meatus</strong> and the <strong>nasolacrimal duct opens</strong> into it.</p>\n<p>The <strong>valve of Hasner</strong>, which is present at the <strong>lower end</strong> of the duct <strong>prevents reflux</strong> from the <strong>nose</strong>. The<strong> inferior turbinate</strong> is a <strong>separate bone </strong>and the inferior meatus lies below it.</p>\n<p><strong>Maxillary</strong> (Antrum of Highmore), <strong>frontal</strong> and <strong>anterior ethmoidal</strong> sinuses <strong>open in the middle meatus </strong>and their ostia lie anterior to basal lamella of middle turbinate.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f8352eb27f9940bda3934e5726cedcefx1280x1001.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "ENT"
  },
  {
    "web-scraper-order": "1727319149-132",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8593",
    "stauts": "Incorrect",
    "question_title": "132.\n        Identify the marked structure in the given image.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/8501a37ab7c34d10888612e706de2219.PNG\">",
    "optionA": "A. Claustrum\n                \n                  \n                    \nCorrect",
    "optionB": "B. Globus pallidus",
    "optionC": "C. Internal capsule\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Putamen",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The structure marked in the given image of transverse section of basal ganglia is a <strong>gray matter structure</strong> known as <strong>claustrum</strong>. It is flanked by <strong>external capsule medially</strong> and <strong>extreme capsule and insular cortex laterally.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f44c35f8eb4f4a5d9700a30834046b43x1280x1047.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The gray matter structures which can be seen on a transverse section of the cerebrum are:</p>\n<ul>\n<li>Head of <strong>caudate</strong> <strong>nucleus</strong> forms the lateral wall of the anterior horn of the lateral ventricle.</li>\n<li><strong>Thalamus</strong>&nbsp;contributes to the floor of the body of the lateral ventricle.</li>\n<li><strong>Lentiform</strong> <strong>nucleus</strong> is a wedge-shaped mass related medially to the internal capsule, which separates it from the caudate nucleus and the thalamus and laterally to the external capsule. A vertical plate of white matter divides the lentiform nucleus into <strong>globus</strong> <strong>pallidus</strong> medially and <strong>putamen</strong> laterally.&nbsp;</li>\n<li><strong>Claustrum</strong> separates the external capsule from the extreme capsule and the subcortical white matter of the insular cortex.<strong>&nbsp;</strong>The function of claustrum is not known.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"magic-line ng-tns-c132-2 ng-star-inserted\"><p>All the capsules (internal capsule, external capsule and extreme capsule) are white matter bundles while all the nuclei (caudate nucleus, lentiform nucleus, thalamus) are masses of gray matter.&nbsp;</p></div><!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-133",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC8054",
    "stauts": "Correct",
    "question_title": "133.\n        A 72-year-old male patient complains of headaches. His son adds that the patient also has memory disturbances. Further questioning revealed a history of a fall a few months back. The most probable diagnosis among the following is",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Extradural Hematoma",
    "optionB": "B. Diffuse Axonal Injury",
    "optionC": "C. Chronic Subdural Hematoma\n                \n                  \n                    \nCorrect",
    "optionD": "D. Subarachnoid Hemorrhage",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>An&nbsp;<strong>elderly</strong>&nbsp;male patient with a history of&nbsp;<strong>memory disturbances&nbsp;</strong>and&nbsp;<strong>headaches</strong> following a history of<strong>&nbsp;fall</strong> point toward&nbsp;<strong>chronic subdural hemorrhage</strong>&nbsp;(SDH).&nbsp;</p>\n<p><strong>Chronic SDH</strong> is commonly seen in <strong>elderly </strong>patients. It is also a common cause of <strong>acute neurological deterioration </strong>in them. Cerebral atrophy in the elderly age group results in the stretching of <strong>cortical–dural bridging veins</strong>, which makes them vulnerable to rupture. The resulting <strong>hematoma</strong> can <strong>expand</strong> over days or weeks by <strong>osmosis</strong>, ultimately leading to symptoms of <strong>raised ICP</strong> or focal deficits.</p>\n<p>There is usually a history of a recent injury. Even apparently <strong>trivial impacts</strong> may be responsible for this condition, especially if on <strong>antiplatelet </strong>or <strong>anticoagulant</strong> medications.</p>\n<p>On head CT scan, chronic SDH appears as a <strong>hypodense</strong>, crescent-shaped (concavo-convex) lesion as shown in the image below.</p>\n<p><strong>Burr hole evacuation</strong> is the preferred treatment in most patients with chronic SDH. Conservative treatment can be considered in small, asymptomatic bleeds.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a234d6bb9b2443b4bb4ff4b3191e9910x123x137.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Acute SDH</strong> results from the accumulation of blood between the <strong>arachnoid membrane</strong> and the <strong>dura</strong>. The tearing of a <strong>bridging vein</strong> running from the cerebral cortex to the dural sinuses is the <strong>most common cause </strong>of acute SDH.</p>\n<p>On head CT scan, acute SDH appears as a <strong>hyperdense</strong>, crescent-shaped (concavo-convex) lesion as shown in the image below.</p>\n<p><strong>Open craniotomy</strong> for the evacuation of acute SDH is indicated for the following:</p>\n<ul>\n<li>Thickness &gt;1 cm</li>\n<li><strong>Midline shift &gt;5 mm</strong></li>\n<li>Or <strong>GCS drops</strong> by <strong>two or more points</strong> from the time of injury to hospitalization.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e4fff63185cd4538bef09320da3e89bbx720x898.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>All other conditions, given as options present with rapid deterioration of neurological signs and symptoms along with a history of <strong>high-energy impact</strong> injury. Hence, they are ruled out.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0111: Types of Intracranial Hemorrhage</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>1. Extradural hemorrhage/epidural hematoma (EDH)</strong></p>\n<ul>\n<li>Source: Arterial - <strong>middle meningeal artery&nbsp;</strong>(m/c)</li>\n<li>Cause: Trauma - fracture of the squamous part of the <strong>temporal bone</strong></li>\n<li><strong>Lens or lentiform</strong> shaped opacity</li>\n<li>Presence of a characteristic <strong>lucid interval</strong></li>\n<li>Treatment: Surgical evacuation of large/rapidly evolving EDH</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/507e530f4b3c4faba01eac509037b78bx784x963.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>2. Acute subdural hemorrhage&nbsp;</strong>(SDH)</p>\n<ul>\n<li>Source: Venous - bridging veins</li>\n<li>Cause: Trauma</li>\n<li>Common in <strong>old age</strong>, <strong>alcoholics</strong>, patients on <strong>anticoagulants</strong>, <strong>shaken baby syndrome</strong> (a form of child abuse seen in infants and toddlers)</li>\n<li>Clinical features: Acute SDH may be associated with a lucid interval; chronic SDH is associated with drowsiness, headache</li>\n<li>CT findings: <strong>Crescent</strong>&nbsp;opacity</li>\n<li>Treatment: May resolve spontaneously or require surgical drainage</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a7e5c451c38e4dedbdc912ca6a22c4dax1280x1026.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>3. Acute on chronic SDH</strong></p>\n<ul>\n<li>Source: Venous - bridging veins</li>\n<li>Cause: Usually, <strong>trivial trauma</strong> in old age or patients on anticoagulants</li>\n<li><strong>Crescent</strong>&nbsp;clots</li>\n<li>Presence of a history of headache, confusion, and <strong>being prone to falls</strong></li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da30bfdd9fb343269e21219017fbda42x1280x1149.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>4. Subarachnoid hemorrhage</strong></p>\n<ul>\n<li>Source: Arterial</li>\n<li>Causes: <strong>Trauma</strong> (most common), <strong>berry aneurysm</strong> (2nd most common)</li>\n<li>M/c sites: Terminal ICA, MCA bifurcation, top of basilar artery</li>\n<li>Clinical features: Characteristic <strong>thunderclap headache</strong></li>\n<li><strong>CSF: Xanthochromia</strong></li>\n<li><strong>Hyperdensity</strong> in the subarachnoid space</li>\n<li>Treatment:&nbsp; <strong>T</strong><strong>riple H therapy</strong> (hypertension, hypervolemia, and hemodilution) to prevent vasospasm, Clipping/coiling of berry aneurysm</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d7cb2373c2794c4684e64759ca20c19ex647x745.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>5. Intra-parenchymal hemorrhage</strong></p>\n<ul>\n<li><strong>Most common</strong> type of intracranial hemorrhage</li>\n<li>Cause:<strong> Hypertension</strong> (most common cause)</li>\n<li>Hyperdensity within the brain parenchyma</li>\n<li>Site: <strong>P</strong><strong>utamen</strong> of the basal ganglia (most common)</li>\n<li>Treatment: Correction of any identified coagulopathy by infusing prothrombin complex concentrates, FFP, or fresh platelets as required; surgical evacuation for cerebellar hematoma &gt;3 cm in size</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/917c06cd8b0241e8995ff2379c1b42f0x831x977.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-134",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2874",
    "stauts": "Incorrect",
    "question_title": "134.\n        A student is studying effects of endplate potential on skeletal muscle using the following graph. All of the following can lead to curve B except?",
    "question_ADD": "<p>&nbsp;&nbsp;</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/9e3ddbd3463645d2a2a8e050fd6a9683.JPEG\">",
    "optionA": "A.  Coupling of neostigmine with acetylcholine esterase\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Coupling of carbachol with nicotinic receptor",
    "optionC": "C. Coupling of curarine with nicotinic receptor\n                \n                  \n                    \nCorrect",
    "optionD": "D. Coupling of diisopropyl fluorophosphate with acetylcholine esterase",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above graph is a depiction of <strong>end plate potential</strong> <strong>initiating action potential </strong>and curve B is <strong>normal end plate potential</strong> causing <strong>muscle action potential</strong>. The coupling of curarine drugs with nicotinic receptors causes <strong>weak endplate potential </strong>(curve A)&nbsp; by preventing the passage of impulses from the nerve endings to the muscle fiber.</p>\n<p>The end plate potential is a <strong>local potential </strong>caused by a sudden rise in the <strong>number of sodium ions</strong> in the muscle fiber when voltage-gated acetylcholine channels open causing a positive rise of potential up to <strong>50 to 75 mV.</strong></p>\n<p>In the given graph end <strong>Point A </strong>and <strong>Point C </strong>denote <strong>weak end plate potential </strong>which are not able to elicit action potential, whereas <strong>point B </strong>refers to a strong end plate potential that can <strong>cross </strong>the<strong> threshold</strong> to <strong>cause action potential</strong>.</p>\n<p><strong>Curve A </strong>is caused by poisoning of the muscle fiber with <strong>curare drugs </strong>by competing with acetylcholine receptors, hence block of action potential takes place</p>\n<p><strong>Curve C </strong>is due to the effect of <strong>botulinum toxin</strong> which <strong>inhibits exocytosis </strong>of<strong> acetylcholine</strong> by binding to <strong>synaptobrevin</strong>.</p>\n<p>Other options:</p>\n<p>Option A) Coupling of<strong> neostigmine </strong>with acetylcholine esterase stimulates the neuromuscular junction by <strong>inactivating acetylcholinesterase</strong>. Hence it is no longer able to hydrolyze <strong>acetylcholine</strong> and causes action potential.</p>\n<p>Option B) Coupling of <strong>carbachol</strong> with a nicotinic receptor causes stimulation of muscle fiber because carbachol is a <strong>sympathomimetic</strong> drug that has a similar action to acetylcholine.</p>\n<p>Option D) Coupling of <strong>diisopropyl fluorophosphate</strong> with acetylcholine esterase causes positive action potential as it is also a <strong>cholinesterase inhibitor</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-135",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1707",
    "stauts": "Incorrect",
    "question_title": "135.\n        A patient presents with dysphagia and hoarseness of voice. A 2D echo shows a dilatation in the thoracic aorta. He is diagnosed with thoracic aortic aneurysm. What is the most commonly associated risk factor for the development of this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Diabetes mellitus\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Systemic vasculitides",
    "optionC": "C. Hypertension\n                \n                  \n                    \nCorrect",
    "optionD": "D. Cigarette smoking",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Hypertension</strong> is the&nbsp;<strong>most</strong> commonly <strong>associated risk factor</strong> for the development of a <strong>thoracic aortic aneurysm(TAA)</strong>, which in this patient presents as hoarseness of voice and dysphagia with a finding of dilatation in the thoracic aorta in the above clinical scenario.</p>\n<p>TAA is associated with multiple risk factors:</p>\n<ul>\n<li><strong>Hypertension</strong> (most common cause)</li>\n<li>Systemic conditions like <strong>vasculitis</strong> and <strong>Marfan</strong> <strong>syndrome</strong></li>\n<li>Tertiary <strong>syphilis</strong></li>\n<li>History of <strong>trauma&nbsp;</strong>like a motor vehicle collision</li>\n<li><strong>Male</strong> &gt; Female&nbsp;</li>\n</ul>\n<p>Clinical features of TAA:</p>\n<ul>\n<li><strong>Dysphagia</strong> due to <strong>compression</strong> of the <strong>esophagus</strong></li>\n<li><strong>Hoarseness</strong> of voice due to <strong>compression</strong> of the <strong>recurrent laryngeal</strong> nerve</li>\n<li><strong>Dyspnea</strong> from <strong>compression</strong> of the <strong>bronchi</strong></li>\n<li><strong>Chest pain</strong> from <strong>bone erosion</strong> or <strong>obstruction</strong> of a <strong>coronary</strong> artery</li>\n</ul>\n<p>Other options:<br><strong>Cigarette smoking</strong> and <strong>diabetes mellitus</strong>&nbsp;are both associated with TAA but <strong>hypertension</strong> is more closely associated. They are, however, <strong>major risk factors </strong>for the development of <strong>abdominal aortic aneurysms.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-136",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD8341",
    "stauts": "Incorrect",
    "question_title": "136.\n        A 7-year-old girl presents with a sore throat, fever, tonsillar exudates, and cervical lymphadenopathy for 3 days. She has a history of frequent sore throats requiring prolonged antibiotics, easy bruising, and bruises of different ages on her arms.  She is fair-skinned and has blonde hair.  Her birth and family history are unremarkable. What is the likely defect?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Disorder of T cell",
    "optionB": "B. Disorder of B cell",
    "optionC": "C. Disorder of complement\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Disorder of phagocytosis\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This clinical vignette is strongly suggestive of <strong>Chediak Higashi syndrome</strong> which is a <strong>disorder </strong>of <strong>phagocytosis</strong>.</p>\n<p>It is&nbsp;an <strong>autosomal recessive disorder</strong>&nbsp;that causes a&nbsp;<strong>loss-of-function mutation</strong> of the&nbsp;<strong>LYST</strong>&nbsp;gene encoding for the&nbsp;<strong>lysosomal trafficking regulator</strong>—a protein required for the normal packaging and distribution of granules. This defect results in defective chemotaxis,&nbsp;phagolysosome fusion,&nbsp;degranulation of T-cells and NK cells, and&nbsp;ADP granule function in platelets.&nbsp;</p>\n<p>Patients with <strong>Chediak-Higashi syndrome</strong> may present clinically with <strong>persistent</strong> skin, respiratory, and gastrointestinal infections, particularly due to <em><strong>Staphylococcus aureus</strong></em>. They may also exhibit <strong>partial oculo-cutaneous albinism</strong>, and <strong>platelet dysfunction</strong> leading to increased bleeding time, easy bruising, and <strong>excessive bleeding</strong> despite<strong> normal platelet counts</strong>. Neurological dysfunctions such as <strong>progressive peripheral neuropathy</strong>, <strong>nystagmus</strong>, and <strong>mental retardation</strong> are common, and patients may experience an <strong>accelerated phase</strong> with <strong>lymphoma-like illness</strong> and <strong>hemophagocytic lymphohistiocytosis</strong>. The latter is a life-threatening condition characterized by prolonged high fever, hepatomegaly, splenomegaly, and cytopenia, and it carries a very poor prognosis.</p>\n<p>Diagnosis can be done by detecting the presence of <strong>peroxidase-positive giant primary granules</strong> in neutrophils and other granule-bearing cells on Wright’s stain. Genetic detection may be confirmatory.&nbsp;</p>\n<p>The image below shows a<strong>&nbsp;</strong>neutrophil in Chediak Higashi Syndrome&nbsp;showing polymorphonuclear leukocytes with abundant giant intracytoplasmic granules-</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/526673e86985427bb1060879324808b3x472x132.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option A: Disorders of <strong>T cells</strong> include conditions such as <strong>Severe Combined Immunodeficiency Disorder</strong>, <strong>Wiskott</strong>-<strong>Aldrich</strong> <strong>syndrome</strong> and <strong>DiGeorge</strong> <strong>syndrome</strong></p>\n<p>Option B: Disorders of <strong>B</strong> <strong>cells</strong> include conditions such as <strong>hyper</strong> <strong>IgM</strong> <strong>syndrome</strong> and <strong>IgA</strong> <strong>deficiency</strong>.&nbsp;</p>\n<p>Option C: Disorders of the <strong>complement</strong> <strong>system</strong> include <strong>angioedema</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0536: Primary immunodeficiency disorders</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Affected component</strong><strong>&nbsp;of the immune system</strong></p>\n</td>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Humoral immunity:&nbsp;</strong>Problems with<strong> B cells</strong>&nbsp;and their <strong>antibody&nbsp;</strong><strong>production</strong></p>\n</td>\n<td>\n<ul>\n<li>Common variable immunodeficiency</li>\n<li>Selective immunoglobulin deficiency, such as IgA deficiency</li>\n<li>Transient hypogammaglobulinemia of infancy</li>\n<li>X-linked agammaglobulinemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cellular immunity:&nbsp;</strong>Problems with<strong> T cells&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic mucocutaneous candidiasis</li>\n<li>DiGeorge syndrome</li>\n<li>X-linked lymphoproliferative syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Combined </strong>humoral and cellular immunity:&nbsp;Problems with<strong> B and T cells</strong></p>\n</td>\n<td>\n<ul>\n<li>Ataxia-telangiectasia</li>\n<li>Hyperimmunoglobulinemia M syndrome</li>\n<li>Severe combined immunodeficiency</li>\n<li>Wiskott-Aldrich syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phagocytes:&nbsp;</strong>Problems with the<strong> movement or killing&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic granulomatous disease</li>\n<li>Chédiak-Higashi syndrome&nbsp;(rare)</li>\n<li>Tuftsin deficiency</li>\n<li>Cyclic neutropenia</li>\n<li>Leukocyte adhesion defects</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Complement </strong>proteins:<strong>&nbsp;</strong></p>\n<p><strong>Deficiency of complement </strong>proteins</p>\n</td>\n<td>\n<ul>\n<li>Complement component 1 (C1) inhibitor deficiency (hereditary angioedema)</li>\n<li>Terminal complement deficiency (C5-C9): Recurrent Neisseria infections</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-137",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF9776",
    "stauts": "Skipped",
    "question_title": "137.\n        Nivolumab and Relatlimab combination can be used in which of these tumours?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Malignant Melanoma\n                \n                  \n                    \nCorrect",
    "optionB": "B. Endometrial Carcinoma",
    "optionC": "C. Non small cell lung cancer",
    "optionD": "D. Urothelial carcinoma",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Nivolumab and Relatlimab combination</strong> can be used in patients with <strong>Malignant Melanoma.</strong></p>\n<p>Both <strong>Nivolumab</strong> and <strong>Relatlimab</strong> are <strong>Immune checkpoint inhibitors</strong>. <span>A </span><strong>combination </strong><span>of <strong>N</strong></span><strong>ivolumab</strong><span>, a </span><strong>PD-1 blocking antibody</strong><span>(programmed death receptor-1), </span><strong>and Relatlimab, a LAG-3 blocking antibody </strong><span>(lymphocyte activation gene-3) is indicated for the treatment of patients with </span><strong>unresectable or metastatic melanoma.</strong></p>\n<p>Binding of the<strong> PD-1 ligands </strong>(PD-L1 and PD-L2) to the PD-1 receptor found on T cells, <strong>inhibits T-cell proliferation and cytokine production.</strong> Upregulation of PD-1 ligands occurs in Malignant melanoma which leads to inhibition of T-cell immune surveillance of tumours. Similarly, the<strong> LAG-3 pathway inhibits T-cell proliferation and cytokine secretion.</strong> The <strong>drugs which inhibit </strong>PD-1 or LAG-3 and other similar <strong>interactions&nbsp;between the Tumour and Immune cells</strong> are termed <strong>Immune checkpoint inhibitors.</strong></p>\n<p>The <strong>synergistic</strong> <strong>combination</strong> of Nivolumab (anti-PD-1) and Relatlimab (anti-LAG-3) results in <strong>increased T-cell activation</strong> compared to the activity of either antibody alone, as LAG-3 blockade potentiates the anti-tumour activity of PD-1 blockage,<strong> inhibiting tumour growth </strong>and <strong>promoting tumour regression</strong>.</p>\n<p>The drug combination is given by <strong>intravenous</strong> route in adults as well as children more than 12 years of age. <strong>Adverse effects</strong> upon usage include <strong>anaemia, lymphocytopenia, increased AST, increased ALT, </strong>and<strong> Hyponatremia.</strong></p>\n<p>Many other immune checkpoint inhibitors have been approved for the treatment of various tumours. <strong>Pembrolizumab </strong>which acts by inhibiting <strong>PD-1, </strong>is approved for the treatment of <strong>carcinoma endometrium</strong>.</p>\n<p><strong>Atezolimumab</strong>&nbsp;is also an immune checkpoint inhibitor, acts by inhibiting <strong>PDL-1,</strong>&nbsp;used for the treatment of <strong>non-small cell lung cancer</strong>.</p>\n<p><strong>Durvalumab</strong> is also a <strong>PD-L1 inhibitor</strong> and is approved for use in <strong>metastatic urothelial</strong>&nbsp;<strong>cancer.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-138",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6491",
    "stauts": "Correct",
    "question_title": "138.\n        A 65 year old male patient came to the outpatient department with cough with expectoration for the past 2 weeks and hemoptysis for the past 1 week. CT image is taken and is shown below. What is the condition the patient is suffering from?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/b32a8ed9c1ec4d958f741dd9011255b3.PNG\">",
    "optionA": "A. Churg strauss syndrome",
    "optionB": "B. Invasive aspergillosis\n                \n                  \n                    \nCorrect",
    "optionC": "C. Cryptogenic organising pneumonia",
    "optionD": "D. Usual interstitial pneumonia",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario with acute hemoptysis and CT imaging showing a <strong>Halo sign</strong> is suggestive of <strong>invasive aspergillosis.</strong></p>\n<p>Aspergillosis is a <strong>fungal disease</strong> caused by Aspergillus sp. HRCT findings of various types of aspergillosis are:</p>\n<ul>\n<li><strong>Angioinvasive aspergillosis</strong> shows <strong>multiple nodules</strong> surrounded by a<strong> halo of ground-glass attenuation</strong> (‘halo sign’) or <strong>pleural-based wedge-shaped </strong>areas of <strong>consolidation</strong>.</li>\n<li><strong>Aspergilloma </strong>(saprophytic) shows a mass with soft-tissue attenuation, which is separated from the thoracic wall by airspace called the<strong> air crescent sign</strong>. <strong>Multiple nodules</strong> and<strong> bilateral involvement </strong>may be seen.</li>\n<li><strong>Allergic bronchopulmonary aspergillosis (ABPA):</strong> It is a hypersensitivity reaction to Aspergillus species. On HRCT, it manifests as branching tubular opacities that resemble <strong>fingers inside a glove</strong>. These opacities represent <strong>mucus-filled dilated bronchi, </strong>often seen in the upper lobes, reflecting the mucus impaction and bronchiectasis characteristic of ABPA.</li>\n</ul>\n<p>Other options:</p>\n<p>Option A: CT findings in Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis) typically include <strong>peripheral and bilateral ground-glass opacitie</strong>s, bronchial wall thickening, pulmonary nodules, and pleural effusion. These findings are often associated with clinical features such as <strong>asthma and eosinophilia</strong>. An image of a CT lung in Churg strauss is shown below</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d373496f0dc94ae08953a48bcf3d845cx770x385.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><br>Option C: <strong>Cryptogenic organizing pneumonia</strong> (COP) shows <strong>patchy subpleural consolidative opacities</strong>. A characteristic<strong> peribronchiolar/ perilobar opacities </strong>with a <strong>rim of subpleural sparing</strong> called the <strong>reverse halo sign</strong> is seen.The image given below shows the reversed halo sign:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00e7e8eb020f43538f9e768540a6f037x273x204.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Option D:<strong> Usual interstitial pneumonia</strong> pattern is most commonly seen in people with <strong>rheumatoid arthritis</strong>. The characteristic HRCT findings of UIP are - Bilateral, lower lobe, subpleural reticular changes, <strong>traction bronchiectasis</strong> and <strong>honeycombing pattern.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6b066a7dd4fd4596a68d94cdebff03f8x952x632.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0149: HRCT Findings in Interstitial Lung Diseases</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Idiopathic interstitial lung diseases</p>\n<ul>\n<li aria-level=\"1\"><strong>Idiopathic pulmonary fibrosis / Usual interstitial pneumonia</strong><br>\n<ul>\n<li><strong>Honeycombing</strong></li>\n<li>Reticular shadows</li>\n<li aria-level=\"1\">Traction bronchiectasis</li>\n<li aria-level=\"1\">Complete loss of lung architecture</li>\n<li aria-level=\"1\">Absence of other nonspecific findings (ground-glass opacities, nodules, cysts, consolidations)</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4689091fe1e944fbb126cdfdbbeab7ddx246x157.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Non-specific interstitial pneumonia</strong>\n<ul>\n<li aria-level=\"1\">Extensive <strong>ground-glass opacities</strong></li>\n<li aria-level=\"1\">Sub pleural sparing (specific, but not seen always)</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c2cc0129f166436b80cdc78eadefca46x706x644.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li aria-level=\"1\"><strong>Cryptogenic organizing pneumonia (COP)</strong></li>\n<ul>\n<li aria-level=\"2\">Patchy consolidation with air bronchogram</li>\n<li aria-level=\"2\"><strong>Reverse halo</strong>/ <strong>Atoll sign</strong>: Ground glass area surrounded by peripheral consolidation (as shown below in red arrows)</li>\n</ul>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/14a2b8cf78af4d09ae90a48b8fcf2a25x598x445.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Lymphocytic interstitial pneumonia (LIP)</strong>\n<ul>\n<li aria-level=\"1\"><strong>Thin-walled cysts</strong> (shown below in red arrows)</li>\n<li aria-level=\"1\">Centrilobular nodules&nbsp;</li>\n<li aria-level=\"1\">Ground glass opacities</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df68360574724c508e6cacf09f3feb6ex663x606.PNG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>&nbsp;<strong>Respiratory bronchiolitis related interstitial lung disease</strong>\n<ul>\n<li>Centrilobular ground-glass nodules</li>\n<li>Bronchial wall thickening</li>\n</ul>\n</li>\n<li><strong>Acute interstitial pneumonia</strong>\n<ul>\n<li>Diffuse patchy ground-glass opacities</li>\n</ul>\n</li>\n<li><strong>Desquamated interstitial pneumonia</strong>\n<ul>\n<li>Patchy ground-glass opacities&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p>Other forms of ILDs</p>\n<ul>\n<li><strong>Lymphangioleiomyomatosis (LAM)</strong>\n<ul>\n<li>Regular thin-walled cysts</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/57506149be7c44bfb863865b2ebefaf4x1126x962.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Pulmonary alveolar proteinosis (PAP)</strong>\n<ul>\n<li aria-level=\"1\">Ground-glass opacification with superimposed septal thickening, known as “<strong>crazy paving</strong>”</li>\n<li aria-level=\"1\">It is characteristic but not diagnostic</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b2c5317c962f4d16b1416ece31e7f352x1279x970.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li><strong>Pulmonary Langerhans cell histiocytosis (PLCH)</strong>\n<ul>\n<li aria-level=\"1\">Bilateral irregular shaped cysts with nodules, predominantly in the upper lobe.</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/31564146821e4b5faa1b5305d8445724x1280x819.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Radiology"
  },
  {
    "web-scraper-order": "1727319149-139",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6811",
    "stauts": "Incorrect",
    "question_title": "139.\n        A patient diagnosed with stroke was started on anticoagulation 2 days ago by his physician. He now presents to the ER this morning with the following skin changes. On examination, he looked tensed, diaphoretic, BP- 110/70 mm of Hg, PR- 98 BPM, RR - 17 / min. Coagulation studies performed are as follows. What is the cause of the below skin finding?",
    "question_ADD": "<p>Prothrombin Time- &nbsp;12 seconds (11-15 seconds)</p>\n<p>APTT- 31 seconds ( 25-40 seconds)</p>\n<p>INR - 2&nbsp;</p>\n<p>Platelet count -2,50,000 cells/mm3</p>\n<p>Bleeding time - 3 minutes (1- 8 minutes)</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/71d641c299af462c8dd92573ab15eb9b.png\">",
    "optionA": "A.  Factor V leiden mutation\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Vitamin K deficiency",
    "optionC": "C.  Protein C deficiency \n                \n                  \n                    \nCorrect",
    "optionD": "D. Anti platelet factor 4 antibodies",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This patient with the skin findings as shown in the image above following consumption of warfarin has developed <strong>warfarin-induced skin necrosis.&nbsp;</strong><strong>Protein C deficiency</strong> is one of the major factor responsible for this.</p>\n<p>Warfarin is an oral anticoagulant that inhibits the <strong>vitamin K epoxide reductase (VKORC1)</strong>, an essential enzyme for activating the vitamin K available in the body. The hepatic synthesis of <strong>coagulation factors II, VII, IX, and X</strong>, as well as <strong>anti-coagulants like protein C and protein S</strong>, requires the presence of vitamin K.&nbsp;</p>\n<p>Because <strong>protein C has a shorter half-life</strong>, the existing protein C depletes before coagulation factors, so <strong>hypercoagulation</strong> sets in initially. This further leads to <strong>skin/tissue necrosis</strong> within the first few days of large doses by causing<strong> small vessel microthrombosis</strong>.&nbsp;</p>\n<p>Heparin “<strong>bridging</strong>” is when heparin is frequently used when starting warfarin. Heparin activates antithrombin which enables anticoagulation during the initial, transient hypercoagulable state caused by warfarin. Initial heparin therapy reduces the risk of recurrent venous thromboembolism and skin/ tissue necrosis.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option A: Production of mutant factor V (guanine to adenine DNA point mutation ) that is <strong>resistant to degradation by activated protein C</strong>. Complications include DVT, cerebral vein thrombosis, and recurrent pregnancy loss. Anticoagulants are given in this condition and initiation of warfarin does not cause hypercoagulability.</p>\n<p>Option B: <strong>Vitamin K deficiency </strong>can also cause a similar presentation;<strong> </strong>however,<strong> PT </strong>and<strong> aPTT </strong>will be<strong> increased</strong> in those patients. This patient had normal coagulation studies.</p>\n<p>Option D: Autoantibodies to platelet factor 4 (PF4) combined with heparin cause heparin-induced thrombocytopenia (HIT), which manifests as necrotic skin lesions at heparin injection sites, thrombocytopenia, and arterial or venous thrombosis within 5–10 days of therapy. There has been no exposure to heparin products for this patient.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0609: Classification of Anticoagulants</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b14dd7e06cd44c95a1d5289e3a32ad8ax1280x1944.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Classification of anticoagulants</strong></td>\n</tr>\n<tr>\n<td>1) Vitamin K antagonist</td>\n<td>Warfarin</td>\n</tr>\n<tr>\n<td>2) Direct thrombin inhibitors (DTI)&nbsp;&nbsp;&nbsp;</td>\n<td>\n<p><strong>Parenteral:&nbsp;Monovalent</strong> DTI-&nbsp;Argatroban</p>\n<p><strong>Bivalent</strong> DTI- Lepirudin, Desirudin, Bivalirudin</p>\n<p><strong>Oral</strong>:&nbsp;Dabigatran&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>3) Indirect thrombin inhibitors&nbsp;</td>\n<td>\n<p>Unfractionated heparin</p>\n<p>Low molecular weight heparins:&nbsp;Enoxaparin, Dalteparin, Tinzaparin, Nadroparin</p>\n</td>\n</tr>\n<tr>\n<td>4) Indirect factor Xa inhibitors</td>\n<td>Fondaparinux</td>\n</tr>\n<tr>\n<td>5) <strong>Oral</strong> Direct factor Xa inhibitors</td>\n<td>Rivaro<strong>xa</strong>ban,Api<strong>xa</strong>ban, Edo<strong>xa</strong>ban,Betri<strong>xa</strong>ban</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-140",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF6990",
    "stauts": "Correct",
    "question_title": "140.\n        A child is brought to the clinic for a routine checkup. When asked about the language milestones, the mother reports that he is able to tell stories and sing songs and poems. The child is not less than ___ of age.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. 3 years",
    "optionB": "B. 4 years\n                \n                  \n                    \nCorrect",
    "optionC": "C. 5 years",
    "optionD": "D. 6 years",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>By <strong>4 years</strong> a child would normally be able to <strong>tell stories</strong> and <strong>sing songs </strong>and <strong>poems</strong>.</p>\n<p>The table below depicts the language milestones developed at various ages:&nbsp;</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>1 month</td>\n<td>Alerts to sound</td>\n</tr>\n<tr>\n<td>2 months</td>\n<td>Coos (musical vowel sound)</td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Laughs aloud</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Monosyllables sounds <br>(ma, ba)</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Bisyllables (mama, baba)</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>1-2 words with meaning</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>8-10 word vocabulary</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>2-3 word sentences (uses pronouns like I, me, you)</td>\n</tr>\n<tr>\n<td><strong>3 years</strong></td>\n<td>Asks questions and knows name and gender</td>\n</tr>\n<tr>\n<td><strong>4 years</strong></td>\n<td><strong>Sings songs,</strong> and <strong>poems</strong> and tells <strong>stories</strong></td>\n</tr>\n<tr>\n<td><strong>5 years</strong></td>\n<td>Asks meaning of words</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0013: Gross motor milestones</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\"><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>3 months</td>\n<td>Neck holding</td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>Rolls over</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Sits with support</td>\n</tr>\n<tr>\n<td>8 months</td>\n<td>Sits without support</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Stands with support</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>\n<p>Stands without support</p>\n<p>Creeps well</p>\n<p>Walks but falls</p>\n</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>\n<p>Walks without support</p>\n<p>Creeps upstairs</p>\n</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Runs</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Walks upstairs and downstairs (2 feet/step)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>\n<p>Walks upstairs with alternate foot</p>\n<p>Rides tricycle</p>\n</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>\n<p>Walks downstairs with alternate foot</p>\n<p>Hopping on 1 foot</p>\n</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Can skip without falling to either side</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1928: Social and adaptive milestones</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\"><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td>\n<div><strong>Age</strong></div>\n</td>\n<td>\n<div><strong>Milestone</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 months</div>\n</td>\n<td>\n<div>Social smile</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 months</div>\n</td>\n<td>\n<div>Recognizes mother</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Stranger anxiety</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>9 months</div>\n</td>\n<td>\n<div>Waves bye-bye</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>12 months</div>\n</td>\n<td>\n<div>Comes when called</div>\n<div>Plays simple ball game</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>15 months</div>\n</td>\n<td>\n<div>Jargon</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>18&nbsp;months</div>\n</td>\n<td>\n<div>Copies parents in the task</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 years</div>\n</td>\n<td>\n<div>Asks for food, drink, toilet</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 years</div>\n</td>\n<td>\n<div>Shares toys</div>\n<div>Knows full name and gender</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4 years</div>\n</td>\n<td>\n<div>Plays cooperatively in a group and goes to the toilet alone</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5 years</div>\n</td>\n<td>\n<div>Helps in household tasks and can dress and undress on its own</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1926: Fine motor milestones</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\"><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Reaches out for objects with both hands (Bidextrous reach)</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Reaches out for objects with one hand (Unidextrous reach) and transfers objects</div>\n</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Immature pincer grasp</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>Mature pincer grasp</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>Imitates scribbling and builds a tower of 2 blocks</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Scribbles and builds a tower of 3 blocks</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Builds a tower of 6 blocks</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Builds a tower of 9 blocks and copies a circle</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Builds a bridge with blocks and copies a cross</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Copies a triangle and&nbsp;builds a gate with blocks</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4773a150d41047a29789e417bb2993e1x1280x936.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-141",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6912",
    "stauts": "Skipped",
    "question_title": "141.\n        Which of the following statements is not true regarding spina ventosa?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Swelling is an important sign",
    "optionB": "B. X-ray may show sclerosis",
    "optionC": "C. Subperiosteal new bone formation is uncommon\n                \n                  \n                    \nCorrect",
    "optionD": "D. It affects the phalanges",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Subperiosteal reaction is a common</strong> feature of spina ventosa, seen in x-ray.</p>\n<p>Sclerosis (healing) may also be seen in long standing cases.</p>\n<p><strong>Spina ventosa</strong> is the name given to <strong>tuberculosis </strong>of the<strong> phalanges </strong>of the <strong>hand.</strong>&nbsp;</p>\n<p>It is a feature of <strong>tuberculous dactylitis</strong>. This refers to the tuberculosis of short tubular bones, i.e., metacarpals, metatarsals, and phalanges.</p>\n<p>The infection is lodged in the <strong>marrow cavity</strong> leading to <strong>spindle-shaped expansion or ballooned-out appearance</strong> of the bone known as spina ventosa. <strong>Periosteal reaction, abscess, </strong>and<strong> sinus formation</strong> are seen and the affected phalanx<strong> swells up.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://assets.cureus.com/uploads/figure/file/701942/article_river_989be7c02c8911ee82ff8fe5eafc2ecb-1.png\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Below is an X-ray image of the spina ventosa showing <strong>soft tissue swelling with cortical erosion</strong> in the distal part of the proximal phalanx.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://assets.cureus.com/uploads/figure/file/701962/article_river_380e82b02c8d11eeaaf611c159aaf960-5.png\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-142",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6489",
    "stauts": "Correct",
    "question_title": "142.\n        You are using southern blotting to diagnose sickle cell trait in a patient. The restriction endonuclease binds to the REN site and then the probe attaches to the 1.15kb segment. Which of the following patterns is expected in a patient with a mutation in one gene copy and one normal gene?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/2acf2aeae298405e8dd6541ea7f48c37.JPEG\">",
    "optionA": "A. A",
    "optionB": "B. B\n                \n                  \n                    \nCorrect",
    "optionC": "C. C",
    "optionD": "D. D",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Southern blotting is used for the detection of <strong>DNA.</strong> In this patient with <strong>suspected sickle cell trait</strong>, the pattern in<strong> lane B</strong> is likely to be seen on southern blotting.&nbsp;</p>\n<p>In this technique, DNA is <strong>extracted</strong> from the cells and <strong>cleaved</strong> into many fragments using a <strong>restriction enzyme</strong>. The resulting fragments are separated based on the size using <strong>electrophoresis.</strong> The DNA fragments are then denatured and transferred to a nitrocellulose membrane for analysis. The DNA fragment of interest is then identified using the<strong> specific DNA probe.</strong></p>\n<p>In this patient with a suspected sickle cell trait, there is<strong> one normal copy (upper gene)</strong> of the gene and <strong>one mutated copy </strong>of the gene (lower gene).<br>Now the restriction endonuclease enzyme cuts the normal gene into<strong> two parts (1.15Kb segment and 0.2Kb segment)</strong>. Since the<strong> DNA probe binds only to the 1.15Kb segment,</strong> it would be identified as a band in the blot. The 0.2Kb segment would get washed away and would not appear as a band in the southern blot.<br>However, in<strong> a mutated gene</strong>, there is<strong> no site for the restriction endonuclease to bind</strong>, leading to the formation of a<strong> longer 1.35Kb fragment </strong>of DNA. The labeled DNA probe would bind to this segment and a 1.35Kb band would be seen in the southern blot.</p>\n<p>Therefore the final blot would have<strong> two visible gene bands</strong> -<strong> one 1.15Kb band (normal gene) </strong>and <strong>one 1.35Kb band (mutated gene) </strong>which is represented by lane B.</p>\n<p>Other options:&nbsp;</p>\n<p>Lane A: The band in lane A is from a<strong> sickle cell anemia patient</strong> with two copies of the mutated gene. This gene results in only the<strong> 1.35-kb band</strong> because the single mutation damages the endonuclease restriction site.</p>\n<p>Lane C: The band in lane C would be seen in an<strong> unaffected patient</strong> with two copies of the normal gene. The gene results in only the <strong>1.15-kb fragment </strong>of DNA cut by the restriction endonuclease enzyme.</p>\n<p>Lane D: The bands in lane D <strong>cannot be from any patient.</strong> The labeled DNA probe does not bind to the 0.2-kb DNA fragment and therefore would not be visualized on the Southern blot.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-143",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6812",
    "stauts": "Skipped",
    "question_title": "143.\n        A 38-year-old male with severe depression was started on imipramine. A few days later he presented with diarrhea, drowsiness, and exaggerated ankle reflex. His attendants gave a history of him using escitalopram on the advice of a pharmacist. Which area of the brain primarily secretes the substance involved in the pathophysiology of his condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/fab1157506544accb4bb29ea2cbd47e4.JPEG\">",
    "optionA": "A. 1\n                \n                  \n                    \nCorrect",
    "optionB": "B. 2",
    "optionC": "C. 3",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario where impiramine (tricyclic antidepressant) and escitalopram (selective serotonin reuptake inhibitor) are being taken together is suggestive of <strong>serotonin syndrome</strong>. Serotonin is secreted by the <strong>raphe nucleus</strong>. In the given cross-section of the brain stem at pons, the area marked as <strong>1</strong> represents <strong>periaqueductal gray matter</strong> which also consists of <strong>raphe nucleus</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53bb2c5daa264e3895601972783dcbd0x1280x1348.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Other marked structures are:</p>\n<p>2: Corticospinal tract</p>\n<p>3: Medial lemniscus</p>\n<p>4: Medial longitudinal fasciculus</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2116: Neurotransmitters</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<table width=\"1103\">\n<tbody>\n<tr>\n<td><strong>Neuro-transmitters</strong></td>\n<td><strong>&nbsp;Major source</strong></td>\n<td><strong>&nbsp;Function</strong></td>\n<td><strong>&nbsp;Increased in</strong></td>\n<td><strong>&nbsp;Decreased in</strong></td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td><span>Midline Raphe Nucleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Regulation of mood, sleep, appetite, sexual behavior, decreases anxiety</span></p>\n<p><span>Inhibits the dopaminergic function</span></p>\n</td>\n<td><span>Serotonin syndrome</span></td>\n<td>\n<p><span>Depression</span></p>\n<p><span>OCD</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Dopamine</strong></td>\n<td>&nbsp;<span>Substantia Nigra</span></td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Motor movement and alertness</span></p>\n<p><span>Reward seeking, pleasure, motivation</span></p>\n<p><span>Major neurotransmitter in the basal ganglia</span></p>\n</td>\n<td>\n<p><span>Schizophrenia</span></p>\n<p><span>OCD</span></p>\n<p><span>Mania</span></p>\n<p><span>Delirium</span></p>\n</td>\n<td>\n<p><span>Parkinson's disease</span></p>\n<p><span>Depression</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Endorphins</strong></td>\n<td>&nbsp;<span>Pituitary gland</span></td>\n<td><span>Pain control, feelings of pleasure, stress reduction, \"natural opium\"</span></td>\n<td><span>Addiction</span></td>\n<td><span>Inability to combat pain</span></td>\n</tr>\n<tr>\n<td><strong>Acetylcholine</strong></td>\n<td>&nbsp;<span>Nucleus Basalis (of Meynert)</span></td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Motor movement, learning and memory</span></p>\n</td>\n<td><span>Parkinson's disease</span></td>\n<td>\n<p><span>Alzheimer's disease</span></p>\n<p><span>Delirium</span></p>\n<p><span>Dementia</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>GABA</strong></td>\n<td>&nbsp;\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Decreases anxiety and reduces insomnia</span></p>\n<p><span>Interacts with dopamine, inhibits dopaminergic neurons</span></p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p><span>Anxiety</span></p>\n<p><span>Seizure disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td><span>Locus ceruleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory:</strong></span></p>\n<p><span>\"Fight or flight\"</span></p>\n</td>\n<td><span>Mania</span></td>\n<td><span>Lack of energy, anhedonia in Schizophrenia,&nbsp;</span><span>Depression</span></td>\n</tr>\n<tr>\n<td><strong>Glutamate</strong></td>\n<td>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Links between neurons for learning and long term memory</span></p>\n</td>\n<td><span>Seizures</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-144",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5290",
    "stauts": "Correct",
    "question_title": "144.\n        A 60-year-old man with a history of diabetes for the past 25 years presented with offensive-smelling discharge and ulceration of the right foot. Which of the following is the most sensitive modality to rule out the involvement of the underlying bone?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. MRI\n                \n                  \n                    \nCorrect",
    "optionB": "B. CECT",
    "optionC": "C. X-ray",
    "optionD": "D. DEXA scan",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 580\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The given scenario is indicative of <strong>diabetic foot. MRI </strong>is the<strong> most sensitive</strong> imaging modality to rule out the involvement of underlying bone in this condition.</p>\n<p>The <strong>etiological agents</strong> of diabetic foot infection are:</p>\n<ul>\n<li><strong><em>Staphylococcus aureus</em></strong></li>\n<li><em>Beta-hemolytic streptococci</em></li>\n<li>Aerobic gram-negative bacilli.</li>\n<li><em>Pseudomonas</em>.</li>\n<li>Anaerobes.</li>\n</ul>\n<p>Fever and systemic symptoms are relatively <strong>unusual</strong> in diabetic foot infections but, if present, may indicate <strong>rapidly advancing infection</strong>, bacteremia, or <strong>necrotizing fasciitis</strong>.&nbsp;&nbsp;</p>\n<div class=\"page\" title=\"Page 580\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Plain radiographs</strong> may show evidence of <strong>osteomyelitis</strong> but can be<strong> normal</strong> (particularly <strong>early infection</strong>). <strong>MRI</strong> is the most sensitive imaging modality for the diagnosis of <strong>bone involvement.</strong> The<strong> limited disease</strong> has a good prognosis, and in the absence of risk factors for resistant organisms (including prior treatment),<strong> empirical treatment</strong> can be justified.</p>\n<p>In extensive or<strong> complicated infections</strong>, antibiotic therapy should be guided by the results of the <strong>culture of deep bone or tissue samples</strong> obtained surgically or radiologically. <strong>Superficial swabs or cultures from ulcers</strong> or sinus tracts are <strong>not reliable</strong> in determining the organisms responsible for underlying deep-seated infection.</p>\n<div class=\"page\" title=\"Page 580\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Surgical debridement </strong>is required for collections, necrotic areas, or more extensive osteomyelitis.&nbsp;<strong>Vascular compromise</strong> should be considered a <strong>relative contraindication</strong> to a surgical approach. In patients with poor peripheral pulses, a full vascular assessment is mandatory. Proximal angioplasty or bypass surgery may improve distal vascularity to a level where infection surgery in the foot may be more successful.</p>\n<p><strong>Amputation</strong> is not an easy option in diabetic foot disease, and wound healing can be problematic. In general, excision should be adequate to remove all infected material, and excess bone may need to be resected to allow <strong>tension-free skin closure.</strong> If there is extensive peripheral neuropathy, a <strong>below-knee amputation</strong> in an area with better sensation may be appropriate.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-145",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD8087",
    "stauts": "Correct",
    "question_title": "145.\n        Which of the following statements is incorrect regarding the method for antibiotic susceptibility testing shown below?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/6783d130175b47b287f28f2a9689d46a.JPEG\">",
    "optionA": "A. It is an example of disc diffusion method.",
    "optionB": "B. Minimum inhibitory concentration can be calculated by this method.\n                \n                  \n                    \nCorrect",
    "optionC": "C. The inoculated organism is spread as a lawn culture on a solid medium like Mueller- Hinton Agar.",
    "optionD": "D. Zone of  inhibition around each disc shows antibiotic sensitivity.",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shown above is <strong>Kirby Bauer's disc diffusion method</strong>&nbsp;and <strong>Minimum inhibitory concentration</strong>(<strong>MIC</strong>)<strong> cannot be calculated </strong>by this&nbsp;method.&nbsp;</p>\n<p><strong>Kirby Bauer’s disc diffusion method:&nbsp;</strong>The inoculated organism is grown as a lawn culture on a specific medium (<strong>Cation adjusted Mueller-Hinton Agar</strong>) and various <strong>antibiotic discs</strong> are placed on its surface.&nbsp;The<strong> zone</strong> of <strong>complete growth inhibition </strong>around each disc is measured.&nbsp;Each measurement is then interpreted to deduce to which <strong>antibiotics </strong>the organism is <strong>resistant</strong> or <strong>sensitive</strong>.</p>\n<p>Laboratory testing for antibiotic sensitivity can be done by:</p>\n<div class=\"page\" title=\"Page 648\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Diffusion tests:&nbsp;Kirby-Bauer disk diffusion method,&nbsp;<strong>Stokes disk diffusion method</strong></li>\n<li>Dilution tests:&nbsp;<strong>Broth dilution method</strong>, Agar dilution method</li>\n<li>Diffusion and dilution method: E–test (Epsilometer)</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Note: Minimum inhibitory concentration (MIC)</strong> is the <strong>lowest concentration </strong>of an antimicrobial agent that will <strong>inhibit </strong>the<strong>&nbsp;growth</strong> of the microorganism. Kirby–Bauer test cannot be used for calculating MIC.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-146",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MB1620",
    "stauts": "Incorrect",
    "question_title": "146.\n        Which of the following conditions is/are not associated with secondary Raynaud phenomenon?",
    "question_ADD": "<ol>\n<li>Systemic lupus erythematosus</li>\n<li>Scleroderma</li>\n<li>Buerger disease</li>\n<li>Raynaud's disease</li>\n<li>Atherosclerosis</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1,2 and 5",
    "optionB": "B. Only 5\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. 1,2 and 3",
    "optionD": "D. Only 4\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The option not associated with secondary Raynaud's phenomenon is<strong> raynaud’s disease</strong>, as it is the <strong>primary raynaud's phenomenon</strong>, and all others are associated with <strong>secondary raynaud's phenomenon</strong>.</p>\n<p><strong>Raynaud's phenomenon </strong>refers to <strong>exaggerated vasoconstriction </strong>of<strong> arteries </strong>and <strong>arterioles </strong>in the extremities<strong>, </strong>particularly the <strong>fingers </strong>and<strong> toes</strong>, but<strong> </strong>also occasionally the nose, earlobes, or lips. Raynaud's phenomenon can be a <strong>primary</strong> entity or <strong>secondary</strong> to other disorders.</p>\n<p>Mechanism of raynaud's phenomenon - Restricted blood flow induces <strong>paroxysmal pallor</strong>, and even <strong>cyanosis</strong> in severe cases. The involved digits classically show red, white, and blue color changes from the most proximal to the most distal regions. This correlates with <strong>proximal vasodilation</strong>, <strong>central vasoconstriction</strong>, and <strong>more distal cyanosis</strong>.</p>\n<p><strong>Raynaud's disease</strong> (primary raynaud's phenomenon) is however diagnosed when all the <strong>secondary causes</strong> of raynaud's phenomenon have been <strong>ruled out</strong>. It accounts for more than 50% of cases and is more <strong>prevalent</strong> in <strong>women</strong>, affecting them about <strong>five times</strong> more frequently than men. Symptoms typically begin between the ages of <strong>20</strong> and <strong>40 years</strong>, with the <strong>fingers</strong> being <strong>more commonly</strong> affected than the toes.</p>\n<p class=\"p1\">The difference between primary and secondary raynaud's phenomenon is given below.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary Raynaud</strong></p>\n</td>\n<td>\n<p><strong>Secondary Raynaud</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Caused by exaggerated central and local vasomotor responses to cold or emotion.</p>\n<p>Has a predilection for young women.</p>\n</td>\n<td>\n<p class=\"p1\">Results from vascular insufficiency due to <strong>arterial</strong> <strong>disease</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Raynaud disease</strong></p>\n</td>\n<td>\n<p>Systemic lupus erythematosus</p>\n<p>Scleroderma</p>\n<p>Buerger's disease</p>\n<p>Atherosclerosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Symmetrically</strong> affects the extremities</p>\n</td>\n<td>\n<p><strong>Asymmetric</strong> involvement of the extremities</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>The severity and extent of involvement typically remain static over time</p>\n</td>\n<td>\n<p>Progressively worsens in extent and severity over time</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-147",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0510",
    "stauts": "Incorrect",
    "question_title": "147.\n        A 30-year-old P3L3 lady complained of bright red bleeding per vagina 15 days after the vaginal delivery of her 3rd baby. Which among the following options could be the likely cause of this bleeding?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Multiparity",
    "optionB": "B. Perineal laceration",
    "optionC": "C. Atonic uterus\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Placental polyp\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The clinical vignette with bright red vaginal bleeding on the 15th day of postpartum is <strong>secondary postpartum hemorrhage</strong>, which can be caused by a <strong>placental polyp</strong>.</p>\n<p><strong>Postpartum hemorrhage</strong> (PPH) occurring <strong>between 24 hours and 12 weeks after delivery</strong> is called <strong>secondary</strong> or late <strong>PPH</strong>.</p>\n<p><strong>Causes </strong>of secondary PPH include:</p>\n<ul>\n<li><strong>Placental polyp</strong>: <strong>Retained products</strong> undergo necrosis with fibrin deposition and eventually form a placental polyp, which on detachment from the myometrium causes brisk hemorrhage.</li>\n<li><strong>Abnormal involution</strong> of the placental site.</li>\n<li><strong>Retention</strong> of <strong>placental cotyledon</strong> or products of conception.</li>\n<li>Uterine artery <strong>pseudoaneurysm</strong>.</li>\n<li>Endometritis</li>\n<li>Coagulopathy</li>\n</ul>\n<p>It is treated with <strong>oxytocin, methyler­gonovine</strong>, or a <strong>prostaglandin analog</strong> if the patient is stable and sonography reveals an empty uterine cavity.&nbsp;<strong>Antimicrobials</strong> are given if a uterine infection is suspected. <strong>Gentle suction curettage</strong> can be done if large clots are seen in the uter­ine cavity on sonography, or <strong>if bleeding persists</strong> after medical management.</p>\n<p>Other options:&nbsp;</p>\n<p>Option A: <strong>Multiparity</strong> can lead to inadequate retraction and frequently adherent placenta and cause <strong>primary PPH</strong>.</p>\n<p>Option B: <strong>Perineal lacerations</strong> and an atonic uterus are causes of <strong>primary</strong> <strong>PPH</strong>.&nbsp;</p>\n<p>Option C: <strong>Atonic uterus</strong> is one of the causes of <strong>primary PPH.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-148",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC9032",
    "stauts": "Incorrect",
    "question_title": "148.\n        Which of the following factors do not contribute to skin colour?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Melanocyte function",
    "optionB": "B. Melanogenic activity\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Number of melanocytes\n                \n                  \n                    \nCorrect",
    "optionD": "D. Number of melanosomes",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>number of melanocytes</strong> does not contribute to the pigmentation of the skin. There is very little inter-racial variation in the number of melanocytes.</p>\n<p>Variation in skin pigmentation is explained by:</p>\n<ul>\n<li>Differences in <strong>melanocyte structure</strong> and function</li>\n<li><strong>Melanogenic activity</strong> i.e the amount of melanin produced</li>\n<li>Size and number of <strong>melanosomes</strong></li>\n<li>Type of melanin deposited onto melanosomes</li>\n<li>Donation of mature melanosomes to adjacent keratinocytes</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1889: Colour of Skin and Fitzpatrick Classification of Skin types</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>The color of the skin is a property of the <strong>pigment melanin</strong> synthesized by <strong>melanocytes</strong>.</li>\n<li>Melanocytes are <strong>dendritic cells</strong> derived from <strong>neural crest cells</strong> and are present in the&nbsp;<strong>stratum basale</strong> of the epidermis.</li>\n<li>Each melanocyte <strong>synthesizes melanin</strong> and packs it in cell organelles to form <strong>melanosomes</strong>. These melanosomes are transferred through <strong>dendritic processes</strong> to<strong> 36 keratinocytes</strong> forming the <strong>epidermal melanin unit</strong>.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/959824a182564d7d8a1cca2e7d80b18ax1280x1525.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>The main function of melanin is to impart <strong>uniform color</strong> to the skin. It also <strong>protects</strong> cells from<strong> UV light.</strong></li>\n<li><strong>Color </strong>of skin<strong> depends </strong>on the following:\n<ul>\n<li>Amount of melanin inside melanocytes</li>\n<li>Number and size of melanosomes</li>\n<li>Degree of transfer of melanin into keratinocytes</li>\n</ul>\n</li>\n<li>It does<strong> NOT</strong> depend on the <strong>number of melanocytes</strong>.&nbsp;This is because all individuals contain the <strong>same number</strong> of melanocytes /cm<sup>2</sup> of skin area.</li>\n</ul>\n<p>Different<strong> shades</strong> of skin<strong> color</strong> in humans is due to 2 factors:</p>\n<ul>\n<li>Difference in <strong>number, size,</strong> and<strong> distribution</strong> of melanosomes.</li>\n<li>Difference in <strong>proportion</strong> of<strong> eumelanin</strong> and<strong>&nbsp;pheomelanin</strong>.&nbsp;</li>\n</ul>\n<table width=\"619\">\n<tbody>\n<tr>\n<td><strong>Eumelanin</strong></td>\n<td><strong>Pheomelanin</strong></td>\n</tr>\n<tr>\n<td>True melanin</td>\n<td>False melanin</td>\n</tr>\n<tr>\n<td>Brown or black pigment</td>\n<td>Yellow-red pigment</td>\n</tr>\n<tr>\n<td>Present in dark-skinned individuals</td>\n<td>Present in fair-skinned individuals</td>\n</tr>\n</tbody>\n</table>\n<p>The different shades have been classified in the <strong>Fitzpatrick classification of skin type scale. </strong>It is based on&nbsp;<strong>tan ability and </strong><strong>burn</strong> <strong>ability </strong>of the skin.</p>\n<table width=\"402\">\n<tbody>\n<tr>\n<td><strong>Type 1</strong></td>\n<td><strong>Type 6</strong></td>\n</tr>\n<tr>\n<td>Excess pheomelanin</td>\n<td>Excess eumelanin</td>\n</tr>\n<tr>\n<td>Always burns</td>\n<td>Never burns</td>\n</tr>\n<tr>\n<td>Never tans</td>\n<td>Always tans</td>\n</tr>\n<tr>\n<td>Maximum malignant Potential</td>\n<td>Least malignant potential</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a0532f51deff4cfda1cd3705efafad20x1280x1038.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-149",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0995",
    "stauts": "Incorrect",
    "question_title": "149.\n        A 52-year-old woman diagnosed with carcinoma cervix stage 2B was advised of brachytherapy. Choose the false statement regarding this treatment modality.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Intensity of radiation is inversely proportional to squared distance",
    "optionB": "B. Tandems are placed in the vagina\n                \n                  \n                    \nCorrect",
    "optionC": "C. Point B is 2 cm above and 5 cm lateral  to the external os",
    "optionD": "D. Point A receives a dose of 7000 cGy\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The false statement about this treatment modality is that the tandems are placed in the vagina. The <strong>tandems</strong> are placed in the <strong>uterine cavity</strong> whereas the <strong>ovoids</strong> and <strong>colpostats</strong> are placed in the<strong> vaginal vault</strong>.</p>\n<div><strong>Brachytherapy</strong> is a form of radiation therapy in which&nbsp;the radiation source is <strong>placed close</strong> to the <strong>tumor</strong>. It can be either a low-dose or high-dose rate system. <strong>High-dose</strong> <strong>brachytherapy</strong> is safe and effective.</div>\n<p>Dosage is calculated with respect to the amount of radiation received at two arbitrary points A and B (image below).</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Point A</strong></td>\n<td><strong>Point B</strong></td>\n</tr>\n<tr>\n<td><strong>Location</strong></td>\n<td>2cm above and 2cm lateral to the external os</td>\n<td><strong>2cm above and 5cm lateral to the external os</strong></td>\n</tr>\n<tr>\n<td><strong>Structure present</strong></td>\n<td>crossing of the ureter and uterine artery</td>\n<td>Obturator lymph node</td>\n</tr>\n<tr>\n<td><strong>Dose of radiation</strong></td>\n<td><strong>7000-8000 cGy</strong></td>\n<td>6000 cGy (2000 cGy by brachytherapy + 4000 cGy by external beam radiotherapy)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7be780d7100f447d9101bfb8c84f2a0bx1280x1211.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Different techniques of brachytherapy:</p>\n<table width=\"449\">\n<tbody>\n<tr>\n<td>&nbsp;Techniques</td>\n<td><strong>Device&nbsp;</strong></td>\n<td><strong>No. of application</strong></td>\n<td><strong>Duration</strong></td>\n</tr>\n<tr>\n<td><strong>Stockholm&nbsp;</strong></td>\n<td>\n<p>Intrauterine tandem</p>\n<p>One vaginal <strong>plaque</strong></p>\n</td>\n<td>Three</td>\n<td>24 hours each weekly</td>\n</tr>\n<tr>\n<td><strong>Paris</strong></td>\n<td>\n<p>Intrauterine tandem</p>\n<p>Three vaginal <strong>ovoids</strong></p>\n</td>\n<td>One</td>\n<td>120 hours</td>\n</tr>\n<tr>\n<td><strong>Manchester</strong></td>\n<td>\n<p>Intrauterine tandem</p>\n<p>Two vaginal <strong>ovoids</strong></p>\n</td>\n<td>TWo</td>\n<td>72 hours each weekly</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Radiation dose in surrounding normal tissue is less due to<strong> inverse square law</strong> (Inverse square law -<strong> the intensity of radiation</strong> is<strong> inversely</strong> <strong>proportional</strong> to <strong>squared distance</strong> from the source of radiation). This method is unsuitable for large tumours and has potential risks of radiation exposure to medical staff.</p>\n<p>Note:&nbsp;<strong>After loading technique</strong> by remote control is the recent development of brachytherapy. It protects the staff from radiation exposure.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-150",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF4434",
    "stauts": "Incorrect",
    "question_title": "150.\n        A 30-year-old male patient presents to the Suraksha clinic with lesions on his genitals, as shown in the image below. Which of the following STI treatment kits would you recommend for this patient?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/cc94cb744d524d838cf75c2f9f7e3a99.JPEG\">",
    "optionA": "A. Yellow kit",
    "optionB": "B. White kit\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Red kit\n                \n                  \n                    \nCorrect",
    "optionD": "D. Grey kit",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows a&nbsp;<strong>cluster </strong>of <strong>vesicles </strong>over the<strong> penis</strong><strong>&nbsp;</strong>which points&nbsp;toward the diagnosis of genital&nbsp;<strong>herpes</strong>&nbsp;infection. It is treated with <strong>kit 5</strong> or the<strong> red kit</strong>, which contains&nbsp;<strong>acyclovir 400 mg </strong>to be taken&nbsp;orally TID for 7 days. <strong>No partner treatment</strong> is required.</p>\n<p><strong>Genital herpes</strong> is more commonly caused by herpes simplex virus&nbsp;<strong>(HSV) 2</strong>. The patients present with <strong>painful</strong> vesicular-ulcerative lesions.&nbsp;In men, it occurs mainly on the penis or urethra. In women, the cervix, vagina, vulva, and perineum can be involved.&nbsp;The primary infection causes serious symptoms accompanied by<strong>&nbsp;fever and malaise</strong>, followed by&nbsp;<strong>recurrent episodes</strong>. A <strong>cesarean section</strong> is performed in a case of <strong>active genital herpes</strong> at the <strong>time of labor</strong> in order to prevent neonatal herpes infection.</p>\n<p>Herpes infection can be caused by HSV-1 and HSV-2 viruses. <strong>HSV-1</strong> causes orofacial lesions, i.e. <strong>herpes labialis</strong>, while HSV-2 mainly causes genital herpes. The typical herpes lesions are&nbsp;<strong>thin-walled, umbilicated vesicles,</strong>&nbsp;the roof of which breaks down, leaving tiny superficial&nbsp;<strong>ulcers.</strong>&nbsp;They heal without scarring.&nbsp;The most common site of cutaneous lesions is in the face, the cheeks, the chin, around the mouth, or on the forehead.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>The Tzanck smear technique is a rapid and inexpensive diagnostic method. Scrapings (preferably from the&nbsp;<strong>base of vesicles</strong>) are obtained from the lesions and stained with a&nbsp; 1% aqueous solution of&nbsp;<strong>O-toluidine blue&nbsp;</strong>for 15 seconds. <strong>Multinucleated giant cells&nbsp;</strong>with faceted nuclei and homogeneously stained ground-glass chromatin, known as&nbsp;<strong>Tzanck cells,</strong>&nbsp;are seen.&nbsp;<strong>Cowdry type A&nbsp;</strong>inclusions are seen in the vesicles in Giemsa-stained smears.</p>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7276ed58f7c408bae69fd4f3cf4578dx510x460.GIF\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The following image shows histology of HSV inclusion bodies.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bb5ebf2e6424f1ca1e40c95cb94e659x510x499.GIF\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2024: Syndromic Management of Sexually Transmitted Infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e7908befff94f9a85b4a7b751999821x1280x1742.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0008: Comparison of Genital Ulcers</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Genital herpes</strong></span></td>\n<td><span><strong>&nbsp;Syphilitic chancre (Hard chancre)</strong></span></td>\n<td><span><strong>Donovanosis/ granuloma inguinale</strong></span></td>\n<td><span><strong>Chancroid (soft chancre)</strong></span></td>\n<td><span><strong>LGV</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Incubation period</strong></span></td>\n<td><span>2-7 days</span></td>\n<td>\n<p><span>10-90 days&nbsp;</span></p>\n<p><span>Average: 21days</span></p>\n</td>\n<td><span>1-12 weeks</span></td>\n<td><span>1-14 days</span></td>\n<td><span>3 days - 6 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Causative agent</strong></span></td>\n<td><span>HSV-2&gt;HSV-1</span></td>\n<td><em><span>Treponema pallidum</span></em></td>\n<td><em><span>Klebsiella granulomatis</span></em></td>\n<td><em><span>Hemophilus ducreyi</span></em></td>\n<td>\n<p><span><em>Chlamydia trachomatis</em></span><span>&nbsp;serovars L1,L2,L3</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Clinical presentation</strong></span></td>\n<td>\n<p><span>Cluster of vesicles on erythematous base.</span></p>\n<p><span> Painful and pruritic lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Single painless ulcer with a clean base and a firm raised border. </span></p>\n<p><span>Painless lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless papule or nodule erodes into beefy red granulomatous ulcer with rolled edges.</span></p>\n<p><span> No lymphadenopathy, pseudobubos are seen</span></p>\n</td>\n<td>\n<p><span>Painful ulcer (ducreyi makes you cry).</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless genital ulcer.</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Diagnosis&nbsp;</strong></span></td>\n<td><span>Tzanck preparation shows multinucleated giant cells, PCR</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Donovan bodies on biopsy</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Nucleic acid amplification tests</span></td>\n</tr>\n<tr>\n<td><span><strong>Treatment</strong></span></td>\n<td><span>Acyclovir/famcyclovir or valacyclovir</span></td>\n<td><span>Penicillin/Ceftriaxone</span></td>\n<td>\n<p><span>Azithromycin/</span><span>Doxycycline</span></p>\n</td>\n<td><span>Azithromycin/ceftriaxone</span></td>\n<td><span>&nbsp;Doxycycline</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2456: Sexually transmitted infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Genital herpes</strong>- caused by <strong>herpes simplex virus</strong> (human herpesvirus 1 and 2).</p>\n<ul>\n<li>It appears as <strong>blisters</strong> (usually multiple) that lead to ulcer formation on breaking.</li>\n<li>The ulcers are <strong>painful</strong>.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ba0cafb8f724e8caf99ab7778d022acx630x761.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Granuloma inguinale&nbsp;</strong>/ Donovanosis- caused by&nbsp;<strong>Klebsiella granulomatis</strong>&nbsp;(formerly known as Calymmatobacterium granulomatis).</p>\n<ul>\n<li>It usually causes <strong>beefy red genital ulcers</strong> that may bleed on touch.</li>\n<li>The ulcers are usually <strong>painless</strong>.</li>\n<li>Lymphadenopathy is usually absent but subcutaneous granulomas cause <strong>pseudo buboes</strong>.&nbsp;</li>\n<li>Microscopy shows <strong>Donovan bodies</strong> with closed safety pin appearance</li>\n</ul>\n<p>The given images show genital ulcer in granuloma inguinale:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4aaa8224b2e7443e94743e1015a44778x560x358.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Chancroid</strong>/ Soft chancre-&nbsp;caused by&nbsp;<strong>Haemophilus ducreyi</strong>.</p>\n<ul>\n<li>Causes genital ulcers that are <strong>non indurated</strong> with undermined edges.</li>\n<li>The ulcer is <strong>painful</strong>.</li>\n<li>Multiple/ Kissing ulcers develop due to autoinoculation from the primary ulcer.</li>\n<li>It usually causes tender unilateral<strong>&nbsp;inguinal buboes</strong>.&nbsp;</li>\n<li>Microscopy- School of fish/Railroad track appearance</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/875f994ab0a44d3a8d26f376c6b54874x597x313.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Syphilitic chancre</strong>/ Hard chancre- caused by <strong>Treponema pallidum</strong>.</p>\n<ul>\n<li>It presents as a <strong>small, button-like, indurated ulcer</strong> that is usually round/oval.</li>\n<li>The ulcer is <strong>painless</strong>.</li>\n<li>Causes <strong>painless lymphadenopathy</strong>.</li>\n<li>Microscopy- Spirochetes seen on dark ground illumination.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/03d21e32213a42c9ab3487da627b053ex336x288.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Lymphogranuloma venereum</strong>- caused by&nbsp;<strong>Chlamydia trachomatis</strong>.</p>\n<ul>\n<li>It usually presents with a transient single <strong>shallow ulcer</strong> that <strong>heals rapidly</strong> and usually goes unnoticed.</li>\n<li>The secondary stage presents with <strong>tender&nbsp;inguinal buboes</strong>.</li>\n<li><strong>Groove sign</strong> is seen when the lymph nodes above and below the inguinal ligament are enlarged leading to the appearance of a groove.</li>\n</ul>\n<p>The given images show the ulcer and the groove sign seen in LGV:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6faad0dd79004ce4898a0d4ec94391e9x495x711.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be01c14fe5b34f6fb923eca0f40d42cex253x357.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Gonorrhea</strong>- caused by <strong>Neisseria gonorrhoeae</strong>.</p>\n<ul>\n<li>It leads to <strong>purulent inflammation</strong> of the genital mucous membranes.</li>\n<li>It may present as&nbsp;urethritis, cervicitis, epididymo‐orchitis, or pelvic inflammatory disease.</li>\n<li>The usual presentation is <strong>acute urethritis</strong> with complaints of burning dysuria and purulent discharge.</li>\n</ul>\n<p>The given image shows purulent genital inflammation due to gonorrhea:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f4fd185c143045fe944bb99f1299a4bbx379x412.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-151",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD2468",
    "stauts": "Incorrect",
    "question_title": "151.\n        Which among the following statements is true regarding the instrument shown in the image?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/a9c6410b55a649b9871a12e1d808d77c.PNG\">",
    "optionA": "A. Used for delivery in a platypelloid pelvis\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Most commonly used for rotational delivery",
    "optionC": "C. Most commonly used forceps in outlet delivery",
    "optionD": "D. It is used in the delivery of aftercoming head in breech\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image shows <strong>Piper's forceps</strong>, identified by its <strong>distinct perineal curve</strong>. It is&nbsp;used to assist the <strong>delivery of the after-coming head</strong> of breech.</p>\n<p>It has a cephalic curve, reverse pelvic curve, long parallel shanks that permit the baby’s body to rest against it during head delivery.</p>\n<p>It maybe applied electively or when the Mauriceau manoeuvre cannot be accomplished easily.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1839: Maneuvers for breech delivery</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Pinard’s manoeuvre&nbsp;</strong></p>\n<p>It is used for the delivery of <strong>extended legs</strong> in case of breech delivery.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Flex and abduct the popliteal fossa</li>\n<li aria-level=\"1\">Catch hold of the ankle</li>\n<li aria-level=\"1\">Pull down along with abduction</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6aa624cb6ac74df887b27ed0db3f7e85x1280x4970.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Lovset’s manoeuvre</strong></p>\n<p>It is used for the delivery of <strong>extended arms</strong> in case of a breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Hold the sacrum with the thumb, and the hips and pelvis with other fingers.</li>\n<li aria-level=\"1\">Turn the infant 90 degrees to bring the shoulder under pubic symphysis and deliver the anterior shoulder.</li>\n<li aria-level=\"1\">Then counter-rotate 180 degrees to engage and deliver the posterior shoulder.&nbsp;</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bbd5c8755d1242329bac304aad0f9f82x1280x3105.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Modified Prague’s manoeuvre</strong></p>\n<p>It is used in breech presentations to deliver the <strong>aftercoming head</strong> when the back of the fetus fails to rotate to the symphysis.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Grasp the shoulders of the baby from below with two fingers of one hand.</li>\n<li aria-level=\"1\">Draw the feet up and over the maternal abdomen with the other hand.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0fb878bf761548269e792fc999b4e8f0x1280x1868.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Burns-Marshall method</strong></p>\n<p>It is used for delivery of <strong>aftercoming head</strong> in case of breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Allow the baby to hang by its own weight.</li>\n<li aria-level=\"1\">When the nape of the neck is visible under the pubic arch, grasp the baby by the ankles with a finger in between the two.</li>\n<li aria-level=\"1\">Swing the baby in an arc in an upward and forward direction.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d2ef75e12c458189a04107a253ae13x1280x5962.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Mauriceau-Smellie-Veit technique</strong></p>\n<p>It is another method that can be used in the delivery of <strong>aftercoming head</strong> in case of breech presentation. It is also called <strong>malar flexion and shoulder traction</strong>.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\"1\">Place the baby on the supinated left arm with limbs hanging on either side.</li>\n<li aria-level=\"1\">Place the index and middle fingers of the left hand on either side over the malar bones.</li>\n<li aria-level=\"1\">Place the ring and the little finger of the pronated right hand on the child’s right shoulder, index finger on the left shoulder and middle finger over the suboccipital region.</li>\n<li aria-level=\"1\">Traction is given in the downward and backward direction till the nape of the neck is visible.</li>\n<li aria-level=\"1\">Thereafter, the baby is carried in an upward and forward direction towards the mother’s abdomen.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ce9f096a6bee481396bcbe161cbb14a1x1280x1187.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Mnemonic:</strong></p>\n<ul>\n<li aria-level=\"1\"><strong>Extend the arm</strong> to express Love(<strong>Lovset's</strong>)</li>\n<li aria-level=\"1\">Put the fingers in <strong>popliteal</strong> fossa for <strong>Pinard's</strong>(P for P)</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0040: Obstetrics forceps</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3aff6b46801e48ccbc8c0b5b1958c478x600x560.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Commonly used forceps:&nbsp;</p>\n<p><strong>1) Simpson forceps</strong></p>\n<ul>\n<li>The most commonly used types of forceps in outlet delivery.</li>\n<li>Has elongated cephalic curve.</li>\n<li>These are used when there is substantial molding of the fetal head.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/53422ca64da04ca1a0bf2350cf6d8025x1280x1143.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>2) Elliot forceps</strong></p>\n<ul>\n<li>Has an adjustable pin for regulating the lateral pressure on the handles.</li>\n<li>They are used most often when there is minimal molding.</li>\n<li>More suitable for outlet delivery.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2a99b799e0494721831ed4d66f6eb451x1280x1108.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>3) Kielland forceps</strong></p>\n<ul>\n<li>Has small pelvic curve and a sliding lock.</li>\n<li>Suitable for head with little molding.</li>\n<li>The most common forceps used for rotational delivery.</li>\n<li>Helps correct asynclitism.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cab2ad62a596485aa475c5e61fc9b23ex1280x1196.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>4) Piper forceps</strong></p>\n<ul>\n<li>Distinct perineal curve.</li>\n<li>Allows for application to the after-coming head in breech delivery.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/46d15861619545899a73faeb532652edx1280x1270.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>5) Tucker-McLane forceps</strong></p>\n<ul>\n<li>Suitable for fetal head with little molding.</li>\n<li>Used in rotational delivery.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/90bdff9bd2e24d76b01753a9d901ce02x1280x1219.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>6) Barton forceps and traction handle</strong></p>\n<ul>\n<li>Used in rotational delivery.</li>\n<li>Most importantly used for delivery of occipitotransverse positions in a platypelloid pelvis.</li>\n<li>It is an obsolete procedure.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b106c6e03bd649ffb4ae8ebc4e209d3dx1280x1213.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-152",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF7410",
    "stauts": "Incorrect",
    "question_title": "152.\n        A 21-year-old young man presents with a neck mass. Past history is significant for surgical removal of a pheochromocytoma 6 months ago. On examination, the following finding is noted. Which of the following should the patient be screened for?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/71c824d0037e498a81741f2222e9532f.PNG\">",
    "optionA": "A. Papillary thyroid carcinoma",
    "optionB": "B. Paraganglioma\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Medullary thyroid carcinoma\n                \n                  \n                    \nCorrect",
    "optionD": "D. Parathyroid adenoma",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This clinical scenario and image showing <strong>mucosal neuromas</strong> are suggestive of <strong>MEN2B syndrome</strong>. This condition is associated with <strong>medullary</strong> <strong>carcinoma</strong> of the <strong>thyroid</strong>.&nbsp;</p>\n<p>The MEN syndromes are a group of inherited diseases of multiple endocrine organs.&nbsp;Tumors&nbsp;occur at a younger age than sporadic tumors,&nbsp;either synchronously (at the same time) or metachronously (at different times).</p>\n<p>MEN2 syndrome occurs due to abnormal activation of the <strong>RET</strong>&nbsp;gene.&nbsp;Medullary carcinoma is seen in both MEN 2A and 2B syndromes. However, it tends to be more <strong>aggressive </strong>and<strong>&nbsp;metastasizes </strong>more frequently in<strong> MEN2B </strong>syndrome.</p>\n<p>Note: RET gene is deactivated in&nbsp;Hirschsprung disease.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1137: MEN 2 Syndrome Features</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple’s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10–25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40–50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-153",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6487",
    "stauts": "Skipped",
    "question_title": "153.\n        What is the punishment for a doctor on the first offence for sex determination under the PCPNDT Act?",
    "question_ADD": "<p>PCPNDT- Pre-Conception and Pre-Natal Diagnostic Techniques</p>",
    "question_imag": "",
    "optionA": "A. 3 years & Rs.10,000 fine\n                \n                  \n                    \nCorrect",
    "optionB": "B. 5 years & Rs. 1,00,000 fine",
    "optionC": "C. 3 years & Rs. 50,000 fine",
    "optionD": "D. 5 years & Rs. 50,000 fine",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Under the<strong> PCPNDT Act</strong>, a <strong>doctor</strong> convicted of a <strong>first offence</strong> for<strong> sex determination </strong>can be<strong> punished </strong>with<strong> imprisonment</strong> for up to<strong> three years </strong>or a<strong> fine </strong>of up to<strong> ten thousand rupees. </strong>If<strong> convicted again</strong>, the punishment increases to<strong> imprisonment</strong> for up to<strong> five years </strong>and a fine of up to<strong> fifty thousand rupees.</strong></p>\n<p><strong>Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994</strong> is an act of the Parliament of India enacted to <strong>stop female foeticides</strong> and arrest the declining sex ratio in India.</p>\n<p>It aimed at <strong>preventing gender-based sex selection</strong> and ensuring ethical practices in pre-conception and prenatal diagnostic procedures. The Act is designed to <strong>regulate the use of diagnostic techniques </strong>and to curb practices that lead to sex-selective abortions.&nbsp;</p>\n<p>Key Objectives:</p>\n<ul>\n<li>Prohibit Sex Selection: The Act <strong>prohibits</strong> the <strong>use</strong> of <strong>pre-conception and prenatal diagnostic techniques for determining the sex </strong>of the fetus with the intent of aborting female fetuses. This is to prevent female feticide and promote gender equality.</li>\n<li>Regulate Diagnostic Techniques: It<strong> regulates the use of technologies such as ultrasound and amniocentesis</strong>, ensuring they are used only for legitimate medical purposes and not for sex determination.</li>\n</ul>\n<p>Registration and Regulation:</p>\n<ul>\n<li><strong>Genetic Clinics</strong> and Laboratories: Facilities providing&nbsp;<span>prenatal diagnostic services, including genetic clinics, laboratories, and ultrasound centres, must be registered with the appropriate authority</span>.</li>\n<li>Equipment and Personnel: The Act mandates <strong>specific qualifications </strong>for personnel performing diagnostic procedures and requires proper registration and record maintenance.</li>\n</ul>\n<p>Consent Requirement: Before performing any pre-natal diagnostic procedures, practitioners must obtain <strong>written informed consen</strong>t from the patient, explaining all potential risks and the nature of the procedure.</p>\n<p><strong>Documentation:</strong> Clinics must maintain detailed records of all procedures, including patient details and the nature of the diagnostic tests performed.</p>\n<p><strong>Penalties:</strong> Violations of the Act, such as illegal sex determination or failure to maintain proper records, can result in imprisonment, fines, and professional sanctions. Violations of the PCPNDT Act are classified as cognizable offences.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Forensic Medicine"
  },
  {
    "web-scraper-order": "1727319149-154",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6754",
    "stauts": "Incorrect",
    "question_title": "154.\n        A 43-year-old lady comes with complaints of fever, abdominal pain, and itching over her arms and legs. On examination, icterus and mild hepatomegaly are seen. Liver function tests show deranged values with elevated serum IgG levels. The patient also tests negative for viral hepatitis markers. Which of the following characteristic histopathological features suggests the diagnosis?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Gound-glass hepatocytes",
    "optionB": "B. Bile duct injury and granulomas",
    "optionC": "C. Councilman bodies\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Piecemeal necrosis\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The clinical features along with increased serum IgG levels and absence of viral hepatitis markers indicates <strong>autoimmune hepatitis (AIH)</strong>. <strong>&nbsp;</strong>The characteristic histopathological picture seen in AIH is<strong> </strong>cluster of plasma cells and lymphocytes at the interface between the portal tract and liver lobule is known as<strong> interface hepatitis or piecemeal necrosis</strong></p>\n<p>Autoimmune hepatitis (AIH) is characterised by extensive <strong>inflammation</strong>, <strong>fibrosis</strong> and ultimately <strong>cirrhosis</strong>. The pathologic features include:</p>\n<ul>\n<li><strong>Emperipolesis</strong> - Lymphocytes and plasma cells within the cytoplasm of hepatocytes.</li>\n<li><strong>Interface hepatitis</strong> or <strong>piecemeal necrosis</strong>.</li>\n<li><strong>Rosette formation</strong> due to necrosis of groups of hepatocytes and resultant regeneration.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/72c5edd3b376459b9e1e28ac3dc6025ex1280x4469.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Below is a histopathological image of AIH.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1282276a113b45348a0beb46208f50a6x1280x1585.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>The simplified <strong>scoring system</strong> for the diagnosis of autoimmune hepatitis includes four variables. They are:</p>\n<ol>\n<li>Autoantibodies</li>\n<li>Elevated serum IgG level</li>\n<li>Typical compatible histologic features</li>\n<li>Absence of viral hepatitis markers</li>\n</ol>\n<p>A small number of drugs such as <strong>minocycline, nitrofurantoin, and α-methyldopa</strong> can trigger the formation of autoantibodies and hepatocellular injury that mimics autoimmune hepatitis.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Ground glass hepatocytes</strong> are characteristically found in <strong>Hepatitis B </strong>and are a diagnostic hallmark.</p>\n<p>Option B: <strong>Bile duct injury and granulomas</strong> are uncommon except in case of overlap with <strong>primary biliary cirrhosis</strong>.</p>\n<p>Option C: <strong>Councilman bodies</strong> are seen in <strong>acute viral hepatitis</strong>. They are apoptotic hepatocytes that are deeply eosinophilic stained.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2264: Types of autoimmune hepatitis (AIH)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Type I AIH</strong></td>\n<td><strong>Type II AlH</strong></td>\n</tr>\n<tr>\n<td>Characteristic antibodies</td>\n<td>Anti-SMA (F-actin), ANA, pANCA,&nbsp;anti-SLA/LP, anti-AMA antibodies</td>\n<td>Anti-LKM1,&nbsp;anti-liver cytosol 1</td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Bimodal, peaks at 10–20 years and 45–70 years</td>\n<td>2–14 years</td>\n</tr>\n<tr>\n<td>Gender distribution</td>\n<td>78% female</td>\n<td>89% female</td>\n</tr>\n<tr>\n<td>lgG increase</td>\n<td>Pronounced</td>\n<td>Moderate</td>\n</tr>\n<tr>\n<td>lgA decrease</td>\n<td>Absent</td>\n<td>Occasional</td>\n</tr>\n<tr>\n<td>Association with HLA&nbsp;haplotypes</td>\n<td>B8, DR3, DR4</td>\n<td>B14, DR3</td>\n</tr>\n</tbody>\n</table>\n<div class=\"page\" title=\"Page 2746\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Type III autoimmune hepatitis does not appear to represent a distinct category but, instead, is part of the spectrum of type I autoimmune hepatitis</p>\n<ul>\n<li>ANA: Anti-nuclear antibodies</li>\n<li>anti-SMA:&nbsp;Anti–smooth muscle actin antibodies</li>\n<li>anti-SLA/LP: Anti–soluble liver antigen/liver–pancreas antigen</li>\n<li>AMA: Anti-mitochondrial antibodies</li>\n<li>anti-LKM: Liver–kidney microsomal antibodies</li>\n<li>pANCA:&nbsp;Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2257: Acute Hepatitis vs. Chronic Hepatitis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Histological features of acute hepatitis</strong></td>\n<td><strong>Histological features of chronic hepatitis</strong></td>\n</tr>\n<tr>\n<td>Ballooning degeneration</td>\n<td>Ductular reaction</td>\n</tr>\n<tr>\n<td>Apoptosis of hepatocytes - <strong>Councilman bodies&nbsp;</strong></td>\n<td>Bridging fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td>Confluent necrosis</td>\n<td>Bridging necrosis</td>\n</tr>\n<tr>\n<td>Spotty necrosis or lobular<strong> hepatitis&nbsp;</strong></td>\n<td>Interface hepatitis&nbsp;</td>\n</tr>\n<tr>\n<td>Bridging necrosis in severe acute hepatitis</td>\n<td>Dense, mononuclear portal infiltration&nbsp;</td>\n</tr>\n<tr>\n<td>Portal inflammation is absent&nbsp;</td>\n<td><strong>Chronic viral hepatitis</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Ground glass hepatocytes&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Lymphoid aggregates or fully formed lymphoid follicles</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Fatty change of scattered hepatocytes</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed3b8d201aea404fbad0181756978b57x1280x3480.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-155",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME9797",
    "stauts": "Incorrect",
    "question_title": "155.\n        Choose the false statement regarding the following instrument which is used for visual field charting.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/30545beca6a442439af77d5005dd20af.JPEG\">",
    "optionA": "A. It can evaluate both peripheral as well as central fields\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. 24-2 pattern is most commonly used to assess glaucoma",
    "optionC": "C. It is an automated test",
    "optionD": "D. It uses kinetic method of perimetry\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image shows a <strong>Humphrey visual field analyzer.</strong> It is an <strong>automated test</strong> that uses the <strong>static method of perimetry</strong> i.e. the location of a stimulus remains fixed, with intensity increased until it is seen by the subject (threshold is reached) or decreased until it is no longer detected.</p>\n<p>It can evaluate both peripheral as well as the central field. <strong>(option A)</strong></p>\n<p>It is most commonly used in interpreting visual field defects in glaucoma, and other neurological lesions.</p>\n<p>Central visual fields are most commonly tested.</p>\n<div>\n<div class=\"notion-scroller vertical horizontal\">\n<div class=\"react-pdf__Document\">\n<div class=\"react-pdf__Page\">\n<ol>\n<li><strong>Central 24-2 test</strong>\n<ul>\n<li><strong>Most </strong>commonly used to assess <strong>glaucoma (Option B)</strong></li>\n<li><strong>54 points</strong> are examined in&nbsp;the central 24 degrees.</li>\n<li>'24’ denotes the extent in degrees to which the field is tested on the temporal side (to 30° on the nasal side). The number after the hyphen (2) describes the pattern of the points tested.</li>\n</ul>\n</li>\n<li><strong>Central 30-2 test</strong></li>\n<ul>\n<li><strong>Most comprehensive form</strong> of visual field assessment of the central 30 degrees.</li>\n<li>It consists of <strong>76 points</strong> 6 degrees apart on either side of the vertical and horizontal axes, such that the inner most points are three degrees from the fixation point.</li>\n</ul>\n<li><strong>Central 10-2 test</strong>.\n<ul>\n<li>Assess<strong> 68 points</strong> 2 degrees apart in the central 10 degree are examined.</li>\n<li>Especially used to<strong> monitor advanced glaucoma.</strong></li>\n</ul>\n</li>\n<li><strong>Macular grid test</strong>&nbsp;\n<ul>\n<li>Assess the <strong>central 5 degrees. </strong></li>\n<li>Examines <strong>10 points</strong> spaced on a 29 degree square grid centred on the point of fixation.</li>\n</ul>\n</li>\n</ol>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Perimetry:</strong> Visual field charting</p>\n<p>Classification:</p>\n<ul>\n<li><strong>Manual:</strong>&nbsp;Confrontation, Listers, Campimetry, Goldmann&nbsp;perimeter</li>\n<li><strong>Automated:</strong>&nbsp;Octopus, Field Master, Humphrey Field Analyzer</li>\n<li><strong>Static:&nbsp;</strong>Friedman, Automated</li>\n<li><strong>Kinetic:</strong>&nbsp;Confrontation, Listers, Scotometry, Goldmann</li>\n</ul>\n<p>The best type is automated perimetry.</p>\n<p>The image given below shows <strong>Lister's perimeter.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1624d5b35428409783f5875999365d6fx1280x1707.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>The image below shows the <strong>confrontation method</strong> for testing the&nbsp;visual field.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5bbb32472c2e4adaa2303971e71de215x311x244.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>The image given below shows<strong> Goldmann perimeter.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/348833f26b0d4c22ac9f7f20e1f10235x187x249.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>The following image depicts the <strong>printout of the results</strong> obtained from the <strong>Humphrey field analyser.&nbsp;</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b1096ef6c6094c91aba087f3678c1fb2x436x600.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-156",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF1869",
    "stauts": "Correct",
    "question_title": "156.\n        A patient presented with features suggestive of acute interstitial nephritis. A microscopy of his urinary casts is shown below. These casts are most likely those of _____.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/fbefb0e1684f4763bc3072f925996756.PNG\">",
    "optionA": "A. Broad casts",
    "optionB": "B. Hyaline casts",
    "optionC": "C. Red blood cell casts",
    "optionD": "D. White blood cell casts\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given scenario, the patient is having features of&nbsp;<strong>acute interstitial nephritis</strong> (<strong>AIN</strong>). So, the casts shown are most likely those of <strong>white blood cell casts</strong>.</p>\n<p>AIN usually occurs as an allergic response to certain medications. The most common offending agents are <strong>non-steroidal anti-inflammatory</strong> drugs. It can also occur with proton pump inhibitors, sulfonamide derivatives and sulfasalazine.&nbsp;</p>\n<p>Individuals with AIN are <strong>usually asymptomatic</strong> and are incidentally found to have elevated creatinine.&nbsp; However, in some instances, they can develop fever and rash. In severe cases, renal failure with proteinuria can occur.&nbsp;</p>\n<p>Laboratory studies may show <strong>peripheral eosinophilia </strong>and<strong> urinary eosinophilia</strong>. The urinalysis usually shows pyuria and occasionally eosinophiluria. But the most characteristic cell types are <strong>activated T lymphocytes</strong> and <strong>plasma cells, </strong>along with a few&nbsp;<strong>white blood cell casts.&nbsp;</strong></p>\n<p>Other options:&nbsp;</p>\n<p>Option A:<strong> Broad&nbsp;casts</strong> are seen in <strong>chronic renal failure</strong>.</p>\n<p>Option B: <strong>Hyaline casts</strong>&nbsp;may be seen normally and are non-specific.</p>\n<p>Option D: <strong>Red blood cell casts</strong> are seen in <strong>acute glomerulonephritis</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1885: Urinary Casts and Their Significance</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ce4f74ab9824f42b8cb05ac3433314cx1280x3456.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-157",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6753",
    "stauts": "Correct",
    "question_title": "157.\n        Increased thickness of layer C leads to.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/83e18a4096484bbfbf74e5b79fad8673.JPEG\">",
    "optionA": "A. Hyperkeratosis",
    "optionB": "B. Acanthosis\n                \n                  \n                    \nCorrect",
    "optionC": "C. Parakeratosis",
    "optionD": "D. Hypergranulosis",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The layer marked as C is<strong> stratum spinosum</strong>. Increased thickness of stratum spinosum is called <strong>acanthosis</strong>.</p>\n<p>Histopathological terminologies used for skin conditions:</p>\n<ol>\n<li><strong>Hyperkeratosis</strong>: increased thickness of <strong>stratum corneum (layer A).</strong></li>\n<li><strong>Hypergranulosis</strong>: increased thickness of <strong>stratum granulosum (layer B)</strong>.</li>\n<li><strong>Parakeratosis</strong>: retention of the nucleus in the <strong>stratum corneum.&nbsp;</strong></li>\n<li><strong>Acanthosis</strong>: increased thickness of <strong>stratum spinosum (layer C).</strong></li>\n</ol>\n<p>Hyperkeratosis, parakeratosis, and acanthosis are seen in <strong>psoriasis</strong>.</p>\n<p>Spongiosis is seen in <strong>acute eczema</strong>.</p>\n<p>Acantholysis which refers to the separation of keratinocytes is seen in <strong>vesico-bullous</strong> disorders.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/793f41a3ebfc4221b27ae346e39d5519x490x713.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-158",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6870",
    "stauts": "Incorrect",
    "question_title": "158.\n        A 2-year-old child presents to the pediatric OPD with a history of diarrhoea for 1 day. The mid-arm circumference of the child is 10 cm. Which of the following is not present in the rehydration solution advised for this child?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Zinc         \n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Selenium\n                \n                  \n                    \nCorrect",
    "optionC": "C. Magnesium",
    "optionD": "D. Copper",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A 2-year-old child with a mid-arm circumference of 10 cm (<strong>&lt;11.5cm</strong>) is having <strong>severe</strong> <strong>acute</strong> <strong>malnutrition</strong> and the rehydration solution used for inpatient management of diarrhoea in a child with SAM is <strong>ReSoMal</strong>. <strong>ReSoMal</strong> <strong>contains</strong> 3 minerals <strong>magnesium</strong>, <strong>zinc</strong>, and <strong>copper</strong>.&nbsp;</p>\n<p>The composition of ReSoMal and ORS are as follows:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Component</strong> (<strong>mmol</strong>/<strong>l</strong>)</td>\n<td><strong>Standard</strong> <strong>ORS</strong></td>\n<td><strong>ReSoMal</strong></td>\n</tr>\n<tr>\n<td>Glucose</td>\n<td>75 (anhydrous)</td>\n<td>125</td>\n</tr>\n<tr>\n<td>Sodium</td>\n<td>75</td>\n<td>45</td>\n</tr>\n<tr>\n<td>Potassium</td>\n<td>20</td>\n<td>40</td>\n</tr>\n<tr>\n<td>Chloride</td>\n<td>65</td>\n<td>70</td>\n</tr>\n<tr>\n<td>Citrate</td>\n<td>10</td>\n<td>7</td>\n</tr>\n<tr>\n<td><strong>Magnesium</strong></td>\n<td>-</td>\n<td>3</td>\n</tr>\n<tr>\n<td><strong>Zinc</strong></td>\n<td>-</td>\n<td>0.3</td>\n</tr>\n<tr>\n<td><strong>Copper</strong></td>\n<td>-</td>\n<td>0.045</td>\n</tr>\n<tr>\n<td>Osmolality</td>\n<td>245</td>\n<td>300</td>\n</tr>\n</tbody>\n</table>\n<p>Compared to the standard ORS, <strong>ReSoMal</strong> contains <strong>less sodium</strong> to prevent complications related to fluid overload and overhydration. Glucose, potassium, and chloride are more than the ORS. <strong>Zinc</strong> helps in <strong>GI re-epithelialization</strong> and <strong>prevents</strong> <strong>recurrence</strong>. <strong>Magnesium</strong> is important for <strong>nerve</strong>, and <strong>muscle</strong> <strong>function</strong> and is an important cofactor for many enzymes. <strong>Copper</strong> plays a role in <strong>immunity</strong> and <strong>iron</strong> <strong>metabolism</strong>. ReSoMal is however <strong>contraindicated</strong> in <strong>cholera</strong> or <strong>profuse</strong> <strong>watery</strong> <strong>diarrhoea</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1776: World Health Organization (WHO) classification of nutritional status of infants and children</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Nutritional status</strong></span></div>\n</td>\n<td>\n<div><span><strong>Criteria </strong>(from birth to 5 years)</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Obese</span></p>\n</td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;3 SD</span></p>\n<p><span><strong>BMI-for-</strong>age &gt;3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Overweight</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;2 SD and ≤3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &gt;2 SD and ≤3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderate acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;≤–2 SD and ≥–3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> ≤–2 SD and ≥–3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> ≥115&nbsp;mm and &lt;125&nbsp;mm</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Severe acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&lt;– 3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &lt;– 3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> &lt;115 mm</span></p>\n<p><span>Bilateral pitting edema</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately stunted (or) moderate chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> ≤–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely stunted (or) severe chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> &lt;–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderately wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length ≤–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length &lt;-3 SD</span></td>\n</tr>\n</tbody>\n</table>\n<p><span><strong>SD</strong> - Standard deviation (from the median)</span></p></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1685: Composition of reduced osmolarity Oral Rehydration Solution (ORS)</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The composition of reduced-osmolarity oral rehydration solution (ORS) is as follows:</p>\n<table width=\"207\">\n<tbody>\n<tr>\n<td><strong>Reduced- osmolarity ORS</strong></td>\n<td><strong>mmol/L</strong></td>\n</tr>\n<tr>\n<td>Sodium&nbsp;</td>\n<td>75&nbsp;</td>\n</tr>\n<tr>\n<td>Chloride</td>\n<td>65</td>\n</tr>\n<tr>\n<td>Glucose (anhydrous)</td>\n<td>75</td>\n</tr>\n<tr>\n<td>Potassium</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Citrate</td>\n<td>10</td>\n</tr>\n<tr>\n<td>Total Osmolarity</td>\n<td><strong>245</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-159",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2285",
    "stauts": "Incorrect",
    "question_title": "159.\n        A pressure tracing curve is shown below. Which process is typically implicated in development of the patient's condition?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/5396bd2b24e748feb59c47c9811a4e75.JPEG\">",
    "optionA": "A. Dystrophic calcification \n                \n                  \n                    \nCorrect",
    "optionB": "B.   Metastatic calcification\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Fibrinoid necrosis",
    "optionD": "D. Type III hypersensitivity reaction",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The pressure tracing in the given image shows a large pressure gradient between the aorta and the left ventricle in systole and is suggestive of <strong>valvular aortic stenosis. </strong>The most likely pathology in aortic stenosis is <strong>dystrophic calcification of the semilunar valves</strong>.&nbsp;</p>\n<p>The images below show a normal pressure gradient between the aorta and the left ventricle and the arrows in the 2nd image demonstrates a large pressure gradient between the aorta and the left ventricle:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a45245f870e54bdbafe1de6ea6dbccfbx1280x2224.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><br>When the deposition of calcium occurs in dead or dying tissues, it is called <strong>dystrophic calcification</strong>. This occurs in the <strong>absence</strong> of <strong>derangements</strong> in <strong>calcium metabolism</strong>, i.e. the calcium levels are normal. Dystrophic calcification is seen in areas of necrosis of any type including <strong>coagulative</strong>, <strong>caseous</strong>, or <strong>liquefactive</strong>, and in foci of enzymatic fat necrosis. Some examples include atheromas of advanced atherosclerosis and areas of caseous necrosis in tuberculosis. It also commonly develops in aging or damaged heart valves.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Metastatic calcification</strong> occurs in <strong>normal tissues</strong>, in the presence of <strong>hypercalcemia</strong>, or in conditions associated with an abnormality of calcium metabolism.</p>\n<p>Option C: <strong>Fibrinoid necrosis</strong> is seen in immune reactions involving <strong>blood vessels</strong> with deposition of fibrinoid material such as various vasculitis syndromes.</p>\n<p>Option D:<strong> Libman Sacks Endocarditis</strong> is a <strong>fibrinous endocarditis</strong> typically seen in association with <strong>systemic lupus erythematosus</strong> and is associated with <strong>aortic regurgitation</strong>, not aortic stenosis. It is an example of a Type III hypersensitivity reaction.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2357: Types of calcifications</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Dystrophic calcification</strong></td>\n<td><strong>Metastatic calcification</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Dead and dying tissues</td>\n<td>Normal interstitial tissues of the vasculature, kidneys, lungs, and gastric mucosa.</td>\n</tr>\n<tr>\n<td>Calcium metabolism</td>\n<td>Normal</td>\n<td>deranged causing hypercalcemia</td>\n</tr>\n<tr>\n<td>Examples</td>\n<td>\n<p>Calcific valvular stenosis</p>\n<p>Advanced Atheromatous plaque</p>\n<p>Monckeberg medial sclerosis</p>\n</td>\n<td>\n<p>Parathyroid tumors</p>\n<p>Hypercalcemia of malignancy</p>\n<p>Paget disease</p>\n<p>vitamin D intoxication</p>\n<p>Sarcoidosis</p>\n<p>Renal failure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-160",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC5369",
    "stauts": "Incorrect",
    "question_title": "160.\n        Lymphatic drainage of prostate is into",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Internal iliac lymph nodes\n                \n                  \n                    \nCorrect",
    "optionB": "B. External iliac lymph nodes",
    "optionC": "C. Para-aortic lymph nodes",
    "optionD": "D. Superficial inguinal lymph nodes\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Lymphatic vessels from the prostate drain mainly in the <strong>internal iliac, sacral, and obturator lymph nodes</strong>.</p>\n<p>Important to note is that lymphatic drainage of the prostate is highly variable. Many of the lymph vessels from the prostate <strong>anastomoses</strong> with their counterparts of several neighboring organs, for example the <strong>urinary bladder</strong> and <strong>rectum</strong>. This can have important clinical implications, especially in cases of <strong>prostate cancer</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2214: Lymphatic drainage of pelvic structures</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\" width=\"620\">\n<tbody>\n<tr>\n<td><strong>LYMPH NODES</strong></td>\n<td><strong>STRUCTURES DRAINING</strong></td>\n</tr>\n<tr>\n<td>Para - aortic lymph nodes</td>\n<td>Ovaries /Testis</td>\n</tr>\n<tr>\n<td>External iliac lymph nodes</td>\n<td>Uterine body, cervix, superior bladder</td>\n</tr>\n<tr>\n<td>Internal iliac lymph nodes</td>\n<td>Prostate, cervix, corpus cavernosum,proximal vagina</td>\n</tr>\n<tr>\n<td>Superficial inguinal lymph nodes</td>\n<td>Distal vagina, vulva, scrotum, distal anal canal</td>\n</tr>\n<tr>\n<td>Deep inguinal lymph nodes</td>\n<td>Glans penis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>*Ref - Snells Clinical Anatomy - 4e&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-161",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6447",
    "stauts": "Incorrect",
    "question_title": "161.\n        A patient diagnosed with a parathyroid adenoma was posted for a parathyroidectomy. Her preoperative parathormone was 150 pg/mL. Her parathormone levels fell by 33% at 10 minutes post-excision. What should the surgeon do next?",
    "question_ADD": "<p>Parathormone - (PTH)</p>\n<p>Normal Range of PTH - 10-65 pg/mL</p>",
    "question_imag": "",
    "optionA": "A. Check the level of PTH again.",
    "optionB": "B. Measure the serum calcium levels. \n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Convert to bilateral neck exploration. \n                \n                  \n                    \nCorrect",
    "optionD": "D. Close the incision.",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In this clinical scenario, PTH's value has fallen by 33% and as the fall is <strong>less than 50%</strong> of the maximum preoperative PTH level, as per the <strong>Miami criteria</strong>, <strong>bilateral neck exploration </strong>should be done to <strong>identify</strong> <strong>multi-gland disease</strong>.</p>\n<p>The Miami criteria were developed to ensure the <strong>adequacy </strong>of <strong>resection in parathyroid surgery</strong>. It is based on the principle that the <strong>half-life </strong>of the PTH is <strong>3-5 minutes</strong>. In a <strong>single-gland disease</strong>, once the gland is removed the PTH levels should drop to the <strong>normal range</strong> and less than half the maximum preoperative PTH at <strong>10 minutes</strong>.</p>\n<p>Most of the patients with <strong>primary hyperparathyroidism</strong> have a <strong>single adenoma</strong> and therefore undergo a<strong> focused or minimally invasive</strong> <strong>parathyroidectomy</strong>, where the localized abnormal parathyroid gland is removed through an incision less than 3 cm. Once the gland is removed, the surgeon can ensure no other hyperactive gland remains by performing an intraoperative PTH assay which is interpreted based on the Miami criteria.</p>\n<p>However, if there is no drop in PTH level, then a multi-gland disease is suspected and the surgery is converted to a bilateral neck exploration. At times during bilateral neck exploration, all four glands are removed and a <strong>forearm autotransplant</strong> of parathyroid tissue in the <strong>brachioradialis</strong> muscle is done.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-162",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8811",
    "stauts": "Skipped",
    "question_title": "162.\n        The virulence factors of Candida albicans include:",
    "question_ADD": "<ol>\n<li>Polysaccharide capsule</li>\n<li>Phospholipase</li>\n<li>Phenol oxidase</li>\n<li>Secreted aspartyl proteinase</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1 and 3",
    "optionB": "B. 2 and 4 \n                \n                  \n                    \nCorrect",
    "optionC": "C. 1, 2, and 3",
    "optionD": "D. 2, 3, and 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The<strong> virulence factors </strong>of<strong> <em>Candida albicans</em></strong> include <strong>Phospholipase (PLB1)</strong>&nbsp;and <strong>secreted aspartyl proteinases (SAP)</strong>.&nbsp;</p>\n<p>Virulence factors of candida species:</p>\n<ul>\n<li><strong>Agglutinin-like sequence (ALS) surface glycoproteins</strong> bind to the host cell membrane receptors and mediate attachment to the epithelial and endothelial cells.</li>\n<li><strong>Secreted aspartyl proteinases (SAPs) </strong>degrade host cell membranes and destroy immunoglobulins.</li>\n<li><strong>Phospholipase (PLB1) is </strong>secreted by the yeasts and pseudohyphae.</li>\n<li><strong>Fungal biofilm</strong>, protected by the extracellular matrix material prevents the penetration of the host’s immune response and antifungal drugs.</li>\n</ul>\n<p>Other options :&nbsp;</p>\n<p>The <strong>polysaccharide capsule</strong> and <strong>laccase (phenol oxidase)</strong> are the virulence factors of <strong>C</strong><em><strong>ryptococcus neoformans</strong></em>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1761: Classification of fungus based on morphology</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Fungi are classified into 4 types based on their morphology:</p>\n<ul>\n<li>Yeast</li>\n<li>Yeast-like</li>\n<li>Molds</li>\n<li>Dimorphic fungi</li>\n</ul>\n<p><strong>Yeast:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding</li>\n<li>Oval to round forms</li>\n<li>Example: Cryptococcus,&nbsp;Saccharomyces.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0f583d17fa494e93b42864de8e82507cx597x599.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Yeast like:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding or binary fission</li>\n<li>Spherical or oval forms</li>\n<li>Pseudohyphae may be seen.</li>\n<li>Example: Candida,&nbsp;Malassezia furfur.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bf7e12378e26462194d6b6f9155af000x800x501.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Molds/filamentous fungi:</strong></p>\n<ul>\n<li>Have hyphae which may be septate or aseptate</li>\n<li>Aseptate or coenocytic hyphae – Rhizopus, mucor,&nbsp;Lichtheimia.</li>\n<li>Septate hyphae – Penicillium, Dermatophytes, Aspergillus, fusarium.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/129499f438c04855bf91806ab6191d23x800x547.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Dimorphic fungi</strong></p>\n<ul>\n<li>Filamentous forms in the culture at 22<sup>0</sup>C – 25<sup>0</sup>C and in the environment.</li>\n<li>Yeast form in the culture at 37<sup>0</sup>C and in tissues.</li>\n<li>Examples – Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracoccidioides brasiliensis, Talaromyces&nbsp;marneffei, Sporothrix schenckii.</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2347: Types of capsules in microorganisms</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Capsule&nbsp;</strong></td>\n<td><strong>Organsim</strong></td>\n</tr>\n<tr>\n<td>Polysaccharide capsule&nbsp;</td>\n<td>\n<p>&nbsp;Streptococcus pneumonia</p>\n<p>&nbsp;Klebsiella pneumonia</p>\n<p>&nbsp;Hemophilius influenza</p>\n<p>&nbsp;Neiserria meningitidis</p>\n<p>&nbsp;Salmonella typhi</p>\n<p>&nbsp;Cryptococcus neoformans</p>\n<p>&nbsp;Bordetella pertussis</p>\n<p>Clostridium perfringens</p>\n</td>\n</tr>\n<tr>\n<td>Hyaluronic acid capsule&nbsp;</td>\n<td>Streptococcus pyogenes</td>\n</tr>\n<tr>\n<td>Polypeptide (Poly-D -Glutamate) Capsule&nbsp;</td>\n<td>Bacillus anthracis</td>\n</tr>\n<tr>\n<td>F1 Protein Capsule&nbsp;</td>\n<td>Yersinia pestis</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-163",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1282",
    "stauts": "Skipped",
    "question_title": "163.\n        A 50-year-old P4L4 patient presented with complaints of involuntary passage of urine on coughing. Which of the following procedures for this condition, is carried out using a vaginal approach?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Burch colposuspension",
    "optionB": "B. Tension-free vaginal taping",
    "optionC": "C. Marshall-Marchetti-Krantz operation",
    "optionD": "D. Kelly's repair\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The procedure among the following options that use a vaginal approach and is suitable for the clinical scenario suggestive of <strong>stress urinary incontinence</strong> is<strong> Kelly's repair.</strong></p>\n<p><strong>Genuine stress incontinence (GSI)</strong> occurs when <strong>increased abdominal pressure</strong> causes urine leakage because bladder pressure exceeds urethral pressure <strong>without</strong> any <strong>detrusor muscle contraction</strong>. It is characterized by small amounts of involuntary urine leakage during <strong>physical activities</strong> or <strong>stress</strong>, without a detrusor contraction.</p>\n<p>The various<strong> surgical procedures </strong>for<strong> </strong>GSI are as follows:</p>\n<ul>\n<li>Vaginal approach\n<ul>\n<li><strong>Kelly's repair</strong></li>\n<li><strong>Pacey's repair</strong></li>\n</ul>\n</li>\n<li>Abdominal approach\n<ul>\n<li><strong>Burch colposuspension</strong></li>\n<li><strong>Marshall-Marchetti-Krantz operation&nbsp;</strong></li>\n</ul>\n</li>\n<li>Combined vaginal and abdominal suspension&nbsp;\n<ul>\n<li><strong> Pereyra</strong> operation</li>\n</ul>\n</li>\n<li>Slings&nbsp;\n<ul>\n<li>Tension-free vaginal taping <strong>(TVT)</strong> - retro-pubic approach</li>\n<li>Transobturator taping<strong> (TOT)</strong> - approach via the obturator foramen</li>\n</ul>\n</li>\n<li>Laparoscopic suspension of the bladder neck</li>\n<li>Periurethral collagen injection</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-164",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1344",
    "stauts": "Incorrect",
    "question_title": "164.\n        A 23-year-old sexually active man presents with fever, malaise, and severe pain in his right knee. Joint aspirate is cloudy and reveals multiple neutrophils but no organisms on gram stain. What is the likely cause of his disease?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Gardnerella vaginalis",
    "optionB": "B. Neisseria gonorrhoeae\n                \n                  \n                    \nCorrect",
    "optionC": "C. Treponema pallidum\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Ureaplasma urealyticum",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This clinical scenario of a sexually active patient with <strong>joint pain </strong>and fever with a joint aspirate showing <strong>neutrophils</strong> and <strong>no organisms</strong> should raise concerns for supportive arthritis caused by <strong><em>Neisseria gonorrhoea</em>.&nbsp;</strong></p>\n<p><em>Neisseria gonorrhoea</em> is commonly implicated in <strong>sexually active young adults</strong> and joint aspirates are usually <strong>sterile</strong>(no organism seen on gram stain) in only up to 30% of patients. Thus diagnosis should be made on clinical suspicion.<strong> Disseminated gonococcal infection</strong> causes <strong>gonococcal arthritis</strong>. It comprises <strong>localized septic arthritis</strong> and <strong>arthritis-dermatitis syndrome</strong>. Other manifestations like endocarditis, pericarditis, osteomyelitis, and meningitis are extremely rare.</p>\n<p><strong>Joint </strong>or <strong>tendon pain</strong> is the most common accompanying feature. <strong>Tenosynovitis</strong> often affects the hands and fingers. One-third of the patients may proceed to <strong>suppurative arthritis</strong>, most commonly of the knee. <strong>Migratory polyarthralgia</strong> affects the knees, elbows, wrists, metacarpophalangeal joints, and ankle joints.</p>\n<p><strong>Lab</strong> <strong>diagnosis</strong> involves the collection of vaginal or urethral discharge which is then subjected to Gram stain, revealing <strong>gram‐negative intracellular diplococci</strong> within phagocytes. Stuart's transport medium is used. Cultures can be obtained from <strong>chocolate agar</strong> or <strong>Mueller-Hinton agar</strong>. Specifically, <strong>Thayer-Martin agar</strong> is used to isolate <em>Neisseria gonorrhoeae</em>.</p>\n<p>The image below shows <strong>gram‐negative intracellular diplococci</strong> within phagocytes suggestive of <em>Neisseria gonorrhoea</em>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a9d5e6003d0643b0ac7bba091a2804cex720x474.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:&nbsp;</p>\n<p>Option A and D: <em><strong>Gardnerella vaginalis</strong></em> and <em><strong>Ureaplasma urealyticum</strong></em> are common sexually transmitted organisms however, they are unlikely to cause septic arthritis in the individuals.</p>\n<p>Option C: Treponema species are not associated with the development of septic arthritis.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2456: Sexually transmitted infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Genital herpes</strong>- caused by <strong>herpes simplex virus</strong> (human herpesvirus 1 and 2).</p>\n<ul>\n<li>It appears as <strong>blisters</strong> (usually multiple) that lead to ulcer formation on breaking.</li>\n<li>The ulcers are <strong>painful</strong>.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ba0cafb8f724e8caf99ab7778d022acx630x761.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Granuloma inguinale&nbsp;</strong>/ Donovanosis- caused by&nbsp;<strong>Klebsiella granulomatis</strong>&nbsp;(formerly known as Calymmatobacterium granulomatis).</p>\n<ul>\n<li>It usually causes <strong>beefy red genital ulcers</strong> that may bleed on touch.</li>\n<li>The ulcers are usually <strong>painless</strong>.</li>\n<li>Lymphadenopathy is usually absent but subcutaneous granulomas cause <strong>pseudo buboes</strong>.&nbsp;</li>\n<li>Microscopy shows <strong>Donovan bodies</strong> with closed safety pin appearance</li>\n</ul>\n<p>The given images show genital ulcer in granuloma inguinale:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4aaa8224b2e7443e94743e1015a44778x560x358.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Chancroid</strong>/ Soft chancre-&nbsp;caused by&nbsp;<strong>Haemophilus ducreyi</strong>.</p>\n<ul>\n<li>Causes genital ulcers that are <strong>non indurated</strong> with undermined edges.</li>\n<li>The ulcer is <strong>painful</strong>.</li>\n<li>Multiple/ Kissing ulcers develop due to autoinoculation from the primary ulcer.</li>\n<li>It usually causes tender unilateral<strong>&nbsp;inguinal buboes</strong>.&nbsp;</li>\n<li>Microscopy- School of fish/Railroad track appearance</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/875f994ab0a44d3a8d26f376c6b54874x597x313.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Syphilitic chancre</strong>/ Hard chancre- caused by <strong>Treponema pallidum</strong>.</p>\n<ul>\n<li>It presents as a <strong>small, button-like, indurated ulcer</strong> that is usually round/oval.</li>\n<li>The ulcer is <strong>painless</strong>.</li>\n<li>Causes <strong>painless lymphadenopathy</strong>.</li>\n<li>Microscopy- Spirochetes seen on dark ground illumination.</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/03d21e32213a42c9ab3487da627b053ex336x288.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Lymphogranuloma venereum</strong>- caused by&nbsp;<strong>Chlamydia trachomatis</strong>.</p>\n<ul>\n<li>It usually presents with a transient single <strong>shallow ulcer</strong> that <strong>heals rapidly</strong> and usually goes unnoticed.</li>\n<li>The secondary stage presents with <strong>tender&nbsp;inguinal buboes</strong>.</li>\n<li><strong>Groove sign</strong> is seen when the lymph nodes above and below the inguinal ligament are enlarged leading to the appearance of a groove.</li>\n</ul>\n<p>The given images show the ulcer and the groove sign seen in LGV:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6faad0dd79004ce4898a0d4ec94391e9x495x711.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be01c14fe5b34f6fb923eca0f40d42cex253x357.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p><strong>Gonorrhea</strong>- caused by <strong>Neisseria gonorrhoeae</strong>.</p>\n<ul>\n<li>It leads to <strong>purulent inflammation</strong> of the genital mucous membranes.</li>\n<li>It may present as&nbsp;urethritis, cervicitis, epididymo‐orchitis, or pelvic inflammatory disease.</li>\n<li>The usual presentation is <strong>acute urethritis</strong> with complaints of burning dysuria and purulent discharge.</li>\n</ul>\n<p>The given image shows purulent genital inflammation due to gonorrhea:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f4fd185c143045fe944bb99f1299a4bbx379x412.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM2024: Syndromic Management of Sexually Transmitted Infections</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e7908befff94f9a85b4a7b751999821x1280x1742.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-165",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF4321",
    "stauts": "Skipped",
    "question_title": "165.\n        Which of the following features is least likely to be associated with vitiligo?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. It is commonly affects the extensor areas of skin",
    "optionB": "B. It is associated with pseudo-koebner phenomenon\n                \n                  \n                    \nCorrect",
    "optionC": "C. It shows milky-white fluorescence under wood's lamp",
    "optionD": "D. It is commonly associated with pernicious anemia",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>It is associated with pseudo-koebner phenomenon is the incorrect statement. <strong>Vitiligo</strong> is associated with <strong>koebner phenomenon</strong>.</p>\n<p><strong>Koebner or isomorphic Phenomenon</strong>&nbsp;is the development of new lesions&nbsp;<strong>along the line of trauma</strong>&nbsp;in previously normal skin. The new lesions have 'iso' (same) and 'morphic' (morphology) as the existing lesions. It is commonly seen in immune-mediated conditions like vitiligo and lichen planus.</p>\n<p><strong>Pseudo-Koebner phenomenon</strong> refers to the appearance of lesions in previously unaffected skin following trauma, but unlike the true Koebner phenomenon, it involves the spread of an<strong> infectious agent </strong>rather than an inherent disease response to trauma. For example. <strong>HPV,</strong> <strong>mechanical trauma</strong></p>\n<p><strong>Vitiligo</strong>&nbsp;is a localized depigmentation that occurs due to a&nbsp;<strong>progressive loss in the melanocytes&nbsp;</strong>in the&nbsp;<strong>basal layer of skin.&nbsp;</strong>It is classified as</p>\n<ul>\n<li><strong>Segmental vitiligo</strong>- which appears as&nbsp;<strong>unilateral</strong>&nbsp;maculae in a segmented or band-shaped pattern</li>\n<li><strong>Non-segmental vitiligo</strong>- which appears as&nbsp;<strong>bilateral</strong>&nbsp;maculae distributed in an acrofacial pattern or scattered symmetrically over the entire body. Non-segmental can either be focal vitiligo or undetermined/unclassified vitiligo.</li>\n</ul>\n<p><strong>Clinical features:</strong></p>\n<p>The lesions become apparent between 20-30 years of age.&nbsp;</p>\n<p class=\"p1\">Hypopigmented macules in vitiligo are commonly found in the&nbsp;<strong>hips, dorsum of the hands/fingers</strong>,&nbsp;<strong>feet, elbows, knees,&nbsp;</strong>and<strong>&nbsp;ankle areas.</strong> (Option A) These are the areas of repeated friction. <strong>Koebner phenomenon&nbsp;</strong>is seen, which is the development of&nbsp;<strong>lesions at the site of trauma</strong>&nbsp;on the uninvolved skin.</p>\n<p class=\"p1\"><strong>Vitiligo universalis</strong>, which is&nbsp;<strong>complete vitiligo,</strong>&nbsp;or trichrome vitiligo where there are areas of depigmentation, hyperpigmentation, as well as areas of normal skin may be seen rarely.</p>\n<p>Several autoimmune conditions can be associated with vitiligo. They are:</p>\n<ul>\n<li class=\"p1\">Thyroid disease<span class=\"s1\">&nbsp;</span>(hyperthyroidism and hypothyroidism)</li>\n<li class=\"p1\">Pernicious anemia (Option D)</li>\n<li class=\"p1\">Addison disease</li>\n<li class=\"p1\">Diabetes</li>\n<li class=\"p1\">Hypoparathyroidism</li>\n</ul>\n<p><strong>Examination:</strong></p>\n<p>Under the Wood's lamp examination&nbsp;the depigmented areas emit a bright&nbsp;<strong>blue-white</strong>&nbsp;or&nbsp;<strong>milky-white</strong><strong> fluorescence</strong>&nbsp;and&nbsp;<strong>appear sharply demarcated. </strong>(Option C)</p>\n<p><strong>Treatment:</strong></p>\n<p>Treatment involves cosmetic camouflage and the use of sunscreen. The topical application of&nbsp;<strong>corticosteroids</strong>&nbsp;is the&nbsp;<strong>first line of treatment</strong>. Topical calcineurin inhibitors like&nbsp;pimecrolimus and tacrolimus have also shown to be successful.&nbsp;<strong>Psoralen photochemotherapy,</strong>&nbsp;khellin, and selective&nbsp;<strong>ultraviolet B therapy</strong>&nbsp;are used as&nbsp;<strong>second-line treatment</strong>. In patients who do not respond to this treatment, surgical grafting techniques can be used, where the melanocytes from a normal pigmented area are transferred to a non pigmented area. In patients with extensive vitiligo where only a few pigmented areas are left, depigmentation can be done.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0260: Wood's lamp examination</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Wood's lamp examination</strong> is a <strong>diagnostic</strong> test&nbsp;wherein the <strong>skin</strong> or <strong>hair</strong> is examined under exposure to the <strong>black</strong> <strong>light</strong> emitted by the <strong>Wood</strong> <strong>lamp</strong>.</p>\n<p>Blacklight is invisible to the naked eye because it is in the ultraviolet spectrum, with a wavelength just shorter than the color violet. The lamp glows violet in a dark environment because it also emits some light in the violet part of the electromagnetic spectrum.</p>\n<p>A traditional Wood lamp is a low-output mercury arc covered by a <strong>Wood</strong> <strong>filter</strong> (<strong>barium</strong> <strong>silicate</strong> and <strong>9% nickel oxide</strong>) and emits light at&nbsp;<strong>wavelength</strong> <strong>320</strong>–<strong>450</strong> <strong>nm</strong> (<strong>peak</strong> <strong>365</strong> <strong>nm</strong>).</p>\n<p><strong>Table</strong>: Various diseases and their color on Wood’s lamp examination</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Colour on Wood’s Light</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tinea capitis</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Microsporum species</strong>: brilliant green (M. canis, M. audouinii, M. ferrugineum, M. distortum)</p>\n<p><strong>Trichophyton schoenleinii</strong>: dull blue</p>\n<p>Most&nbsp;<strong>Trichophyton&nbsp;</strong>species, with the exception of&nbsp;T. schoenleini<em>i</em>, are&nbsp;non-fluorescent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Erythrasma</p>\n</td>\n<td>\n<p>Coral pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n<td>\n<p>Faint yellow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pseudomonas</p>\n</td>\n<td>\n<p>Green</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Scabies</p>\n</td>\n<td>\n<p>Fluorescein solution fills the burrows and fluoresces on Wood’s light.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Porphyria</p>\n</td>\n<td>\n<p>Urine, feces, blister fluid fluoresce red or pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitiligo</p>\n</td>\n<td>\n<p>Ivory or milky white</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2242a0f1720540909975b6853638f735x800x531.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1956: Koebner phenomenon</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Koebner or isomorphic Phenomenon</strong> is the development of new lesions <strong>along the line of trauma</strong> in a previously normal skin. The new lesions have 'iso' (same) and 'morphic' (morphology) as the existing lesions.</p>\n<p>The trauma may include mechanical trauma, thermal trauma, allergic or irritant reactants or any treatment procedures.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>True</strong> Koebner's phenomenon</td>\n<td>In immune-mediated conditions</td>\n<td>\n<p>Psoriasis</p>\n<p>Vitiligo</p>\n<p>Lichen planus</p>\n</td>\n</tr>\n<tr>\n<td><strong>False</strong> Koebner's phenomenon</td>\n<td>In infectious diseases</td>\n<td>\n<p>Viral warts</p>\n<p>Molluscum contagiosum</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Remote reverse</strong> Koebner phenomenon</td>\n<td>\n<p><strong>Spontaneous repigmentation</strong> of vitiligo patches <strong>distant</strong> from the autologous skin graft sites (trauma)</p>\n<p>Generalized granuloma annulare</p>\n</td>\n<td>\n<p>Vitiligo</p>\n<p>Psoriasis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Some <strong>rare causes</strong> of True Koebner Phenomenon are : Darier's disease, Hailey-Hailey disease, Erythema multiforme, Kaposi's Sarcoma and Lichen sclerosus.</p>\n<p><strong>Image:</strong>&nbsp;Koebner phenomenon with linear psoriasis patch on the abdomen</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d31270bf5e5f4b709adfe08cf50556d9x131x217.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1911: Algorithm for the differential diagnosis of Hypomelanosis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/76d12e9fdf3e477fa5ca155bed1ddaacx657x456.PNG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-166",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5963",
    "stauts": "Incorrect",
    "question_title": "166.\n        A 55-year-old man is started on hydrochlorothiazide for the treatment of hypertension. Which of the following complications is he least likely to develop?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Erectile dysfunction\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Hypocalcemia\n                \n                  \n                    \nCorrect",
    "optionC": "C. Hyperuricemia",
    "optionD": "D. Hypokalemia",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div><strong>Thiazide diuretics&nbsp;</strong>are associated with <strong>hypercalcemia</strong>, not hypocalcemia.</div>\n<div>&nbsp;</div>\n<div>Adverse effects of thiazide diuretics like hydrochlorothiazide:</div>\n<ul>\n<li>Hypokalemia</li>\n<li>Hyponatremia</li>\n<li>Hyperglycemia</li>\n<li>Hyperuricemia</li>\n<li>Hypercalcemia</li>\n<li>Rashes</li>\n<li>Headache</li>\n<li>Gastrointestinal upset</li>\n<li>Dizziness</li>\n<li>Erectile dysfunction</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0486: Effect of diuretics on excretion of electrolytes</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td><strong>Diuretics</strong></td>\n<td><strong>Sodium</strong></td>\n<td><strong>Potassium</strong></td>\n<td><strong>Calcium</strong></td>\n</tr>\n<tr>\n<td><strong>Carbonic anhydrase inhibitors</strong></td>\n<td>↑</td>\n<td>↑↑</td>\n<td>No change</td>\n</tr>\n<tr>\n<td><strong>Osmotic diuretics</strong></td>\n<td>↑↑</td>\n<td>↑</td>\n<td>↑</td>\n</tr>\n<tr>\n<td><strong>Loop diuretics</strong></td>\n<td>↑↑</td>\n<td>↑↑</td>\n<td>↑↑</td>\n</tr>\n<tr>\n<td><strong>Thiazides</strong></td>\n<td>↑</td>\n<td>↑↑</td>\n<td>↓</td>\n</tr>\n<tr>\n<td><strong>Epithelial sodium channel blockers</strong></td>\n<td>↑</td>\n<td>↓</td>\n<td>↓</td>\n</tr>\n<tr>\n<td><strong>Aldosterone antagonists</strong></td>\n<td>↑</td>\n<td>↓</td>\n<td>Insufficient data</td>\n</tr>\n</tbody>\n</table>\n<p>Acute effects of thiazides on Ca<sup>2+</sup> excretion are variable but when administered chronically, it decreases Ca<sup>2+</sup> excretion.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-167",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6817",
    "stauts": "Incorrect",
    "question_title": "167.\n        A 8-year-old male child is brought with complaints of restricted joint movement and difficulty to walk due to progressive limb contracture . On examination, the child had coarse facial features, macrocephaly, hepatosplenomegaly,  umbilical hernia and cloudy cornea. However his IQ was normal. Which of the following recombinant enzymes is useful in treating this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Aldurazyme",
    "optionB": "B. Naglazyme\n                \n                  \n                    \nCorrect",
    "optionC": "C. Elaprase",
    "optionD": "D. Myozyme\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A child presenting with<strong> contractures, </strong>coarse facial features, visceromegaly, <strong>cloudy cornea</strong> with <strong>normal IQ </strong>points to the diagnosis of <strong>Maroteaux–Lamy syndrome. Naglazyme</strong> <span>a.k.a</span><span> <strong>Galsulfase</strong> is used in the treatment of this condition.</span></p>\n<p><strong>Maroteaux–Lamy syndrome</strong>,<strong> </strong>also known as<strong> mucopolysaccharidosis type VI </strong>is caused by the deficiency of <strong>arylsulfatase B</strong> enzyme. <strong>Preservation of intelligence</strong> is the feature of this syndrome. . It is characterized by <strong>macrocephaly</strong>, hydrocephalus, <strong>macroglossia</strong>, disproportionate short stature, <strong>umbilical hernia</strong>, <strong>marked corneal clouding</strong>, frequent respiratory illness or otitis media, <strong>cardiac defects</strong>, <strong>contractures </strong>and<strong> Carpal tunnel syndrome.</strong>&nbsp;&nbsp;</p>\n<p>Rapidly progressive Maroteaux-Lamy syndrome is associated with an onset of symptoms before three years of age. Affected individuals may develop walking problems (impaired mobility) by the age of 10 and experience delayed or absence of puberty.&nbsp;</p>\n<p>Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans.</p>\n<p>MPS with <strong>no mental retardation</strong>: Scheie’s disease, Morquio syndrome, and <strong>Maroteaux–Lamy syndrome</strong>.<br>MPS with <strong>no corneal clouding</strong>: <strong>Hunter’s disease</strong> and Sanfilippo syndrome<br>MPS with <strong>XLR</strong> inheritance: <strong>Hunter’s disease</strong><br>MPS with <strong>no visceromegaly</strong>: <strong>Morquio’s disease</strong><br><strong>Skeletal deformity</strong> associated with <strong>all</strong> MPS: <strong>Dysostosis multiplex</strong><br>MPS with <strong>no leucocyte inclusions:</strong> <strong>Morquio’s disease</strong></p>\n<p>Other options:</p>\n<p>Option A: <strong>Aldurazyme</strong> <span>a.k.a</span><span>&nbsp;</span><strong>Laronidase</strong><span>&nbsp;in the treatment of</span><strong>&nbsp;</strong><strong>Hurler's disease,&nbsp;</strong><span>also known as mucopolysaccharidosis type I. It is associated with <strong>mental retardation, </strong>which is not seen in this patient.</span></p>\n<p>Option C: <strong>&nbsp;Elaprase</strong><span> a.k.a <strong>Idursulfase</strong></span><span> is used in the treatment of this <strong>Hunter's disease</strong> is also known as mucopolysaccharidosis II. <strong>Corneal clouding </strong>is <strong>not</strong> a feature of Hunter's disease.</span></p>\n<p>Option D: <strong>Myozyme</strong> a.k.a <strong>alglucosidase alfa</strong>, a recombinant form of alpha-1,4-glucosidase is used in the treatment of <strong>Pompe's disease</strong>. Clinical features include&nbsp;<strong>hypotonia&nbsp;</strong>(<strong>floppy baby</strong> syndrome), motor delay,&nbsp;<strong>cardiomegaly</strong>, macroglossia, hepatomegaly, <strong>failure to thrive,</strong> and poor feeding. Where as in this child there is no hypotonia, instead has contractures of limbs.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0941: Enzyme Replacement Therapy for Lysosomal Storage Disorders</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>α-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux–Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-α-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>β-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;β-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>α-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>β-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br>Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid α-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0939: MPS and Their Respective Enzyme Deficiencies</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br>Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>α-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br>Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br>coarse facial features,&nbsp;<br>Hepatosplenomegaly<br>Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br>Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br>Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>α-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>α-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br>Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br>short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>β-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br>Short stature<br>Skeletal dysplasia<br>Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>β-glucuronidase</td>\n<td>Dermatan sulfate<br>Heparan sulfate<br>Chondroitin 4-sulfate&nbsp;<br>Chondroitin 6-sulfate&nbsp;<br><br></td>\n<td>Short stature<br>Skeletal dysplasia<br>Hepatomegaly<br>Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br>Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-168",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5627",
    "stauts": "Incorrect",
    "question_title": "168.\n        A chronic alcoholic patient presents with abdominal pain and vomiting. He had similar episodes in the past along with steatorrhea, weight loss, and fatigue. Which of the following radiological tests is the gold standard investigation for this condition?",
    "question_ADD": "<p>ERCP - Endoscopic retrograde cholangiopancreatography</p>\n<p>MRCP - Magnetic resonance cholangiopancreatography</p>\n<p>CT - Computed Tomography</p>",
    "question_imag": "",
    "optionA": "A. MRCP\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. HIDA scan",
    "optionC": "C. ERCP\n                \n                  \n                    \nCorrect",
    "optionD": "D. Abdominal CT scan",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario suggests the diagnosis of <strong>chronic pancreatitis </strong>and&nbsp;<strong>ERCP</strong> is the gold standard investigation for this condition.</p>\n<p>Pancreatic <strong>calcifications</strong> can be seen on <strong>abdominal X-rays.</strong></p>\n<p><strong>Endoscopic ultrasound </strong>showing the presence of four or more of the following features is highly suggestive of chronic pancreatitis:</p>\n<ul>\n<li><strong>Presence of stones</strong></li>\n<li>Visible side branches</li>\n<li><strong>Cysts</strong></li>\n<li>Lobularity</li>\n<li>An irregular main pancreatic duct</li>\n<li>Hyperechoic foci and strands</li>\n<li>Dilatation of the main pancreatic duct</li>\n<li>Hyperechoic margins of the main pancreatic duct&nbsp;&nbsp;</li>\n</ul>\n<p>An <strong>abdominal CT scan</strong> is the <strong>initial </strong>modality of choice for diagnosing chronic pancreatitis. CT or MRI scan will show the outline of the gland, the main area of damage, and the possibilities for surgical correction.</p>\n<p>The <strong>investigation of choice </strong>for chronic pancreatitis is<strong> MRCP with secretin stimulation</strong>. <strong>ERCP </strong>is the <strong>gold-standard</strong> investigation. ERCP is the best way to get detailed information about the ducts and the overall shape of the gland.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1641: Clinical Features of Chronic Pancreatitis</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Abdominal pain</strong>: <strong>most common symptom</strong></p>\n<ul>\n<li>Site:\n<ul>\n<li>If infectious foci are in the <strong>head of the pancreas</strong>, then <strong>epigastric and right subcostal pain</strong> is common;</li>\n<li>If the infection is limited to the <strong>left side of the pancreas, left subcostal and back pain</strong> are seen.</li>\n</ul>\n</li>\n<li>Precipitated by food intake, thus <strong>weight loss </strong>is also seen.</li>\n<li>Associated with nausea, vomiting</li>\n</ul>\n<p>Exocrine insufficiency:</p>\n<ul>\n<li><strong>Precedes endocrine insufficiency</strong></li>\n<li>Correlates with morphological changes</li>\n<li>Manifests with <strong>malabsorption symptoms</strong>: steatorrhea, diarrhea.</li>\n<li>Manifests with signs and symptoms of <strong>fat-soluble vitamin deficiency, </strong>such as <strong>bleeding, osteopenia, and osteoporosis: </strong>Severe cases</li>\n</ul>\n<p>Endocrine insufficiency: Diabetes mellitus</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-169",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5699",
    "stauts": "Incorrect",
    "question_title": "169.\n        A 38-year-old mountaineer who has been missing for 12 hours is brought in a semi-conscious state. His heart rate is 26 beats per minute and BP is 70/40 mmHg. Despite initial therapy with rewarming and iv atropine, his heart rate remains critically low, and he continues to exhibit cold, clammy skin, and rapid, shallow breathing. The attending physician decides to initiate an adrenaline infusion. What is the recommended dosage range for adrenaline infusion in this situation?",
    "question_ADD": "<p>IV- Intravenous</p>",
    "question_imag": "",
    "optionA": "A. 0.001 mg/min - 0.005 mg/min IV\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. 0.02 mcg/min - 0.1mcg/min IV",
    "optionC": "C. 0.002 mg/min - 0.01 mg/min IV\n                \n                  \n                    \nCorrect",
    "optionD": "D. 0.2 mcg/min - 1 mcg/min IV",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The recommended infusion rate of <strong>intravenous adrenaline</strong> for symptomatic bradycardia after initial treatment with atropine is <strong>2-10 mcg/min or 0.002-0.01 mg/min.</strong></p>\n<p>Atropine <strong>0.5 mg IV every 3 to 5 minutes</strong> to a maximum total dose of <strong>3 mg</strong> is the initial line of management for symptomatic bradycardia but if its ineffective, then adrenaline / dopamine infusion should be started.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0190: Adult Bradycardia with Pulse Algorithm</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p dir=\"ltr\">When a patient is in <strong>bradyarrhythmia</strong> typically with a <strong>heart rate</strong> of <strong>&lt;50 bpm</strong> the initial intervention consists of identifying and treating the underlying cause. This includes:&nbsp;</p>\n<ul>\n<li dir=\"ltr\" role=\"presentation\">Maintaining a patent airway and assisting breathing as necessary</li>\n<li dir=\"ltr\" role=\"presentation\">Administering oxygen if hypoxemic</li>\n<li dir=\"ltr\" role=\"presentation\">Attaching cardiac monitor to identify rhythm; monitor blood pressure and oximetry</li>\n<li dir=\"ltr\" role=\"presentation\">IV access</li>\n<li dir=\"ltr\" role=\"presentation\">12-Lead ECG&nbsp;</li>\n</ul>\n<p>If the bradyarrhythmia is persisent causing<strong> hemodynamic instability</strong>, then the management is as depicted by the flowchart (based on the AHA guidelines) below:</p></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ca90a6d0c948407698a4711a5cb0d095x1280x1558.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anaesthesia"
  },
  {
    "web-scraper-order": "1727319149-170",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG5763",
    "stauts": "Correct",
    "question_title": "170.\n        A 52 year old woman, known case of SLE, on chronic glucocorticoid therapy, presented to the emergency with acute appendicitis and underwent an emergency laparoscopic appendectomy without any complications. Post-operatively the patient becomes hypotensive with BP <90/60 mm Hg despite multiple intravenous fluid boluses. Which of the following is the best immediate step in management?",
    "question_ADD": "<p>SLE - systemic lupus erythematosus</p>\n<p>RLQ - Right lower quadrant</p>",
    "question_imag": "",
    "optionA": "A. Dobutamine infusion",
    "optionB": "B. Intramuscular epinephrine",
    "optionC": "C. Intravenous hydrocortisone\n                \n                  \n                    \nCorrect",
    "optionD": "D. CT scan of the abdomen",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The patient is experiencing sudden onset refractory hypotension after surgery, which is highly suggestive of <strong>acute adrenal insufficiency (adrenal crisis)</strong>. In adrenal crisis, the hypotension is often <strong>resistant to fluid resuscitation </strong>alone. Therefore, the best immediate management step is administering <strong>intravenous hydrocortisone</strong> in addition to aggressive volume repletion.</p>\n<p>An adrenal crisis may occur when individuals with <strong>chronic adrenal insufficiency (AI)</strong> encounter <strong>acute stressors</strong> like <strong>illness</strong> or <strong>surgery</strong>. This patient's medical history includes systemic lupus erythematosus, often requiring prednisone treatment during flares. <strong>Long-term glucocorticoid use</strong> can lead to <strong>suppression</strong> of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent <strong>secondary AI</strong>. Due to the impaired ability of their pituitary gland to increase ACTH secretion during times of stress, these patients face a heightened risk of experiencing an adrenal crisis.</p>\n<p>Adrenal crisis primarily presents with <strong>hypotension</strong> and <strong>shock</strong> because cortisol plays an important role in maintaining vascular tone. <strong>Hypoglycemia</strong> may also be present.</p>\n<p>Option (A, B, D) <strong>CT scan</strong> of the abdomen might aid in diagnosing <strong>postoperative hemorrhage</strong> causing shock, <strong>dobutamine infusion</strong> is used to treat <strong>cardiogenic shock</strong>, and <strong>intramuscular epinephrine</strong> is used in the treatment of <strong>anaphylactic shock</strong>. However, this patient's history of chronic glucocorticoid use makes adrenal crisis due to secondary Al more likely.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-171",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0342",
    "stauts": "Correct",
    "question_title": "171.\n        In the case of a patient diagnosed with pneumonia on antibiotics who returns with worsening right lower chest pain on inspiration and a fever of 102°F. Given pleural fluid analysis showing frank pus with a pH of 5.0, what is the most appropriate next step in managing this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Tube thoracostomy\n                \n                  \n                    \nCorrect",
    "optionB": "B. Surgical decortication",
    "optionC": "C. Thoracocentesis",
    "optionD": "D. High dose parenteral antibiotics",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In a patient presenting with <strong>worsening right lower chest pain</strong>, a<strong> fever</strong> of 102°F, and <strong>pleural fluid </strong>analysis revealing <strong>frank pus</strong> with a <strong>pH </strong>of <strong>5.0</strong>, the most appropriate next step is <strong>tube thoracostomy (chest tube drainage)</strong>. This clinical scenario suggests <strong>empyema</strong>, a <strong>severe</strong> form of <strong>parapneumonic effusion </strong>characterized by the <strong>accumulation</strong> of <strong>pus</strong> in the<strong> pleural space</strong> following bacterial infection.</p>\n<p><strong>Parapneumonic</strong> <strong>effusion</strong> is pleural effusion associated with <strong>bacterial</strong> <strong>pneumonia</strong>, <strong>lung</strong> <strong>abscess</strong>, or <strong>bronchiectasis</strong>. <strong>Empyema</strong> typically occurs as a <strong>complication</strong> of pneumonia, marked by a significantly <strong>low pleural fluid pH (&lt;7.2)</strong>, the presence of <strong>pus</strong>, and often negative or slow-growing bacterial cultures. It indicates an advanced stage of infection where <strong>simple antibiotic therapy </strong>alone is <strong>inadequate</strong>. <strong>Tube thoracostomy</strong> is essential for <strong>draining</strong> the pus, <strong>relieving symptoms</strong>, and promoting recovery.</p>\n<p>Parapneumonic pleural effusions are categorized as follows:</p>\n<ul>\n<li><strong>Uncomplicated parapneumonic effusions</strong> are <strong>exudative</strong> and neutrophilic, with negative gram stain and culture, glucose level &gt; 60 mg/dL, and <strong>pH &gt; 7.20</strong>.</li>\n<li><strong>Complicated parapneumonic effusions </strong>result from <strong>bacterial invasion</strong>, characterized by decreased glucose levels and <strong>pH &lt; 7.20.</strong> Despite negative cultures, rapid bacterial clearance or low bacterial counts may be present, necessitating drainage for resolution.</li>\n<li><strong>Empyema thoracis</strong> involves <strong>frank pus</strong> or evidence of <strong>bacterial infection</strong> in the <strong>pleural fluid</strong> via gram stain or positive culture.</li>\n</ul>\n<p>Investigations commonly done include:&nbsp;</p>\n<ul>\n<li aria-level=\"1\">Chest X-ray:&nbsp;</li>\n<ul>\n<li aria-level=\"2\"><strong>Loculations</strong> or encystments indicate a <strong>complicated parapneumonic effusion</strong></li>\n<li aria-level=\"2\"><strong>Intrapleural</strong> air-fluid level indicates the presence of <strong>bronchopulmonary</strong> <strong>fistula</strong></li>\n<li aria-level=\"2\"><strong>Parenchymal</strong> infiltrations in the lung lobes indicate an <strong>underlying pneumonia</strong></li>\n</ul>\n</ul>\n<p>Chest X-ray depicting <strong>empyema thoracis </strong>on the right side is given below.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a0a840ea21ae4c1ab18ebb5f7fe791fbx512x432.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li aria-level=\"1\">Ultrasound: Shows echogenic pleural fluid with septations and helps in characterizing the effusion</li>\n<li aria-level=\"1\">Pleural fluid analysis:</li>\n<ul>\n<li aria-level=\"2\">Exudative neutrophilic effusion&nbsp;</li>\n<li aria-level=\"2\"><strong>Low pH &lt;7.2, low glucose &lt;60 mg/dL, high LDH &gt;1000 IU/L</strong> in complicated parapneumonic effusion</li>\n</ul>\n<li aria-level=\"1\">CECT: <strong>Split pleura </strong>sign seen in empyema (given in the image below)</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c9fa28eb83cb4f73848029d4e10723c2x512x348.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Other options:</p>\n<p>Option B: <strong>Surgical decortication</strong> is considered for more <strong>chronic</strong> cases with <strong>fibrous encasement</strong> of the lung, typically after <strong>initial drainage</strong> has <strong>failed</strong>.&nbsp;</p>\n<p>Option C: <strong>Thoracocentesis</strong> may provide <strong>temporary relief</strong> or be useful for <strong>diagnostic purposes </strong>but is <strong>not</strong> a <strong>definitive treatment</strong> for empyema.&nbsp;</p>\n<p>Option D: <strong>High-dose parenteral antibiotics</strong> are critical in managing the underlying infection but are <strong>not sufficient without drainage</strong>. Therefore, immediate tube thoracostomy is crucial to manage the empyema effectively and prevent further complications.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-172",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC8662",
    "stauts": "Incorrect",
    "question_title": "172.\n        Which of the following is at the transpyloric plane?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Origin of celiac trunk\n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Uncinate process of pancreas",
    "optionC": "C. Origin of portal vein\n                \n                  \n                    \nCorrect",
    "optionD": "D. Lower limit of spinal cord in neonates",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Origin of <strong>portal vein</strong> occurs at the transpyloric plane<strong>&nbsp;(L1).</strong></p>\n<p><strong>Other options:</strong></p>\n<p><strong>Uncinate process of pancreas </strong>is at<strong> L2 level.</strong></p>\n<p><strong>Celiac trunk</strong> is at <strong>T12</strong> vertebral level.</p>\n<p><strong>Lower limit of spinal cord in neonates </strong>is at upper border of <strong>L3</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0592: Abdominal planes and their landmarks</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a8342468e1f4b4eac719ca7d878730cx1280x2558.JPEG\"><!---->\n              </div><!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Planes that divide the abdomen into 9 regions are:</p>\n<ul>\n<li><strong>Horizontal planes</strong>&nbsp;\n<ul>\n<li>At the level of<strong> L3</strong> - <strong>Subcostal plane</strong> (between 10<sup>th</sup> costal cartilages). It corresponds to the 3<sup>rd</sup> part of the duodenum</li>\n<li>At the level of<strong> L5</strong> - <strong>Transtubercular plane</strong> (between tubercles of iliac crests). It corresponds to the origin of inferior vena cava.&nbsp;</li>\n</ul>\n</li>\n<li><strong>Vertical planes</strong>&nbsp;(paramedian or lateral planes)\n<ul>\n<li>From mid-clavicular point to mid-inguinal point on both sides&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p>The&nbsp;nine regions&nbsp;of the abdomen include:</p>\n<ul>\n<li>Right hypochondriac, epigastric, left hypochondriac</li>\n<li>Right lumbar, umbilical (central), left lumbar</li>\n<li>Right iliac, hypogastric (suprapubic), left iliac</li>\n</ul>\n<p>Other planes and angles in the abdomen are:</p>\n<ul class=\"ul1\">\n<li class=\"li1\"><strong>Transpyloric </strong>(Addison's)<strong> plane -&nbsp;</strong>passes&nbsp;<strong>midway</strong>&nbsp;between the&nbsp;<strong>suprasternal notch</strong>&nbsp;and the&nbsp;<strong>upper border of the pubic</strong>&nbsp;<strong>symphysis</strong>.</li>\n<li class=\"li1\"><strong>Supracristal plane -</strong> passes through the <strong>highest point </strong>of the<strong> iliac crest</strong> on both sides. It corresponds to the level of the<strong> L4 body</strong> or L4/5 disc and its spinous process. It is an important landmark when performing a lumbar puncture or spinal injection. The bifurcation of the abdominal aorta lies approximately in this plane.</li>\n<li class=\"li1\">The <strong>plane </strong>of the <strong>pubic crest -</strong>&nbsp;passes through the <strong>upper border </strong>of the<strong> pubic symphysis</strong>. In supine, this plane intersects the tip of the coccyx and the femoral head.</li>\n<li class=\"li1\"><strong>Renal angle -</strong>&nbsp;between the <strong>12th rib</strong> and the outer border of<strong> erector spinae </strong>muscle. The lower border of normal kidneys may occasionally be felt here.&nbsp;</li>\n<li class=\"li1\"><strong>Lumbar triangle of Petit -</strong>&nbsp;formed below by the <strong>iliac crest</strong>, anteriorly by <strong>external oblique,</strong> and posteriorly by <strong>latissimus dorsi</strong>. Lumbar hernia can occur here.&nbsp;</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-173",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2622",
    "stauts": "Correct",
    "question_title": "173.\n        From the following image, identify the structure that marks the boundary between the embryological basal plate and alar plate.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/e8302f15e70e48e086aae2e4e0d8e1e6.JPEG\">",
    "optionA": "A. 1",
    "optionB": "B. 2",
    "optionC": "C. 3\n                \n                  \n                    \nCorrect",
    "optionD": "D. 4",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The structure marked as <strong>3 </strong>is the<strong> sulcus limitans</strong> which is a longitudinal groove that marks the<strong> boundary </strong>between the<strong> basal </strong>and<strong> alar plates.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/946e2b70db894a249b24db6039ff992cx1280x1830.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Embryologically, the continuous addition of<strong> neuroblasts </strong>to the <strong>mantle layer </strong>of the neural tube produces thickenings <strong>ventrally and dorsally</strong> - producing the <strong>basal and alar plates respectively.&nbsp;</strong></p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Basal Plate&nbsp;</strong></td>\n<td><strong>Alar plate&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Ventral thickening</td>\n<td>Dorsal thickenings</td>\n</tr>\n<tr>\n<td>Give rise to motor nuclei - general visceral efferent nuclei, special visceral efferent of CN IX, X, and XII; and somatic efferent of XII</td>\n<td>\n<p>Give rise to sensory nuclei&nbsp; CN V, VII, VIII, IX, X, inferior&nbsp; olivary nucleus, and&nbsp; mesencephalic nucleus of&nbsp; CN V</p>\n</td>\n</tr>\n<tr>\n<td>Forms the motor part of the spinal cord (ventral horns)</td>\n<td>\n<p>Forms the sensory part of the spinal cord (dorsal horns).&nbsp;</p>\n<p>The rhombic lip develops into&nbsp; the cerebellum and its nuclei.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a84fa3444ff6486d94342b2eb51cb886x1280x2893.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Structures on the<strong> floor</strong> of the <strong>4th ventricle (Rhomboid Fossa)</strong></p>\n<ul>\n<li>Ridges:\n<ul>\n<li>Transverse fibers: <strong>Striae medullares</strong></li>\n<li>Striae medullaris divides rhomboid fossa into 2 parts: <strong>Rostral pontine and Caudal medullary</strong></li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Medial to lateral in rostral pontine part:\n<ul>\n<li>Midline longitudinal sulcus: <strong>Median sulcus</strong></li>\n<li>Bilateral eminences:<strong> Medial eminence</strong></li>\n<li>Bilateral longitudinal sulcus: <strong>Sulcus limitans</strong></li>\n<li>Bilateral areas: <strong>Vestibular area (deeper to it is the vestibular nucleus)</strong></li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Upper and lower ends of sulcus:\n<ul>\n<li>Bluish-colored, uppermost area where sulcus limitans ends: <strong>Locus coeruleus</strong></li>\n<li>Depression, the upper area of sulcus limitans: <strong>Superior fovea</strong></li>\n<li>Depression, the lower area of sulcus limitans:<strong> Inferior fovea</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/728a34fe43224e968d44f48c855712d2x1279x1938.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-174",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8307",
    "stauts": "Incorrect",
    "question_title": "174.\n        A 17-year-old boy who is a long-distance cyclist presents with complaints of knee pain over the past month. He does not recall falling or experiencing any injury. A skyline view of his knees shows a bipartite patella. Which is the most appropriate management in this case?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Above knee cast",
    "optionB": "B. NSAIDs and activity restriction\n                \n                  \n                    \nCorrect",
    "optionC": "C. Immediate surgical intervention\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Surgical management if symptomatic",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The most appropriate management in this case is <strong>NSAIDs and activity restriction</strong>. Nonsteroidal anti-inflammatory drugs (NSAIDs) can help <strong>alleviate pain and inflammation</strong>, while rest and modification of activities can <strong>reduce stress </strong>on the knee.</p>\n<p>A&nbsp;<strong>bipartite patella</strong>&nbsp;(two-part patella) is a patella with an unfused accessory ossification centre, typically at the superolateral aspect. It usually is asymptomatic and is noted incidentally, however pain, when present, can be caused by overuse (such as in a cyclist or climber).</p>\n<p>The X-ray below shows the bipartite patella:&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8943180da9984cb1b89db74464db813fx720x453.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>There are three types of bipartite patella</p>\n<ol>\n<li>Type I (5%) occurs at the inferior pole</li>\n<li>Type II (20%) occurs along the entire lateral border of the patella</li>\n<li><strong>Type III (75%) </strong>the <strong>most common</strong> type, occurs as an elliptical area in the <strong>superolateral</strong> portion of the patella.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li>\n</ol>\n<p>Depending on the number of fragments they may be classified as bipartite, tripartite or multipartite.</p>\n<p>For diagnosis, a conventional <strong>skyline </strong>view is followed by a skyline view with the patient in a <strong>squatting weight-bearing</strong> position to assess if the pain is caused by a <strong>nonunion</strong> at the <strong>bipartite site</strong>. If the <strong>gap</strong> is <strong>higher</strong> in the<strong> squatting weight-bearing</strong> posture than in the <strong>standard skyline</strong> view, the test result is considered<strong> positive</strong>.</p>\n<p><strong>MRI</strong> is <strong>not required</strong> to diagnose the condition.</p>\n<p>Treatment:</p>\n<p>If pain occurs with a bipartite patella, limiting and restricting activity, correcting the activity that is causing an overuse syndrome, and prescribing <strong>nonsteroidal antiinflammatory agents</strong> can result in <strong>improvement</strong> in <strong>3 weeks</strong>.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: Above Knee Cast: This is generally <strong>not appropriate</strong> for a bipartite patella, as it does not address the underlying issue and is not effective in managing the condition.</p>\n<p>Option C and D: <strong>Surgical treatment </strong>with the <strong>Ogata technique</strong> is rarely necessary. Surgery may be considered only if the patient has persistent symptoms that do not improve with conservative treatment. This is not the first-line approach and is reserved for cases where conservative measures fail.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Orthopaedics"
  },
  {
    "web-scraper-order": "1727319149-175",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3224",
    "stauts": "Correct",
    "question_title": "175.\n        While monitoring the saturation of a patient using a pulse oximeter, an intern records readings of SpO2 between 80% to 85% even with a flow of 100% oxygen. Which of the following conditions will lead to these pulse oximetry readings irrespective of the arterial oxygen saturation (SaO2)?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Carboxyhemoglobinemia",
    "optionB": "B. Methemoglobinemia\n                \n                  \n                    \nCorrect",
    "optionC": "C. Severe anemia",
    "optionD": "D. Hypotension",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In a patient&nbsp;with <strong>methemoglobinemia</strong>, the <strong>pulse oximetry</strong> reading will be <strong>80% to 85% irrespective&nbsp;</strong>of<strong> arterial oxygen saturation </strong>(SaO2).&nbsp;</p>\n<div class=\"page\" title=\"Page 1539\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Carboxyhemoglobin and methemoglobin absorb light at one or both of the wavelengths used by the pulse oximeter. Therefore, the presence of these Hb species in the blood leads to errors in SpO2 readings. In a patient with methemoglobinemia, the SpO2 will be 80% to 85%, irrespective of the SaO2, and&nbsp;a patient with carbon monoxide poisoning will have a falsely elevated SpO2 level.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Pulse oximetry is a <strong>non-invasive </strong>measurement of the<strong> oxygen saturation</strong>&nbsp;of hemoglobin. The pulse oximeter probe consists of a light emitter and a photodetector. Transmission pulse oximetry involves placing the emitter and detector on opposite sides of the tissue that is being measured, which is usually the finger.</p>\n<p>Potential reasons for&nbsp;<strong>artifacts</strong> in measurement with a pulse oximeter are given in the table below:</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>\n<p><strong>Falsely increased</strong> O2 saturation value</p>\n<ul>\n<li><strong>Carboxy-</strong><strong>hemoglobinemia</strong></li>\n<li>Intra-aortic balloon pump</li>\n<li>Severe hyper-bilirubinemia</li>\n</ul>\n</td>\n<td>\n<p><strong>Falsely decreased</strong> O2 saturation value</p>\n<ul>\n<li><strong>Anemia</strong></li>\n<li><strong>Hypotension</strong> (blood pressure- BP&lt;80 mm Hg)</li>\n<li>Application of nail paint and henna</li>\n<li>Venous pulsations&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\"page\" title=\"Page 1539\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SpO2 estimates the SaO2 of circulating hemoglobin but does not provide information about tissue oxygenation, ventilation, or acid-base status.</p>\n<p>Conditions that show inaccuracies in pulse oximeter readings include:</p>\n<div class=\"page\" title=\"Page 1539\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Variant hemoglobin species- <strong>carboxyhemoglobin, methemoglobin</strong></li>\n<li>Motion artifacts -&nbsp;<strong>SpO2</strong> is <strong>decreased</strong> compared to SaO2.</li>\n<li>Venous pulsation</li>\n<li>The presence of intravascular dyes- <strong>methylene blue</strong> decreases SpO2 to 65%</li>\n<li>Presence of nail polish- black, purple, and dark blue show lower SpO2.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anaesthesia"
  },
  {
    "web-scraper-order": "1727319149-176",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF7066",
    "stauts": "Correct",
    "question_title": "176.\n        The illustration given below is used for which female genital pathology?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/2cbbbe2ce9a54c9891de851d3ac6c08d.PNG\">",
    "optionA": "A. Uterine prolapse\n                \n                  \n                    \nCorrect",
    "optionB": "B. Cervical cancer",
    "optionC": "C. Gartner's cyst",
    "optionD": "D. Uterine inversion",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image shows&nbsp;<strong>POP-Q (</strong><strong>pelvic organ prolapse quantification) system</strong>&nbsp;which was described by the Interna­tional Continence Society for the <strong>prolapse&nbsp;</strong>of pelvic organs&nbsp;and has the following features:</p>\n<ul>\n<li>The hymen is taken as a fixed point&nbsp;</li>\n<li><strong>Six reference points</strong> are measured, using a scaled spatula: <br>\n<ul>\n<li>Two on the anterior vaginal wall&nbsp;</li>\n<li>Two on the apical vagina</li>\n<li>Two on the posterior vaginal wall&nbsp;</li>\n</ul>\n</li>\n<li><strong>Three measurements:&nbsp;</strong>The genital hiatus, perineal body, and total vaginal length.</li>\n<li>The points <strong>above</strong> the <strong>hymen</strong> are described as <strong>minus</strong> and points <strong>below</strong> as <strong>plus.</strong></li>\n</ul>\n<p>Staging of POP Q:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Stage 0</td>\n<td>No descent of pelvic organs.</td>\n</tr>\n<tr>\n<td>Stage 1</td>\n<td>The leading edge of the prolapse is <strong>&gt;1 cm above</strong> the level of the <strong>hymen.</strong></td>\n</tr>\n<tr>\n<td>Stage 2</td>\n<td>The leading edge of the prolapse is <strong><span>&lt;</span>1cm</strong> proximal or distal to the hymen.</td>\n</tr>\n<tr>\n<td>Stage 3</td>\n<td>The leading point of prolapse is <strong>&gt;1cm below</strong> the <strong>hymen</strong> but protrudes no further than 2 cm less than the total length of the vagina.</td>\n</tr>\n<tr>\n<td>Stage 4</td>\n<td>Complete <strong>eversion</strong> of vagina</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e849497ff314477d9a3f81077b0beb85x1280x1716.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>&nbsp;</p>\n<p>Option D: <strong>Uterine inversion</strong> is an extremely rare but life-threatening complication in the 3rd stage of <strong>labor</strong>, in which the uterus is turned inside out partially or completely.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-177",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG0968",
    "stauts": "Correct",
    "question_title": "177.\n        A 68-year-old male presents with pain in his right upper abdominal quadrant. Examination shows a vesicular rash along the 7th rib border that does not cross the midline. Which of the following would have prevented this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Recombinant zoster vaccine\n                \n                  \n                    \nCorrect",
    "optionB": "B. Pneumococcal conjugate vaccine",
    "optionC": "C. oka varicella vaccine",
    "optionD": "D. Meningococcal vaccine",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given stem describing <strong>unilateral, grouped vesicles </strong>in a single<strong>&nbsp;dermatome</strong> associated with <strong>pain</strong>&nbsp;is highly<strong>&nbsp;</strong>suggestive of<strong> reactivated herpes zoster(shingles).</strong> This could have been prevented by receiving <strong>two doses</strong> of the <strong>recombinant zoster vaccine.</strong>&nbsp;</p>\n<p>This condition arises from the <strong>reactivation</strong> of the<strong> varicella-zoster </strong>virus, which lies <strong>dormant</strong> in the<strong> dorsal root ganglia</strong> after a <strong>prior</strong> infection with <strong>chickenpox (varicella)</strong>. Zoster is a <strong>self‐limiting infection</strong> but it is <strong>painful </strong>and carries a risk of secondary infection and <strong>post‐herpetic neuralgia</strong>. <strong>Analgesia</strong> and treatment of secondary infections are sufficient for mild infections.</p>\n<p>The most effective preventive measure for shingles is the <strong>recombinant zoster vaccine</strong>. This vaccine is recommended for <strong>all individuals aged 50</strong> and <strong>older</strong>, as well as for those with <strong>compromised immune systems</strong> who are not severely immunocompromised. It is designed to <strong>boost</strong> the <strong>immune response</strong> in older adults who are at increased risk of shingles due to <strong>age-related immune decline</strong>.</p>\n<p>The recombinant zoster vaccine is administered as a <strong>two-dose</strong> series, with the second dose given <strong>2-6 months</strong> after the first. Common side effects include <strong>pain, redness</strong>, or <strong>swelling</strong> at the injection site, along with <strong>mild fever</strong> and<strong> fatigue.</strong> These side effects are typically brief and resolve without intervention. This vaccine is <strong>more potent </strong>than the varicella vaccine given to children, making it suitable for older adults who may not respond as well to the varicella vaccine.</p>\n<p>Other options:&nbsp;</p>\n<p>Option B: The <strong>pneumococcal conjugate vaccine</strong> prevents infections caused by <em><strong>Streptococcus pneumonia.&nbsp;</strong></em></p>\n<p>Option C: The <strong>oka varicella vaccine</strong> is intended for <strong>children</strong>, but is <strong>not as effective</strong> for <strong>preventing shingles</strong> in adults. hile the varicella vaccine, intended for children, is not as effective for preventing shingles in adults. The meningococcal vaccine targets Neisseria meningitidis infections and is generally given to adolescents and young adults.</p>\n<p><span>Option D: <strong>M</strong><strong>eningococcal vaccine </strong>is used for the prevention of <strong>meningococcal pneumonia</strong> caused by <em><strong>Neisseria meningitidis</strong></em>. It is given to students when they are <strong>11-13 years old</strong>.</span></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-178",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG1720",
    "stauts": "Skipped",
    "question_title": "178.\n        The following graph shows a certain pattern of occurrence of disease. Which of the following cancers is not associated with this distribution?",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/d7affb6809af462ca4757ee933f75f2b.JPEG\">",
    "optionA": "A. Craniopharyngioma",
    "optionB": "B. Nasopharyngeal carcinoma",
    "optionC": "C. Chondrosarcoma\n                \n                  \n                    \nCorrect",
    "optionD": "D. Breast cancer",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The above graph shows a <strong>bimodal distribution</strong> curve of disease. Out of the given options, <strong>chondrosarcoma</strong> is the only one <strong>not</strong> known to exhibit a bimodal distribution.&nbsp;</p>\n<p>Chondrosarcoma is the<strong> second most common</strong> malignant matrix-producing bone tumor after osteosarcoma. It predominantly affects individuals in their <strong>40s or older,</strong> with<strong> men </strong>being twice as likely to be affected.&nbsp;</p>\n<p><strong>Bimodality</strong> refers to the occurrence <strong>two separate peaks</strong>&nbsp;in the <strong>age incidence curve</strong> of a disease.</p>\n<p>Example: Hodgkin's lymphoma shows a bimodal curve with peaks at&nbsp;15–20 years and 70–80 years.</p>\n<p>Examples of Cancers that exhibit bimodality:</p>\n<ul>\n<li>Hodgkin's lymphoma</li>\n<li>Craniopharyngioma</li>\n<li>Nasopharyngeal carcinoma</li>\n<li>Breast cancer</li>\n<li>Cervical cancer</li>\n<li>Osteosarcoma</li>\n<li>Acute lymphoblastic leukemia</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-179",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF5824",
    "stauts": "Incorrect",
    "question_title": "179.\n        FFA in a patient with macular ischemia would demonstrate:",
    "question_ADD": "<p>FFA - Fundus Fluorescein Angiography</p>",
    "question_imag": "",
    "optionA": "A. Enlarged foveal avascular zone \n                \n                  \n                    \nCorrect",
    "optionB": "B. Stars in the sky appearance",
    "optionC": "C. Smoke stack pattern",
    "optionD": "D. Petaloid appearance\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The<strong>&nbsp;</strong>FFA would show<strong> an enlarged foveal avascular zone arrow&nbsp;</strong>(white arrow)<strong>, and capillary non-perfused areas&nbsp;</strong>(blue arrow) in patients with macular ischemia.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/68396012922643d5a6920295ed8408b8x720x528.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Interpreting fluorescein angiography images in a case of diabetic retinopathy<strong>:</strong></p>\n<ul>\n<li><strong>Punctate</strong> (pinpoint) areas of <strong>hyperfluorescence</strong> - <strong>microaneurysms</strong></li>\n<li><strong>Abnormal branching</strong> or dilatation of blood vessels - intraretinal microvascular abnormalities <strong>(IRMA)</strong> or retinal neovascularization</li>\n<li><strong>Fluorescein leakage</strong> - retinal <strong>neovascularization</strong>. Leakage in the disc region suggests neovascularization of the disc and leakage in other regions suggests&nbsp;<strong>proliferative diabetic retinopathy</strong></li>\n<li>Patchy non-perfused retinal capillaries&nbsp;(seen as<strong> filling defects in capillaries</strong>) - ischemia from <strong>nonperfused</strong> retinal capillaries</li>\n<li><strong>Increase</strong> in the size of the <strong>foveal avascular zone</strong> - <strong>macular ischemia&nbsp;</strong></li>\n</ul>\n<p>&nbsp;The image below shows pinpoint areas of hyperfluorescence and areas of fluorescein leakage in the disc region and elsewhere.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2ad3f075fcfa4636a03ce2c8603532b4x1280x1363.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image below depicts the i<strong>nkblot pattern</strong> in<strong> FFA. </strong>This is characteristically seen in<strong>&nbsp;central serous retinopathy (CSR).&nbsp;</strong><strong>Fundus fluorescein angiography </strong>helps in confirming the diagnosis of <strong>CSR. </strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d5bb4e6b1ec4794965d24f2136eda65x496x329.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The image below shows the following charectaristic appearances:</p>\n<ul>\n<li>Image A -&nbsp;Cystoid macular edema - Petaloid appearance</li>\n<li>Image B -&nbsp;Central serous retinopathy - Smoke stack pattern</li>\n<li>Image C - Drusen - Stars in the sky appearance</li>\n<li>Image D -&nbsp;Macular Ischemia -&nbsp;enlarged foveal avascular zone and capillary non perfused areas.</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a502d962725047b98d3e4e18fb22e2eex720x574.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-180",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC5390",
    "stauts": "Correct",
    "question_title": "180.\n        A 40 year old patient with complaints of unilateral progressive hearing loss, tinnitus and mild balance problems over the past 8 months is diagnosed to have acoustic neuroma. Which among the following is likely to be seen in this patient?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. A flat curve on tympanogram",
    "optionB": "B. A SISI Score of 80% is seen",
    "optionC": "C. Recruitment phenomenon is seen",
    "optionD": "D. Speech audiogram shows roll over curve\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Acoustic neuroma</strong> is a <strong>retro-cochlear </strong>disease and the speech audiogram of this patient will show a <strong>rollover curve</strong>.</p>\n<p>Speech audiogram can be used to <strong>differentiate</strong> <strong>retro-cochlear </strong>lesions from <strong>cochlear</strong> lesions. <strong>Roll over phenomenon</strong> is the <strong>fall </strong>in <strong>curve </strong>rather than <strong>maintenance </strong>of <strong>plateau</strong> as seen in the cochlear lesions.</p>\n<p>Acoustic neuroma, also known as <strong>vestibular schwannoma</strong>, <strong>neurilemmoma</strong>, or <strong>eighth nerve tumor</strong>, comprises <strong>80%</strong> of all tumors located in the <strong>cerebellopontine angle. </strong>It is a <strong>benign</strong>, slow-growing tumor that <strong>encapsulates </strong>the <strong>VIIIth cranial nerve</strong>. <strong>Bilateral</strong> tumors can occur in patients with <strong>neurofibromatosis</strong>. Speech audiometry typically reveals <strong>disproportionately</strong> poor speech discrimination compared to the loss of pure tone hearing. A common observation is the <strong>\"roll-over\"</strong> phenomenon, where <strong>discrimination scores</strong> <strong>decrease</strong> when loudness exceeds a certain threshold.</p>\n<p>Different tests to differentiate between cochlear lesions from retro-cochlear lesions :&nbsp;</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Test Type</strong></td>\n<td><strong>Normal Hearing</strong></td>\n<td><strong>Cochlear Lesions</strong></td>\n<td><strong>Retrocochlear Lesions</strong></td>\n</tr>\n<tr>\n<td><strong>Pure Tone Audiometry</strong></td>\n<td>Normal</td>\n<td>Sensorineural hearing loss</td>\n<td>Sensorineural hearing loss</td>\n</tr>\n<tr>\n<td><strong>Recruitment phenomenon</strong></td>\n<td>Negative&nbsp;</td>\n<td><strong>Present</strong></td>\n<td>Negative</td>\n</tr>\n<tr>\n<td><strong>Roll over phenomenon</strong></td>\n<td>Negative</td>\n<td>Negative</td>\n<td><strong>Present</strong></td>\n</tr>\n<tr>\n<td><strong>SISI score</strong></td>\n<td>0-15%</td>\n<td>Above 70%</td>\n<td><strong>0-20%</strong></td>\n</tr>\n<tr>\n<td><strong>Brainstem Evoked Response Audiometry (BERA)</strong></td>\n<td>Interval between wave I and V is normal</td>\n<td>Interval between wave I and V is normal</td>\n<td>Delayed or absent wave V</td>\n</tr>\n</tbody>\n</table>\n<p>Note:<span>&nbsp;A&nbsp;<strong>flat</strong></span><strong>&nbsp;curve</strong> in the <strong>tympanogram</strong> indicates <strong>fluid</strong> in the <strong>middle ear</strong>.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "ENT"
  },
  {
    "web-scraper-order": "1727319149-181",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC5104",
    "stauts": "Incorrect",
    "question_title": "181.\n        A surgeon performing a modified radical mastectomy decides to remove the pectoralis minor and level III lymph nodes but preserve the pectoralis major. Identify the procedure.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Scanlon’s modified radical mastectomy",
    "optionB": "B. Patey’s modified radical mastectomy\n                \n                  \n                    \nCorrect",
    "optionC": "C. Halsted radical mastectomy\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Auchincloss modified radical mastectomy",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given procedure&nbsp;where&nbsp;<strong>pectoralis minor</strong> and <strong>level III</strong> lymph <strong>nodes</strong> are <strong>removed</strong> but <strong>pectoralis major</strong> was <strong>preserved</strong> is <strong>Patey's modified radical mastectomy.&nbsp;</strong></p>\n<p><strong>Patey's modified radical mastectomy&nbsp;</strong>is a total mastectomy. It includes removal of&nbsp;the breast tissue and axillary lymph nodes up to level III along with the removal of pectoralis minor muscle, but pectoralis major is preserved.</p>\n<p>Other options:</p>\n<p>Option A:&nbsp;<strong>Scanlon’s modified radical mastectomy&nbsp;</strong>is a modification of Patey's procedure in which <strong>pectoralis minor is incised</strong> and not removed following which the level III nodes are approached.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Halsted radical mastectomy</strong> involves excision of the breast tissue, skin, and nipple-areolar complex, dissection of level I, II, and III axillary lymph nodes, and pectoralis major and minor muscles.&nbsp;</p>\n<p>Option D: In, <strong>Auchincloss modified radical mastectomy,&nbsp;pectoralis minor </strong>is<strong> left intact</strong> and level III nodes are not removed.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0880: Important surgeries for breast cancer</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><ul>\n<li>Tylectomy:&nbsp;Excision of lump</li>\n<li><strong>Breast conservation surgery (BCS)/WLE (wide local excision)</strong>: Tumour removal with a 3D clearance of a 1 mm margin of normal tissue</li>\n<li><strong>Simple mastectomy:</strong>&nbsp;Palpable extent of breast +&nbsp;Nipple–areola complex + overlying skin.</li>\n<li>Extended simple mastectomy: Simple mastectomy + removal of level I axillary lymph nodes.</li>\n<li>Skin-sparing mastectomy: Mastectomy with breast envelope preservation and nipple-areola complex removal</li>\n<li>Skin+ nipple/areola-sparing mastectomy: Mastectomy with breast envelope and nipple-areola complex preservation</li>\n<li><strong>Total mastectomy:</strong>&nbsp;All breast tissue + Nipple–areola complex + skin.</li>\n<li><strong>Level I oncoplasty (volume displacement surgery):</strong> Tumour excision with wide margins followed by defect repair via dual-plane mobilisation of the breast parenchyma to maintain shape and symmetry</li>\n<li><strong>Level II oncoplasty (volume replacement surgery):</strong> Skin excision and glandular mobilisation involving &gt;20% resection of breast volume</li>\n<li><strong>Modified radical mastectomy:</strong>&nbsp; Entire breast tissue + Nipple–areola complex + skin + axillary lymph nodes (levels I + II ± III) dissection\n<ul>\n<li><strong>Patey’s:</strong> Pectoralis minor is removed</li>\n<li><strong>Scanlon’s</strong>: Pectoralis minor incised</li>\n<li><strong>Auchincloss</strong>: Pectoralis minor only retracted</li>\n</ul>\n</li>\n<li><strong>Halsted’s radical mastectomy:</strong>&nbsp;Entire breast tissue + Nipple–areola complex + skin + Levels I + II+ III Axillary lymph nodes + Pectoralis major and minor</li>\n<li>Extended radical (Urban) - Halsted’s + internal mammary lymph nodes dissection</li>\n<li>Extended radical (Dahl-Iverson) mastectomy: Halsted’s + internal mammary and supraclavicular lymph nodes dissection</li>\n<li>Super radical mastectomy: Halsted’s + internal mammary, supraclavicular and mediastinal lymph nodes dissection.</li>\n</ul>\n<p>*Dual-plane mobilisation of breast parenchyma: Mobilisation of the dermoglandular plane and plane between breast parenchyma and pectoralis muscle.</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  },
  {
    "web-scraper-order": "1727319149-182",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: ME8194",
    "stauts": "Incorrect",
    "question_title": "182.\n        A 40-year-old female patient is brought with complaints of acute and bilateral impairment of vision. She also has features of transverse myelitis and intractable hiccups. Antibodies against AQP-4 were detected. Which of the following is the likely diagnosis?",
    "question_ADD": "<p>AQP-4 - Aquaporin-4</p>\n<div class=\"page\" title=\"Page 223\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>p-ANCA - perinuclear antineutrophil cytoplasmic antibody</p>\n</div>\n</div>\n</div>\n</div>",
    "question_imag": "",
    "optionA": "A. Autoimmune encephalitis with associated myelitis",
    "optionB": "B. Systemic Lupus Erythematosus with CNS involvement",
    "optionC": "C. Neuromyelitis optica\n                \n                  \n                    \nCorrect",
    "optionD": "D. Sjögren’s syndrome \n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll ng-star-inserted\">\n<p>The clinical features are consistent with a diagnosis of&nbsp;<strong>neuromyelitis optica&nbsp;</strong>(NMO).</p>\n<p class=\"p3\">NMO, otherwise known as <strong>Devic’s disease</strong>, is an <strong>autoimmune</strong>, inflammatory <strong>demyelinating</strong> disorder that is predominantly seen in <strong>middle-aged women</strong>. It is associated with specific IgG antibodies against AQP-4.</p>\n<p class=\"p3\">There are recurrent attacks of <strong>bilateral optic neuritis</strong> as well as severe <strong>transverse myelitis</strong>. NMO is also characterized by brain lesions such as:</p>\n<ul>\n<li>area postrema in the lower medulla causing <strong>area postrema syndrome</strong> (intractable hiccups and vomiting)</li>\n<li>cerebral hemispheres causing focal symptoms, seizures, and <strong>encephalopathy</strong></li>\n<li>hypothalamus causing endocrinopathies</li>\n</ul>\n<p>It is a recurrent disease and acute attacks are treated with <strong>glucocorticoids</strong>.&nbsp;<span><strong>Steroid-resistant </strong>patients</span>&nbsp;are given empirical <strong>plasma exchange</strong>. <strong>Prophylactic</strong> empirical regimens are recommended and include <strong>mycophenolate mofetil</strong>, rituximab, and a combination of steroids and azathioprine. The newer <strong>monoclonal antibodies</strong> used in prophylaxis include:</p>\n<ul>\n<li><strong>eculizumab</strong></li>\n<li><strong>inebilizumab</strong></li>\n<li><strong>satralizumab</strong>&nbsp;</li>\n</ul>\n<p>Other options:&nbsp;</p>\n</div>\n</div>\n<div class=\"row mt-3\">Option A:<strong> Autoimmune encephalitis </strong>can present with a range of neurological symptoms and sometimes associated <strong>myelitis.</strong> However, autoimmune encephalitis is generally associated with <strong>anti-NMDA receptor antibodies</strong> and not AQP-4 antibodies.</div>\n<div class=\"row mt-3\">&nbsp;</div>\n<div class=\"row mt-3\">Option B: <strong>Systemic lupus erythematosus (SLE)</strong> can cause a variety of neurological symptoms, including visual impairment and transverse myelitis. However, SLE is <strong>not</strong> typically associated with AQP-4 antibodies.</div>\n<div class=\"row mt-3\">&nbsp;</div>\n<div class=\"row mt-3\">Option D:&nbsp;<strong>Sjögren’s syndrome</strong>&nbsp;causes lymphocytic <strong>infiltration</strong> of <strong>exocrine glands</strong> and is characterized by <strong>keratoconjunctivitis sicca</strong> (dry eyes), <strong>xerostomia</strong>, and profound B-cell hyperactivity.&nbsp;<strong>Anti-SSA/Ro60</strong> autoantibodies are seen in this condition.</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Ophthalmology"
  },
  {
    "web-scraper-order": "1727319149-183",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8809",
    "stauts": "Skipped",
    "question_title": "183.\n        Which of the following factors may lead to a false-positive result during a dexamethasone suppression test?",
    "question_ADD": "<ol>\n<li>Phenobarbitone</li>\n<li>Pregnancy</li>\n<li>Phenytoin</li>\n<li>Rifampin</li>\n<li>OCPs</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1 and 2 only",
    "optionB": "B. 2, 3 and 4 only",
    "optionC": "C. 1, 2 and 3 only",
    "optionD": "D. 1, 2, 3, 4, and 5\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>All the factors mentioned here lead to a <strong>false-positive</strong> result during a <strong>dexamethasone suppression test</strong>.</p>\n<p><strong>Dexamethasone suppression test </strong>is a diagnostic tool used primarily to <strong>screen</strong> for ACTH-independent hypercortisolism (also known as <strong>Cushing’s syndrome</strong>) caused by an adrenal nodule.&nbsp;</p>\n<p>It can give a <strong>false positive</strong> result with:</p>\n<ul>\n<li>Antiseizure drugs: Drugs such as phenytoin, phenobarbital, and primidone can induce liver enzymes that increase cortisol metabolism, potentially affecting test results</li>\n<li>Rifampin: also induces liver enzymes, affecting cortisol metabolism and test results.</li>\n<li>Estrogen, during pregnancy or as oral contraceptives or HRT</li>\n</ul>\n<p>In an overnight dexamethasone suppression test,<strong>&nbsp;Dexamethasone 1 mg</strong> is given orally at 11 pm and serum is collected for cortisol determination at 8 am the next morning; a cortisol level <strong>less than 1.8 mcg/dL</strong>, is a <strong>negative result </strong>and <strong>excludes Cushing syndrome.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1550: Initial Tests for Diagnosing Cushing's Syndrome</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>These include two steps:</p>\n<p><strong>1. Tests to detect hypercortisolism</strong></p>\n<ul>\n<li><strong>Midnight salivary or serum cortisol</strong> (highly sensitive test):<strong>&nbsp;</strong>The presence of cortisol in the saliva or serum at midnight signifies loss of diurnal variation of cortisol</li>\n<li><strong>24-hour urinary free cortisol excretion</strong>:&nbsp;Increased three times the normal value</li>\n<li><strong>Overnight dexamethasone suppression test</strong> (DST):&nbsp;Plasma cortisol &gt;1.8 μg/dL at 8 a.m after overnight exposure to dexamethasone (1 mg given at 11 p.m)</li>\n<li><strong>Low dose DST</strong> (highly specific test):&nbsp;Plasma cortisol &gt;1.8 μg/dL at 8 a.m. on the third day after giving 0.5 mg dexamethasone every 6 hours for 2 days</li>\n</ul>\n<p><strong>2. Test </strong><strong>to rule out pseudo Cushing's syndrome</strong></p>\n<ul>\n<li><strong>Low-dose DST + CRH stimulation test</strong>: Plasma cortisol levels are increased in true Cushing’s but remain unaffected in pseudo Cushing's.&nbsp;Dexa-induced negative feedback is overcome by CRH in true Cushing’s.</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1549: Causes of Cushing's Syndrome</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Exogenous causes </strong>(iatrogenic)</p>\n<ul>\n<li>Prolonged administration of glucocorticoids (most common cause of Cushing's)</li>\n</ul>\n<p><strong>Endogenous causes</strong></p>\n<ul>\n<li><strong>ACTH independent </strong>(primary hypercortisolism)\n<ul>\n<li>Adrenocortical adenoma&nbsp;</li>\n<li>Adrenocortical carcinoma&nbsp;</li>\n<li>Bilateral adrenal hyperplasia</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>ACTH dependent&nbsp;</strong>(secondary hypercortisolism)\n<ul>\n<li><strong>Cushing’s disease:&nbsp;</strong>ACTH secreting&nbsp;<strong>pituitary adenoma </strong>(most common cause of endogenous Cushing's)</li>\n<li><strong>Paraneoplastic causes: </strong>Ectopic ACTH secreting tumors\n<ul>\n<li><strong>Small-cell lung carcinoma</strong></li>\n<li>Bronchial or pancreatic carcinoid tumors</li>\n<li>Medullary thyroid carcinoma</li>\n<li>Pheochromocytoma</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Rare causes</strong></p>\n<ul>\n<li>Macronodular adrenal hyperplasia</li>\n<li>Primary pigmented nodular adrenal disease</li>\n<li>McCune <strong>–</strong> Albright syndrome</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Medicine"
  },
  {
    "web-scraper-order": "1727319149-184",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF0155",
    "stauts": "Incorrect",
    "question_title": "184.\n        In the given image, the value of the ratio y/x is pathognomic if it is above:",
    "question_ADD": "<p>y - thickness of the mucous gland layer</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/2e0209932d8f42b888867b32e3d81885.JPEG\">",
    "optionA": "A. 0.5",
    "optionB": "B. 0.7",
    "optionC": "C. 0.6\n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. 0.4\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given image depicts&nbsp;the <strong>Reid index.&nbsp;</strong>It&nbsp;is the ratio of the thickness of the mucous gland layer (y) to the thickness of the wall between the cartilage and the epithelium (x). It is normally<strong> 0.4</strong> and is increased in&nbsp;<strong>chronic bronchitis.&nbsp;</strong>The increase is in&nbsp;proportion to the severity and duration of the disease.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/785b7e3ba6c94b46aea7b4ccdae98962x1280x1391.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Chronic bronchitis is defined by the presence of a<strong> persistent productive cough </strong>for at least<strong> 3 consecutive months </strong>in at least<strong> 2 consecutive years</strong>.</p>\n<p>The single most important cause is<strong> cigarette smoking.&nbsp;</strong>The distinctive features of chronic bronchitis are as follows:</p>\n<ul>\n<li>Hypersecretion of mucus</li>\n<li>Hypertrophy of submucosal glands</li>\n<li>Goblet-cell hyperplasia</li>\n<li>Inflammation</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 684\"><strong>Difference between emphysema and chronic bronchitis:</strong></div>\n<div class=\"page\" title=\"Page 684\">\n<table><colgroup><col><col><col></colgroup>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Predominant Bronchitis</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Predominant Emphysema</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Age (year)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>40-45</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>50-75</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dyspnea</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mild; late</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Severe; early</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cough</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Copious sputum</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Scanty sputum</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Infections</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Common</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Occasional</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Respiratory insufficiency</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Repeated</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Terminal</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Cor pulmonale</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Common</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Rare</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Airway resistance</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Increased</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal or slightly increased</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Elastic recoil</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Low</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Chest radiograph</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Prominent vessels; large heart</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hyperinflation; normal heart</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Appearance</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Blue bloater</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pink puffer</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-185",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6849",
    "stauts": "Incorrect",
    "question_title": "185.\n        A patient presents to the psychiatric OPD with a history of a sudden fall after his friend threw a plastic snake on him as a prank. He gives a history of similar episodes in the past, having vivid hallucinations and being in a dream-like state when he goes to sleep. The drug of choice for the given condition can also be used in which of the following conditions?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Insomnia        \n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Depression",
    "optionC": "C. ADHD\n                \n                  \n                    \nCorrect",
    "optionD": "D. Schizophrenia",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>A history of sudden falls indicating loss of muscle tone following intense emotions like surprise, shock and vivid hallucinations and a <strong>dream</strong>-<strong>like</strong> <strong>state</strong> while going to <strong>sleep</strong> (hypnogogic hallucinations) is suggestive of <strong>narcolepsy</strong>. The <strong>drug of choice </strong>for narcolepsy is <strong>modafinil</strong>. It is also indicated for <strong>ADHD</strong>.</p>\n<p><strong>Modafinil</strong> is a mild stimulant and weak <strong>dopamine</strong> <strong>transporter</strong> <strong>inhibitor</strong> that prevents reuptake of extracellular dopamine, thereby <strong>increasing</strong> <strong>dopamine</strong> <strong>levels</strong> in the synapse and <strong>enhancing</strong> <strong>dopaminergic</strong> <strong>transmission</strong>. Other than narcolepsy, the stimulant action can be used for the treatment of ADHD. It can also be used as an <strong>off-label drug for cocain</strong>e, <strong>alcohol</strong>, <strong>amphetamine</strong>, and <strong>methamphetamine withdrawal.</strong>&nbsp;</p>\n<p><strong>Narcolepsy</strong> is a disorder of sleep architecture characterized by <strong>excessive</strong> <strong>daytime</strong> <strong>sleepiness</strong>. The sleep attacks of narcolepsy represent episodes of irresistible sleepiness, leading to perhaps 10 to 20 minutes of sleep, after which the patient feels refreshed, at least briefly. The patients often experience symptoms related to the intrusion of REM sleep characteristics into wakefulness.</p>\n<p>The hallmark of narcolepsy is <strong>decreased REM latency</strong>, i.e. decreased latent period before the first REM period occurs. Normal REM latency is 90-100 minutes. In narcolepsy, REM sleep usually occurs<strong> within 10 minutes </strong>of the onset of sleep (sleep onset REM).</p>\n<p><strong>Attention-deficit/hyperactivity disorder (ADHD)</strong> is a neuropsychiatric condition characterized by a pattern of <strong>diminished attention</strong> span and <strong>increased impulsivity or hyperactivity</strong>. The prefrontal cortex of the brain has been implicated in its etiology and <strong>dopamine</strong> is the main neurotransmitter. The<strong> CNS stimulants</strong> used for treatment are <strong>dopamine agonists </strong>like methylphenidate, amphetamine salts, and dextroamphetamine.</p>\n<p>Other options:</p>\n<p>Option A: Drugs used for <strong>insomnia</strong> can be inducing agents like <strong>ramelteon</strong> and Z drugs and maintenance agents like dual orexin receptor antagonists (DORA).&nbsp;</p>\n<p>Option C: SSRIs, SNRIs, TCA, and atypical drugs like bupropion, and <strong>mirtazapine</strong> are used for the treatment of <strong>depression</strong>.&nbsp;</p>\n<p>Option D:<strong> Typical</strong> and <strong>atypical</strong> <strong>antipsychotics</strong> are used for the treatment of <strong>schizophrenia</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Psychiatry"
  },
  {
    "web-scraper-order": "1727319149-186",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC4759",
    "stauts": "Correct",
    "question_title": "186.\n        A recently weaned child presents with perioral vesicular plaques sparing the upper lip and diarrhea. What is he likely to be deficient in?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Selenium",
    "optionB": "B. Copper",
    "optionC": "C. Vit B12",
    "optionD": "D. Zinc\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>This is the classical presentation of <strong>zinc deficiency</strong> leading to <strong>acrodermatitis enteropathica </strong>(Transient neonatal zinc deficiency) with <strong>diarrhea, alopecia, and a perioral and acral cutaneous eruption. &nbsp;</strong></p>\n<p class=\"p1\">The perioral eruption usually spares the upper lip, resulting in a <strong>‘U' or ‘horseshoe‐shaped’</strong> appearance. Risk factors include <strong>weaning from the breast</strong>, anorexia nervosa, alcoholism, vegetarianism, and inadequately supplemented total parenteral nutrition.&nbsp;Clinical features include failure to thrive, anorexia,&nbsp;<strong>diarrhea,</strong>&nbsp;recurrent infections,&nbsp;<strong>alopecia,</strong>&nbsp;male hypogonadism, and neurological manifestations like&nbsp;<strong>tremor,</strong>&nbsp;nystagmus, photophobia, hypogeusia, irritability, etc.</p>\n<p>Skin manifestations such as&nbsp;<strong>vesiculobullous dermatitis</strong>&nbsp;on the extremities and periorificial(perianal, perigenital, perioral) regions are commonly seen as shown below. Affected infants require long-term supplementation with zinc.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/923c5b06b3494532a4e9a7fd9b532ff5x1280x1610.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The deficiency of copper leads to <strong>Menkes kinky hair syndrome.</strong></p>\n<p>Deficiency of selenium leads to <strong>Keshan disease and Kashin–Beck disease.</strong></p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Dermatology"
  },
  {
    "web-scraper-order": "1727319149-187",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8907",
    "stauts": "Correct",
    "question_title": "187.\n        Assertion: The thick ascending limb of the loop of Henle and the early part of the distal tubule are called diluting segment.\nReason: The diluting segment reabsorbs sodium and is impermeable to water.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Both assertion and reason are true and the reason is the correct explanation of the assertion\n                \n                  \n                    \nCorrect",
    "optionB": "B. Both assertion and reason are true but the reason is not the correct explanation of the assertion",
    "optionC": "C. Assertion is true and reason is false",
    "optionD": "D. Assertion is false and reason is true",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Here, <strong>both the assertion and the reason are true</strong> and the reason is the <strong>correct explanation</strong> of the assertion.</p>\n<p><strong>Sodium </strong>is<strong> reabsorbed</strong> in the<strong> thick ascending limb </strong>of the<strong> loop of henle</strong> by secondary active transport facilitated by <strong>Na–K–2Cl cotransporter</strong>. Also, the thick ascending limb and early part of the distal tubule are impermeable to <strong>water</strong>. As a result, the fluid that enters the early part of the distal tubule is <strong>hypotonic</strong>.</p>\n<p>Due to these reasons, the thick ascending limb and the early part of the distal tubule are called the <strong>diluting segment.</strong></p>\n<p>The image which shows the structure of the nephron and the tubular function is given below:</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3cf627030c604be1ad01a41e89323e82x1218x1600.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a48fe13e2f9438c98a4500fc58bc7fcx1225x1600.PNG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-188",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3327",
    "stauts": "Incorrect",
    "question_title": "188.\n        A 1-year-old baby is brought to the emergency room with bluish discoloration of the skin and rapid breathing. His mother reveals a history of congenital heart disease in the baby and adds that this episode was provoked by an incessant cry. Which of the following is least likely to be used for managing this child?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Subcutaneous morphine",
    "optionB": "B. Intravenous sodium bicarbonate\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. Intravenous propranolol",
    "optionD": "D. Intravenous nitroglycerin\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The least likely drug to be used for managing this child is <strong>intravenous nitroglycerin</strong>. The given scenario is suggestive of a paroxysmal <strong>hypercyanotic attack/ cyanotic spell.</strong> The administration of intravenous <strong>nitroglycerin </strong>is of <strong>no use </strong>and can <strong>worsen</strong> the condition, as it decreases peripheral resistance.</p>\n<p>Paroxysmal hypercyanotic spells may also be referred to as <strong>tet spells</strong>/ <strong>blue spells</strong>/ hypoxic spells. Though commonly associated with <strong>Tetralogy of Fallot</strong>, they can be associated with&nbsp;other forms of pulmonary stenosis with ventricular septal defect as well. <strong>Precipitating factors</strong> include <strong>crying,</strong> defecation, feeding, wakening from sleep, dehydration, fever, tachycardia, tachypnea, and events provoking agitation.</p>\n<p>They are characterized by:</p>\n<ul>\n<li>Period of <strong>uncontrolled crying</strong>/ panic/ irritability</li>\n<li><strong>Rapid</strong> and deep <strong>breathing</strong></li>\n<li><strong>Increased cyanosis</strong></li>\n<li>Limpness and lethargy</li>\n<li>Reduced murmur intensity (signifying substantial blood flow reduction across the right ventricular outflow tract)</li>\n</ul>\n<p>Management options for this child include the following:</p>\n<ul>\n<li>Calm the child and minimize the stimuli</li>\n<li>Place in the <strong>knee-chest</strong> <strong>position</strong></li>\n<li>Administer oxygen</li>\n<li><strong>Subcutaneous morphine</strong> (not in excess of 0.2mg/kg)</li>\n<li><strong>IV sodium bicarbonate</strong>&nbsp;- for correction of the ongoing metabolic acidosis</li>\n<li>IV phenylephrine - as it increases the systemic vascular resistance</li>\n<li><strong>IV propranolol</strong>&nbsp;- as it reduces the pulmonary infundibular spasms in TOF</li>\n<li>If the spell is resistant to all the above-said measures, then intubation and sedation of the child are required to break the spell</li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1213: Classification of congenital heart disease</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Acyanotic</strong></div>\n</td>\n<td>\n<div><strong>Cyanotic </strong>(5TE²VP)<strong><br></strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Left to right shunts</strong>:</div>\n<p>Ventricular septal defect (VSD)</p>\n<p>Atrial septal defect (ASD)</p>\n<p>Patent ductus arteriosus (PDA)</p>\n<p><strong>Obstructive lesions</strong>:</p>\n<p>Coarctation of aorta</p>\n<p>Infundibular stenosis</p>\n<p>Pulmonary valve stenosis</p>\n<p>Congenital mitral &amp; tricuspid regurgitation</p>\n</td>\n<td>\n<div><strong>Right to left shunt</strong>:</div>\n<p>Persistent <strong>T</strong>runcus arteriosus</p>\n<p><strong>T</strong>ransposition of great vessels</p>\n<p><strong>T</strong>ricuspid atresia</p>\n<p><strong>T</strong>etrology of Fallot</p>\n<p><strong>T</strong>otal anomalous pulmonary venous communication</p>\n<p><strong>E</strong>bstein anomaly</p>\n<p><strong>E</strong>isenmenger's syndrome</p>\n<p><strong>V</strong>SD with pulmonic stenosis</p>\n<p><strong>P</strong>ulmonary arteriovenous malformation</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Paediatrics"
  },
  {
    "web-scraper-order": "1727319149-189",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6850",
    "stauts": "Incorrect",
    "question_title": "189.\n        A 22-year-old P1L1 one day post normal vaginal delivery is having bleeding PV. Her vitals are normal. You reassure her that expulsion of the remaining placental tissue and blood is a normal physiological process. However, she insists on getting investigated, so you send the discharge for microscopy. Which of the following will not be predominantly seen in the discharge's workup?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Bacteria",
    "optionB": "B. Leucocytes\n                \n                  \n                    \nCorrect",
    "optionC": "C. Epithelial cells \n                \n                  \n                  \n                    \nIncorrect",
    "optionD": "D. Erythrocytes",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The normal physiological discharge described here is <strong>lochia rubra</strong> and it predominantly <strong>does not contain leucocytes. &nbsp;</strong></p>\n<p><strong>Lochia&nbsp;</strong>refers to the vaginal discharge resulting from the <strong>sloughing</strong> of <strong>decidual tissue</strong> in the early puerperal period.&nbsp;</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Name</strong></td>\n<td><strong>Colour</strong></td>\n<td><strong>Timings&nbsp;after delivery</strong></td>\n<td><strong>Contents</strong></td>\n</tr>\n<tr>\n<td>Lochia&nbsp;<strong>Rubra</strong></td>\n<td>Red</td>\n<td>First few days&nbsp;</td>\n<td>Blood, decidua, fetal membranes, Vernix, lanugo, meconium</td>\n</tr>\n<tr>\n<td>Lochia&nbsp;<strong>Serosa</strong></td>\n<td>Yellowish/pink</td>\n<td>After 3 to 4 days</td>\n<td>WBCs, cervical mucus, micro-organisms</td>\n</tr>\n<tr>\n<td>Lochia&nbsp;<strong>Alba</strong></td>\n<td>Pale White</td>\n<td>After 10th day</td>\n<td>Decidua, cells, WBC, mucin, cholesterin crystals and fat cells&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>The average amount of discharge for the first week is&nbsp;<strong>250 mL&nbsp;</strong>and may persist for <strong>about 3 weeks.</strong></p>\n<p><strong>Foul-smelling lochia </strong>may be a symptom of<strong> post-partum endometritis.&nbsp;</strong> Copious or absent lochia may also indicate infection or <strong>lochiometra</strong>. The persistence of lochia rubra beyond the normal limit may signify <strong>subinvolution</strong> or <strong>retained bits</strong> of the conceptus. Prolonged discharge of lochia alba for more than 3 weeks may signify a <strong>local genital lesion</strong>.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Obstetrics & Gynaecology"
  },
  {
    "web-scraper-order": "1727319149-190",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8844",
    "stauts": "Incorrect",
    "question_title": "190.\n        Match the following leukodystrophies with their corresponding abnormalities.",
    "question_ADD": "<table style=\"border-collapse: collapse; width: 53.7138%; height: 134.39px;\" border=\"1\">\n<tbody>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px; text-align: center;\">Column A</td>\n<td style=\"width: 51.3089%; height: 22.3984px; text-align: center;\">Column B</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px;\">1. Lysosomal arylsulfatase A deficiency</td>\n<td style=\"width: 51.3089%; height: 22.3984px;\">a. Alexander disease</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px;\">2. GFAP gene mutations</td>\n<td style=\"width: 51.3089%; height: 22.3984px;\">b. Adrenoleukodystrophy</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px;\">3. Translation initiation factor eIF2B mutations</td>\n<td style=\"width: 51.3089%; height: 22.3984px;\">c. Metachromatic leukodystrophy</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px;\">4. ABCD1 peroxisomal transporter</td>\n<td style=\"width: 51.3089%; height: 22.3984px;\">d. Vanishing white matter leukoencephalopathy</td>\n</tr>\n<tr style=\"height: 22.3984px;\">\n<td style=\"width: 48.6911%; height: 22.3984px;\">&nbsp;</td>\n<td style=\"width: 51.3089%; height: 22.3984px;\">e. Pelizaeus-Merzbacher disease</td>\n</tr>\n</tbody>\n</table>\n<p><br>GFAP: Glial fibrillary acidic protein</p>\n<p>ABCD1: ATP binding cassette subfamily D</p>",
    "question_imag": "",
    "optionA": "A. 1-a, 2-c, 3-b, 4-e",
    "optionB": "B. 1-d, 2-a, 3-c, 4-b\n                \n                  \n                  \n                    \nIncorrect",
    "optionC": "C. 1-c, 2-a, 3-d, 4-b\n                \n                  \n                    \nCorrect",
    "optionD": "D. 1-c, 2-b, 3-d, 4-a",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The correctly matched set is 1-c, 2-a, 3-d, 4-b (option C).</p>\n<table border=\"1\">\n<tbody>\n<tr>\n<td>Lysosomal arylsulfatase A deficiency</td>\n<td>Metachromatic leukodystrophy</td>\n</tr>\n<tr>\n<td>GFAP gene mutations</td>\n<td>Alexander disease</td>\n</tr>\n<tr>\n<td>Translation initiation factor eIF2B mutations</td>\n<td>Vanishing white matter leukoencephalopathy</td>\n</tr>\n<tr>\n<td>ABCD1 peroxisomal transporter</td>\n<td>Adrenoleukodystrophy</td>\n</tr>\n</tbody>\n</table>\n<p><strong><br>Leukodystrophies</strong> are a group of <strong>genetic</strong> disorders caused by mutations affecting the creation, maintenance, or repair of <strong>myelin</strong>.&nbsp;</p>\n<p><strong>Metachromatic leukodystrophy</strong> is an autosomal recessive disease that results from a <strong>deficiency of the lysosomal enzyme arylsulfatase A</strong>.</p>\n<p>Mutations in intermediate filament proteins such as <strong>GFAP</strong> cause <strong>Alexander disease</strong></p>\n<p>A mutation in genes for various subunits of <strong>translation initiation factor eIF2B</strong> results in <strong>vanishing white matter</strong> <strong>leukoencephalopathy</strong>.</p>\n<p><strong>Adrenoleukodystrophy</strong> is an X-linked recessive disease associated with mutations in a member of the ATP-binding cassette transporter family of proteins (<strong>ABCD1</strong>), which is involved in the <strong>transport</strong> of molecules into the <strong>peroxisome</strong>.</p>\n<p>Mutations in genes that encode proteins required for myelin formation result in <strong>Pelizaeus-Merzbacher disease</strong>. It is a rare, X-linked recessive disorder characterized by central nervous system dysmyelination. Proteolipid protein gene (PLP1) located at Xq22 is affected, leading to the failure of axon myelination by oligodendrocytes in the central nervous system.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-191",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8540",
    "stauts": "Correct",
    "question_title": "191.\n        Choose the incorrect statement regarding the marked structure in the given image of the head.",
    "question_ADD": "",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/5ea3810f80084dd686c5a5a04e8b3ed8.JPEG\">",
    "optionA": "A. It arises from the posteromedial aspect of the external carotid artery.\n                \n                  \n                    \nCorrect",
    "optionB": "B. It supplies the palatine tonsils.",
    "optionC": "C. It contributes to the supply of the nasal septum.",
    "optionD": "D. It give off branches in the cervical region.",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 1029\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The structure marked in the given image, emerging on the edge of the mandible at the <strong>anteroinferior border of the masseter muscle</strong> is the <strong>facial artery</strong>.&nbsp;</p>\n<p>The facial artery is an <strong>anterior</strong> <strong>branch</strong> (option A) of the <strong>external carotid artery</strong>, given off in the neck region, just <strong>above</strong> <strong>the</strong> <strong>greater</strong> <strong>cornua</strong> of the hyoid bone.&nbsp;The artery is very sinuous throughout its course. This is so that the artery is able to adapt to the movements of the neck and the face during daily activities. It gives of four branches in the neck and four on the face.</p>\n<p>Its <strong>4 branches in the neck</strong> region are (option D):</p>\n<ul>\n<li><strong>Ascending palatine </strong>artery supplies the <strong>soft palate</strong> and the <strong>eustachain tube</strong>.&nbsp;</li>\n<li><strong>Tonsillar</strong> artery is the main arterial supply to the <strong>palatine tonsils</strong> (option B)</li>\n<li><strong>Submental</strong> artery is the <strong>largest</strong> <strong>cervical</strong> <strong>branch</strong> of facial artery. It supplies the overlying <strong>skin and muscles in the submental region</strong>.&nbsp;</li>\n<li><strong>Glandular</strong> branches supply the <strong>submandibular</strong> <strong>salivary</strong> <strong>gland</strong>.&nbsp;</li>\n</ul>\n<div class=\"page\" title=\"Page 956\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Its <strong>4 named branches on the face</strong> are:</p>\n<ul>\n<li><strong>Premasseteric </strong>artery is small and inconstant. When present, it goes upwards along the anterior border of masseter and supplies the surrounding area.</li>\n<li><strong>Inferior labial</strong> artery arises near the angle of the mouth. It runs between the orbicularis oris muscle and the mucous membrane. It supplies the <strong>glands</strong>, <strong>mucous membrane</strong> and the <strong>muscles</strong>.</li>\n<li><strong>Superior labial</strong> artery is larger and more tortuous than the inferior labial artery. It pursues a similar course along the superior labial margin, between the mucous membrane and orbicularis oris, anastomoses with its contralateral fellow, and supplies the <strong>upper lip</strong>. It gives off a <strong>septal branch</strong> that ramifies anteroinferiorly in the <strong>nasal septum</strong>. (option C)</li>\n<li><strong>Lateral nasal</strong> artery is given off by the side of the nose, supplies the <strong>dorsum and ala of the nose</strong>, and anastomoses with its contralateral fellow.&nbsp;</li>\n</ul>\n<p>The part of the artery distal to its terminal branch is called the angular artery.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f59d8321436400d8928581850d0edc2x960x720.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Anatomy"
  },
  {
    "web-scraper-order": "1727319149-192",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2744",
    "stauts": "Incorrect",
    "question_title": "192.\n        A 5-month-old boy was recently diagnosed with bronchiolitis. The doctor explains to the mother that it is caused by a virus which is the most common cause of the disease in infants. Which of the following statements are true regarding the management of this condition?",
    "question_ADD": "<ol>\n<li>The treatment depends mostly on supportive care</li>\n<li>The drug approved for the treatment of the condition is ribavirin</li>\n<li>The drug can be given in both oral and aerosol forms</li>\n<li>The preferred mode of administration is inhalational for 3–6 days</li>\n<li>Immunoglobulins can be used for prophylaxis</li>\n</ol>",
    "question_imag": "",
    "optionA": "A. 1,2,4",
    "optionB": "B. 1,2,4,5\n                \n                  \n                    \nCorrect",
    "optionC": "C. 2,3,4",
    "optionD": "D. 1,2,3,4,5\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The most common cause of <strong>bronchiolitis</strong> in infants is <strong>respiratory syncytial virus (RSV) </strong>and all the statements given are true except the statement that \"the drug can be given in both oral and aerosol forms\".&nbsp;</p>\n<p>The mainstay of treatment for bronchiolitis in infants is <strong>supportive care</strong>.&nbsp;<strong>Ribavirin</strong> is the approved treatment of the lower respiratory tract infection caused by RSV, especially in infants who are at <strong>risk </strong>of<strong> severe disease</strong>. <strong>Oral</strong> ribavirin is <strong>not useful</strong>, so it is administered as an <strong>aerosol</strong> for <strong>3–6 days</strong>.&nbsp;</p>\n<p><strong>Palivizumab</strong> is a monoclonal antibody against the <strong>RSV F glycoprotein</strong> that is used for the <strong>prevention</strong> of RSV lower respiratory tract disease in children at high risk of RSV disease.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-193",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG2776",
    "stauts": "Incorrect",
    "question_title": "193.\n        Given below is a graph charting the hormone levels in a normal pregnancy. Which of the following hormones is represented by curve 1?",
    "question_ADD": "<p>(hCG - human chorionic gonadotropin)</p>\n<p>(hCS - human chorionic somatomammotropin)</p>",
    "question_imag": "<img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2\" src=\"https://cdn1.dailyrounds.org/uploads/1673803283994365a0dc812c07bd36b3.JPEG\">",
    "optionA": "A. hCG\n                \n                  \n                    \nCorrect",
    "optionB": "B. hCS",
    "optionC": "C. Estrogen",
    "optionD": "D. Progesterone \n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>In the given graph of hormone levels in a normal pregnancy, the hormone represented by <strong>curve 1 </strong>is human chorionic gonadotropin.&nbsp;</p>\n<p><strong>Human chorionic gonadotropin</strong> (hCG) is a hormone secreted in pregnancy. It is a glycoprotein similar in structure to LH, FSH and TSH. It is produced by the<strong> syncytiotrophoblast</strong> of the <strong>placenta.</strong> hCG <strong>maintains</strong> the <strong>corpus luteum</strong> for secretion of estrogen and progesterone till 13 to 17 weeks after conception and thus has a role to play in <strong>maintaining early pregnancy</strong>.&nbsp;</p>\n<p>hCG can be detected in the blood by radio-immunoassay as soon as 8 to 9 days after ovulation. Its level peaks at 10 to 12 weeks of pregnancy and then falls by the 16th to 20th week. It remains at this<strong> low level </strong>for the <strong>rest </strong>of the <strong>pregnancy.</strong>&nbsp;</p>\n<p>hCG can also be detected as early as 14 days after conception in urine, which is more commonly used as a sample for <strong>pregnancy diagnosis.</strong> However, hCG is not specific for the diagnosis of pregnancy, as hCG is also detected in gastrointestinal tumors in both males and females.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/86a81d93811e4754be562d0af11828e3x1280x1381.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Curve 2</strong> represents <strong>estrogen</strong> (option C), and <strong>curve 3</strong> represents<strong> progesterone</strong> (option D). In pregnancy, both hormones are secreted in large quantities by the placenta. <strong>Estrogen</strong> levels <strong>rise steadily </strong>throughout pregnancy. However, from the seventh month onwards, progesterone secretion remains constant. Thus, the<strong> estrogen-to-progesterone</strong> <strong>ratio</strong> <strong>increases</strong> towards the <strong>end</strong> of <strong>pregnancy</strong>, as depicted by curve 2 crossing curve 3 towards the latter half of pregnancy. &nbsp;</p>\n<p><strong>Human chorionic somatomammotropin</strong> (hCS) (option B) is a protein hormone secreted from the placenta during the 5th week of pregnancy. Its <strong>levels rise throughout pregnancy.</strong> hCS causes&nbsp;<strong>decreased insulin sensitivity</strong> in the pregnant woman and acts similarly to growth hormone.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Physiology"
  },
  {
    "web-scraper-order": "1727319149-194",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6444",
    "stauts": "Correct",
    "question_title": "194.\n        A 60-year-old male presents with a history of vivid dreams and physical movements during sleep, as reported by his spouse. He has injured himself and his bed partner during these episodes. Polysomnography reveals prominent muscle activity during REM sleep without associated atonia. Which of the following conditions is associated with his symptoms?",
    "question_ADD": "<p>Rapid Eye Movement- REM</p>",
    "question_imag": "",
    "optionA": "A. REM Sleep Behavior Disorder\n                \n                  \n                    \nCorrect",
    "optionB": "B. Sleep related epilepsy",
    "optionC": "C. Sleepwalking",
    "optionD": "D. Nigthmares",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Among the following conditions, the one that is associated with his symptoms is<strong> rapid eye movement sleep behavior disorder (RBD). </strong>&nbsp;</p>\n<p><strong>RBD </strong>involves a <strong>disruption </strong>in normal <strong>REM sleep paralysis</strong>, allowing patients&nbsp;<span>to&nbsp;<strong>act out&nbsp;</strong>their <strong>dreams</strong> <strong>physically</strong></span>. During <strong>REM sleep</strong>, the brain usually <strong>inhibits motor neurons</strong> to <strong>prevent movement</strong>. However, in RBD, this paralysis is <strong>incomplete </strong>or intermittent, leading to <strong>behaviors</strong> that <strong>correlate with dream content</strong>. Unlike sleepwalking, where individuals may perform activities calmly and with some awareness of their surroundings, RBD patients are more likely to <strong>aggressively act ou</strong>t their dreams, potentially causing <strong>harm</strong> to themselves or others. This can result in injuries ranging from <strong>minor cuts</strong> to <strong>severe fractures</strong>.&nbsp;</p>\n<p><strong>Diagnostic confirmation</strong> of RBD involves <strong>polysomnography</strong> that reveals <strong>RBD without atonia </strong>(loss of muscle tone). <strong>Management</strong> of RBD typically begins with <strong>melatonin</strong>, commonly prescribed at doses up to <strong>20 mg daily</strong>. Melatonin aims to <strong>regulate sleep-wake cycles</strong> and mitigate symptoms of RBD. However, if melatonin proves ineffective or intolerable, <strong>alternative medications</strong> such as <strong>clonazepam</strong>, <strong>gabapentin</strong>, or <strong>codeine</strong> may be considered cautiously. These options require careful monitoring due to potential adverse effects such as worsened cognition or increased risk of falls.</p>\n<p>Other Options:</p>\n<p>B. Sleep-related epilepsy: typically presents with seizures that occur at any stage of sleep and is less specifically associated with muscle activity during REM sleep.</p>\n<p>C. Sleepwalking: occurs during non-REM (NREM) sleep and is not characterized by vivid dreams or REM sleep-related muscle activity</p>\n<p>D. Nightmares: They typically do not involve physical movements or muscle activity during REM sleep</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Psychiatry"
  },
  {
    "web-scraper-order": "1727319149-195",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MG6859",
    "stauts": "Incorrect",
    "question_title": "195.\n        Which of the following drugs used in the management of pulmonary artery hypertension cannot be given orally?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Iloprost       \n                \n                  \n                  \n                    \nIncorrect",
    "optionB": "B. Riociguat",
    "optionC": "C. Tadalafil",
    "optionD": "D. Epoprostenol\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Epoprostenol</strong> is a drug used in <strong>pulmonary</strong> <strong>hypertension</strong> which <strong>cannot be taken orally. </strong>It is given as IV infusion.&nbsp;</p>\n<p><strong>Epoprostenol</strong> is a synthetic prostacyclin and hence causes <strong>vasodilation</strong> in both <strong>systemic</strong> and <strong>pulmonary</strong> <strong>vasculature</strong>. It is rapidly degraded by digestive enzymes and the liver due to which it has a short half-life (3-5 mins). It is, therefore, given as a continuous IV infusion.&nbsp;</p>\n<p>It is used in <strong>advanced stages of pulmonary artery hypertension.&nbsp;</strong></p>\n<p><strong>Side</strong> <strong>effects</strong> are extended pharmacological actions of prostacyclins such as flushing, dizziness, systemic hypotension, and diarrhoea. All other drugs above can be administered <strong>orally</strong>.&nbsp;<br>All patients with pulmonary artery hypertension should undergo certain lifestyle modifications like reducing heavy physical exercise. Normally during physical exercise blood flow to the lungs increases, but in PAH it is impaired due to vascular remodeling as a result of increased pressure.&nbsp;</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://trello.com/1/cards/66d7fd58df42e0a10d4ac84b/attachments/66d849ab6487cdf5186e0162/previews/66d849ac6487cdf5186e016a/download/1383._PAH_management-medicine-INICET_GT_1-124193.jpg\"><!---->\n          </div><!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pharmacology"
  },
  {
    "web-scraper-order": "1727319149-196",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF8977",
    "stauts": "Correct",
    "question_title": "196.\n        Assertion: Cardiac hypertrophy shows increased gene expression of atrial natriuretic factor.\nReason: Hypertrophy leads to the switch of contractile proteins from adult to fetal forms.",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Both assertion and reason are true and the reason is the correct explanation for the assertion",
    "optionB": "B. Both assertion and reason are true, but the reason is not the correct explanation for the assertion\n                \n                  \n                    \nCorrect",
    "optionC": "C. The assertion is true, but the reason is false statement",
    "optionD": "D. The assertion is false, but the reason is true statement",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The <strong>assertion</strong> and <strong>reason</strong> are independently <strong>true/correct</strong> statements, but the <strong>reason</strong> is <strong>not</strong> the correct <strong>explanation</strong> for the assertion.</p>\n<p><strong>Hypertrophy </strong>refers to the <strong>enlargement</strong> of cells, leading to an <strong>increase</strong> in the <strong>size</strong> of the affected organ. Cells that <strong>do not divide</strong>, such as <strong>myocardial fibers</strong>, <strong>increase</strong> the <strong>mass </strong>of their tissue through <strong>hypertrophy</strong>. Cardiac hypertrophy<strong> </strong>shows <strong>increased gene expression </strong>of<strong> atrial natriuretic factor</strong>, a peptide hormone.<strong> </strong>This hormone facilitates <strong>salt secretion </strong>by<strong> </strong>the kidneys,&nbsp;<span><strong>reducing blood volume&nbsp;</strong>and <strong>lowering</strong></span><strong>&nbsp;blood pressure</strong>, thereby alleviating hemodynamic stress.</p>\n<p><strong>Cardiac hypertrophy</strong> occurs due to an <strong>increase</strong> in the production of <strong>cellular proteins</strong>. It also involves a change in gene expression where <strong>adult-type</strong> <strong>contractile proteins</strong> are swapped for <strong>fetal isoforms</strong> of the same proteins. For instance, the <strong>α isoform</strong> of <strong>myosin heavy chain</strong> is replaced by the <strong>β isoform</strong>, which contracts more slowly and with greater energy efficiency. Additionally, hypertrophic myocardial cells exhibit <strong>changes in proteins</strong> governed by genes responsive to cellular stress.</p>\n<p>Hence, both assertion and reason are independently true/correct statements, but the reason is not the correct explanation for the assertion.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-197",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD3097",
    "stauts": "Correct",
    "question_title": "197.\n        A 24-year-old man comes to the OPD with decreased vision. He also gave a history of tremors and dysarthria for 2 months now. After a thorough examination, the physician suspects Wilson's disease. Which is the most sensitive and accurate test for diagnosing this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Serum ceruloplasmin levels",
    "optionB": "B. Hepatic copper content\n                \n                  \n                    \nCorrect",
    "optionC": "C. 24-hour urinary excretion of copper",
    "optionD": "D. Blood copper levels",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><div class=\"page\" title=\"Page 869\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The <strong>most sensitive and accurate test</strong> in diagnosing <strong>Wilson's disease</strong> is measuring the <strong>hepatic copper content.</strong></p>\n<div class=\"page\" title=\"Page 856\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The diagnosis of Wilson's disease is based on the following:</p>\n<ul>\n<li>Increased 24-hour urinary excretion of copper (<strong>the most specific screening test</strong>)</li>\n<li>Increase in hepatic copper content (<strong>the most sensitive and</strong> <strong>accurate test</strong>)</li>\n<li>A decrease in serum ceruloplasmin</li>\n<li>Kayser–Fleischer rings&nbsp;</li>\n<li>Genetic testing for mutations in<em>&nbsp;the ATP7B</em> gene</li>\n</ul>\n<div class=\"page\" title=\"Page 7269\">&nbsp;</div>\n<div class=\"page\" title=\"Page 7267\"><strong>Serum</strong>&nbsp;<strong>copper levels </strong>are of<strong> no diagnostic use</strong> since they may be low, normal, or elevated depending on the stage of the disease.</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        <!---->",
    "subject": "Pathology"
  },
  {
    "web-scraper-order": "1727319149-198",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MF2891",
    "stauts": "Correct",
    "question_title": "198.\n        A teenager was admitted to the hospital for evaluation of mental retardation and delayed growth and sexual development. Ultrasonography revealed thyroid atrophy. Which of the following nutrient deficiency is most likely to be associated with this condition?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Selenium\n                \n                  \n                    \nCorrect",
    "optionB": "B. Chromium",
    "optionC": "C. Flouride",
    "optionD": "D. Copper",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Selenium deficiency</strong> is most likely to be associated with mental retardation and, delayed growth and sexual development in this patient.</p>\n<p>The clinical presentation of the child is indicative of a&nbsp;<strong>myxedematous</strong> type of<strong>&nbsp;endemic</strong> <strong>cretinism,&nbsp;</strong>which can be caused by a deficiency<strong>&nbsp;</strong>of <strong>selenium</strong> and iodine.</p>\n<div class=\"page\" title=\"Page 5244\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endemic cretinism includes two overlapping syndromes: a <strong>neurologic</strong> type and a <strong>myxedematous</strong> type.</p>\n<div class=\"page\" title=\"Page 5244\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Persons with myxedematous syndrome are <strong>intellectually challenged, deaf</strong>, and they have <strong>delayed growth and sexual development, myxedema, and thyroid atrophy</strong>. Delayed skeletal maturation is present, which may extend into the 3rd decade or later.</p>\n<p><strong>Selenium deficiency</strong> has been implicated in the myxedematous syndrome; it decreases the synthesis of thyroid hormones by impaired functioning of selenoproteins like <strong>iodothyronine deiodinases,</strong>&nbsp;which are responsible for the conversion of T4 to T3. This decreased production of thyroid hormones leads to the stimulation of the hypothalamic-pituitary axis due to the lack of negative feedback control, thereby, <strong>increasing TSH production</strong>. TSH stimulates the iodothyronine deiodinases to convert T4 to T3,&nbsp;with consequent <strong>production of hydrogen peroxide</strong>, which accumulates itself in the thyroid tissue causing thyrocyte damage with subsequent fibrosis. Therefore, <strong>serum T4</strong> levels are<strong> low</strong> and <strong>TSH</strong> levels are markedly <strong>elevated.</strong> It also contributes to antioxidant defense in the thyroid. Ultrasonographic examination shows thyroid atrophy.</p>\n<p>Other causes of the myxedematous type of endemic cretinism include foods like linseed, sorghum, sweet potato, cabbage, cauliflower, turnips, soy and millet, which are all goitrogenic; thiocyanates and <em>Yersinia</em>.</p>\n<p>Deficiency of selenium can also give rise to depressed mood and hostile behaviour; it is implicated in&nbsp;<strong>Keshan disease</strong>, which is congestive cardiomyopathy along with heart failure, ECG abnormalities, cardiac enlargement and cardiogenic shock, seen in children and women of child-bearing age and in <strong>Kashin-Beck disease</strong>, which is characterised by bone, cartilage and joint deformity. Additionally, selenium along with vitamin E is essential for normal functioning glutathione peroxidase, an enzyme that protects cell membranes and lipid-containing organelles from peroxidative damage.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Chromium deficiency</strong> leads to <strong>impaired glucose tolerance.</strong></p>\n<p>Option C: <strong>Fluoride</strong> <strong>deficiency</strong> leads to an increased susceptibility to <strong>dental caries.</strong></p>\n<p>Option D: <strong>Copper deficiency</strong> leads to <strong>anemia,</strong> growth retardation, <strong>defective keratinization</strong> and <strong>pigmentation</strong> of <strong>hair,</strong> hypothermia, degenerative changes in aortic elastin, osteopenia and mental retardation.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0124: Differences between the two types of endemic cretinism</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><table border=\"1\">\n<tbody>\n<tr>\n<td><strong>Neurological type</strong></td>\n<td><strong>Myxedematous type</strong></td>\n</tr>\n<tr>\n<td>Goiter&nbsp;</td>\n<td>No goiter (USG shows thyroid atrophy)</td>\n</tr>\n<tr>\n<td>Euthyroid&nbsp;</td>\n<td>Permanent hypothyroidism</td>\n</tr>\n<tr>\n<td>Intellectual disability, deaf-mutism, squint, proximal spasticity,&nbsp;and rigidity</td>\n<td>Intellectual disability, Deaf, coarse facial features, and myxedema.</td>\n</tr>\n<tr>\n<td>Normal pubertal development and adult stature</td>\n<td>Delayed skeletal maturation and sexual development, severe short stature</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Biochemistry"
  },
  {
    "web-scraper-order": "1727319149-199",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MC6598",
    "stauts": "Incorrect",
    "question_title": "199.\n        Penile scrapings from an immunocompromised patient show multinucleate giant cells with Lipschultz bodies. If he develops encephalitis, which of the following lobes is most commonly involved?",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Parietal lobe",
    "optionB": "B. Frontal lobe",
    "optionC": "C. Temporal lobe\n                \n                  \n                    \nCorrect",
    "optionD": "D. Occipital lobe\n                \n                  \n                  \n                    \nIncorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>Lipschultz bodies</strong> are intranuclear inclusion bodies seen in the multinucleated giant cells (<strong>Tzanck cells</strong>) in case of <strong>herpes simplex infection (HSV-1 &amp; HSV-2)</strong>. Tzanck preparation (Wright &amp; Giemsa staining) of the tissue scrapings reveals these findings. Herpes simplex can cause <strong>encephalitis</strong> and <strong>temporal lobe</strong> is most commonly involved.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bb5ebf2e6424f1ca1e40c95cb94e659x510x499.GIF\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>MRI showing prominent swelling, increase T2 signal involving the left temporal lobe and insular cortex.</p></div><!---->\n          <!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <!---->\n          <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n            <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4aae5ffe99ae4450b3fd10a81ee180a9x452x454.JPEG\"><!---->\n          </div><!---->\n          <!---->\n        </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>Herpes simplex usually spreads by <strong>sexual contact</strong> or <strong>vertical transmission</strong> from the pregnant mother to the fetus. Clinical manifestations range from oral-cutaneous lesions to disseminated disease-causing encephalitis, pneumonitis, and hepatitis.</p>\n<p><strong>Safe sexual practice </strong>and the use of antivirals like<strong> acyclovir</strong> remain the mainstay of treatment.</p></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM0144: Inclusion bodies seen in various conditions/diseases</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>1. Bacterial Inclusion Bodies&nbsp;</strong></p>\n<table width=\"508\">\n<tbody>\n<tr>\n<td><strong>Disease/Bacteria&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Granuloma inguinale,&nbsp;<em>Klebsiella granulomatis</em></td>\n<td>Donovan bodies</td>\n</tr>\n<tr>\n<td>Psittacosis, <em>Chlamydia psittacci&nbsp;</em></td>\n<td>Levinthal-Cole-Lille bodies (LCL bodies)</td>\n</tr>\n<tr>\n<td>Trachoma, <em>Chlamydia trachomatis</em></td>\n<td>Halberstaedter-Prowazek bodies</td>\n</tr>\n<tr>\n<td>Lymphogranuloma venereum,&nbsp;<em>Chlamydia trachomatis</em></td>\n<td>Miyagawa’s granulocorpusles</td>\n</tr>\n<tr>\n<td>Diphtheria,&nbsp;<em>Corynebacterium diptheriae</em></td>\n<td>Babes-Ernst granules</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>2. Viral Inclusion Bodies</strong></p>\n<ul>\n<li><strong>Intra-cytoplasmic Inclusion Bodies</strong></li>\n</ul>\n<table width=\"513\">\n<tbody>\n<tr>\n<td><strong>Disease/Virus</strong></td>\n<td><strong>Inclusion bodies</strong></td>\n</tr>\n<tr>\n<td>Rabies</td>\n<td>Negri bodies</td>\n</tr>\n<tr>\n<td>Vaccinia, variola (smallpox)</td>\n<td>Guarnieri bodies</td>\n</tr>\n<tr>\n<td>Variola (smallpox)</td>\n<td>Paschen bodies</td>\n</tr>\n<tr>\n<td>Molluscum contagiosum</td>\n<td>Henderson-Patterson bodies</td>\n</tr>\n<tr>\n<td>Fowlpox</td>\n<td>Bollinger bodies</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Intra-nuclear Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n<td><strong>Disease/Virus</strong></td>\n</tr>\n<tr>\n<td rowspan=\"2\">Cowdry type A</td>\n<td>Lipschutz inclusions</td>\n<td>Herpes Virus</td>\n</tr>\n<tr>\n<td>Torres bodies</td>\n<td>Yellow fever</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Cowdry type B</td>\n<td>Basophilic inclusions</td>\n<td>Adenovirus</td>\n</tr>\n<tr>\n<td>Acidophilic inclusions</td>\n<td>Poliovirus</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Both Intra-nuclear and Intra-cytoplasmic Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table width=\"521\">\n<tbody>\n<tr>\n<td><strong>Disease/Virus&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Measles Virus</td>\n<td>Warthin-Finkedly giant cells</td>\n</tr>\n<tr>\n<td>Cytomegalovirus</td>\n<td>Owl-eye inclusions (basophilic,&nbsp;predominantly intra-nuclear, small granular intracytoplasmic inclusions are found)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>3. Inclusion Bodies in Parasitic Infections&nbsp;</strong></p>\n<table width=\"522\">\n<tbody>\n<tr>\n<td><strong>Disease/Parasite</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Trypanosomiasis</td>\n<td>Morula cells with IgM Deposits</td>\n</tr>\n<tr>\n<td>Kala-azar</td>\n<td>Leishman-Donovan Bodies</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>4. Miscellaneous Inclusion Bodies&nbsp;</strong></p>\n<table width=\"521\">\n<tbody>\n<tr>\n<td><strong>Disease/Location</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Ovarian cortex</td>\n<td>Walthard Inclusions</td>\n</tr>\n<tr>\n<td>Spherical globules surrounded by granulosa cells in the ovary</td>\n<td>Call-Exner bodies</td>\n</tr>\n<tr>\n<td>Parkinsonism, Lewy body dementia&nbsp;</td>\n<td>Lewy Bodies</td>\n</tr>\n<tr>\n<td>Amyotrophic Lateral Sclerosis&nbsp;</td>\n<td>Bunina bodies</td>\n</tr>\n<tr>\n<td>Multiple Myeloma</td>\n<td>Russell Bodies</td>\n</tr>\n</tbody>\n</table></div><!---->\n              <!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Microbiology"
  },
  {
    "web-scraper-order": "1727319149-200",
    "web-scraper-start-url": "https://www.marrow.com/test/668f6d4a21032eec5f906bdb/review",
    "test": "Grand Test 1 - INICET Pattern  (review)",
    "mCQ_id": "MCQ ID: MD6265",
    "stauts": "Skipped",
    "question_title": "200.\n        A 40-year old male patient was referred to you with the features of testicular and renal tumor. While going through his radiological reports, you identified the presence of parathyroid and pituitary adenoma and hence advised him to undergo chromosomal studies. The gene mutation responsible for this condition is located on ___________",
    "question_ADD": "",
    "question_imag": "",
    "optionA": "A. Chromosome 9",
    "optionB": "B. Chromosome 10",
    "optionC": "C. Chromosome 11",
    "optionD": "D. Chromosome 12\n                \n                  \n                    \nCorrect",
    "explanation": "<div _ngcontent-gbh-c132=\"\" class=\"explanation ng-tns-c132-2\">Explanation</div>\n        <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\" style=\"\">\n          <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>The given clinical scenario is suggestive of&nbsp;<strong>MEN 4</strong>&nbsp;syndrome which is&nbsp;caused by germline mutations in the&nbsp;<strong>CDKN1B</strong> gene, located on <strong>chromosome 12.</strong></p>\n<p>Multiple endocrine neoplasia (MEN) is characterized by the occurrence of tumors involving two or more endocrine glands within a single patient.</p>\n<p>MEN 4 comprises:</p>\n<ul>\n<li>Reproductive organ tumors such as&nbsp;testicular cancer, neuroendocrine cervical cancer</li>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Adrenal and renal tumors</li>\n</ul>\n<p>Note :</p>\n<ul>\n<li><strong>MEN 1</strong> is caused by a germline mutation in the <strong>MEN1 </strong>gene (menin protein),&nbsp; tumour suppressor gene on <strong>chromosome 11.</strong></li>\n<li><strong>MEN 2(both 2A and 2B)</strong>&nbsp;is caused by a germline mutation in the&nbsp;<strong>RET</strong>&nbsp;proto-oncogene, located on&nbsp;<strong>chromosome 10.</strong></li>\n</ul></div><!---->\n          <!---->\n          <!---->\n        </div><!---->\n\n        \n          <div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1138: MEN 4 Syndrome Features</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p>It is associated with CDKN1B gene on&nbsp;chromosome 12.</p>\n<p>Associated conditions:</p>\n<ul>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Reproductive organ tumors like testicular cancer, neuroendocrine cervical carcinoma</li>\n<li>Adrenal and renal tumors</li>\n</ul></div><!---->\n              <!---->\n            </div><!---->\n          </div><div _ngcontent-gbh-c132=\"\" class=\"mcq-pearl ng-tns-c132-2 ng-star-inserted\" style=\"\">\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pull-right ng-tns-c132-2\">\n                <pearl-bookmark _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\"><a class=\"mcq-save pointer\">\n    <span aria-hidden=\"true\" class=\"bookmark-types ng-star-inserted\">\n        <svg fill=\"#D6D6D6\" width=\"21\" height=\"20\" viewBox=\"0 0 13 20\" class=\"unbookmarked-state ng-star-inserted\">\n            <use xlink:href=\"#unbookmark\"></use>\n        </svg><!---->\n        <!---->\n        <!---->\n        <!---->\n    </span><!---->\n    <!---->\n</a>\n<div class=\"bookmark-states\">\n    <span>\n        <svg width=\"13\" height=\"16\" viewBox=\"0 0 13 20\">\n            <use xlink:href=\"#normal-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"17\" height=\"16\" viewBox=\"0 0 21 20\">\n            <use xlink:href=\"#star-bookmark\"></use>\n        </svg>\n    </span>\n    <span>\n        <svg width=\"16\" height=\"16\" viewBox=\"0 0 16 16\">\n            <use xlink:href=\"#question-bookmark\"></use>\n        </svg>\n    </span>\n</div>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"normal-bookmark\" fill=\"#62C8DF\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 13 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark\" fill-rule=\"evenodd\" d=\"M11.597 19.89L7.493 17.51c-.674-.4-1.516-.4-2.19 0L1.2 19.89c-.526.316-1.2-.084-1.2-.694V.8C0 .358.358 0 .8 0h11.176c.442 0 .8.358.8.8v18.395c0 .61-.653.989-1.18.694z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 15 22\" style=\"display: none;\">\n<symbol>\n    <path id=\"unbookmark-hover\" fill=\"#D6D6D6\" fill-rule=\"evenodd\" stroke=\"#62C8DF\" d=\"M12.976.5H1.8c-.36 0-.684.145-.92.38-.235.236-.38.56-.38.92v18.395c0 .438-.139.993 1.806 1.21l4.249-2.461c.262-.156.553-.233.843-.233.29 0 .581.077.84.23l4.108 2.381c.437.245.919.21 1.293-.01.371-.22.636-.621.636-1.117V1.8c0-.36-.145-.684-.38-.92-.235-.235-.56-.38-.92-.38z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 21 20\" style=\"display: none;\">\n<symbol>\n    <path id=\"star-bookmark\" fill=\"#D56F62\" d=\"M11.213 16.862l-5.876 3.089c-.29.153-.627-.092-.57-.418l1.12-6.544c.02-.127-.02-.26-.112-.346L1.021 8.01c-.235-.23-.107-.627.219-.673l6.569-.953c.127-.02.24-.096.295-.214L11.045.218c.143-.29.56-.29.708 0l2.94 5.952c.057.118.17.2.297.214l6.569.953c.32.046.453.444.219.673l-4.76 4.638c-.092.091-.138.219-.112.346l1.12 6.544c.057.321-.28.566-.57.418l-5.876-3.089c-.117-.066-.25-.066-.367-.005z\"></path>\n</symbol>\n</svg>\n\n\n<svg xmlns=\"http://www.w3.org/2000/svg\" width=\"0\" height=\"0\" viewBox=\"0 0 16 16\" style=\"display: none;\">\n<symbol>\n    <path id=\"question-bookmark\" fill=\"#FC0\" d=\"M8 16c4.418 0 8-3.582 8-8s-3.582-8-8-8-8 3.582-8 8 3.582 8 8 8zm0-3.556c-.485 0-.889-.404-.889-.888 0-.485.404-.89.889-.89s.889.405.889.89c0 .5-.404.888-.889.888zm2.222-4.77c-.338.49-.676.743-.913.925-.27.2-.355.272-.389.707-.017.272-.237.472-.473.472h-.609c-.135 0-.27-.055-.355-.163-.084-.11-.135-.254-.135-.4.085-1.179.524-1.596 1.048-1.995.203-.145.372-.29.558-.544.169-.254.186-.599.05-.907-.1-.2-.354-.545-.963-.545-.794 0-1.048.527-1.116.962-.05.254-.253.435-.49.435h-.608c-.135 0-.27-.072-.372-.181-.085-.109-.135-.254-.118-.4.152-1.142.946-2.484 2.687-2.484 1.048 0 1.927.544 2.367 1.469.422.87.355 1.887-.17 2.648z\"></path>\n</symbol>\n</svg>\n</pearl-bookmark>\n              </div>\n              <h4 _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                <em _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">\n                  <span _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2\">Pearl PM1137: MEN 2 Syndrome Features</span>\n                </em>\n              </h4>\n            </div>\n            <!---->\n            <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <div _ngcontent-gbh-c132=\"\" class=\"pearl-table ng-tns-c132-2 ng-star-inserted\"><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple’s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10–25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40–50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n              <!---->\n            </div><div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n              <!---->\n              <div _ngcontent-gbh-c132=\"\" class=\"ng-tns-c132-2 ng-star-inserted\">\n                <img _ngcontent-gbh-c132=\"\" class=\"img-responsive ng-tns-c132-2 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\"><!---->\n              </div><!---->\n            </div><!---->\n          </div><!---->\n        <!----><!---->",
    "subject": "Surgery"
  }
]